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Obesity prevalence continues to rise and can be partially attributed to the obesogenic 
environment. However, there is increasing evidence that environmental exposures in early 
development can influence later-life disease, known as the Developmental Origins of Health 
and Disease hypothesis. Whilst some early life exposures have been associated with later-life 
adiposity, the underlying mechanism is less understood. One hypothesised mechanism is 
through epigenetic changes, such as DNA methylation.  
Multiple longitudinal cohorts were used to investigate the hypothesis; DNA methylation is a 
mediating mechanism between early life events and subsequent obesity. The Newcastle 
Thousand Families (NTFS) and Gateshead Millennium (GMS) studies (established 1947 and 
2000 respectively), were used to investigate the impact of early life exposures (i.e. 
socioeconomic status, growth, adversity) on childhood (GMS) and adult (NTFS) obesity. 
Using both cohorts provided an opportunity to investigate regional temporal changes on 
childhood obesity, and the impact of obesogenic environments. The Avon Longitudinal study 
of Parents and Children (ALSPAC), which has methylation data (Illumina 450K array), was 
used to investigate associations between early life exposures and DNA methylation (in 
childhood and late adolescence) at CpG loci.  
Early life rapid weight gain (RWG) was consistently associated with childhood body 
composition in both local cohorts over time. In ALSPAC, RWG was significantly associated 
with a 1% increase in childhood methylation (age 7, n=116) at an individual CpG locus 
(CG11531579). Furthermore, the highest levels of methylation (+2%) were in those with 
RWG who were subsequently overweight/obese (OWOB, age 17).  
The CG11531579 loci was investigated further in NTFS adults (age 50, n=134) to examine 
whether the epigenetic marks persist.  RWG was also associated with methylation changes in 
adults, although this was a decrease in methylation (-2%, age 50). These findings suggest 
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Chapter 1. Introduction 
 
Overweight and obesity, particularly in children, have increased at alarming rates in recent 
times. Whilst genetic factors contribute to overweight/obesity (OWOB), the recent surge in 
incidence and younger age of onset suggest early life and environmental factors are key to 
this phenomenon.  
The developmental origins of health and disease (DOHaD) hypothesis proposes that 
exposures in early life predispose an individual to diseases, such as obesity, in later life. The 
literature suggests that early life factors related to birthweight, early growth, maternal body 
composition and lifestyle factors, infant feeding, and adversity and sleep in infancy may be 
linked to childhood body composition. It is unclear if each of these early life factors has an 
independent influence on childhood overweight and obesity, beyond socioeconomic status 
(SES) and obesogenic environments. Therefore, this thesis examines the relationship 
between early life factors, lifestyle and SES and the development of obesity in children and 
adults, and how these factors and their influence on obesity outcomes have changed over 
time with the emergence of modern obesogenic environments.  
The mechanisms behind the DOHaD hypothesis are largely unknown, but DNA methylation 
(DNAm), an epigenetic mechanism with the capacity to regulate gene expression, has been 
proposed to be involved. Accumulating evidence suggests that early life factors are 
molecularly programmed. These epigenetic changes could reveal more about the underlying 
biological mechanisms of how early life factors increase susceptibility to later obesity. 
Epigenetic changes could also be used as predictive biomarkers of future risk, in order to 
identify those who would benefit from early intervention.  
Therefore, underlying epigenetic mechanisms of theoretically relevant early life exposures 
on child and adult obesity were investigated. Differential methylation has been associated 
with some early life exposures (such as birthweight), however this is the first study that 
attempts to link to DNAm with both early life exposures and adiposity outcomes. 
Furthermore, many of these changes have only been identified in cross-sectional studies, 
however due to the latency between the exposure and outcome there is the need to 
examine these relationships using longitudinal cohorts. 
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The thesis is organised as follows: chapter 1 provides the background literature and 
rationale for this study and presents the aims of the study. Chapter 2 details the data and 
the statistical methods used in analyses. Chapter 3 and chapter 4 investigate early life and 
socioeconomic factors influencing obesity in adults and children, using data from two 
longitudinal cohorts from the same region in the UK born 50 years apart. Chapter 5 uses 
these same cohorts to examine the role of the changing socio-economic environment on 
childhood obesity. The potential role of DNAm in mediating obesity-associated exposures is 
examined using data from a third UK longitudinal study in chapter 6. Validation of these 
findings was carried out using samples from the original cohort of adults in chapter 7. Finally, 
chapter 8 discusses the findings, summarises strengths and limitations of the study and 
concludes with future research directions. 
1.1 Obesity: An overview 
1.1.1 Epidemiology of obesity 
Obesity was first highlighted as a major global concern by the World health Organization 
(WHO) in 1997 and since then has become an ever-increasing issue. The Health Survey for 
England has been measuring the nation’s height and weight since the early 1990’s and has 
determined that and has shown that the prevalence of OWOB has been increasing steadily: 
over the last three decades adult obesity prevalence has increased from less than 10% to 
almost 25% of the population in England (noo, 2015). Of particular concern is the 10 fold 
increase in childhood obesity worldwide (Butland et al., 2007, Abarca-Gómez et al.), that 
children are becoming obese at younger ages (Johnson et al., 2015), and the upwards trends 
in prevalence of severe obesity (PHE Publishing, 2018). The government’s Foresight report 
predicts that obesity will affect 60% of men, 50% of women and 25% of children by 2050 
(Butland et al., 2007). 
Routine measurement of children’s weight and height in England has been achieved via the 
National Child Measurement Programme (NCMP) which commenced in 2006 (Ridler et al., 
2009). The programme successfully measures over 95% of eligible children, with measures 
taken at both the start (reception, age 4/5) and the end (year 6, age 10-11) of primary 
school. The 2016/17 NCMP data show that prevalence of obesity in reception was 9.6%, and 
20% in year 6 children (NHS Digital, 2017). Prevalence was highest in the North East (10.7% 
in reception, 22.5% in year 6) compared to other regions in England (NHS Digital, 2017). 
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There are distinct social inequalities in childhood obesity; the prevalence of obesity is 2 fold 
higher in the most deprived decile compared to the least (PHE Publishing, 2018). 
1.1.2 The relationship between child and adult obesity 
OWOB in childhood are of great concern due to the ‘tracking’ into adulthood, which is the 
persistence and relative stability of overweight over time (Twisk, 2003). A systematic review 
by Singh et al,. determined that all high-quality studies reported at least 2x increased risk of 
OWOB in adults in those that were OWOB in childhood (Singh et al., 2008). However, most 
of the studies were from cohort studies from 20 years prior to the year 2000, and all of the 
studies were from high-income countries, therefore as prevalence of obesity has increased 
over time these estimates may be conservative for current populations. Although there have 
been few studies outside of North America and Europe, there is evidence that BMI tracking 
is influenced by ethnicity (Bayer et al., 2011a), and that BMI increases with age may also be 
higher in black children compared to white children (Freedman et al., 2005a). 
The risk of the tracking of obesity is much higher than for OWOB, and multiple cohort 
studies have demonstrated that obese children are around 5 times more likely to be obese 
as adults (Simmonds et al., 2015b). In terms of when to intervene, obesity appears resistant 
to change, as by age 5, most excess weight prior to puberty has been laid down  (Gardner et 
al., 2009) and children are more likely to remain obese (Mostazir et al., 2015, Buscot et al., 
2018). Childhood obesity is also related to adult morbidity (Llewellyn et al., 2016). Therefore, 
understanding the key early life factors driving the upwards prevalence of childhood obesity 
will be important for prevention and for designing effective interventions. 
However, this tracking of obesity is a relatively recent phenomenon. Examining the trends 
using several British birth cohorts with over 56,000 participants, found that cohorts born 
more recently had greater probabilities of overweight or obesity at younger ages (Johnson et 
al., 2015). However, even in the cohorts born between 1946 and 1970, tracking was 
consistently stronger at the higher quantiles of the BMI distribution (Norris et al., 2019). 
Bayer et al., (2011) conducted a meta-analysis using multiple cohorts from all ages and time 
periods and found strong evidence of tracking of weight over time, and a low probability of 
spontaneous weight changes (without intervention) (Bayer et al., 2011b). These findings 
suggest that a high proportion of children obese today are likely maintain an obese body 




Regarding the mechanisms underlying the tracking of body composition, there is evidence of 
the tracking of both physical activity and of diet behaviours between childhood and 
adulthood, each to similar degrees (Craigie et al., 2011), whilst follow-up from adolescence 
to adulthood seems to also support that physical activity is pertinent (Kvaavik et al., 2003).   
However, an important feature of tracking is that those at high risk for diseases later in life 
can be identified at an early age, and therefore this feature could be utilised and those at 
‘high-risk’ could be the target for early risk reduction interventions (Twisk, 2003). Crucially, 
the majority of obese adults (70%) were not obese in childhood (Simmonds et al., 2016), 
suggesting factors impacting and accumulating over the life course. This also emphasises 
that further understanding of the many factors and how they interact to influence obesity 
across the life course is necessary. Furthermore, this highlights the need for biomarkers that 
could identify those who are at risk of subsequent obesity, so that interventions can be 
targeted. 
 
1.1.3 The consequences of obesity  
On average, obesity decreases life expectancy by three years, and severe obesity by up to 10 
years (Prospective Studies, 2009). Obesity can cause ill health in childhood and premature 
mortality and physical morbidity in later life (Reilly and Kelly, 2010), drastically impacting on 
the individual’s physical and psychological health as well as socioeconomic effects (Reilly et 
al., 2003). The clinical consequences can range from type 2 diabetes (T2DM), metabolic 
complications, risk of some cancers, cardiovascular disease (CVD), asthma, sleep apnoea, 
and menstrual cycle abnormalities (in females)(Reilly et al., 2003, Lee, 2009, Reilly and Kelly, 
2010, Umer et al., 2017). Furthermore, life course body mass index (BMI) gains and earlier 
obesity onset are associated with poorer physical functioning in middle age (age 50), 
stressing the importance of prevention and delaying onset of obesity (Rogers et al., 2019).  
Obesity also represents a global economic problem, as obesity-related diseases could cost 
the National Health Service (NHS) an extra £2.51 billion by 2035 (The UK Health Forum and 
Cancer Research UK, 2015). 
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1.1.4 Definition and measurement of body composition in adults 
Obesity is defined by the WHO as “abnormal or excessive fat accumulation that may impair 
health” (World Health Organization, 2019). Therefore, definitions of obesity in children or 
adults should meet these two criteria of: diagnosing high body fat and increased risk of 
health outcomes.  
There is no accepted ‘gold standard’ of measuring obesity. There are many methods for 
determining body composition, which each have acknowledged advantages and drawbacks (  
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Table 1.2). No single measure is error-free, and the choice of measurement is dependent on 
cost, availability, the population under study and the outcomes of interest (i.e. disease risk). 
BMI, a measure of weight related to height, is the measure most frequently used to 
categorise individuals into weight categories (Table 1.1). Obesity is defined according to the 
WHO criteria as a BMI greater than 30 kg/m2, with well-established risks of all-cause 
mortality (Aune et al., 2016). Overall, BMI is a quick, easy, inexpensive measure to determine 
weight status. Generally, BMI is practical on a population level, however it represents a 
proxy, rather than a direct measure of body fat, and there is some disagreement as to 
whether BMI is the best diagnostic measure (Adab et al., 2018). Furthermore, BMI does not 
adjust for sex or age, or consider variation by pubertal status or ethnicity (although different 
cut-offs do exist). BMI also does not provide information on fat distribution or proportions of 
lean and fat mass (World Health Organization, 2011c).  
Alternative measures to BMI that are viable in a clinical setting include measures of 
abdominal fat (i.e. waist-to-hip ratio or waist circumference) or body fat (i.e. skinfold 
measurements or bio-electrical impedance). 
Waist circumference (WC) is an indicator of visceral fat (the fat stored around internal 
organs). Cut-off points are used to identify individuals at increased risk of metabolic 
complications (Table 1.1). Waist circumference-based measures have been shown to more 
accurately reflect obesity prevalence than BMI (O'Neill, 2015), and are independently 
associated with cardiovascular risk (Huxley et al., 2009) and all-cause mortality (Pischon et 
al., 2008, Sahakyan et al., 2015). Whilst a WC greater than the cut-off is purported to 
increase risk, it will not accurately capture all of those at risk due to differences in body 
composition (small frame), however it does represent a quick method of identifying 
individuals with central obesity. An additional measure including the hip circumference, the 
waist-to-hip ratio (WHR), can reveal more about fat distribution. There is often not much 
difference between the measures of central obesity, either WC or WHR (Seidell, 2009). WHR 
is arguably a more informative measure as it describes fat distribution around the waist in 
proportion to the hips, and is usually a strong predictor of cardiovascular risk (Dalton et al., 
2003, Myint et al., 2014, Egeland et al., 2016). 
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Table 1.1. Categorisation of body composition according to the proxy measures BMI, waist circumference and waist-hip 
ratio 
M, Male; Female. WHO cut-off points and risk of metabolic complications for Caucasian populations (World Health 
Organization, 2011c). 
Alternatively, body fat can be measured directly. Estimates of lean and fat mass can be made 
from routine measures such as skinfolds or bioelectrical impedance. Advanced imagining 
techniques can provide more accurate measures of body composition (Lee and Gallagher, 
2008), although these are costly and more difficult to perform in routine settings.  Examples 
of these are dual energy x-ray absorptiometry (DXA), developed to measure bone mineral 
mass, or air displacement plethysmography, which measures the volume of air displaced by 
the subject in a confined space (i.e. the BOD POD). Body fat determined by bioelectrical 
impedance (BIA), estimates body composition based on the conductive properties of lean 
and adipose tissue. However, BIA replies on the assumption that fat free mass is composed 
of 73% water, and is therefore affected by hydration level through food and drink 
consumption, medications, and stage of the menstrual cycle (Dehghan and Merchant, 2008). 
BIA has the advantage of being fast, simple and low susceptibility to inconsistencies from 
operator technique (Prentice and Jebb, 2001). The choice of prediction equation for BIA is a 
great source of variability (Reilly et al., 1996), and needs to be appropriate for the ethnicity 
of study participants (Dehghan and Merchant, 2008). 
Frankenfield et al,. found that 30% of men and 46% of women with a non-obese BMI (below 
30 kg/m2)  had ‘obese levels’ of body fat (Frankenfield et al., 2001), indicating that BMI will 
misclassify some of those at risk. BMI measures both lean and fat mass and does not 
Measure Ranges Category 
BMI <18.5 kg/m2 Risk of underweight 
 18.5-24.9 kg/m2 Normal weight 
 25-29.9 kg/m2 Overweight 
 30-34.9 kg/m2 Class I obesity 
 35.0–39.9 kg/m2 Class II (severe) obesity  
 ≥ 40.0 kg/m2 Class III (morbid) obesity  
Waist circumference >94cm (M), >80cm (F) Increased risk of metabolic 
complications 
 >102cm (M), >99cm (F) Substantially increased risk of 
metabolic complications Waist-hip ratio ≥0.90cm (M), ≥0.85cm (F) 
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distinguish between the ratios, which can change over time. For example, the loss of lean 
tissue and hormonal changes (i.e. growth hormone and Insulin-like growth factor (IGF) 
decreases with age) are important considerations in middle age.  
An advantage of using BF% over BMI is in that two individuals could have the same height 
and weight and therefore the same BMI whilst one has a higher proportion of body fat and 
the other higher muscle mass. Similarly, the same could be said for individuals with the same 
BMI but one apple-shaped, with a high central fat distribution and the other pear shaped 
with less visceral fat. These two individuals would have different health risks associated with 
their body composition and therefore it is important taking into account different measures 





Table 1.2 Advantages and disadvantages of different methods of measuring body composition routinely used in cohort 
studies 
Measure Advantages Disadvantages 
BMI  Simple, inexpensive 
measure 
 Easy to obtain, therefore 
useful screening tool and 
population measure 
 Well-characterised with 
standard cut-off points  
 BMI categories are 
associated with health risks  
 Strongly correlated with 
sophisticated measures of 
body fat 
 Questionable validity for non-
Caucasian populations  
 Not an accurate measure in 
athletes as it does not 
differentiate fat from muscle 
mass 
 Does not account for age or 
sex or age  





Percent body fat 
using BIA 
 Fast and simple 
 Less prone to error from 
operator technique  
 Portable and convenient  
 BIA is less accurate than 
advanced imaging techniques  
 Hard to calibrate 
 Body water could be affected 






 A measure of central fat 
distribution and visceral fat 
 An independent risk factor 
for disease, and specifically 
a marker of CVD 
 Simple, straightforward and 
inexpensive  
 Strongly correlated with 
more sophisticated 
measures of body fat 
 Perhaps less accurate than a 
measure of waist and height  
 WHR could be prone to error, 
as requires accuracy of two 





1.1.5 Measurement of body composition in children 
When choosing a measure in children, there are similar considerations as in adults, based on 
cost, acceptability, and ease of application (  
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Table 1.2). There is no ‘gold standard’ in body composition measurement in children, 
however BMI is the most common means of categorising weight. The main difference in 
children is that measurements need to take into account that they are still growing and 
hence require growth charts. For example, growth references derived from an appropriate 
reference population can be used to transform absolute BMI values (standard deviation z-
scores). Each growth curve has its own set of recommended thresholds to classify 
overweight or obesity. The UK90 growth reference is most commonly used in UK 
populations, and either centiles or standard deviation can be used as BMI cut-offs (Weng et 
al., 2012, Bammann et al., 2014, Woo Baidal et al., 2016). BMI cut-offs in children have high 
specificity and moderate sensitivity (Javed et al., 2015), meaning that some obese children 
may be missed, but healthy weight children are not likely to be wrongly classified as OWOB 
(Mast et al., 2002, Bedogni et al., 2003). In children, BMI has good acceptability as a 
measure, compared to more intrusive measures, or those that require clothing to be 
removed, which may not be appropriate in some settings or populations (Simmonds et al., 
2015a). 
Similar to body composition measures in adults, growth charts have been developed for use 
in children’s for measures: BMI (Lindgren et al., 1995, Wells et al., 2012, Weber et al., 2013), 
BIA (Chumlea et al., 2002), skinfolds (Tanner and Whitehouse, 1975), DXA (Van der Sluis et 
al., 2002) and more recently for 4-component models (divides body weight into fat, water, 
mineral, and protein)(Wells et al., 2012).  
Whilst waist measurements of obesity have been well characterised as risk factors in adults, 
there is less evidence to suggest that WHtR is also associated with cardio-metabolic risk in 
children (Kuba et al., 2013). Generally fat distribution patterns, either android (‘apple-
shaped’) or gynoid (‘pear-shaped’), generally start to emerge in puberty (Lobstein et al., 
2004), although some studies have found evidence of fat patterning in pre-pubertal children 
(Mast et al., 1998). Waist-to-height ratio is a measure of whether the amount of upper body 
fat is appropriate relative to height (McCarthy and Ashwell, 2006). It is calculated as the 
waist measurement divided by height measurement in cm. A simple cut-off of a WHtR >0.5 is 
the commonly accepted value (regardless of sex or age) determining ‘waist obesity’, which 
translates to a weight that is over half height. In children WC sensitivity ranges from 35-
100% and specificity from 81-100%, however waist-to-height ratio (WhtR) has the best 
diagnostic accuracy, although examined in fewer studies (Simmonds et al., 2015a).                    
11 
 
Whether it is a better indicator than BMIz is unclear, however increased waist obesity (using 
WHtR) has been found in children even when BMIz remains the same (Fredriksen et al., 
2018). 
Direct measures of fat have advantages over proxy measures. Fat mass can be measured in 
similar ways as in adults and carries the same limitations (section 1.1.4). Skinfold 
measurements offer an alternative, however compliance is low and there are issues in 
ensuring correct technique when measuring young children (Kehoe et al., 2011). 
Alternatively, fat mass can be measured using BIA, and in systematic reviews has been found 
to have good reliability (Talma et al., 2013), reproducibility (Chula de Castro et al., 2018), and 
performs well in measuring change in body composition (Meredith-Jones et al., 2015) in 
children. However, BIA may be prone to measurement error (Talma et al., 2013), 
underestimate fat mass (Chula de Castro et al., 2018), and in terms of outcomes is not 
superior to BMI in predicting cardiovascular risk factors in OWOB children (Bohn et al., 
2015). When examining fat mass in children it is important that measures take into account 
height. Fat mass index (FMI) is calculated as fat mass (kg) divided by height (m) squared. 
Findings from the Gateshead Millennium study determined that FMI was a more sensitive 
measure than BMI (Basterfield et al., 2012a) and proxy measures of adiposity were inferior 
(Basterfield et al., 2012b).  
Whilst BMI is imperfect, there are a lack of validated reference values for alternative 
measures of adiposity in children (Javed et al., 2015). BMI is the only measure recommended 
for use of determining obesity in children in the UK (Simmonds et al., 2015a), and will 
therefore likely remain the most frequently used measure for now. However, there is 
support for using additional measures such as WHtR or FMI which may be able to detect 
larger waist circumferences and higher fat mass in children.  
1.2 Aetiology of obesity  
1.2.1 Current concepts 
The convincing factors that increase risk of obesity determined by WHO include; high intakes 
of energy dense, nutrient poor foods and a sedentary lifestyle (World Health Organization, 
2003). However, obesity aetiology extends beyond the archaic notion that weight gain 
simply results from intake of more calories than required for whole-body metabolism 
(energy expenditure). Energy expenditure is a combination of the basal metabolic rate, the 
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thermic effect of food, and activity related expenditure (Levine, 2005). From a physical 
perspective, the laws of thermodynamics regarding energy conservation in living organisms 
are often applied as an explanation, namely calories in vs. calories out, or dietary intake vs. 
physical activity.  
This reductionist approach disregards the multitude of factors that influence food intake, 
energy expenditure, and whole-body metabolism, which are regulated by complex feedback 
mechanisms. Regulatory processes in the human body ensure that, for the most part, body 
mass and energy intake/expenditure remain fairly stable (Jéquier and Tappy, 1999). 
Therefore, excess weight gain must be driven by other factors. The environmental basis for 
obesity was also addressed in the Governments Foresight report, which acknowledged the 
multiple societal influences and the need for a multifaceted approach (Butland et al., 2007). 
Addressing the underlying causes of obesity requires an understanding of the socio-
economic, psychological, behavioural, and socio-cultural factors, including the drivers of 
food choices, eating patterns and participation in physical activity. However, environmental 
factors are ubiquitous and not everyone has obesity, suggesting underlying factors that 
increase susceptibility for some.  
It is important to distinguish between risk factors and causes. Causality is the study of the 
relationship between an event (the cause) and an outcome (the effect) which occurs 
consequently. The presence (or absence) of a causal factor can lead to illness or disease, 
therefore when a cause is removed the outcome should cease. Whereas a risk factor is 
something that increases the statistical risk of a disease, but a risk factor is not necessarily a 
cause and could be a surrogate for the underlying cause.  
In terms of the genetics of human obesity, there is evidence for genetic mutations and 
genetic variation. Specific gene mutations, such as those related to leptin, have been 
implicated in development of monogenic obesity, these however are very rare (Montague et 
al., 1997). Distinguished genetic mutations include those involved in food intake control 
(Neuropeptide Y, leptin, Pro-opiomelanocortin), energy regulation (β2-adrenergic and β3-
receptors), thermogenesis (uncoupling proteins 1–3), adipogenesis, signalling (peroxisome 
proliferator-activated receptor), and leptin and the leptin receptor (Farooqi and O'Rahilly, 
2004). There is also the capacity for small genetic changes, such as single nucleotide 
polymorphisms (SNPs), to influence susceptibility across the life course (Thorleifsson et al., 
2009, Willer et al., 2009). A genome-wide association study, which combined multiple 
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polymorphisms into a risk score using 97 genetic loci, explained 2.7% of the variation in BMI 
(Locke et al., 2015). Although important, genetic variants remain fairly stable over time and 
cannot explain the extent of the rise in obesity (Yang et al., 2007).  
Gene-environment interactions refer to phenotypic changes in response to environmental 
cues, dependent on genotype. These dictate individual responses to environment and 
downstream effects on weight. However, those genetically susceptible would be more likely 
to gain weight in a weight-promoting environment, and hence genetic factors may exert 
more of an effect when colluding with obesity risk factors. For example, in the case of the 
FTO genotype, which is associated with an increased risk of obesity in children and adults 
(Frayling et al., 2007), the risk can be attenuated by physical activity (Kilpeläinen et al., 
2011), or diet composition (Sonestedt et al., 2009).  
In summary, probable aetiological factors in obesity are likely a mixture of genetics, 
individual lifestyle factors, and perhaps more importantly, gene-environment interactions.  
1.2.2 Obesogenic environments 
Increases in childhood obesity in the last 20 years have been somewhat attributed to social 
change and a changing environment. Over this time, there has been widening social 
inequalities in childhood overweight (NHS Digital, 2016, Bann et al., 2018), and changes in 
the social patterning of obesity (Knai et al., 2012). All of the environmental influences and 
conditions of life that encourage overweight and obesity have been termed the ‘obesogenic 
environment’ (Lake et al., 2011).  
The ever-increasing ‘obesogenic’ macro and microenvironments have developed over the 
last 30 to 40 years. Diets have changed; food is widely available and easily accessible, in 
particular energy-dense convenience foods. Decreasing levels of physical activity and 
increasingly sedentary lifestyles have been facilitated by labour-saving devices, 
improvements in transport and shifts to more sedentary jobs, highlighting another 
dimension to the problem. Additionally, marketing of food has become aggressive and 
advertising ever-present.  
Health behaviours are often targeted for interventions at the individual level. Social 
characteristics are a more difficult avenue for intervention as they require large-scale 
changes, but are important determinants of health (Tarlov, 1999). Minimising the exposure 
to harmful environments may even-out the distribution of health, although there are 
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obvious health inequalities between social groups that need to be considered in public 
health interventions.  
1.2.3 Obesity and inequalities  
 
In the UK, socioeconomic status (SES) and obesity are related across all ages (PHE, 2013). 
Current statistics from Public Health England show an increased risk of obesity with 
increasing levels of deprivation across all indicators for women, whilst the relationship is less 
clear for men (Marmot et al., 2010). Although trends in UK childhood obesity prevalence 
have begun to stabilise in the past decade, this is not the case for children in the lower 
socioeconomic groups (Stamatakis et al., 2009).  
The relationship between SES and obesity is thought to be due to a number of factors, which 
have been explored by Cutler et al. (2008). Generally, lower SES leads to greater exposure to 
health-compromising issues. It also creates vulnerability (i.e. lower income→ lower nutrient 
intake→more vulnerable to infection→more time off work→lower earnings) thereby 
facilitating the cycle of disadvantage. This is similar to Riley’s life course model, which 
theorises the accumulation of risk, which is the idea that exposures accumulate throughout 
life, for example from periods of illness, adverse conditions and detrimental health 
behaviours (Riley, 1989). Lower SES can also contribute to psychosocial issues, for example, 
uncertainty of future access to resources can lead to increased stress levels.  
Research consistently shows that adverse early life socioeconomic conditions are associated 
with poorer adult health (Smith et al., 1998, Power et al., 1999, Poulton et al., 2002). 
Socioeconomic factors are considered important risk factors in childhood obesity, but also a 
potential source of confounding. There is a cycle of obesity in families, and parental obesity 
can be considered one of the greatest risk factors for childhood obesity (Parsons et al., 
1999). This is likely related to genetics and SES, but also further exacerbated by maternal 
overweight as an in utero exposure. Obesity risk is lower in adoption studies but still 
remains, suggesting the shared socioeconomic environment has an effect (Stunkard and 
Sorensen, 1993). 
Findings from a review of longitudinal studies support that SES precedes obesity risk (Ball 
and Crawford, 2005). A systematic review determined that socioeconomic differences in BMI 
emerge by age five, with the majority of studies demonstrating an inverse association, in 
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particular for parental education (Shrewsbury and Wardle, 2008). Findings from the 
Millennium Cohort Study indicate that education of the primary carer is more strongly 
associated with obesity rates in in children age 5 than income (Brophy et al., 2009). In the 
Avon Longitudinal study of Parents and Children (ALSPAC) cohort, trajectory modelling of 
obesity on the basis of maternal education revealed differences emerging at age 4, which 
then widened with age (Howe, 2012). Parental income and education will determine food 
and lifestyle choices, access to health care services and housing conditions, all of which can 
affect child health. 
These shifts in obesity prevalence in the lower socioeconomic groups in developed countries 
(McLaren, 2007b, Shrewsbury and Wardle, 2008), and more recently in low-mid income 
countries (Popkin et al., 2012) is termed the nutrition transition. This occurred with the 
accessibility of relatively cheap, low nutrient, high energy dense foods, leading to increased 
caloric intake (Popkin, 2001). Generally, socioeconomic disadvantage is associated with 
consumption of poorer diets which do not meet dietary recommendations: lower fruit and 
vegetable intake and higher intake of sugar and fat (Hanson and Chen, 2007). Socioeconomic 
disadvantage also affects infant feeding, and is associated with decreased duration or 
initiation of breastfeeding (Thulier and Mercer, 2009, Wijndaele et al., 2009a). Features of 
the built environment including neighbourhood safety, access to local facilities and food 
outlets, and social facilitation of unhealthy behaviours are important factors (Papas et al., 
2007, Lovasi et al., 2009). Although parental SES often predicts obesity within the individual, 
intergenerational upward social mobility can have a positive impact (Cavaco et al., 2014), 
therefore SES represents an important target for interventions.   
Overall, these findings demonstrate that obesogenic environments play an important role. 
An issue that remains unresolved is to disentangle the relative importance of environment 
factors and SES on later life obesity (Parsons et al., 1999). 
1.2.4 The Developmental Origins of Health and Disease Hypothesis  
 Background of the theory 
Hypotheses attributing early life factors in the development of subsequent disease later in 
life are relatively contemporary, as is the field of life course epidemiology. The seminal work 
by Barker and colleagues introduced the foetal origins of adult disease hypothesis (Barker, 
1994). They noted a correlation between low birthweight and rates of coronary heart 
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disease in adulthood, leading to the theory that foetal undernutrition alters physiology and 
metabolism, leading to increased risk of heart disease in later life (Barker et al., 1989). The 
Barker hypothesis has since expanded into the Developmental Origins of Health and Disease 
(DOHaD) hypothesis, which has a broader scope. The hypothesis proposes that exposures in 
early life predispose an individual to many diseases in later life, including obesity 
(Samuelsson et al., 2008, Schellong et al., 2012), CVD (Barker et al., 1989) and T2DM 
(Whincup et al., 2008).  
However, as early as 1962, James Neel noted that Human history was defined by periods of 
feast or famine, and those who had had fat reserves would have better survival and fertility  
(the ‘Thrifty gene’ hypothesis)(Neel, 1962). Neel’s adaptive hypothesis has since been 
counteracted by the non-adaptive ‘Drifty gene’ hypothesis: that excess adiposity was not a 
survival advantage, but that genetic drift in genes encoding the upper body weight limit 
occurred when the risk of predation diminished (Speakman, 2008). The thrifty genotype has 
been hailed as ‘too simplistic’ (Reddon et al., 2018), in that everyone would be predisposed 
to obesity and therefore any high-risk SNPs would have appeared in the last 900,000 years 
(Speakman and Westerterp, 2013), which appears not to be the case (Wang and Speakman, 
2016).  
Commonality across these hypotheses is that susceptibility to disease is determined in 
developmentally critical periods, originating from prenatal and early life experience (Hales 
and Barker, 1992, Barker, 1995). These theories have shaped the discipline that is life course 
epidemiology as it stands today. Life course epidemiology examines how different aspects of 
biological, social and physiological disease risk factors impact at different stages over the life 
span, with potentially independent, cumulative or synergic effects (Ben-Shlomo et al., 2016). 
A life course approach can examine the effects of exposures at one time point on 
prospective outcomes, useful in the study of obesity due to its multi-dimensional aetiology.  
Initially, this accumulation of risk was believed to have specific ‘critical’ or sensitive periods, 
operating in early life (i.e. foetal origins). However, longitudinal cohorts, which have the 
advantage of monitoring change over time, have also identified factors impacting at 
different time points. For example, the prenatal period, early infancy, the period of adiposity 
rebound and adolescence have been suggested to be critical time windows for early life 
programming of adult disease (Dietz, 1994). However, the term ‘programming’ has been 
criticised, as it implies disease is predetermined, and ‘conditioning’ has since been suggested 
17 
 
as a term to encompass how an individual is primed to respond to environmental challenges 
in a certain way, but it is not set in stone (Hanson and Gluckman, 2014). The DOHaD model 
has three key avenues; i.) Immediate homeostatic response; ii.) Predictive adaptive 
response; and iii.) Natural selection over many years (Ben-Shlomo et al., 2016). When there 
is mismatch between in-utero and postnatal environments, disease can occur. The predictive 
adaptive response, a phenotype with advantages in a predicted environment, could be 
harmful when there is a mismatch between a nutrient deprived intrauterine environment 
and a postnatal obesogenic environment. 
 Evidence from human studies on mismatched environments 
One of the key examples of early life nutrient restriction in humans is the Dutch hunger 
winter of 1944-45, a result of the German occupation of the Netherlands during the World 
War II (WWII). It provides a rare opportunity to study the long-term effects of in utero 
nutrient restriction (<1000kcal/day) in humans previously well nourished. Pregnant women 
exposed to famine in early and mid-gestation, followed later by an adequate diet, had 
offspring who were more at risk of increased adiposity and impaired glucose tolerance as 
adults (Ravelli et al., 1998, Ravelli et al., 1999, Stein et al., 2007). Furthermore, the offspring 
of prenatally undernourished fathers (but not mothers) were more obese than offspring of 
parents who had not been undernourished, independent of paternal BMI, and thereby 
demonstrating potential transgenerational effects (Veenendaal et al., 2013).  
In the Chinese famine of 1959-61, sex differences were also observed in that females born 
during the famine had a higher prevalence of OWOB but not males (Yang et al., 2008). It is 
interesting that these historical famines demonstrate sex differences in obesity outcomes. 
Additionally, evidence of seasonal nutritional variation in The Gambia also supports the 
theory that alterations in maternal nutrient intake can affect birthweight (Rayco-Solon et al., 
2005) and early mortality (Moore, 2016). The mechanisms have been examined using 
various animal models, and findings support that nutrient restriction leads to metabolic 
dysfunction in the offspring, both dependent (McKay et al., 2014) and independent of 
subsequent maternal food intake (Bispham et al., 2003). These findings highlight the 




1.3 Evidence for early life risk factors associated with obesity 
With the earlier age of onset of childhood obesity, as well as the evidence supporting the 
DOHaD hypothesis, there is increasing interest in the early life factors contributing to obesity 
development.  
Potential early life risk factors for obesity have been examined in multiple cohorts. A 
comprehensive systematic review of 30 prospective studies identified risk factors for 
childhood overweight to be; high birthweight, maternal smoking during pregnancy, early 
rapid weight gain, maternal pre-pregnancy overweight, whilst breastfeeding was protective 
(Weng et al., 2012). Another review determined maternal BMI, childhood growth and family 
SES to be probable risk factors (Brisbois et al., 2012). Similar themes emerge from these 
reviews surrounding maternal lifestyle influences, early life feeding and growth and 
socioeconomic disadvantage (Table 1.3).  
A large review of risk factors for childhood obesity in the first 1,000 days found consistent 
associations for maternal pre-pregnancy BMI, prenatal tobacco exposure, maternal excess 
gestational weight gain, high infant birthweight, and accelerated infant weight gain (Woo 
Baidal et al., 2016). There was also some support for gestational diabetes, low SES, low 
maternal–infant bonding, and in infants; child care attendance (as a proxy for infection), 
antibiotic exposure, disturbed sleep, early introduction of solid food intake (Woo Baidal et 
al., 2016). Birthweight is often used as a proxy measure of factors affecting growth and 
development (Table 1.3). 
Table 1.3 Summary table of the pre- and post-natal early life risk factors of OB, and proxy measures utilised in birth cohort 
studies lacking prenatal data 
Category Risk factor Proxy measure 
Pre-natal   
 Smoking LBW/SGA 
 Stress LBW/SGA 
Maternal factors Maternal obesity HBW/LGA 
Diabetes HBW/LGA 
Maternal diet HBW/LGA 
Maternal age  
Paternal factors Nutrition & sperm quality  
Smoking  
Post-natal   
 Infant feeding  
 Early life growth  
 Early life stress Adverse childhood experiences 
 Childhood infection Antibiotic exposure 
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 Sleep issues Sleep disturbance, night-time waking 
 Socioeconomic status Maternal education 
Parental socioeconomic status 
LBW, low birthweight; HBW, high birthweight; SGA, small for gestational age; LGA, large for gestational age.  
 Birthweight 
There is empirical evidence of a U-shaped curve between birthweight and adult obesity 
(Curhan et al., 1996), implying risk for both low and high birthweight infants. 
1.3.1.1.1 Low birthweight (LBW) 
Intrauterine growth restriction (IUGR) is classified as a birthweight below the 10th percentile, 
adjusted for gestational age. It can occur as a result of pre-eclampsia, placental insufficiency 
or maternal undernutrition (Villar et al., 2006, Salam et al., 2014), which can result from 
nutrient restriction, maternal smoking and stress. The foetus prioritises brain development 
at the expense of other body systems such as the renal or endocrine (Desai et al., 1996). In 
the case of the latter, it can lead to impaired Beta cell development and hence altered 
insulin secretion which predisposes the infant to glucose intolerance and diabetes (Portha et 
al., 2011). Pre-eclampsia is also more likely in mothers with a high BMI, pre-gestational 
diabetes, chronic hypertension, and in assisted reproductive technology pregnancies 
(Bartsch et al., 2016).  
A potential mechanism as to how foetal undernutrition results in increased offspring 
adiposity could be through altered appetite regulation. In a rat model of undernourished 
mothers, food intake was significantly elevated at an early postnatal age in offspring, and 
continued to increase with age (Vickers et al., 2000). This hyperphagia when combined with 
a high fat diet resulted in increased offspring weight, indicating that both intrauterine and 
environmental factors are important. A rat model of IUGR demonstrated decreased plasma 
leptin and increased ghrelin, with a postnatal period characterised by excess food intake, 
catch-up growth and metabolic syndrome with comorbidities including obesity (Desai et al., 
2005). Appetite stimulatory factors in the growth-restricted animals were at levels 
comparable to those of the fasting controls, demonstrating the potential for in utero 
programming of orexigenic hormones. 
Other exposures that could suppress in utero growth (i.e. maternal smoking, stress and 
nutrient restriction) are examined in subsequent sections. 
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1.3.1.1.2 High birthweight (HBW)  
The associated risk factors for large for gestational age (LGA) infants include pre-pregnancy 
obesity, excessive maternal weight gain, maternal or gestational diabetes mellitus (GDM), 
increasing parity and prolonged gestation (Jolly et al., 2003). LGA is defined as birthweight 
above the 90th percentile. LGA is related to childhood obesity, T2DM, CVD, and altered 
appetite and energy regulation in the offspring (Heerwagen et al., 2010, Dabelea and Crume, 
2011, Frias and Grove, 2012).  
 
Findings from the Southampton Women's Survey found that parity was associated with 
increased birthweight (Harvey et al., 2007), although this effect could be confounded by 
maternal obesity or SES. However, Hinkle et al. (2014) determined that the effects of parity 
were independent of factors related to maternal BMI or weight gain. The effects of parity 
appear to persist and are evident in adult offspring (Reynolds et al., 2010).   
 Maternal factors 
1.3.1.2.1 Maternal body composition  
In a large meta-analysis including 39 cohorts (265,270 births), both high pre-pregnancy BMI 
and gestational weight gain (GWG) were associated with risk of pregnancy complications, 
including gestational hypertensive disorders, GDM, and LGA (Santos et al., 2019). Obese 
mothers who had excessive GWG had the highest risk of pregnancy complications, and 
strikingly, 24% of pregnancy complications were attributed to maternal OWOB. Maternal 
body composition has also been associated with child overweight in many longitudinal birth 
cohorts (Baker et al., 2004, Harvey et al., 2007, Wright et al., 2010a, Bammann et al., 2014, 
Fairley et al., 2015b), yet Mendelian randomization analysis did not support a strong causal 
intrauterine effect of higher maternal BMI on offspring adiposity (Richmond et al., 2017).  
However, the effects may be indirect via birthweight, as evidence suggests the relationship 
between maternal BMI and GDM on birthweight is casual (Tyrrell et al., 2016).  
In England around half of women of childbearing age are OWOB (Craig et al., 2014). This has 
accompanying short-term risks of increased birth complications, increases the likelihood of 
GDM, and is associated with lower breastfeeding rates (Leddy et al., 2008). However, a 
randomised controlled trial (RCT) of antenatal dietary and lifestyle interventions in OWOB 
pregnant women (LIMIT study), was not successful in reducing the risk of adverse maternal 
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pregnancy and birth outcomes (Dodd et al., 2014), and further research is required into the 
mechanisms driving these associations.  
1.3.1.2.2 Diabetes 
Similar to the effects of maternal obesity, GDM is associated with HBW and increased risk of 
obesity and T2DM later in life (Bartsch et al., 2016). There is the increased risk of obesity in 
offspring of mothers who were diabetic before conception and those with GDM (Pettitt et 
al., 1983, Pettitt et al., 1988, Silverman et al., 1998). The risk is not likely due to genetic 
transmission, as siblings born when the mother was not diabetic do not have the same risk, 
implying that the disease state alters offspring phenotype (Dabelea et al., 2000). 
An Australian trial for pregnancy treatment of GDM reduced macrosomia and pregnancy 
complications (Crowther et al., 2005), however there was no difference in offspring body 
composition in childhood (age 4-5) (Gillman et al., 2010). Other trials have also not found 
promising results, although long-term follow-up is needed (Guillemette et al., 2017). 
1.3.1.2.3 Maternal age 
Advanced maternal age, commonly considered as over 35 years of age, has been associated 
with GDM, gestational hypertension, preeclampsia, small for gestational age infants, 
spontaneous late preterm delivery, and caesarean section (Kahveci et al., 2018). Maternal 
age at birth is increasing in England (Office for National Statistics, 2017), therefore there 
could be important clinical implications.  
Increasing maternal age could be synonymous with increases in parity, or to age-related 
metabolic changes relating to glucose regulation (Chandler-Laney et al., 2013). When 
controlling for all covariates, only maternal age below 25 and above 35 was associated with 
adverse offspring health outcomes (Myrskylä and Fenelon, 2012). Evidence for parity is 
mixed and warrants further investigation. 
There are numerous biological and social theories surrounding this phenomenon of a U-
shaped relationship between maternal age and offspring health outcomes. Older mothers 
are subject to physiological disturbances which occur with age, and a decline in reproductive 
functionality. There is increased risk of adverse outcomes in pregnancy, such as LBW and 
pre-term birth (Goisis et al., 2017, Sohn, 2017, Fuchs et al., 2018). In terms of metabolic 
health, it has been shown that offspring of both younger and older mothers had higher adult 
fasting glucose concentrations (Fall et al., 2015).  
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However, it is not necessarily the age of the mother that is the underlying cause, but the 
individual life circumstances, such as health behaviours in older mothers (Goisis et al., 2017), 
or age-related increases in maternal BMI (Sutcliffe et al., 2012). A study in Swedish youths 
(aged 19 in 2009), found that having an older mother was associated with lower self-rated 
health, including lower likelihood of regular exercise, and increased likelihood of obesity in 
adolescence (Barclay and Myrskylä, 2016).On the other hand, older maternal age has been 
shown to have many beneficial effects on child (up to age 5) health and development 
(Sutcliffe et al., 2012). Furthermore, sibling analysis has shown that although children born 
to older mothers are born smaller, as adults they are taller, more intelligent and are less 
likely to smoke (Carslake et al., 2017). 
Although less recognised, paternal effects can also impact. Advanced paternal age has also 
been associated with adverse offspring health effects such as risk of stillbirth, some cancers, 
autism, and neurodevelopmental disorders (Malaspina et al., 2015, Nybo Andersen and 
Urhoj, 2017). Maternal and paternal age are likely to be similar, therefore there will be a 
high risk of collinearity and residual confounding, leading to heterogeneity in findings.  
1.3.1.2.4 Maternal smoking 
It has long been known that smoking during pregnancy has adverse outcomes on foetal 
development, in particular yielding LBW infants who are at increased risk of poor health 
outcomes, in particular when exposed during the third trimester (Kleinman and Madans, 
1985, Lieberman et al., 1994). Maternal smoking during pregnancy is associated with a dose-
dependent decrease in birthweight (Newnham, 1991), and is independently associated with 
later catch-up growth and childhood overweight (Harvey et al., 2007, Fairley et al., 2015a). 
Systematic reviews support that maternal prenatal smoking is consistently associated with 
increased odds of childhood OWOB (Rayfield and Plugge, 2017). In a UK longitudinal birth 
cohort, maternal smoking during pregnancy was associated with a higher offspring BMI-z 
score and increased risk of child overweight as early as 3 years old (Fairley et al., 2015a). 
Whilst a Swedish cohort found maternal overweight and maternal smoking to be the 
greatest determinants of offspring overweight in young men (Koupil and Toivanen, 2007). 
There is uncertainty regarding a causal link between maternal smoking and offspring BMI in 
humans, as paternal smoking also demonstrates similar outcomes, which suggests factors 
operating within the shared environment (Howe et al., 2012). There is evidence for a causal 
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influence of maternal smoking during pregnancy on birthweight as the link was stronger for 
exposure for mothers than for fathers (Davey-Smith, 2008), which may suggest smoking has 
indirect effects on offspring body composition.  
Under stringent experimental conditions, prenatal exposure to nicotine in rats resulted no 
differences in birthweight, but significant increases in weight were observed after 10 weeks 
of age (Gao et al., 2005). Although causal mechanisms were not explored (Gao et al., 2005), 
the increased adiposity could be a result the polycyclic aromatic hydrocarbons in tobacco 
smoke, as exposure to high doses in pregnant rats dysregulates lipogenesis leading to weight 
gain (Ortiz et al., 2013). However, doses examined in the rats were much higher than 
assumed exposure in human pregnancy. 
Second-hand smoke could also have detrimental effects, as rodents and pups exposed 
during lactation also exhibit altered growth and metabolic complications (Santos-Silva et al., 
2013). Rat pups had a lower body weight and length at weaning, but a 50% increase in fat 
mass and a 10% increase in food intake and a blood profile indicating metabolic disorder in 
adulthood (Santos-Silva et al., 2013). This is important regarding information given to new 
mothers, as even mothers who abstain from smoking during pregnancy but who restart 
postpartum may still be putting their children at risk.  
Smoking prevalence during pregnancy has been found to negatively correlate with the 
socioeconomic variables such as maternal education (Cnattingius, 2004). Findings from the 
National Child Development Study, suggest that low social class and smoking during 
pregnancy influence the development of "high risk" adults, classified as those of a low 
birthweight and with a high BMI at age 33 (Power et al., 2003). The growth trajectories of 
the high-risk group showed that they gained weight steadily through life with a linear BMI 
trajectory. This suggests that in utero factors are of precedence, as factors restricting foetal 
growth were found to be associated with the high-risk phenotype, which could support 
theories on detrimental catch-up growth or metabolic programming in LBW infants.  
1.3.1.2.5 Maternal diet 
Dietary intake of nutrients has been linked to subsequent obesity in numerous studies, 
however due to difficulty in measuring this exposure in humans, the bulk of the evidence is 
from animal research.  There is evidence to suggest that maternal exposure to a high fat diet 
(Venu et al., 2004, Bayol et al., 2007, Sun et al., 2012), polyunsaturated fatty acids 
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(Muhlhausler et al., 2010), sugar (Frazier et al., 2008), a low protein diet (Desai and Ross, 
2011), vitamin restriction (Venu et al., 2004) and vitamin D deficiency (Morales et al., 2015) 
can impact on offspring adiposity. Furthermore, the timing of the nutritional exposure is 
complex, with differential effects observed based on stage of pregnancy or lactation, and 
therefore further discussion of specific nutrients is beyond the scope of this review. 
 Infant feeding 
Infant feeding is another important factor that can affect early childhood growth and 
subsequent risk of obesity (Ong et al., 2002c, Oken et al., 2008). Exclusive breastfeeding is 
recommended for the first 6 months of life by the WHO (World Health Organization, 2011b), 
however UK breastfeeding rates fall short (McAndrew et al., 2012). 
Human milk has the perfect combination of nutrients, hormones and immune factors 
required for infant development, and the beneficial effects of breastfeeding are well-
established (Ip et al., 2007) (Victora et al., 2016). However, studies have demonstrated 
mixed results concerning offspring obesity (Koletzko et al., 2009, Beyerlein and von Kries, 
2011, Marseglia et al., 2015). Systematic reviews and meta-analysis have found small, 
protective effects of breastfeeding on obesity in later life, although effect sizes decrease 
after adjustment for some confounding factors (parental obesity, maternal smoking and 
social class)(Arenz et al., 2004, Owen et al., 2005b, Oken et al., 2008). 
A dose-response effect has also been observed between duration of breastfeeding and 
decreased risk of childhood obesity in a recent meta-analysis, particularly for durations over 
7 months (Yan et al., 2014). Similarly breastfeeding was deemed protective, either long-term 
(over 2 years) or exclusive for 6 months, however only long-term breastfeeding remained 
significant in the multivariate analysis (Rathnayake et al., 2013). Long-duration breastfeeding 
exerted a protective effect with an age-dependent decrease in body fat in males born to 
overweight mothers (Buyken et al., 2008). 
Findings should be interpreted with caution, as although most epidemiological studies 
demonstrate a protective effect (Armstrong et al., 2002, Harder et al., 2005), the effect is 
small and could signify publication bias (Dewey, 2003, Owen et al., 2005a) or residual 
confounding (Brion et al., 2011). The Promotion of Breastfeeding Intervention Trial (PROBIT) 
in Belarus, an intervention which successfully increased duration of exclusive breastfeeding, 
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found no differences in childhood adiposity or metabolic markers, therefore not supporting 
a protective role for breastfeeding on body composition (Martin et al., 2017).  
Breast milk composition is determined by maternal diet and diabetes status and therefore in 
some circumstances breastfeeding could have a detrimental effect. Breastmilk composition 
can differ in obese and diabetic mothers with higher levels of fat, glucose and insulin (Young 
et al., 2012). This may explain why breastfed infants of diabetic mothers had a greater risk of 
overweight in childhood, with a dose-dependent relationship of breast milk ingested, 
independent of total milk intake and post-natal diet (Plagemann et al., 2002). In a mouse 
model of T2DM, cross-fostering pups from diabetic mothers to non-diabetic reduced body 
weight, perhaps due to the high lipid content of obese dam’s breast milk (Reifsnyder et al., 
2000), supporting an influence of both breastmilk and intrauterine exposure. A recent study 
also found that maternal obesity was associated with changes in the in human milk 
metabolites, and infant body weight (Venditti et al., 2019). Similar to diabetic mothers, 
obese women have higher levels of certain hormones and growth factors such as insulin, 
leptin, TNF-α, and IL-6 (Fields and Demerath, 2012, Andreas et al., 2014), but the role these 
factors has on infant growth is yet to be determined.  
Many studies have found that formula-fed infants have different body composition 
trajectories, which could be a result of the differing milk composition compared to breast 
milk. As formula contains 1.5-2 times more protein than breastmilk this could accelerate 
growth velocity (the IGF-1 theory) and hence adiposity (Koletzko et al., 2005). A Cochrane 
review also reported that in LBW infants, high protein formula accelerates weight gain 
(Fenton et al., 2014). Furthermore, interventions using lower protein formula have 
demonstrated a positive effect on childhood body composition (reviewed by Redsell et al. 
(2016)).  
Discrepancies in findings could also be attributed to the populations under study, for 
example due to genetic differences or differences in social attitudes towards breastfeeding, 
where there is not support for a causal relationship (Brion et al., 2011). SES is associated 
with likelihood of breastfeeding in the UK, with those in the more deprived groups less likely 
to breastfeed (Oakley et al., 2013) and evidence that the protective effect on BMI could be 
due to social patterning (Brion et al., 2011). 
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 Early life growth 
Greater infant weight gain has been consistently associated with increased risk of 
subsequent obesity in meta-analyses (Ong and Loos, 2006a, Druet et al., 2012, Zheng et al., 
2018).  
A deprived intrauterine environment is associated with rapid postnatal weight gain, leading 
to increased central adiposity at various life stages (Khandelwal et al., 2014). Although LBW 
infants are more likely to have catch-up growth (Ong et al., 2000), it is not necessarily 
detrimental and is essential for neurodevelopment, particularly in preterm or SGA infants 
(Belfort et al., 2011). This advocates for a balance between adequate early life growth and a 
need to differentiate ‘unhealthy’ catch-up growth. 
Rapid growth occurs in all infants in the first year of life and is followed by a decline and a 
plateau, until growth commences an upward trajectory again at the onset of puberty. 
Adiposity rebound begins at the lowest BMI value, and if occurs early has been shown to be 
predictive of later adiposity (Rolland-Cachera et al., 2006). Findings from the ALSPAC cohort 
suggest various facets of early life growth are important risk factors for childhood obesity at 
7 years, including birthweight, very early BMI or adiposity rebound, catch-up growth, weight 
at 8 months and weight gain in the 1st year, (Reilly et al., 2005b). 
Infant weight gain was found to have moderate predictive ability for childhood obesity in a 
meta-analyses using 10 cohorts studies (area under receiving operating curve of 77%) (Druet 
et al., 2012). A 1 standard deviation unit in weight in the first year was associated with twice 
the odds of childhood obesity, and 23% increased odds of adult obesity. Recent systematic 
reviews have also supported that rapid weight gain (RWG) during infancy is associated later 
adiposity outcomes spanning from childhood to adulthood, but with higher odds in 
childhood (Zheng et al., 2018).  
Regarding the timing of the exposure, using a life course approach, weight gain as early as 
the first week of life was a predictor of adult overweight status (for each 100-g increase OR 
1.28, 95% CI 1.08 -1.52) suggesting that this very early period of life could have a lifelong 
impact (Stettler et al., 2005). RWG from birth to 1 year tends to be associated with higher 
odds of childhood adiposity than the timespan between birth to 2 years (Zheng et al., 2018). 
Infant fat mass at one year of age was significantly predicted by maternal age at delivery 
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(Chandler-Laney et al., 2013). Other factors that can affect early life growth include 
birthweight (section 1.3.1.1) and infant feeding (section 1.3.1.3). 
 Early life stress and childhood adversity 
Early life stress is another proposed exposure in foetal programming of obesity. Stress is 
purported to contribute to obesity through hormonal regulation of appetite and eating 
behaviour (Torres and Nowson, 2007). A 2010 review by Entringer et al,. summarises 
multiple mechanisms that could mediate the effects of prenatal stress, with targets including 
metabolic, endocrine, or inflammatory systems (Entringer et al., 2010). 
The stress response can be measured via corticotropin-releasing hormone (CRH) levels, 
which when released stimulate the hypothalamic–pituitary–adrenal (HPA) axis. When 
maternal CRH levels were measured in the late 2nd trimester of pregnancy there was an 
negative association with offspring BMI z-score at age 3, but an increase in central adiposity 
(Gillman et al., 2006). Studies using biochemical measures of stress are yet to yield results of 
a long-term follow-up, however animal studies have provided more evidence. In dams 
exposed to stress during the third week of gestation, as measured via corticosterone levels, 
offspring had higher birthweights, greater postnatal body weights, and evidence of impaired 
glucose tolerance (Tamashiro et al., 2009). Additionally, in mother-offspring bonnet 
monkeys, a 4 month period of imposed variable foraging demand in early life, which acts as 
a stressful exposure without food restriction, resulted in higher BMI and abdominal 
circumference in the offspring (Kaufman et al., 2007). There are parallels with this study to 
the current situation in the UK with increased reliance on food banks (Loopstra and Lalor, 
2017), and uncertain food availability could be an important early life stressor.  
In humans, stressful early life events are often defined as adverse childhood experience 
(ACEs), and there is a growing body of evidence that suggests these can impact on multiple 
health outcomes. The most frequent stressors examined are those which are direct, such as 
maltreatment, abuse or neglect, or indirect acting at the household or environment level, 
such as parental violence, parental separation or criminal behaviour (World Health 
Organization, 2011a). Other less common ACEs examined are extrafamilial (such as bullying, 
natural disasters)(Finkelhor et al., 2013, Mersky et al., 2017). For example, gestational 
exposure to extreme weather such as an ice storm (Dancause et al., 2012) or flooding 
(Dancause et al., 2015), have been shown to predict childhood BMI and adiposity. 
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A systematic review, summarising results from eight studies, found that the direct 
associations between ACEs and OWOB ranged 13–71% increased odds (Hughes et al., 2017). 
Adolescents who reported an ACE were more likely to have a higher BMI, and there were 
incremental increases in risk of overweight, obesity and severe obesity with increasing 
numbers of ACEs (Davis et al., 2019). Whereas a large UK study found 4+ ACEs were 
associated with 3x increased likelihood of morbid obesity, but not obesity (Bellis et al., 
2013). Considering family member death as a stressful exposure, antenatal bereavement has 
also been associated with later life overweight (Li et al., 2010, Hohwü et al., 2014). These 
results may suggest that more severe or more frequent exposure may be related to more 
severe outcomes in terms of body composition.  
In a longitudinal study examining childhood neglect and adolescent obesity, the potential 
mediators were impulsivity, depression, and compulsive eating behaviour (Shin and Miller, 
2012). Findings from the ALSPAC cohort, found that ACEs (birth-16 years) were associated 
with lower risk of educational attainment and drug use and smoking, independent of SES 
(Houtepen et al., 2019). This suggests that ACEs may influence the likelihood of risky or 
compulsive behaviours, or more generally are associated with socioeconomic outcomes such 
as lower education, unemployment and poverty (Hughes et al., 2017). 
There is considerable heterogeneity in the literature regarding the definition and 
measurement of ACEs, and many studies utilise questionnaire data or retrospective data. 
Many studies examine early life the stressors across childhood (<18 years)(Hughes et al., 
2017), therefore further work examining very early life (as a critical period) stressful events 
on later obesity could yield insight. 
 Factors affecting colonisation of the gut microbiota 
There is growing interest in the role of the gut microbiota in disease. Maternal pre-
pregnancy BMI, antibiotics usage in the first 6 months and breastfeeding are factors that 
have been associated with establishment of the gut microbiota (Ajslev et al., 2011). 
Caesarean section is also an independent risk factor for childhood overweight, which may 
perhaps be mediated by bacterial colonisation of the gut microbiota (Tun et al., 2018), and 
the effects of caesarean section have been shown to be independent of maternal antibiotic 
usage (Mueller et al., 2015a). 
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Generally, observational studies suggest a link between antibiotic use and weight gain 
(Million et al., 2013). As microbial populations are largely established in early life this could 
link to disruptions in gut microbiota leading to altered physiology (Jernberg et al., 2010, 
Robinson and Young, 2010, Martin and Sela, 2013). This could impact very early on in 
development, as maternal antibiotic use in the 2nd or 3rd trimester has also been associated 
with higher childhood adiposity (Mueller et al., 2015b). However postnatal antibiotic use (1st 
year) has been associated with increased likelihood of overweight or obese in childhood (age 
9) (Azad et al., 2014), and a review found antibiotic exposure (first 6-12 months) or childcare 
attendance (as a proxy), to be a risk factor for later child overweight in a small number of 
studies (Woo Baidal et al., 2016), suggesting effects may not just be due to in utero 
exposure. 
Postnatal timing of the exposure may also be important, as a recent systematic review and 
meta-analysis found that exposure to antibiotics in the first 6 months postnatal was 
associated with OWOB (Rasmussen et al., 2018). Exposure between 6-24 months was not 
associated, which may suggest the first 6 months reflect a critical period. Some studies only 
find associations with >1 episode of antibiotics (Rasmussen et al., 2018), and evidence of a 
dose-response effect with recurrent courses of antibiotics (Shao et al., 2017). In line with 
this, antibiotic use throughout childhood was also associated with childhood weight gain 
(Schwartz et al., 2016), and small associations for pre and post-natal infections with obesity 
in early adulthood were uncovered in a large Danish cohort (Cocoros et al., 2013), suggesting 
an effect beyond early life on outcomes in later life. 
Furthermore, the type of antibiotics may also have an impact, as in ALSPAC post-natal 
exposure to broad-spectrum antibiotics during the first 6 months of life was associated with 
greater impact on body mass in infancy (Trasande et al., 2013, Bailey et al., 2014).  
There is increasing interest in obesity as an infectious disease of viral origin, termed 
‘Infectobesity’(Dhurandhar, 2011), likening the rapid spread of obesity to that of an 
infectious disease (Atkinson, 2007). For example, SMAM-1 is an avian adenovirus that acts 
on adipocytes and has been associated with human obesity (Dhurandhar et al., 1997). Ad-36 
is another example of a adenovirus associated with human obesity (Esposito et al., 2012), 
with some evidence of a causative role, as twin studies discordant for infection have shown 
the infected twin to be heavier (Atkinson et al., 2005). Obese adults also take longer to shed 
influenza virus, and therefore there is the possibility that obesity may play a role in viral 
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transmission (Maier et al., 2018). There is however the risk of reverse causality, for example 
Heras et al. (2019) found that short-term consumption of a high-fat diet could increase 
susceptibility to listeria infection in mice.  
These findings are interesting, but currently there is limited evidence for a causal 
relationship between infection and obesity.  
 Sleep 
The first few months of life are important for development of healthy sleep patterns and 
circadian rhythm (Parmelee et al., 1964, Glotzbach et al., 1994). Short sleep duration in 
infancy has been associated with OWOB (Bell and Zimmerman, 2010) and fat mass in 
childhood (Reilly et al., 2005b, Bell and Zimmerman, 2010, Diethelm et al., 2011). 
Associations were not evident for older children or for day-time sleeping (Bell and 
Zimmerman, 2010). A systematic review examining risk factors for childhood obesity 
operating in the first 1,000 days found some evidence for curtailed infant sleep, which 
included quality and timing as well as duration (Woo Baidal et al., 2016). Most studies show 
weak-moderate associations for short sleep duration and childhood body composition and 
some evidence of a dose-response (Chen et al., 2008, Taveras et al., 2008). Obese children  
(6-7 years old) slept half an hour less, but this could perhaps reflect reverse causality (Heppe 
et al., 2012). 
Many of the studies have been cross-sectional and findings from longitudinal cohorts are 
less encouraging. There was no observed association between sleep duration and BMI in the 
Longitudinal study of Australian Children (aged 0-7 years)(Hiscock et al., 2011), in the 
GenerationR study in pre-school children (Heppe et al., 2012), or in the Born in Bradford 
cohort (age 3)(Fairley et al., 2015a).  
Differing results may be due to the definition of sleep problems, which is a great source of 
heterogeneity. The studies outlined in Table 1.4 are not intended as an exhaustive review of 
the literature but outline some of the differences in definitions of sleep disturbance or sleep 
problems, and the associations with measures of body composition. The definitions most 
frequently involve sleep duration, or alternatively, multiple occurrences of night-time waking 
plus another factor. For example definitions have also included: parental report of 
disturbance (Lozoff et al., 1985, Zuckerman et al., 1987), co-sleeping (Richman, 1981), 
extended duration of a waking event (Richman, 1981, Zuckerman et al., 1987), or frequent 
31 
 
waking and difficultly falling asleep. However there is no commonly accepted definition 
(Gaylor et al., 2001), and there is still a need for a single definition of infant sleep problems 
(Alamian et al., 2016). 
Many children (20-30%) experience sleep problems in the early years (Sadeh et al., 2011). 
Defining sleeping issues is further complicated by the subjectivity in parental perception of 
sleep problems, and individual variation in infant sleeping patterns by developmental stage 
(Thiedke, 2001, Sadeh et al., 2011). ActiGraph measures, which use a wearable device that 
records body movement during sleep, can be translated to more reliable sleep–wake 
measures (Sadeh et al., 1991). In a cross-sectional study using ActiGraph measures, there 
was a positive correlation between short night time sleep at 6 months and greater weight-
for-length at age 6 months (Tikotzky et al., 2010b). However, a longitudinal study found no 
association between ActiGraph infant sleep and adiposity later in infancy (36 months) 
(Klingenberg et al., 2013).  
Currently studies on sleep have demonstrated mixed results, which may be due to 
differences in the definition, measurement, timing, severity of sleep problems, and age at 
outcome. There is a need for longitudinal studies with more objective measures of early 




Table 1.4 Sleep assessment definitions used in studies examining both sleep and childhood body composition  
Author (year) Criteria for sleep disturbance Associations with childhood 
body composition 
Zuckerman et al. 
(1987)  
Either waking 3+ per night, an event 
lasting 1 hour, or parental report of 
severe disturbance to the mother’s 
sleep 
Increased risk of overweight in 
11-12 year olds (Alamian et al., 
2016) 
Richman (1981) Waking 5+ nights per week in addition 
to; co-sleeping with parents, waking >3 
times per night, or duration of a waking 
event over 20 minutes 
Increased risk of overweight in 
11-12 year olds (Alamian et al., 
2016) 
Lozoff et al. (1985) 3+ waking occurrences per week and 
parental report of disturbance 
No associations with 
overweight in 11-12 year olds 
(Alamian et al., 2016) 
Taveras et al. (2014) A score of ‘curtailed sleep’ (which 
included quality, timing and duration), 
from ages 6 months to 7 years 
Sleep curtailment from infancy 
to school age was associated 
with higher odds of obesity in 
mid-childhood 
Heppe et al. (2012) Infant sleep duration, at age 2 years was 
dichotomised into “<11.5 h/night” and 
“≥11.5 h/night,” in accordance to the 
mean sleep duration stated by the 
American Academy of Paediatrics  
No association with preschool 
overweight (around age 4 
years) 
Reilly et al. (2005b) Questionnaire data on sleep duration at 
age 3 years 
Increased risk of obesity at age 
7 years 
Tikotzky et al. (2010a) Various parameters from Actigraph 
sleep analysis  
Sleep duration was negatively 
correlated with weight‐to‐
length ratio measures at age 6 
months 
Chen et al. (2008) Meta-analysis which used various 
measures of sleep duration from 
questionnaire data 
Increased risk of OWOB 
(throughout childhood).  
There were reduced odds for 
each hour increase in sleep, 
and evidence of a linear dose-
response in younger children 
(<10 years). 
 
 Cumulative risk factors  
Whilst the exposures explored here could act in an independent manner, it is also plausible 
that they could interact, or have a cumulative influence on obesity (graphically represented 
in the Directed Acyclic Graph (DAG) in Appendix A).  
The effect of multiple early life risk factors on childhood obesity has been investigated in a 
handful of prospective birth cohorts. In the Southampton Women's Survey, the presence of 
five risk factors (maternal obesity, excess GWG, smoking during pregnancy, low maternal 
vitamin D status), was associated with a 3.99 relative risk of OWOB at age 4 years, which 
increased to 4.65 at 6 years (Robinson et al., 2015).  
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Similarly, Gillman et al. (2008a) examined four combined modifiable early life risk factors 
(maternal smoking during pregnancy, excess GWG, short breastfeeding duration, and infant 
sleep duration), which were associated increased the risk of overweight (age 3), with 
sustained increased risk later in childhood (Gillman and Ludwig, 2013). 
These studies demonstrate that clusters of socially patterned risk factors show evidence of 
accumulation of risk over time, and therefore could be important targets for interventions.  
1.4 Summary of early life risk factors and adiposity  
The increases in obesity prevalence in children are of great concern due to the tracking of 
weight from childhood to adulthood and will raise new issues for future generations. There 
are acknowledged problems with primarily using BMI to determine obesity, and its use in 
children due to differences in growth patterns and onset of puberty.  
The majority of the literature on the developmental origins of obesity has focused on 
maternal exposures, yet risk factors for obesity operate at different stages across the life 
course (Parsons et al., 1999, Gillman et al., 2008a, Gillman et al., 2008b). Maternal risk 
factors during pregnancy, such as smoking, excessive GWG or maternal obesity, are 
important risk factors that can affect the likelihood of the offspring being overweight in 
childhood (Robinson et al., 2015). Birthweight, often used as a proxy for an adverse 
intrauterine environment, is well-studied factor that has demonstrated predisposition to 
both childhood and adult obesity (Ravelli et al., 1999, Carolan-Olah et al., 2015).  
There is evidence and plausible hypothesis for several early life risk factors (summarised in 
Table 1.3). However there is uncertainty regarding a causal effects on BMI for exposures: 
maternal smoking, infant feeding, maternal age, sleep and caesarean birth, which may be 
due to confounding. Evidence from animal studies seems to support causal mechanisms for 
stress and infection. However, in epidemiological studies, there is more support for early life 
factors to indirectly impact on offspring BMI through birthweight and early life growth. 
Therefore, aside from birthweight, which has been studied in detail, the evidence for other 
early life modifiable risk factors is less robust, and factors have not been studied with 
respect to adult obesity (Monasta et al., 2010).  
 
It is also important to note that as well as being independent risk factors, these factors are 
also likely to interact and influence one another (Appendix A). For example, early life 
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factors may be strongly influenced by SES, and perhaps more so in recent times due to 
widening social inequalities in childhood OWOB and changes in social patterning which may 
lead to clustering of exposures (Knai et al., 2012). Considering the multifactorial aspects of 
obesity, the interactions between pre-natal events, and post-natal behavioural and 
environmental factors could increase susceptibility, and ideally should be investigated 
collectively using longitudinal studies. 
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Table 1.5 A summary of the risk factors investigated, supporting hypotheses, potential confounders, and evidence (from 
studies listed in section 1.3). 
Risk factor Hypotheses Potential 
confounder(s) 
Reference(s) 
Birthweight Causal effect due to programming of body 
composition (fat and lean mass). 






maternal diabetes  
(Boney et al., 2005) 
(Parsons et al., 1999) 
Rapid weight 
gain 
A mismatch of intrauterine and post-natal 
conditions encourages rapid growth in 









Breastfeeding effects colonisation of gut 
microbiota and self-regulation of appetite. 
The nutritional composition of breastmilk 
may be beneficial or detrimental based on 
maternal characteristics.  
SES, maternal BMI (Armstrong and 
Reilly, 2002)  
(Yan et al., 2014) 
Early 
weaning  
Nutritional programming of metabolic 
systems and child growth. Could be 
dependent on diet quality and may have 
more of an impact in formula fed infants. 
SES, breastfeeding (Thompson, 2012) 
(Agostoni et al., 
2008) 
Parity First-born children have lower birthweights 
and experience catch-up growth, 
compared to second-born.  
Maternal age, 
maternal BMI 
(Ong et al., 2002b) 
Maternal age The mechanisms are unclear. Biological 
mechanisms would suggest both young 
and advanced maternal age are associated 
with negative birth outcomes. However, 
the role may not be causal as maternal age 






(Savage et al., 2013) 
Adversity Stress leading to altered HPA via 
glucocorticoid pathways, leading to fat 
deposition.  
SES (Tamayo et al., 2010) 
(Anda et al., 2006) 
Sleep issues Shorter sleep duration may affect appetite 
regulation and stress-related pathways 
SES (Bell and 
Zimmerman, 2010) 
(Anda et al., 2006) 
Infection  Antibiotics can lead to disruption of gut 
microbiota, or early life infection could 
alter growth trajectories.  
Breastfeeding (Mueller et al., 
2015a) 






(Li et al., 2012) 
SES Socioeconomic inequalities affect many 
dimensions; the effects are multifactorial 
encompassing income, education, 
environment, and diet quality. 
Potential bidirectional relationship and 
transgenerational influences. 
Maternal BMI (Shrewsbury and 
Wardle, 2012) 
(Gibbs and Forste, 
2014) 




1.5 Epigenetics as a mechanism linking early life factors and later disease 
For the DOHAD theory to operate, there must be an underlying mechanism in which an 
exposure affects and then ‘marks’ an individual, with a lasting impact on health outcomes 
years later. The underlying mechanisms are hypothesised to be related to epigenetics. 
Epigenetic patterns are established early on in development and events in utero could 
possibly program the foetus to anticipate a specific environment postpartum, thereby acting 
as cellular memory. An insult at a critical period of development could lead to lasting and 
perhaps permanent effects (Ben-Shlomo and Kuh, 2002). It is plausible that epigenetic 
mechanisms could act as a mediator between early life exposures and obesity outcomes 
(such as for birthweight, section 1.5.3.1).  
1.5.1 Introduction to epigenetics 
Epigenetic modifications are heritable alterations to the genome, which do not change the 
underlying genetic code but can affect gene activity and expression. Epigenetic modifications 
can be grouped into broad categories of; chromatin remodelling and histone modifications, 
DNAm, and small non-coding RNA mechanisms. Within the cell nucleus, genetic material is 
tightly packaged into chromosomes made up of chromatin. Chromatin, the condensed form 
of DNA, is wrapped around structural histone proteins known as nucleosomes, forming the 
characteristic beads on a string appearance. Thereby, modifications which alter chromatin 
structure and hence packaging (and accessibility) of DNA can influence gene expression. 
DNAm is the most well-characterised and well-studied epigenetic mark. DNAm is a cellular 
regulatory mechanism that involves the covalent addition of a methyl group (CH3) on 
cytosine residues adjacent to guanine on DNA, and in mammals is catalysed by DNA 
methyltransferase enzymes (DNMTs)(Suzuki and Bird, 2008). The ten eleven translocation 
(TET) family of enzymes oxidise 5-methylcytosines and facilitate reversal of DNAm (Tahiliani 
et al., 2009, Ito et al., 2010). Methylation plays an essential role in early development and 
cell differentiation, but also in mediating gene expression thereby determining cell function 
(Sardina et al., 2018). Clusters of methylated cytosines tend to occur in promoter regions 
and are referred to as CpG islands (Suzuki and Bird, 2008). Generally, promoter methylation 
is associated with low or no transcription or gene silencing (Suzuki and Bird, 2008), whilst 
intragenic methylation is positively associated with gene expression (Jones, 1999). Gene 
body methylation was originally thought to be a mechanism for silencing repetitive elements 
(Yoder et al., 1997). However, whole-genome studies have indicated that due to exons being 
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more highly methylated than introns, with the occurrence of along exon-intron boundaries, 
it could play a role in alternative splicing (Laurent et al., 2010). DNAm may function in the 
formation of open chromatin structure and maintenance of enhancer elements (Wiench et 
al., 2011). 
Epigenetic modifications occur during developmental processes and are particularly 
important in early development and cell specialisation (Hochberg et al., 2011). These times 
when the epigenome (the collective term for all the chemical modifications to DNA within 
the genome) is sensitive to change are referred to as critical or sensitive periods. During 
development, the epigenome is ‘reset’, and some epigenetic marks are re-established. There 
is widespread demethylation, followed by specific re-methylation, which must occur for cells 
to have specialised functions. Specific inherited epigenetics marks are generally at imprinted 
genes. However, modifications can also occur in response to environmental factors such as 
diet and lifestyle (Jaenisch and Bird, 2003). Patterns of methylation are now being 
recognised are more dynamic than previously thought, and there is growing evidence that 
DNAm can be influenced by environmental factors (section 1.5.3).  
DNAm is a good candidate for the biological embedding of early life risk factors for obesity 
as; it has the capacity to modulate gene expression, can be influenced by environmental 
factors such as diet and lifestyle (Jaenisch and Bird, 2003), and has demonstrated 
associations with adiposity.  
1.5.2 Epigenetic mechanisms and obesity 
The Agouti mice models demonstrated the importance of maternal diet on offspring 
phenotype (Wolff et al., 1998). In mice, when the Agouti gene is unmethylated, the 
phenotype is yellow coat colour and a predisposition to obesity, hyperinsulinemia, cancer, 
and reduced lifespan. Whereas when the agouti gene is methylated (i.e. normal state), mice 
have a brown coat, with low risk of obesity and are healthier than their yellow counterparts. 
Other than the methylated allele, the mice are genetically identical. When pregnant female 
yellow mice are fed a methyl-donor rich diet, the pups had a brown coat and a healthy 
phenotype (Wolff et al., 1998) thereby demonstrating the importance of methyl-donor 
availability. Animal studies have demonstrated the potential for environmental and dietary 
influences on health and disease, and suggest a mediating role for DNAm linking early 
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development and postnatal body composition (Drake et al., 2005, Burdge et al., 2007, 
Godfrey et al., 2011). 
There have been a number of human studies which have identified methylation patterns 
associated with later life adiposity ((for reviews see (Reynolds et al., 2013b, Rohde et al., 
2018) and (van Dijk et al., 2015)).  
Replication has been problematic in many candidate gene studies. There was a robust, large-
scale BMI EWAS that utilised data from across multiple cohorts, and successfully validated 
187 loci in independent cohorts (Wahl et al., 2016). However, regarding the direction of the 
effects, the majority of these loci were deemed a consequence rather than a cause of BMI. 
Others have also found that changes in BMI may occur prior to methylation changes 
(Richmond et al., 2016, Wahl et al., 2017), for example weight loss after bariatric surgery 
influences DNAm (reviewed by (Izquierdo and Crujeiras, 2019)). Overall, these studies 
provide evidence for epigenetic changes in relation to obesity or weight change.  
There may also be a link between being biologically older and childhood body composition, 
as positive epigenetic age acceleration (measured using Horvath’s epigenetic clock) at birth 
was associated with developmental characteristics longitudinally across childhood, including 
increased fat mass (Simpkin et al., 2017). DNAm has important roles in expression of 
imprinted genes, which are expressed from the parent of origin and which may play a role in 
the transgenerational development of obesity. Insulin-like growth factor 2 (IGF2), a key 
human growth factor, is an example of an imprinted gene differentially methylated in those 
periconceptionally exposed to famine (Heijmans et al., 2008a).  
Overall, these studies establish a link between epigenetics and obesity. From candidate 
studies there have been many promising epigenetic biomarkers, with accumulating evidence 
linking DNAm changes and metabolic health outcomes. So far, for many of these genes the 
functional consequences of methylation changes remain uncertain.  
1.5.3 Evidence for DNA methylation markers of early life exposures 
There is growing interest in the use of malleable epigenetic markers as potential molecular 
mediators (i.e. intermediary), as biomarkers to identify those most at risk of subsequent 
disease, or as potential targets in disease treatment as a means of personalised medicine. 
There have been DNAm changes associated with some of the early life risk factors for 
subsequent obesity. More specifically, these DNAm changes have been linked with foetal 
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growth, birthweight, metabolism, and linked to maternal factors such as smoking and 
nutrition (Reynolds et al., 2013b). This section will focus on validated markers or markers 
from meta-analyses of human studies focusing on DNAm changes at individual CpG loci. 
 Birthweight 
The Pregnancy and Childhood Epigenetics (PACE) Consortium, combines multiple cohorts 
with methylation data from 450K or EPIC arrays on newborns and children. It includes many 
large prospective studies such as ALSPAC and the Generation R study. Therefore, PACE can 
be used to conduct meta-analyses due to large sample size with much greater statistical 
power. In a large meta-analysis of 24 birth cohorts from the PACE consortium, birthweight 
was associated with differential methylation at 914 loci in neonatal blood (Küpers et al., 
2019). Some of the loci demonstrated overlap with loci previously identified as associated 
with maternal smoking (n=55) (Joubert et al., 2016), and a few loci also with maternal BMI 
(n=3)(Sharp et al., 2017). There were a handful of CpG loci that were differentially 
methylated across the life course (in childhood, adolescence and adulthood), which mapped 
to genes; KCNC4, GLI2, HOXC4, ZNF274, MIR548F5.  
The biological effects of glucocorticoids, steroid hormones hat play a role in foetal growth 
and development, are relayed by glucocorticoid receptors (GR). It is established that 
glucocorticoid exposure in utero is associated with low birthweight (Seckl, 2004). It has been 
found that increased methylation in the GR promoter, which leads to reduced expression of 
GR thereby reducing levels of glucocorticoid signalling, is associated with higher birthweights 
(Filiberto et al., 2011). In mothers, increased methylation (leading to reduced transcription) 
of the enzyme which inactivates glucocorticoid (11β‐hydroxysteroid dehydrogenase type 2) 
(Alikhani-Koopaei et al., 2004), leads to higher circulating glucocorticoids, and has also been 
associated with low birthweight (Marsit et al., 2012).  
Birthweight is often used as proxy for nutrient restriction. Those exposed to famine in the 
peri-conceptional period exhibited hypomethylation of IGF2 differentially methylated region 
compared to unexposed siblings (Heijmans et al., 2008b). Exposure late in gestation was not 
associated with changes in IGF2 methylation, suggesting that very early development is a 
critical period in the establishment of environmentally patterned epigenetic marks. 
Mediation analysis also suggests that DNAm may be a mediator between early life famine 
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and subsequent increased BMI, interesting near genes with metabolic roles including energy 
metabolism (PIM3), glycolysis (PFKFB3), and adipogenesis (METTL8) (Tobi et al., 2018). 
 Maternal factors 
1.5.3.2.1 Maternal BMI 
In a large meta-analysis, maternal BMI was robustly associated with cord blood methylation 
at eight CpG loci within the PACE consortium (Sharp et al., 2017). Higher maternal BMI was 
associated with lower methylation at two CpG loci located in the VIPR2 gene, a gene which 
encodes vasoactive intestinal peptide receptor 2 (VIPR2). The VIP pathway has been strongly 
associated with fat mass, and therefore may be important for obesity development (Liu et 
al., 2010). 
In ALSPAC, increased GWG was associated with increased methylation at several CpG sites in 
offspring cord blood DNA (Morales et al., 2014). In addition, offspring DNAm differences 
have been observed in those born to both overweight and underweight ALSPAC mothers 
(Sharp et al., 2015a). In a small study,  there was evidence of altered methylation in 
differentially methylation regions (DMRs) of imprinted genes in cord blood in association 
with parental obesity (Soubry et al., 2013). Thus far there has been inconsistency in the 
associations found in various cohorts for maternal BMI, and many of the associations 
between maternal BMI and offspring methylation at birth have not been replicated (Sharp et 
al., 2017). Although there is some evidence that the detrimental effects of maternal obesity 
are causally related to epigenetic alterations (Godfrey et al., 2017). 
1.5.3.2.2 Maternal smoking 
DNAm measures are particularly useful for exposures such as smoking when self-report data 
may be prone to bias (Dietz et al., 2010) and cotinine (metabolite of nicotine) measures are 
not available. When data were combined across studies (PACE consortium), there were 
many significant CpGs associated with maternal smoking, robust to different adjustment and 
analytical methods (Joubert et al., 2016). Associations were stronger for sustained smoking 
rather than smoking at any time during pregnancy (Joubert et al., 2016). PRDM8 had the 
most CpGs associated on the array, and belongs to the SET domain family 
of histone methyltransferases (Fog et al., 2012), more specifically, this gene targets H3K9 of 
histones to repress transcription (Eom et al., 2009). Gene expression was analysed further in 
genes that had differential methylation, it was found that there was agreement for 6 genes. 
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PASK (PAS domain containing serine/threonine kinase), was one of the genes, and is a 
‘nutrient sensor’, involved in the regulation of glucose and lipid homeostasis, and therefore 
may play a role in metabolic syndrome (DeMille and Grose, 2013, Zhang et al., 2015). Mice 
lacking PASK who are fed a high fat diet do not develop obesity (Zhang et al., 2015), 
therefore PASK deficiency can protect against diet-induced obesity.  
Longitudinal analyses carried out in the ALSPAC cohort found that some CpGs that were 
altered in cord blood demonstrated reversible methylation, whilst others had persistent 
methylation (AHRR, MYO1G, CYP1A1 and CNTNAP2) across childhood and adolescence 
(Richmond et al., 2014). Recent work has been in the development of a methylation score, 
which could be used to predict previous smoking exposure. The score uses methylation 
across 15 CpG sites in 11 genes in order to predict prenatal smoke exposure (Richmond et 
al., 2018). This useful approach could be utilised to develop predictive models for other early 
life exposures.   
1.5.3.2.3 Maternal age 
Offspring of older mothers are at risk of adverse birth outcomes, which can impact via a 
number of mechanisms. As established by Horvath, age is associated with DNAm changes 
(Horvath, 2013). Furthermore, gene expression in human oocytes changes with age, which 
could affect biological function (Grondahl et al., 2010).  
An EWAS (450K) in newborns from the Norway Facial Clefts Study identified 
hypomethylation within the KLHL35 gene in offspring born to older mothers (Markunas et 
al., 2016). The findings were replicated in the MoBa cohort and also in women in age 40-60 
years, suggesting that methylation differences persisted across the life course.   
Another smaller study examined methylation using the 27K array in a cohort of 168 
newborns, and found a correlation between maternal age and methylation at genes related 
to neurological regulation, embryo development, and glucose regulation and metabolism 
(Adkins et al., 2011). 
Increasing maternal age was associated with epigenetic differences in adult daughters, 
including an inverse association with methylation in the promoter region of LHX8, a gene 
related to female fertility (Moore et al., 2019). Furthermore LHX8 expression is a marker for 
the activity of brown adipose tissue (Jespersen et al., 2013), with increased activity related 
to lower BMI (Cypess et al., 2009). Researchers also identified a set of genes associated with 
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maternal age that are important regulators of the development of various cancers and 
neurodevelopmental disorders. 
Although there is a biological in utero connection between mothers and offspring, it is likely 
that maternal and paternal age will be highly correlated for most. Epigenetic changes that 
occur within sperm DNA have also been associated with offspring disease risk, in particular 
related to neuropsychiatric disorders (Jenkins et al., 2014).  
 Infant feeding 
A systematic review examining breastfeeding and offspring DNAm found evidence of a 
negative association with promoter methylation in the LEP (Leptin), CDKN2A (tumour 
suppressor) and SLC2A4 (glucose transporter) genes, in a handful of studies (5 in 
humans)(Hartwig et al., 2017). Breastfeeding was positively associated with NPY (encodes an 
orexigenic neuropeptide). Duration of breastfeeding is negatively associated with LEP 
methylation and with decreased infant growth (Obermann-Borst et al., 2013, Pauwels et al., 
2019), therefore leptin may be a mediator of the developmental programming effects 
(Vickers and Sloboda, 2012).  
Differential CpG methylation (buccal) in the RXRA gene was associated with duration of 
breastfeeding and with infant growth (Pauwels et al., 2019), a gene which has been 
previously associated with childhood fat mass (Godfrey et al., 2011). 
Mischke and Plosch (2013), hypothesised that the effects of breast milk on DNA may be 
mediated by the microbiome (Mischke and Plosch, 2013). 
These results overall do provide some evidence of a relationship between breastfeeding, 
infant growth and DNAm in some metabolic and appetite-related genes. 
 Early growth 
There has not been an EWAS so far that has specifically examined RWG and childhood 
methylation, however some early life methylation changes have been observed. RWG is 
more likely in LBW infants; being SGA and weight gain in the first 3 months has been 
associated with lower IGF2 DMR DNAm (Bouwland-Both et al., 2013). Specific DMRs of 
imprinted genes in umbilical cord blood and infant body composition were investigated in 
the Newborn Epigenetics Study (NEST) (Gonzalez-Nahm et al., 2018). Sex differences were 
identified, whereby lower weight-for-length z score at 1 year was associated with higher 
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methylation within mesoderm-specific transcript MEST in females, whilst in males higher 
methylation was observed in the paternally expressed gene 10 (PEG10) and IGF2.  
Postnatal growth was associated with differential methylation in the TACSTD2 gene 
using gene-specific pyrosequencing (Groom et al., 2012). Both gene expression and DNAm 
within the gene were also associated with childhood fat mass, however subsequent causal 
analyses demonstrated that the association was likely due to reverse causation or 
confounding. 
 Stress 
In the first few years of life the immune system is sensitive to environmental stimuli (Danese 
and J Lewis, 2017). The pathways through which stress can impact on health could be 
through disturbance of inflammatory processes or via the hypothalamic–pituitary–adrenal 
axis (HPA). As a key pathway, many studies have focused on the components of the HPA axis 
and the glucocorticoid system, and how epigenetic alterations may disrupt of normal 
function in these pathways. 
Early emotional experiences could lead to epigenetic alterations that impact on offspring 
obesity. This was observed in rat pups; offspring groomed by their mother had reduced 
anxiety in adulthood and associated epigenetic changes in the GR (Weaver et al., 2004a). 
Whereas pups raised by less nurturing mothers had hypermethylation within the GR 
receptor and increased stress response (Weaver et al., 2004b). In mice, early life stress 
(separation of pups from dams) was associated with DNAm changes and accompanying 
upregulated expression of the pituitary POMC gene, which mediates the adrenocortical 
response to stress (Wu et al., 2014b). Although human studies are limited, lower parental 
warmth has been associated with childhood overweight and therefore DNAm could mediate 
this association (Fairley et al., 2015a). Furthermore, there is some evidence for a role of GR 
methylation and stress in humans, determined using hippocampal tissue from the Quebec 
Suicide Brain Bank (Labonté et al., 2012). In the suicide completers who experienced 
childhood trauma, there was differential methylation in the promoter region of NR3C1 
(encodes glucocorticoid receptor) when compared to controls (Labonté et al., 2012). 
The effects of natural disasters and a periods of hardship during pregnancy demonstrate that 
stress has the capacity to alter offspring methylation levels (Meaney and Szyf, 2005). Child 
abuse and exposure to partner violence can also alter offspring methylation (McGowan et 
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al., 2009, Radtke et al., 2011). In adolescents, adverse childhood experiences were 
associated with DNAm in genes also related to risk of obesity (PCK2, CxCl10, BCAT1, HID1, 
PRDM16, MADD, PXDN, GALE)(Kaufman et al., 2018). Findings for PCK2 were most robust 
and were replicated across 2 cohorts, suggesting that PCK2 methylation may be a mediator 
for intrafamilial childhood adversity (e.g., physical abuse, witnessing domestic violence) and 
BMI.  
In a study on internationally adopted adolescents from deprived backgrounds, appropriately 
matched with non-adopted controls, differences in methylation patterns were investigated 
in an EWAS (Esposito et al., 2016). There were marked differences in cell type composition in 
adopted youths and differential methylation at 30 CpG loci, which mapped to enriched gene 
clusters related to neural and developmental functions. The adopted children were selected 
to model significant childhood adversity, although it is unclear specifically which forms of 
adversity they experienced but could include abuse, neglect, malnutrition or infection each 
with varying severity (Esposito et al., 2016).   
A systematic review examining DNAm and childhood trauma summarised that numerous 
studies have identified differential methylation in the genes: SLC6A4, BDNF, 
OXTR and FKBP5, and most robustly in the GR NR3C1 gene (Nöthling et al., 2019). For a 
comprehensive review on trauma-induced changes in DNAm see (Vinkers et al., 2015). 
There have now been several epigenome-wide association studies for childhood adversity 
and DNAm, however as noted by (Houtepen et al., 2018a) many of these studies utilise a 
candidate gene approach or use susceptible populations (Houtepen et al., 2018a). Currently 
there are few studies that have examined very early life (rather than childhood) stress and 
DNAm in humans.  
 Infection 
Epigenetic mechanisms are critical for normal development of the immune system, and the 
early postnatal period (0-12 months) reflects a time when the epigenome is amenable to 
environmental exposures affecting innate and adaptive immune responses (Martino et al., 
2014).  
It is plausible that pathogens could affect epigenetic processes, in particular viruses that 
reproduce undiscovered in host cells (reviewed by (Paschos and Allday, 2010)). There is 
evidence of DNAm changes in responses to Epstein-Barr virus infection (Birdwell et al., 
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2014), human rhinovirus (McErlean et al., 2014), and HIV infection (Horvath and Levine, 
2015, Nelson et al., 2017). 
There is limited evidence on bacterial infections and DNAm in humans. Bacterial infections 
have been associated with rapid and active demethylation, rarely occurring at promoter 
regions, but localising to distal enhancer elements that regulate activation of key immune 
transcription factors (Pacis et al., 2015). Mycobacterium tuberculosis has been shown to 
alter the epigenome, but the mechanism is not fully understood (Kathirvel and Mahadevan, 
2016). There is also evidence that some pathogens can disrupt histone modifications and 
reprogram host gene expression (reviewed by (Strunk et al., 2013)).  
DNAm changes and early life exposure to antibiotics have not been examined. Maternal 
antibiotic use during pregnancy was examined in 397 pregnant women in DMRs of imprinted 
genes using bisulfite pyrosequencing (Vidal et al., 2013) in the NEST cohort. Differences were 
observed for IGF2, H19, MEG3, PEG3 and PLAG1, with the latter also associated with 
birthweight. This could suggest that the association between prenatal exposure to 
antibiotics and birthweight may be mediated by changes in regulatory regions of some 
imprinted genes. DNAm at imprinted regions has also been investigated with respect to 
intrauterine infections. In cord blood, DNAm was increased at the PLAGL1 DMR in pre-term 
infants with chorioamnionitis (a bacterial infection that occurs before or during labour), and 
for infants with funisitis (inflammation of the connective tissue of the umbilical cord), in the 
NEST cohort (Liu et al., 2013b). 
 Sleep 
Overall there have been few studies examining sleep deprivation and DNAm, and non in 
children. In mice, sleep deprivation has a broad impact on DNAm in the cerebral cortex, in 
gene pathways involved in neuritogenesis and synaptic plasticity, and can increase the 
expression of DNA methyltransferases (Massart et al., 2014). In an EWAS in adults, even one 
night of sleep deprivation altered DNAm, particularly in the Notch and Wnt signalling 
pathways, which are important developmental pathways often dysregulated in cancer 
(Nilsson et al., 2016).  
 Transgenerational influences  
Data from animal studies has demonstrated that the impact of a high fat diet has lasting 
effects for three successive generations in mice (Sarker et al., 2018). First generation 
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offspring of those exposed to prenatal famine have a higher BMI (particularly women) 
(Roseboom et al., 2000) and grandchildren exhibiting increased neonatal adiposity (Painter 
et al., 2008). It is possible that these effects are transmitted through transgenerational 
epigenetic inheritance but human data are sparse. 
 SES 
There are a handful of studies examining the effects of early life SES on DNAm in peripheral 
blood (Demetriou et al., 2015). In young children (17 months, n=120), low maternal 
education was associated with a 1.3% increase (p=0.043) in INSIGF methylation; the 
overlapping region of IGF2 and INS (insulin) (Obermann-Borst et al., 2012).  
However, most studies examining SES have measured outcomes in adults. A genome-wide 
methylation analysis examined childhood SES and methylation in middle-age adult males 
(42-45 years) from the 1958 British Birth Cohort Study (Borghol et al., 2012). The study 
examined methylation of around 22,000 gene promoters using methylated DNA 
immunoprecipitation (MeDIP). Childhood SES was associated with differential methylation at 
1252 sites, with enrichment in genes related to extra- and intracellular signalling and 
metabolism. This was in contrast with adult SES for which there were fewer (n=545) 
significant associations.  
A genome-wide approach using the 27k array found 3 loci that had e small (less than a 5%) 
changes in methylation when comparing low and high early life SES (by occupation) in adults 
(mean age 33) (Lam et al., 2012), and no significant CpG loci were found for adult SES.  
In a large sample (n=857) of healthy adults from the EPIC-Italy cohort, low life course SES 
was associated with lower methylation in pro-inflammatory genes (Stringhini et al., 2015). 
Lower life course SES has also been associated with epigenetic age acceleration (the 
difference between DNAm age and chronological age), using data from 3 large prospective 
cohorts (Fiorito et al., 2017). Furthermore, consistent results were found by Austin et al, 
with the observation that low SES in early life predicts age acceleration, whilst no 
associations found for later life SES (Austin et al., 2018). Both studies did not find 
attenuation of the association with upward social mobility. In additional to changes at 
individual CpG loci, global changes in methylation have been associated with SES 
(Subramanyam et al., 2013, Tehranifar et al., 2013).  
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These studies suggest that DNAm may provide a link between early life, or life course SES 
and disease risk. However, heterogeneity in study designs including the measure of SES and 
the measurement of DNAm make comparisons difficult. 
1.6 Integrating the social determinants of health and epigenetic mechanisms with regards to 
obesity  
There have been a number of theories to explain the rise in obesity (see section 1.2). A 
failure of previous frameworks is that they often fail to take into account the complexity of 
the interaction of early life factors, lifestyle, socioeconomic status and gene-environment 
interactions. There are a number of lifecourse models that more generally discuss lifecourse 
factors with regards to health, but few have attempted to model lifecourse factors 
specifically with regards to obesity.  
There has been a life-course framework for obesity prevention proposed by Pérez-Escamilla 
and Kac (2013). Their approach uses a social ecological model which has layers from the 
individual, microsystem (home), mesosystem (neighbourhood), exosytem (larger 
environment), and macrosystem (social and health policies), and focuses on the 
consequences of maternal–child obesity. Hawkins et al, apply a similar approach, utilising 
the same factors but term these ‘above water’ levels, with the addition of ‘below water’ 
levels as the biological factors (Hawkins et al., 2018). Additionally, whilst many studies have 
examined many individual, independent factors (section 1.3), few studies have incorporated 
empirical data into a lifecourse framework model. 
 
It is well established that social inequalities and lifestyle factors are significant contributors 
to health and are included in most theoretical models regarding the determinants of health. 
However, as epigenetics is a relatively new area of research, where it fits within models of 
the determinants of health has not yet been considered. Marmot and Wilkinson (2004) 
acknowledge many important factors impacting in early life that can affect health and 
wellbeing. Dahlgren and Whitehead’s determinants of health model acknowledges 
hereditary factors and individual lifestyle factors (Dahlgren and Whitehead, 1992), however 
epigenetic factors would fall between the two. Their model also encompasses the 
socioeconomic, cultural, and environmental conditions, which collectively can have a great 
impact on health, and are factors which may have accompanying epigenetic changes.  
48 
 
In the Grossman model, health is treated as stock which depreciates over time without 
adequate investment in health (Grossman, 1972). For instance, as education increases, an 
individual is more efficient at taking care of their own health and therefore they increase 
investment in health. The Grossman model assumes individuals are born with a given level 
of health stock, however in terms of the DOHaD hypothesis, the level of health stock would 
potentially be determined by maternal and transgenerational influences, and early life 
exposures. Therefore, an individual with detrimental early life experiences embarks on life 
with less health stock and therefore lower health. These individuals would need greater 
investment in their health to simply maintain an equivalent level of health to that of an 
individual born with neutral health stock without negative exposures in early life. Risk could 
further be increased when combined with an obesogenic environment and underlying 
genetic susceptibility. Therefore a new conceptual model is required in order to incorporate 
these factors that can impact in utero via maternal exposures, on the individual level across 
the life course, or that have transgenerational influences, and ultimately influence ‘health 
stock’. 
In light of this, I propose a new model of the social determinants of health, which 
acknowledges the role of epigenetics and the interaction with behavioural-lifestyle, and 
socioeconomic factors (Figure 1.1). In this model each of the risk factors presented (circles) 
has the capacity to impact on DNAm, acting at the individual level, through maternal 
influences or transgenerationally.  By applying this framework, the integration of the various 
sources of data, such as epigenetic, genetic and epidemiological data has the capacity to 





Figure 1.1 Conceptual framework of factors influencing obesity risk. 
The framework encompasses the complex interactions of socio-economic, behavioural and lifestyle factors that contribute to 
the development of obesity. It is an adaptation of Dalgren and Whitehead’s determinants of health model (1991), which 
incorporates the DOHaD hypothesis and the literature on early life risk factors of obesity.  
In this model, the many determinants of obesity do not act in isolation, but are layered, interlinked (indicated by the arrows) 
and influence other factors (circles). The socio-economic factors influence the behavioural-lifestyle factors and vice versa. 
Each of these factors would have the capacity to impact on the individual level but also from maternal factors and 
transgenerationally. For example, diet on the individual level would encompass eating patterns, nutrient intake and early life 
feeding. On the maternal level, this refers to maternal diet during pregnancy and weaning. On the transgenerational level, 
this would refer to the individual’s grandmother’s diet. Within this hypothesis, each of the circled factors in theory could 
have associated epigenetic changes. The demographic factors (age, sex, ethnicity, genetics and biological factors including 
metabolism, puberty status etc), are positioned on the outer edge indicating that they are non-modifiable but 





In summary, themes emerging from epidemiological studies indicate that nutrition and early 
feeding may be important, perhaps due to the relationship between to intrauterine 
conditions, birthweight, and catch-up growth. Aside from nutrition, maternal factors are of 
great importance as they represent a sustained in utero exposure. Very early postnatal life 
also represents a critical period, with the potential risk factors of infant feeding, adversity, 
sleep, and socioeconomic disadvantage. Additional research is required in order to 
determine the relative contribution of early life, lifestyle, and environmental factors to later 
life OWOB.  
In studies examining early life risk factors, there are a lack of long-term follow-up data from 
childhood to adulthood, and a limitation of current research is that much is cross-sectional in 
nature or relies on retrospective data collection, which could be addressed by utilising 
longitudinal data sets. The timing of the exposure can also lead to differing effects in the 
offspring; therefore, further research is required in order to pinpoint critical periods in an 
infant’s life. At present it is unclear if these early life factors of childhood obesity are risk 
factors for adult obesity in populations with low levels of childhood obesity, or if the risk is 
due to the tracking of obesity in childhood into adulthood (Freedman et al., 2001). Future 
studies ideally would examine multiple indices of adiposity to determine if exposures are 
related to overall body size, body fatness or the positioning of fat, each of which can carry 
different risks. 
It is not only plausible, but also likely that epigenetic mechanisms could be a mediator 
between early life exposures and obesity outcomes. However, many of the earlier epigenetic 
studies used basic techniques and did not state whether they have adjusted for confounders 
(Obermann-Borst et al., 2012) or corrected for multiple testing in their analysis. Findings so 
far are suggestive and further replication studies are required using longitudinal cohorts. 
Investigation of the epigenetic changes associated with exposures may elucidate causal 
pathways and underlying mechanisms, and hence identify therapeutic targets. Furthermore, 
epigenetic markers could improve prediction models or highlight those ‘high-risk’ individuals 
who would benefit from intervention or monitoring, thereby guiding personalised 




1.8 Hypothesis and aims   
This study will investigate the hypothesis that DNAm may be a mediating mechanism 
between early life exposures and subsequent obesity. 
The aims of this thesis are: 
1.) To investigate the impact of early life exposures and SES on childhood and adult 
adiposity using multiple indicators  
2.) To investigate regional temporal changes on obesity, allowing scrutiny of the impact 
of modern environmental and socioeconomic factors 
3.) i.) To identify gene-specific methylation differences in relation to those early life 
exposures found to influence obesity in children and adults 
ii.) To investigate the methylation differences in relation to the early life exposure(s) 
found to influence obesity in an adult population. 
This study will address the limitations and unanswered questions summarised in section 1.7. 
Aim 1 examines the latency of effects; in particular, which early life exposures are associated 
with adult obesity, as it unknown whether some exposures that are associated with 
childhood obesity are also associated with adult obesity. Aim 1 also addresses whether 
associations for exposures differ across outcome measures of adiposity. 
Aim 2 addresses the unanswered questions around cohort-timing and environmental effects, 
i.e. if exposures are associated with adult obesity in those without an early life obesogenic 
environment.  
The final aim attempts to uncover novel changes in methylation in early life exposures that 
have demonstrated consistency from aims 1 and 2. This can be split into two parts; firstly to 
identify DNA methylation changes in children and adolescents, and secondly to quantify 
these methylation changes in adults, thereby examining the persistence of the effects.  
1.9 Study design 
Figure 1.2 outlines the study design and how data from each cohort was employed to 
address the aims.  
Firstly, a literature search was carried out to explore the early life exposures implicated in 
obesity (section 1.3), to in order to determine exposures of interest. This study primarily 
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utilised epidemiological data from two North East birth cohorts; the Newcastle Thousand 
Families Study (NTFS) and the Gateshead Millennium Study (GMS). The objectives for aim 1 
were to examine early life exposures with respect to adiposity outcomes in NTFS adults, and 
GMS children.  
Using two cohorts from the same geographical area allows examination of these 
relationships over time and observation of the role of environment. To address aim 2, using 
both NTFS and GMS outcomes in childhood, the associations between early life factors, SES, 
and obesity were also investigated. 
To fulfil aim 3, exposures of interest were investigated using DNAm data from the Avon 
Longitudinal Study of Parents and children (ALSPAC) cohort (Alspac Study Team, 2001), to 
examine exposures in relation to methylation and obesity. The basis of these findings guided 
methylation targets to examine in the NTFS samples.  
The findings of this analysis could further understanding of the biological, social and 





 Investigate associations between exposures of interest in NTFS & GMS   
 Investigate the association between early life SES, later life SES and obesity 
1 
Investigate the associations between key 
exposures and methylation in ALSPAC, and 
between methylation loci of interest and 
obesity  
2 
 Measure methylation and investigate relationships 
between early life exposures, methylation of 
target genes and obesity in and NTFS 
3 
1991 
Figure 1.2 Overview of the study design, cohorts and aims  
The years refer to the cohort year of birth. NTFS, Newcastle Thousand Families study, GMs, Gateshead millennium study; ALSPAC, Avon 
Longitudinal Study of Parents and children (AKA children of the 90s); SES, socio-economic status. 
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Chapter 2. Data and methods 
The analysis undertaken in this thesis can be broadly arranged into two sections. First was 
the epidemiological analysis to determine the focal early life exposures associated with 
childhood and adult body composition in two North East cohorts (GMS and NTFS). The 
second part was the epigenetic analysis, whereby the focal early life exposures were 
investigated in a cohort with epigenetic data (ALSPAC). This also included a simplified version 
of the epidemiological analysis using the key early life exposures to substantiate the 
associations, and then investigated these exposures and DNAm in childhood and 
adolescence. Finally, to determine if DNAm patterns persist, the significant CpG loci 
identified in ALSPAC children were investigated in NTFS adults. This chapter details each of 
the cohorts and the methods for all analyses.  
2.1 Datasets used 
2.1.1 The Newcastle Thousand Families study (NTFS) 
The Newcastle Thousand Families study (NTFS) is a birth cohort based in the North East of 
England. The study began in 1947, two years after the end of WWII. The study’s original 
intent was to investigate the high infant mortality rate, which at the time was mostly 
attributed to acute infections. This conclusion was made prior to WWII by Sir James Spence, 
a paediatrician who undertook a review of the causes of death in children under 5. After the 
war, the NTFS was set up to investigate risk factors for infection, with the original intent to 
run the study for 1 year. However, the study continued and is now in its 8th decade.  
Data were primarily prospectively recorded for the cohort. There are data available on a 
variety of early life factors, along with physical outcome measures in early and late 
adulthood, which makes it possible examine body composition in later life in relation to 
exposures in early life. 
The cohort originally included nearly all (n=1142) babies born in Newcastle upon Tyne 
between May and June 1947 (Pearce et al., 2009). Data have been collected at numerous 
time points over the participant’s life course (up until age 60 to date). The cohort have been 
followed extensively by utilising general practitioners, health visitors and schools throughout 
childhood (until they were 15 years old). Data collection was facilitated through the 
55 
 
placement of red spots on the study member’s medical records to identify them, and hence 
they were referred to as ‘red spots’. There were further intermittent follow-ups during 
adulthood (ages 18, 22, 32) with data collected on employment, anthropometrics, 
psychology, and crime.  
At age 50 (49-51), the cohort were traced and took part in a physical assessment (n=412) 
and questionnaire (n=574). The clinical assessment covered a range of health outcomes 
through physical assessment including cardiovascular, metabolic, and musculoskeletal 
measures. Biological samples (serum and urine) were also obtained. Another similar clinical 
assessment took place at age 60. Comprehensive details on key findings and data collected 
can be found in the cohort profile (Pearce et al., 2009). 
 
 
Figure 2.1 NTFS data collection to date.  
There were multiple data collection sweeps throughout childhood to age 15, and then intermittent revisits at various time 
points during participant’s lives, until the most recent age 60 follow-up.  
 Measurement of body composition outcomes 
Measures of height and weight were taken throughout childhood at ages 3, 5, 9, 13, 14 and 
15 years. At the age 50 and 60 clinical assessment, anthropometric measures (height, 
weight, waist and hip circumferences and bioelectrical impedance) were taken, which were 
performed in the morning after an overnight fast of at least 10 hours. An average of three 
measurements of bioelectrical impedance (Holtain) were used to estimate percentage body 
fat (BF%), using standard regression equations.  
 Measurement of exposure variables and covariates  
In NTFS, maternal age, gestational age, and birthweight were recorded at the time of 
delivery and taken from hospital records. All other factors were recorded by health visitors.  
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Duration breastfed was the difference between the date of first and last time the participant 
had breast milk (in days), recorded by health visitors. This was analysed as a continuous and 
categorical variable. The duration of exclusive breastfeeding was the difference in days 
between the date breastfeeding commenced and the date of introduction of bottle-feeding 
with an alternative milk (dried, cow’s or mixed feed). The age at weaning was the age at the 
introduction of solid foods. If date ranges were noted rather than a single date, the lowest 
date was taken. If no date for first breast milk was noted (but there was a date of cessation), 
date of birth was used.   
Infections were reported throughout childhood by doctors, health visitors, or hospital 
referrals. Infections in the first year of life were used in this study. Only infection data with 
low risk of ascertainment bias were used. Bacterial infections included whooping cough, 
Tuberculosis (TB), scarlet fever, and pneumonia. Viral infections included measles, mumps, 
rubella, meningitis, bronchitis, and chicken pox. Infection in first year was defined as a 
dichotomous variable if the study member experienced any of the aforementioned 
infections (“had”, “did not have”). Viral and bacterial infections were grouped initially, 
however as coefficients had opposite effects, viral and bacterial were then separated as 
variables.  
Socioeconomic indicators in early life included; father’s occupational social class, and 
household deprivation. To increase group sizes, social class was re-categorised into least 
advantaged (class IV and V), mid (class III skilled and unskilled) and most advantaged (class I 
and II).  
Household deprivation was determined through indicators of inadequate housing conditions 
as assessed by Newcastle’s public health department around time of birth. These were the 
presence of (0-4 factors) including; overcrowding, lack of hot water, shared toilet, and 
dampness or poor repair. As low numbers were observed in some categories, this variable 
was recoded to a binary variable representing either no housing issues (0) or evidence of 
housing issues (>=1).  
2.1.1.2.1 Later life and lifestyle factors  
Later life socioeconomic variables were determined from the age 50 questionnaire and 
included occupational social class, highest education level achieved and total household 
income (after tax). Although these are often used interchangeably in studies examining 
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health inequalities, they measure different components of SES and could have different 
underlying aetiologies in obesity development.  
Social mobility was determined using the change in occupational social class using the three 
groups (least, mid and most advantaged) from birth to age 50.  The highest level of achieved 
education was categorised (including equivalent qualifications) as none, O-level, A-level, and 
degree level and above. Previously, leaving school at an early age (≤17 years) has been 
associated with obesity (Wardle et al., 2002). Therefore, education was recoded to a binary 
variable indicating achieved education past secondary school level (greater than GCSE level, 
the main qualification undertaken by adults in the UK), indicating undertaking of higher 
education beyond compulsory school age (age 16).  
Household income was a choice between 17 categories on the questionnaire. Household 
income was equivalised to account for household size. The Organisation for Economic 
Cooperation and Development (OECD) equivalence scales are used by the Statistical Office of 
the European Union and by the UK government to adjust household income according to 
household composition, acknowledging that resources required are not directly proportional 
to household size. To determine equivalised household income, the median value of the 
questionnaire income categories was divided by the square root of household size and then 
log2 transformed for normality. The square root scale is a method utilised in recent OECD 
publications, and denotes a household of four people requires twice as many resources than 
a house composed of one person. This method was used as it does not rely on knowing the 
ages of the household members (data were not available).  
Data on lifestyle factors were taken from the self-report questionnaire at age 50. Study 
members were deemed as current smokers if they were current but not ex-smokers. Pack 
years (the number of packs of cigarettes smoked per day by the number of years the person 
has smoked) and categorical (current, ex, never) were also analysed. Physical activity level 
was derived from questionnaire responses based on frequency of various activities (based 
on the Medical Research Council’s Physical Activity Questionnaire (Kuh and Cooper, 1992)) 
and was categorised to ‘inactive’, ‘light activity’, ‘moderate activity’ or ‘heavy activity’. 
Whether a study member was single, married, widowed, divorced was also taken from the 
questionnaire and transformed to currently married/unmarried.  
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2.1.1.2.1.1 Energy intake 
Dietary assessment was conducted at age 50 (using the EPIC food frequency questionnaire 
(FFQ)) and the FFQ EPIC Tool for Analysis (FETA) was used to calculate nutrient and food 
group data (Mulligan et al., 2014). These data were processed prior to use (for details see 
(Mann, 2017)). In accordance with the FETA guide, if there were 10+ missing answers 
nutrient data was defined as invalid.  
The energy intake data were investigated prior to use, however due to some discrepancies 
these data were deemed invalid and were not included in the analysis (Appendix A). 
2.1.2 The Gateshead millennium study (GMS) 
The Gateshead millennium study (GMS), is a prospective birth cohort that recruited 1029 
infants born to mothers resident in Gateshead during pre-specified weeks from June 1999 to 
May 2000. Gateshead is located on the southern bank of the River Tyne opposite the city of 
Newcastle upon Tyne in the UK. The original aims of the study were to investigate infant 
feeding behaviour and growth; however, it has since expanded to encompass multiple 
aspects of child health, including nutrition, physical activity, and well-being.  
The cohort have been followed up intermittently throughout their early life and childhood 
with 15 phases of data collection so far. This has involved detailed questionnaires on growth, 
feeding, behaviour, illness and social factors (Parkinson et al., 2011), typically completed by 
the mother throughout study member’s early life. After birth and in the days following, data 
were collected in the hospital or at home from mothers, midwives, and health visitors. 
Questionnaires in early life were completed by parents at around ages 6 weeks, 3 months, 4 
months, 8 months, 12 months, 13 months, and 30 months. Schools also facilitated data 
collection throughout childhood and adolescence. Detailed information on the waves of data 




Figure 2.2 Data collection phases in GMS to date  
 Measurement of outcome variables  
Measures of height and weight were taken throughout childhood. Height was determined 
using a Leicester portable height measure (Chasmors, London, UK), measured to the nearest 
0.1 cm. Weight (kg) and bio-impedance (BIA) were measured using a Tanita TBF300MA in 
light clothing. Values for total body water, hydration, and lean mass were age and sex-
specific (Wright et al., 2008b). 
 Measurement of exposure variables and covariates 
Birthweight, gestation, number of previous children, mode of delivery, maternal age and 
postcode (for determination of Townsend deprivation score (Townsend et al., 1988)) were 
requested at recruitment. Birth order was analysed as a binary (first-born) variable. Maternal 
age was analysed as both a continuous measure and as categories of <25 years, 25-34 years 
and over 35 years. Pre-term was determined as a gestation length less than 38 weeks, 
normal was 38 to 41 and post-term was greater than 41 weeks.  Weight was measured in a 
clinic at the 13-month health check. 
All other variables were collected via questionnaires administered at regular intervals 
including adversity (4 month), sleeping (8 month) SES (birth and age 6-8) and infant feeding 
(recurrent questionnaires). 
Parents were asked about feeding shortly after birth and in the 6-week, 3, 4, 8, and 12 
month questionnaires. Parents were asked about mode of milk feeding, the cessation of 
breastfeeding and initiation of complimentary feeding.  Duration breastfed (non-exclusive) in 
GMS was categorised by the study team as ‘never’, ‘<6 weeks’, ‘>6 weeks’ and ‘>4 months’. 
Breastfeeding was also categorised according to the time period of exclusivity (only breast 
milk), as ‘>4 months’, ‘>8 months’, ‘>12 months’ or ‘not exclusive (i.e. <4 months)’. Due to 
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the small group sizes in categories over 4 months upwards (average 2.8% prevalence) these 
were combined, and exclusive breastfeeding was analysed as ‘not exclusive’ and ‘exclusive 
for 4+ months’. Formula fed was those who were never breastfed. Introduction of solid 
foods was in weeks.  
Adversity in GMS was derived from the questionnaires at age 4 months that asked, ‘Have 
you experienced any of the following in the last 12 months?’ which therefore included up to 
8 months prenatal exposure.  
Infection data available for the first year were taken at the age 4 and 12 month 
questionnaires. Infections included any mention of infections, receipt of antibiotics, measles, 
mumps, influenza, rubella, chicken pox, whooping cough, bronchitis, gastroenteritis. These 
questionnaires also asked whether the child had been admitted to hospital and the reason 
for admittance. Responses that mentioned infection or a known infectious illness were 
determined to be an infection. These included terms "VIRUS" "VIRAL" "INFECTION" "RSV" 
"MENIN" "BRONC" "CHICKEN"  "CROUP" "GASTRO" "PNEU" "MENEN" and "SEPTACEMIA". 
Data were then screened individually to check for any further spelling errors. Colds, 
influenza and ear infections were not included due to their high incidence in infants, with 
acute and minor effects.  
The literature examining early life sleep and childhood overweight for the most part only 
examines sleep duration (Reilly et al., 2005a, Patel and Hu, 2008, Taveras et al., 2008), 
however sleep duration was not measured in GMS. Alternatively, there are various 
definitions of sleep problems in the literature (Table 1.4).  
There were questions on sleep in the 8-month GMS questionnaire. Whilst there were no 
questions on sleep duration, parents were asked about disturbed sleep and issues falling 
asleep, which could affect sleep duration. The two questions were on a scale of 1 to 7 
(ranging from always to never): ‘how often did the child show fussing falling asleep’; ‘how 
often did the child have disturbed sleep’. Parents often reported sleep issues, and frequent 
night-time waking and issues settling are common in infants (Armstrong et al., 1994). 
Therefore, to summarise the extremes and to capture those with the worst sleep problems, 
a dichotomous (two component) variable for sleep issues was determined as those who 
always (in the top 1 of 7) reported issues for both falling asleep and for disturbed sleep.  
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SES was assessed using an area-based indicator (Townsend score) and maternal education at 
birth. Townsend deprivation score was transformed into quintiles with 1 being the least 
advantaged and 5 the most advantaged. Maternal education was assessed at time of birth as 
the highest qualification attained. Deprivation was measured through ownership (both car 
and home ownership/mortgage) and employment (wage earner), at birth and in childhood. 
In childhood, parental occupation data were available at age 7-8 and 8-10. Upward mobility 
0-8 was determined as the change from being deprived at birth (no ownership and no wage 
earner), to not deprived in childhood (ownership and wage earner). 
Physical activity was measured over 7 days using Actigraph GT1M accelerometers (Actigraph 
LLC, Pensacola, Florida, USA) when participants were around 7 years of age. The Actigraph is 
an established, practical measurement of both activity (physical and sedentary) with high 
reliability and validity (de Vries et al., 2006, Penpraze et al., 2006). This was continuously 
worn on the right hip, attached with an elastic belt, but was permitted to be removed for 
water-based activities. Parents also completed a time log stating when the accelerometer 
was worn, however this was found to overestimate child physical activity (Basterfield et al., 
2008). Data were processed manually prior to use as described previously (Basterfield et al., 
2008, Basterfield et al., 2012a). Accelerometry measurement over 7 days is regarded as the 
optimum amount of time for measuring habitual physical activity (Ward et al., 2005) and 
shows good reliability in children (Penpraze et al., 2006). However in this cohort, 3 days of 
wear for over 6 hours/day was shown to produce acceptable reliability (Basterfield et al., 
2011), therefore this was the criteria used to minimise loss due to missing data. Established, 
validated cut-off points were used to convert accelerometry data to levels of moderate–
vigorous intensity physical activity (MVPA)(Puyau et al., 2002, Basterfield et al., 2008). 
Physical activity was analysed as the mean daily percentage of time spent in MVPA 
(%MVPA). 
Seasonal differences in physical activity must also be considered in UK populations (Atkin et 
al., 2016). Generally, GMS children have been shown to be less active in the winter (Pearce 
et al., 2012a). Seasons were categorised as ‘spring’ (March to May, reference category, 




2.1.3 The Avon Longitudinal Study of Parents and Children (ALSPAC) 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort based in the 
former county of Avon, in the Bristol area (South West England). The original aim of ALSPAC 
was to further understand the ways in which physical and social environments interact, with 
a focus on the influence of genetic factors on health, behaviour and development of children 
over the life course (Alspac Study Team, 2001). The continuing aim has extended the study 
into a transgenerational resource for life course epidemiology, with enrolment of the 
original participant’s children, siblings, and grandparents (Boyd et al., 2013). 
The study recruited 14,541 pregnant women between 1990-92 with an expected delivery 
date between 1st April 1991 and 31st December 1992 (Boyd et al., 2013). There were 14,062 
live births and 13,988 children alive at age 1 year. Through additional recruitment phases the 
sample has increased to 15,247.  
Data collection has been via self-completion questionnaires and data linkage to external 
records. There has also been direct measurement of study members, through clinical 
assessments and biological samples (Boyd et al., 2013). At the clinical assessments around 
ages 7 and 17 years, blood samples were taken and DNA extracted. There were 68 data 
collection assessments between ages 4 weeks to age 18 years. The vast data collected have 
covered multiple dimensions of health, including social, genetic, physical, cognitive, 
environmental, and developmental factors. The ALSPAC data has been comprehensively 
coded and inspected by the ALSPAC study team. Complete details on recruitment and 
follow-up can be found in the cohort profile (Boyd et al., 2013).  
 Measurement of outcome variables 
Weight and height were measured at annual clinics and at multiple time points throughout 
childhood (ages 9+, 10+, 11+, 13+, 15+). Anthropometric measures at (approximately) age 7 
and 17 were used as outcomes in these analyses (when there were epigenetic data 
available). At age 7, height was measured to the nearest millimetre without shoes or socks 
using a Holtain stadiometer (Holtain Ltd, Crymych, Pembs, UK), whilst weight was measured 
using Tanita THF 300GS body fat analyser and weighing scales (Tanita UK Ltd, Yewsley, 
Middlesex, UK). At age 17, height was measured with a Harpenden stadiometer to the 




 Measurement of exposure variables 
Maternal age at delivery was originally categorised in ALSPAC as; <16 years, individual years 
between the ages 16-43, or >43 years. As the actual ages for those coded as <16 years and 
>43 years were unknown, this was categorised as done previously to "Less than 25" (young 
maternal age), "25-34" and "35+" (advanced maternal age) and was not analysed as a 
continuous variable.  
Using medical records, gestational age was determined using the recorded date of the last 
menstrual period and date of delivery. Birthweight was taken from obstetric records. At 12 
months, infants were weighed using the Seca 724 (or Seca 835 for children who could only 
be weighed with a parent). 
Parity was determined from the 18-week questionnaire, and was defined as the number of 
previous pregnancies resulting in either a livebirth or a stillbirth. First-born was binary 
variable (‘yes’ if number of previous pregnancies was 0). 
Occupational social class was determined as the highest category of parental social class 
using the 1991 British Office of Population and Census Statistics (OPCS) classification. 
Parental occupational social class was determined by the ALSPAC study team from 
questionnaire answers prior to use. Occupational social class was coded using the OPCS job 
codes to create six categories (I, II, III non-manual, III manual, IV and V). There was an 
additional category for armed forces, however there were no data on specific occupations or 
rank for those in the armed forces. Due to this, and also to harmonise with the occupational 
social class groupings in the other cohorts, armed forces were recoded to missing (total 
excluded, n=31, 0.2%).  
There were no data on bacterial infection in ALSPAC; therefore, antibiotic exposure was used 
as a proxy. In the 6-month questionnaire, parents were asked whether the child had 
received antibiotics in the last 6 months (ages 0-6 months). This was coded to binary 
variables if the response was one or more episodes.  
In ALSPAC, questions on adversity featured on both pre and post-natal questionnaires, 
therefore in order to harmonise with findings in GMS, three distinct adversity variables 
(prenatal, postnatal, and pre and post-natal) were investigated in ALSPAC. As the question 
on the GMS questionnaire specifically referred to child abuse of the study member, this will 
obviously only be relevant for the post-natal period. Therefore, in ALSPAC, any reference to 
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child abuse was only included in the post-natal period (8 month questionnaire), to reflect the 
study member’s own exposure (rather than the mother’s). In ALSPAC this referred to if the 
mother or partner were ‘emotionally or physically cruel to children,’ which may reflect 
events occurring within the household (other children), but that may not be directed 
towards the study member. Neither NTFS nor GMS had detailed information on the 
dimension(s) of the abuse. Questionnaire responses for adversity were only extracted up to 
age 8 months, as the next questionnaire was administered at age 21 months and would 
include responses out of the specified exposure period (parental to 12 months postnatal).  
Maternal smoking was self-reported on the questionnaires at 18 and 32 weeks gestation and 
8 weeks postnatal, and asked if cigarettes were smoked during pregnancy. Maternal smoking 
during pregnancy was coded as ‘yes’ if the mother answered yes to smoking on any of the 
three questionnaires. If there were any missing data at any of the time points, this was 
coded to missing (as it cannot be assumed that the mother did not smoke at this time point), 
i.e. mothers had to say they did not smoke at all time points to be counted as non-smokers 
during pregnancy. However, if the answer was yes to smoking at any of the time points, this 
was counted as a ‘yes’. 
2.1.4 The Accessible Resource for integrated Epigenomic Studies (ARIES) 
The Accessible Resource for integrated Epigenomic Studies (ARIES) is a subset of the ALSPAC 
cohort. The ARIES project aims to find links between exposure, phenotype, genotype, and 
methylation data. Genome-wide DNAm analysis was done for a subset of 1,018 mother and 
child pairs at three time points in children and two in mothers, as well as profiling various 
tissues for references. ARIES selection was based on availability of DNA samples at the three 
time points (birth, childhood (age 7.5) and adolescence (age 17.1)).  
In the offspring, DNAm was quantified from cord blood at birth, and peripheral blood in 
childhood (mean age 7.5 years) and adolescence (mean age 17.1 years). This was done using 
the Illumina Infinium HumanMethylation450 BeadChip. Pre-processing, quality control and 
estimation of cell type proportions were carried out by the ALSPAC team prior to researcher 
use (Relton et al., 2015). 
The sub-sample was mostly representative of the main study population; however, ARIES 
mothers were slightly older, less likely to have a manual occupation and were less likely to 
smoke during pregnancy (Relton et al., 2015). 
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2.2 Definition and measurement of outcomes, exposures and covariates  
2.2.1 Outcomes: Body composition measurements  
Previous studies have found differing results when assessing BMI (continuously) to 
categorical obesity with regards to maternal exposures and offspring adiposity (Sharp et al., 
2015b). Therefore, it is valuable to examine health risks associated with a higher BMI using 
both BMI on a continuous scale and indicators for overweight and obesity. As BMI is a proxy, 
alternative measures were analysed in order to determine if risk factors vary by outcome 
measure. To encompass each aspect of defining obesity this study will use BMI, BMI 
categories, a measure of central obesity (WhtR or WHR), and a measure of body fat (%BF or 
FMI). Comparing all three measures could uncover more about risk factors-specific 
mechanisms. These methods are discussed in detail in sections 1.1.4 and 1.1.5. 
 
Outcomes were BMI, BF% and WHR in adults, and BMIz, WHtR and FMI in children. Body 
mass index (BMI) was calculated as weight (kg) divided by height (m) squared. In children, 
BMI is confounded by age-related physiological variation, and so needs to be assessed with 
respect to a growth reference. The UK90 reference was used as it is the most appropriate 
reference, recommended for use in British children (Wright et al., 2002). The UK90 growth 
reference was determined from a sample of 32,222 measurements taken from 12 surveys 
between 1978 and 1994. It was sampled from a UK population with ages ranging from 0-23 
years, and is used for population monitoring and published figures using Health Survey for 
England and National Child Measurement Programme data. Childhood BMI was transformed 
to z-scores (adjusted for age and sex) using the UK90 growth reference with the Zanthro 
program in STATA (Vidmar et al., 2004). The program calculates standard deviation z-scores 
using Cole’s LMS method. L, M, and S represent the skew, mean, and coefficient of variation 
of the measurement as it changes with the x variable (age)(Cole, 1990).  
In adults, BMI was classified into weight categories according to the World Health 
Organisation guidelines (World Health Organization, 2000) (Table 1.1). In children, weight 
categories were grouped as ‘normal weight’ or ‘overweight/obese’ using BMIz. In line with 
previous analyses in this cohort (Parkinson et al., 2017), clinical cut-offs were used to 
determine weight categories, whereby healthy weight is between the 2nd and 91st centiles, 
overweight greater than 91st centile and obese greater than the 98th centile (SACN, 2012). 
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Clinical cut-offs are recommended by NICE in a clinical setting for individual children 
(Dinsdale et al., 2011).  
Measures of waist obesity and body fat were also considered as important adiposity 
outcomes in NTFS and GMS (section 1.1.4). In adults, waist-hip ratio (WHR) was calculated as 
waist circumference divided by hip circumference, measured by research nurses at the 
clinical examination. A WHR >0.9 in men and >0.85 in women corresponds to increased risk 
of metabolic complications (World Health Organization, 2011c). Waist-to-height ratio 
(WHtR) was used in children and is calculated as the waist circumference (cm) divided by 
height (m). This study utilised the acknowledged cut-off of WHtR >0.5 to signify waist obesity 
(Ashwell et al., 2012). Body fat was determined by bioelectrical impedance (BIA) in both 
cohorts. In adults, BF% was the proportion of fat mass relative to total body weight. In 
children, fat mass index (FMI), a relative measure of body fat, was calculated as fat mass (kg) 
divided by height (m) squared. 
2.2.2 Definition of early life 
Firstly, the definition of early life must be addressed. There are many definitions of early life 
with emphasis on the first 1000 days, which covers conception to around 24 months. The 
first 1000 days concept appears to have originated from the importance of ensuring 
adequate nutrition in early life, most frequently in the developing world. The idea appears to 
have been taken on by DOHaD researchers, with the first 1,000 days of an infant’s life having 
a great impact on the child’s growth and development, including cognitive development and 
immune function. However, this arbitrary figure relates to nutrition-related factors for 
cognitive development, and therefore this definition may be less important for non-
nutritional factors.  
A medical definition would determine infancy as the first year of life. For the purpose of this 
study, and due to the loose definitions of critical and sensitive periods, exposures will focus 
on conception to the first year of life. However, most of the data collected in the cohorts 
was postnatal.  
2.2.3 Defining early life exposures 
This study hypothesised that a number of early life factors would be associated with 
subsequent OWOB, based on the literature review presented in Chapter 1. Table 2.2 
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summarises the definition of the early life factors and covariates, which were harmonised 
across cohorts for consistency. Exposures were selected based on the availability of data 
from the NTFS and GMS. 
Birthweight was analysed as both a continuous (z-score) and categorical variable. Originally 
birthweight was recoded into low (<2.5kg), normal (2.5kg - 4.5kg) and high birth (>4.5kg) 
weight categories. However, due to the low frequency of low birthweight and high 
birthweight (in NTFS, Table 3.5), these categories were not analysed further. Instead, 
birthweight was converted to weight-for-gestational age z-scores (method outlined in 
section 2.1.1.1) and was used to determine categories of small (SGA) and less than the 10th 
or greater than the 90th percentile respectively. 
Similarly, weight at 12 months was transformed into a z-score (see section 2.2.1 for details). 
RWG was analysed as a dichotomised variable, defined as greater than +0.67 change in 
weight for age z-score from birth to 12 months. This change in is equivalent to crossing one 
major growth centile band on a standard child growth chart between the two time 
points(Ong and Loos, 2006b). 
In addition, in the cohort comparison (chapter 5) due to the large difference in birthweight z-
scores between the cohorts, weight gain conditional on birthweight was also considered. 
Conditional weight gain, or thrive index (TI), accounts for normal catch-up growth from low 
birthweight, as a linear measure of weight gain adjusted for regression to the mean (Wright 
et al., 1994). TI was calculated as weight for age z-score at around 12 months, minus the 
birthweight z-score multiplied by the regression coefficient (r, between the two weight 
measures) for the cohort (i.e. TI birth to 12 months  =  z-score12m − r × z-scorebirth). Similar to 
RWG, rapid thrive (RT) was defined as TI >0.67. 
Maternal age was categorised into 3 groups; less than 25, 25-34 and over 35. Advanced 
maternal age, defined as over 35 years, is associated with adverse pregnancy outcomes such 
as LBW, still birth and labour complications, preterm delivery and chromosomal defects 
(Jacobsson et al., 2004, Cleary-Goldman et al., 2005).  
The categories for duration breastfed determined in GMS were ‘never’, ‘<6 weeks’, ‘6 weeks 
– 4 months’ and ‘>4 months’. Equivalent categories formed using NTFS data to match when 
comparing the cohorts.  
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Adverse events in the first year of life were based around potentially stressful exposures of 
social, monetary and care issues. These events included parental separation, police 
involvement, child abuse, debt and illness or death of parent or sibling. Adversity was a 
dichotomous variable defined as experiencing any of the following; parental separation, 
police involvement, abuse, debt or death of a family member, in the first year of life.  
To increase group sizes, occupational social class was recoded to most advantaged (I, II), mid 
(III) and least advantaged (IV, V) (Table 2.1). Household deprivation coding was cohort 
specific and are explained in sections 2.1.1.2 (NTFS) and 2.1.2.2 (GMS). 
 
Table 2.1 Occupational social class recoding 
Occupational social class groupings Occupational social class recoded 
I Professional occupations  
II Managerial and technical occupations  
Most advantaged 
III(N) Skilled occupations: non-manual  
III(M) Skilled occupations: manual 
Mid advantaged 
IV Partly skilled occupations  
V Unskilled occupations 
Least advantaged 
 
Table 2.2 Definitions of the early life exposures across the cohorts 
Exposure Class Definition NTFS GMS ALSPAC 
Maternal age Continuous individual years 
Harmonised 
Analysed 
only as a 
categorical 
variable  





Continuous Bwt (kg) was 






sex and gestational 
age 
Harmonised 
SGA, LGA Categorical <10th percentile z-
score small for 
gestational age 
(SGA), and >90th 
percentile for large 





Caesarean Categorical Mode of delivery 
was caesarean  
Not measured Vaginal or 
caesarean birth 
Not analysed 
in this cohort 
First-born Categorical Birth order was 






SES (birth) Categorical Varied by cohort Father's 
occupational 

























ownership) or not 
deprived indicated 
by presence of 
ownership (both 










Categorical >0.67 SD change 
(birth to ~12 
months) in weight 









The duration of 
any kind of breast 
feeding 
Harmonised 









The duration of 







The age when solid 
foods were 











abuse, debt, death 
or illness in the 
family 
0-12 months From 8 months 
pre-natal to 4 






and both pre 
and postnatal 
*Not analysed in this cohort – only exposures that were important exposures in NTFS and GMS were analysed further in 
ALSPAC 
^ Electronic data were not available  
 
2.2.4 Definition of a confounder 
A confounder is a variable associated with the exposure of interest and the outcome, which 
when unaccounted for can lead to biased regression estimates. Kleinbaum et al,. define a 
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confounder as that whose presence or absence from the full model changes the coefficient 
of the primary explanatory variable by 10% or more (Kleinbaum et al., 1982). This definition 
was kept in mind when adjusting models for potential confounders, and as confounders 
were incorporated into the models their effects on the coefficients of other variables was 
noted to assess their impact. Key confounders were however identified from the literature 
and are listed in Table 1.5.  
2.3 Methods for the epidemiological analysis 
2.3.1 General analytical strategy 
A systematic approach was taken to determine the early life exposures associated with 
subsequent body composition in each of the cohorts. The primary focus of this work was on 
the North East cohorts; NTFS and GMS, and the workflow for the statistical analysis of these 
cohorts is presented in Figure 2.3. Additional analyses are detailed in section 2.3.7. 
In order to compare results across cohorts the data were harmonised as coherently as 
possible (see Table 2.2). Twins/non-singleton births (in the original cohorts: GMS, n=36; 
NTFS, n=28; ALSPAC, n=264) were excluded to satisfy assumptions of independence within 
the regression models, and due to differential intrauterine environments (affecting foetal 
growth) compared to singleton pregnancies. All childhood weight-related variables were 
transformed to z-scores using the same growth reference, and underweight participants (z-
score <-2 or BMI<18.5kg/m2) were excluded, as underweight shows inverse associations with 
all-cause mortality (Prospective Studies Collaboration, 2009), and therefore should not be 
combined with normal weight (the reference group). 
The ALSPAC cohort was utilised primarily for the epigenetic data. However, prior to the 
epigenetic analysis, the associations between exposures and body composition were 
examined to determine the strength and magnitude of the associations. The analysis in the 
ALSPAC cohort was a streamlined analysis utilising only BMIz and OWOB, in order to justify 
the focal exposures for the epigenetic analysis. Although some exposures have been 
analysed with regards to childhood body composition in ALSPAC (Reilly et al., 2005a) some 
were not comparable in their definitions or adjusted for the same confounders, therefore it 
was necessary to run the models for comparability.  
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2.3.2 Descriptive characteristics, sample representativeness and sex differences 
Summary statistics are provided for each exposure and outcome variable for all cohorts. All 
data were checked for the presence of extreme/implausible values, and any invalid 
measures were checked for coding errors (cross-referenced with original data where 
possible), recoded or removed. 
Early life exposures were analysed longitudinally with respect to body composition in later 
life. Attrition is common in longitudinal cohorts and therefore body composition measures 
were not available for the entire original sample at the later time point(s).  
Missing data can reduce the statistical power, can lead to biased estimates and can reduce 
the representativeness of the samples. There are three types of missing data: missing 
completely at random (MCAR), missing at random (MAR), and missing not at random (Kang, 
2013). Ideally a study will be well-planned in order to be representative of a population at 
baseline and with systematic data collection at subsequent follow ups to minimise data loss. 
However, attrition is inevitable in long-term studies. The most common approach to dealing 
with missing data is to exclude those with data missing and performing a complete case 
analysis. It is advised that researchers seek to understand the reasons for the missing data 
(Kang, 2013). In large sample sizes and if the assumption of MCAR is satisfied, then list wise 
deletion can produce unbiased estimates. However, if the sample size is small and MCAR is 
not satisfied then results may be biased. A method of dealing with missing data is 
imputation, which uses the other variables available in the dataset to estimate the missing 
variable, which has the benefit of retaining the initial cohort sample size. However, 
imputation assumes MAR and many imputation procedures assume data are normally 
distributed, therefore when these conditions are not met this could lead to incorrect coding 
of variables. In this study, as many variables were not normally distributed and were either 
binary or categorical variables, a complete case analyses was done. 
The impact of attrition and whether there were differences between those with and without 
body composition measures (the sub-sample) was assessed. This was done using t-tests, 
Mann-Whitney tests or chi-square tests for parametric, non-parametric or categorical 
exposures respectively. The reasons for the missing data was partly due to retention of the 
more advantaged groups, and therefore this was addressed using weighting in the cohort 
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comparison (section 2.3.7.3). Sex differences (if anticipated), were also assessed using these 
methods in the sub-samples (those with body composition measures).  
 
2.3.3 Correlations between exposures and body composition measurements  
To determine whether BMI is an adequate proxy measurement, the strength of correlations 
between weight outcome measures were assessed with Pearson correlation. Correlations 
between exposure variables were also assessed. The correlation coefficient (r), can range 
from +1 to -1, with r>0 indicating a positive association, and r<0 indicating a negative 
association. Results are presented as scatter graphs with Pearson correlation coefficients (r). 
2.3.4 Socioeconomic differences in infant feeding 
In the case of infant feeding, which is often socially patterned in the UK, SES is an important 
confounder. Therefore, differences in infant feeding by socioeconomic groups (birth) were 
assessed. In NTFS, the data were continuous and therefore this was done using either 
analysis of variance test (parametric data), or a Kruskal-Wallis equality-of-populations rank 
test (non-parametric). In GMS, the breastfeeding data were categorical; therefore, a Chi2 test 
was used. 
2.3.5 Examining the associations between early life factors and subsequent body composition 
Linear regression modes were used to examine associations between exposures and 
continuous outcome variables (i.e. BMI/BMIz). Linear regression, in its simplest form 
(bivariate), can be used to establish the strength of the relationship between the dependent 
variable (y, outcome) and independent variable (x, exposure), which can be viewed as the 
equation: 
y = α +  βx +  ε 
Where α is the constant or y-axis intercept, and ε is the residual model error. β is the 
coefficient of x or the slope of the regression line, and x is the independent variable.  
 
Linear regression uses the principle of least squares, whereby it aims to minimise the sum of 
all squared deviations of the observed data points from the best fitting regression line, and is 
sometimes referred to as ordinary least squares (OLS) regression.  
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An extension of bivariate regression is multiple regression, which includes multiple 
independent variables. In this model, the β coefficient is adjusted for the effect of any 
additional covariates included in the model.  
The assumptions of linear regression, and how these were addressed are in Box 2.1 and 
Table 2.3 respectively. 
Although linearity is assumed, performing a simple linear regression using a binary 
independent variable is not invalid, it is equivalent to performing a two-sample t-test 
(although addressing slightly different objectives) however with the capacity to adjust for 
covariates. 
Variable selection is an important step when estimating a linear model that explains the data 
in the simplest way. When there are many covariates, stepwise regression is helpful method 
for identifying key predictors. The goal is to produce a parsimonious and accurate model as 
it excludes variables that do not explain the variation in the outcome, and aims to retain 
independent variables that best predict the outcome. This approach is useful for explanatory 
model building; however, it may exclude important explanatory variables and known 
confounders, particularly in very large datasets where other methods may be more 
appropriate (see (Smith, 2018)). Another approach could be to leave all variables in the 
model (full model), however this may lead to many independent variables. This may 
introduce issues with collinearity or insufficient sample sizes to accurately estimate a model 
with many degrees of freedom. Alternatively, existing knowledge could guide variable 
selection, which would thereby only include the key exposures. A disadvantage to this 
approach is that relies on previous knowledge of the relationships, which might not apply in 
different populations. 
Therefore, a combined approach was taken here, utilising stepwise regression to identify the 
key exposures explaining variation in the outcome, but then models were adjusted for key 






Key assumptions of linear regression 
 A linear relationship between the exposure and outcome  
 Homogeneity of residuals (homoscedasticity, residuals should have 
constant variance) 
 Independence of errors (residuals should not be correlated with 𝑦 or 𝑥) 
Other important considerations 
 The residuals are normally distributed (necessary for hypothesis tests to 
be valid rather than estimation of coefficients) 
 Any potential issues with outliers or influential data points (high leverage 
points, a measure of those which deviate from the mean) 
 There should be little collinearity between predictor variables  
 Model specification, the model should be appropriately specified with 
relevant variables and no important missing (omitted) variables 
 Predictor variables should be accurately measured  
 
Box 2.1 Key assumptions and considerations of linear regression 
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Table 2.3 Assumptions of linear regression and how these were investigated in STATA 
Issue/assumption How the assumption was checked 
Linear relationship Using a scatter plot of the x and y variable  
Homoscedasticity  Using a scatter plot of the standardised residuals against the 
predicted values  
Independence of 
errors 
This should not be an issue utilising cross-section data with 
independent study members (twins excluded) 
Normality of residuals Can be examined using a kernel density plot of the residuals with 
the normal density line overlaid, a standardised normal probability 
(p-p) plot, or quantiles of a variable quantiles plot (q-q) 
Influential data Examined using plots that shows the leverage by the residual 
squared 
Multi-collinearity Examined the variance inflation factor (variance inflation factors 
below 10 accepted) 
Model specification The STATA linktest command performs a model specification test 
based on the Goodness of link test (Pregibon, 1980) 
 The regression specification error test (RESET) for omitted variables 
implemented in STATA ovtest (Ramsey, 1969) 
 
Firstly, to determine the relationship between exposures and outcomes of interest, separate 
(bivariate) models were examined for each exposure and outcome. Next, adjusted 
regression models were constructed. Stepwise forward regression models were constructed 
using STATA stepwise modelling, with a p value of <0.1 for inclusion, informed by bivariate 
analyses. Covariates were added manually to models, with model fit informed 
by the Bayesian information criterion (BIC), whereby the model with the lowest BIC is 
preferred (Schwarz, 1978). The BIC is a model selection criterion. Adding more variables to a 
model can result in overfitting; the BIC applies a penalty accounting for the number of 
parameters to identify the best model. 
Logistic regression was performed to examine the relationships between each exposure and 
binary outcome variables (i.e. obesity, or OWOB). Coefficients or odds ratios (OR) with 
corresponding 95% confidence intervals and level of significant (p) are presented. Good 
76 
 
model fit for the multivariable logistic models was determined by Hosmer and Lemeshow’s 
test, no evidence of collinearity and no observations that deviate in an influential manner. 
In addition, to determine the impact of SES on the relationship between early life factors and 
body composition, bivariate models were adjusted for SES. Models were sequentially 
adjusted for SES at birth, SES at age 9, and at both time points, to examine their relative 
effects on regression coefficients. Similarly, the impact of lifestyle factors (at time of body 
composition measurement) was examined in GMS children by adjusting regression models 
for physical activity, and in NTFS adults by adjusting the path model (outlined in section 
2.3.6) for lifestyle factors (smoking and physical activity).  
2.3.6 Examining the pathways between early life factors and BMI 
When examining the relationship between X (exposure) and Y (outcome), all multivariate 
approaches (with more than two variables) involve the questions of moderation and 
mediation. Moderation asks if a third variable interacts with X, whereas mediation asks 
whether it intervenes on the X-Y relationship. Approaches involve statistical methods dealing 
with correlation and partial correlation. For example, these include: multiple regression, 
general linear models, linear mixed models, path analysis, or structural equation modelling 
for continuous data (Garson, 2017). 
Path analysis, which is a form of structural equation modelling, is one way to examine the 
relationships between variables, and as a means of determining which assumptions best fit 
the data at hand (Garson, 2017). Additional information is acquired using path analysis than 
through addition of variables and product terms (interactions) to regression models (Garson, 
2017).  
Alternatively, in the econometrics literature, instrumental variable methods (Sobel, 2008), 
such as two-stage least-square (2SLS) regression models are often used (Cameron and 
Trivedi, 2010). In short, in a regression of x on y, when there is endogeneity, x may be 
correlated with the error term of y which thereby incorporates the effect of unmeasured 
variables (i.e. confounders) (Angrist and Imbens, 1995). The 2SLS models address this by 
using an instrumental variable that predicts X but is uncorrelated with the y error term, 
thereby resolving the issue of endogeneity (Antonakis et al., 2014). A key benefit of this 
method is that it doesn’t require all confounders to be measured and incorporated. 
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However, this approach has several assumptions and requires good instrumental variables, 
which makes it difficult to apply appropriately (Podsakoff et al., 2011).  
If causal inference is the aim, there are numerous other methods that can be employed 
(Antonakis et al., 2014). However, if the aim is to model the relationships between variables 
and depict the relationships graphically, then path analysis is well-equipped. Therefore, a 
path analysis approach was used to investigate the life course impact of early life risk factors 
(0-1 year), SES and lifestyle on subsequent BMI. Path models were used to uncover the 
associations between variables, to disentangle the relative influence of each risk factor, and 
the indirect pathways to BMI.  
The initial baseline path model included the variables that demonstrated significant 
associations in the multivariable linear regression model. Confounders and exposures not 
included in the adjusted model were sequentially included, the model estimated and 
assessed for model fit. The model was grown adding paths between variables with a priori 
hypotheses (Table 1.5, hypothesised relationships presented in the DAG, Appendix A) and 
modification indices (suggested paths to improve model fit, as a measure of change in the 
likelihood ratio chi-square), then non-significant paths were removed until a good model fit 
was achieved.  
Good model fit was determined to be a non-significant χ2, root mean square error of 
approximation (RMSEA)<0.05 and non-significant PCLOSE, and also comparative fit index 
(CFI) and goodness-of-fit index (GFI) both >0.95. All direct paths with p<0.05 were modelled 
and standardised β coefficients are presented. Confidence intervals were determined using 
bootstrapping (50,000 iterations for two rounds of thinning). Standardised β coefficients are 
presented, which represent partial regression coefficients between connected variables, 
controlling for all prior variables (Garson, 2008).  
The indirect effect is the product of each component path, the direct effects are 
straightforward relationships (not going through any other variable) and the total effects are 
the sum of direct and indirect effects.  
A p value <0.05 was used to denote significance throughout. All statistical analyses were 
done in STATA 14 and updated to version 15 in 2017 (StataCorp, College Station, TX) and 





Figure 2.3 Workflow of the statistical analysis in the NTFS and GMS cohorts 
 
2.3.7 Additional chapter-specific sensitivity analyses  
 Sensitivity analysis by ethnicity (chapter 4) 
Whilst it is acknowledged that OWOB disproportionately affect minority groups, there was 
no evidence that early life risk factors varied by ethnicity in the Born in Bradford cohort 
(Fairley et al., 2015a), a cohort with a larger proportion of ethnic minorities. Due to the small 
proportion of non-Caucasian children, the sample was not stratified by ethnicity. However, 
results were checked for robustness by religion due to a notable proportion of ultra-
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orthodox Jewish (UOJ) families in GMS. Sensitivity analysis was carried out to assess whether 
differences in religion may affect estimates in GMS children, which could represent 
socioeconomic differences or differences in feeding practices (as determined previously in 
the GMS cohort (Wright et al., 2010b)).  
 Robust regression (chapter 4) 
There were some outliers in FMI model, therefore a robust regression model was utilised. In 
comparison to OLS, robust regression produces a model which is less affected by outliers or 
influential observations (Rousseeuw and Leroy, 2005). It uses iteratively reweighted least 
squares whereby each point is assigned a weight and then coefficients are estimated using 
OLS. With further iterations, weights are reassigned, with points further from the model 
predictions having smaller weights. The coefficients are then recomputed using the weights. 
Estimation continues until convergence is achieved.  
The workflow for the statistical analysis is specified in section 2.3.5 (Figure 2.3). 
 Inverse probability weighting (chapter 5) 
Additional analyses were carried out in chapter 5 (cohort comparison), including testing for 
interactions within models and inverse probability weighting (IPW). In the regression 
models, interactions between explanatory variables and SES, were tested within the model 
using likelihood ratio tests.  
As cohorts were not representative of the original sample, inverse probability weighting 
(IPW) was carried out as sensitivity analysis, using variables that were significantly different 
between the cohorts (Appendix D, Table X). IPW applies weighting to the sample to 
account for the imbalanced representation of exposures. However repeating analyses with 
weighting minimally altered results, therefore unweighted results are presented.   
 Investigation of early life growth and BMI trajectories (chapter 5) 
Utilising the longitudinal data available, rapid thrive was investigated further with regards to 
BMIz over the life course. Height and weight data were available at various points in 
childhood and adolescence for GMS (ages 0, 1, 3, 6-8, 8-10, 14-16) and NTFS (ages 0, 1, 9, 
13), which were transformed into z-scores as described previous (section 2.2.1). BMIz 
trajectories were plotted by to examine the average growth patterns based on early life 
growth (rapid thrive). 
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2.4  Methods for the epigenetic analysis 
2.4.1 DNA methylation arrays and considerations  
The Illumina Infinium® HumanMethylation450K BeadChip assay (450K array) is a popular, 
cost-efficient method for large-scale profiling of DNAm. The array determines genome-wide 
methylation status of over 485,000 CpG sites. Essentially, it utilises bisulfite treated DNA to 
determine the relative proportions of methylated and unmethylated fragments (Pidsley et 
al., 2013). 
There are multiple platforms for measuring CpG methylation across the genome, with 
perhaps the most popular being the 450K array (>450,000 CpG sites), or the newer EPIC 
platform (>850,000 CpG sites). There is also the capacity to build a custom array, however 
this limits comparability between studies.  
The 450K array covers most known genes, with many probes focused in promoter regions, 
however the array also covers non-CpG island loci including in the; gene body, 3’ 
untranslated region (UTR) and intergenic sequences. Whilst the array has good coverage of 
known genes and previously identified methylated sites, it spans fewer than 2% of CpG sites 
across the genome. 
Prior to the DNAm analysis, DNA is bisulfite modified, which converts unmethylated cytosine 
residues to uracil (and subsequently replaced by thymine), whilst methylated cytosines are 
resistant to bisulfite conversion. The array determines methylation levels by quantifying the 
proportion of cytosine and thymine bases. Estimated cytosine methylation levels are 
expressed as beta values (β), which range from 0 (0% or no cytosine methylation) to 1 (100% 





β =                                                            Methylated signal                                                        
Methylated signal + unmethylated signal +100 
Figure 2.4 The calculation of beta values in methylation arrays. 
Beta values are calculated as the proportion of the signal due to methylated signal over the total signal. To ensure the 
denominator is not zero, a constant (100) is added. Beta values range from 0-1, with higher values indicating higher 




With this feature in mind, it is important to remember that, as a relative proportion across 
all cells, a 50% methylation level could represent half of all cells fully (100%) methylated and 
half of all cells completely unmethylated (0%), or alternatively that 50% the of alleles are 
methylated (allele-specific methylation), or various combinations of these two factors. 
Bisulfite sequencing techniques can provide more information about methylation patterns 
(Song et al., 2013), with the caveats being that the region sequenced is relatively small, and 
any allele-specific driven methylation patterns can be extrapolated only from the region 
sequenced (Fang et al., 2012, Kuleshov et al., 2014). Therefore, if genotype data are not 
available, the influence of other genomic loci nearby or elsewhere cannot be discerned (for 
example the influence of single nucleotide polymorphism (SNPs)). 
The 450K array uses two types of probes that quantify methylation in different ways. Type I 
use a similar design to that exploited in the older 27K beadchip array, which use a single 
colour but with two different probes to capture methylated and un-methylated. Whilst type 
II probes use one probe but two different colours for methylated (red) and un-methylated 
(green). The design of the array creates some issues in analysis, for example; the distribution 
of methylation values differ by probe; type II probes show greater variability and are often 
less reproducible (Dedeurwaerder et al., 2011). Furthermore, some probes exhibit cross-
reactivity or contain polymorphisms (Chen et al., 2013). Difference in colour channel 
performance (related to chip lot and scanner) can affect calculation of beta values. 
Normalisation methods can help to combat these issues.  
At present, the 450K array is the most widely used platform, however with the advent of the 
larger EPIC array it is likely that studies in the future will begin to transition to the newer 
platform.  
The key limitations of the 450K array (cell types, SNPs, batch effects) can be quelled using 
appropriate statistical techniques, as described further in the following sub-sections.  
 Adjusting for cell type heterogeneity  
Determining the proportion of cell types is an important factor in epigenetic analysis. Ideally, 
DNAm would be measured in the tissue relating to the phenotype of interest, however 
obtaining such tissues is often not feasible and considered invasive in human population 
studies. DNAm is most frequently measured in blood, as it is an easily accessible tissue, 
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therefore acting as a surrogate medium. Whole blood is composed of erythrocytes (red 
blood cells), leukocytes (white blood cells) and platelets (Figure 2.5). Leukocytes comprise of 
granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (monocytes, 
lymphocytes), whilst subtypes of lymphocytes include B cells, T cells and natural killer (NK) 
cells. These cells are all nucleated and therefore contain genomic DNA.  
However, this presents a challenge when analysing because DNAm is cell-type specific 
(Illingworth et al., 2008, Mill and Heijmans, 2013), and therefore variations in cell 
proportions will give different methylation profiles. Factors influencing DNAm marks and 
cell-type proportions can be related to; age, phenotype or disease (Mill and Heijmans, 2013). 
Therefore, cell composition, being both associated with the methylation level and in some 
cases also with the exposure/outcome of interest, can confound the relationship between 




Figure 2.5 Lineage of blood cell development.  
Stem cells differentiate to form different white blood cells, platelets or red blood cells.  
 
Discrepancies arising as a result of not adjusting for cell type composition were first noted by 
Liu et al,. in an epigenome-wide association study (EWAS) comparing rheumatoid arthritis 
cases and controls (Liu et al., 2013a). They found that there were many false positive 
associations due to the ratio of granulocytes to lymphocytes, but after correction these 
associations were no longer significant. Re-analysis of previous studies found that much of 
the observed variability in DNAm could be explained by cell composition (Jaffe and Irizarry, 
2014a), highlighting the importance of adjusting for cell composition when using whole 
blood (Adalsteinsson et al., 2012). In an ideal situation, individuals would have their blood 
cellular subtypes sorted and profiled, to determine the proportion of each cell type. 
 
Image from NIH National Cancer Institute 
Image: NCI Dictionary of cancer terms, “Blood cell development”, National Cancer Institute, Available at 




However, this often is not often carried out, therefore computation methods and algorithms 
have been developed for estimation. 
Cell proportions were calculated in ALSPAC using the Houseman reference-based algorithm 
(Houseman et al., 2012). The Houseman algorithm is a popular method to estimate cell 
proportions and has been independently validated (Houseman et al., 2012, Accomando et 
al., 2014). Other reference-based methods exist (Newman et al., 2015), however the 
Houseman reference-based method is often preferred (Kaushal et al., 2017). Alternatively, 
methods not utilising cell references use unsupervised deconvolution methods instead, such 
as surrogate variable analysis, which shows robust sensitivity and specificity (Leek and 
Storey, 2007, Houseman et al., 2016).   
Phenotypic variation in cell-type composition could confound analyses. On the other hand, it 
could also represent an important physiological change in response to an exposure or 
disease, which may be related to the phenotype of interest. When searching for biomarkers 
(related to an exposure) that are associated with a disease outcome, to regress out variation 
from cell counts could potential disregard important loci. Obesity is an acknowledged 
chronic, inflammatory condition. It has been associated with inflammatory indicators 
including C-reactive protein (Visser et al., 1999a) and white blood cell counts (Bastard et al., 
2006, Farhangi et al., 2013). A degree of inflammation is a component of the obesity 
phenotype, therefore to find novel biomarkers associated with this phenotype, biomarkers 
were investigated in models with and without adjustment for cell composition and findings 
were compared.  
 Methods of adjusting for confounding  
There are many potential sources of confounding in DNAm studies. Microarrays are run in 
separate batches due to scale, therefore major sources of variation are row, slide or chip 
effects, processing date or operator (Leek et al., 2010). Thoughtful experimental design and 
randomisation can help mitigate these effects. Direct adjustment will only account for the 
influence of known confounding variables (such as batch, age, or sex). The epigenome is 
complex and influenced by the environment in a manner that is still not fully understood, 
and even in the best-designed studies, there will be many unmeasured factors, which could 
have an impact on DNAm and lead to spurious findings.  
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Methods that account for unmeasured confounders are useful in longitudinal studies on 
human populations where it would be impossible to; measure or to know all potential 
confounding factors, or if they were known, to attempt to integrate them all into a statistical 
model. Many methods have been proposed for dealing with the heterogeneity, either by 
removing non-specific variation (not just from cell types) from unmeasured confounders 
(such as those utilising surrogate variables) (Gagnon-Bartsch and Speed, 2012), or methods 
that were designed specifically for methylation data, such as those developed by Houseman 
et al, (Houseman et al., 2012, Houseman et al., 2014).   
The aim of surrogate variable analysis (SVA) is to remove the unwanted variation, whilst 
retaining differences due to primary variable of interest; thereby identifying consistent 
differences between groups and removing latent variation. These methods are also capable 
of dealing with variation from batch, slide or chip , which cannot always be adequately 
corrected for (Teschendorff et al., 2009). 
SVA finds sources of variation from the methylation data itself, and models these as singular 
vectors (surrogate variables) derived from singular value decomposition, which will be 
linearly uncorrelated. The surrogate variables are then included as covariates in the 
regression model (Leek and Storey, 2007). Independent SVA (ISVA) is a modified version of 
SVA whereby the surrogate variables are deemed independent. In support of ISVA, known 
confounding factors such as age and batch are obviously statistically independent variables 
and are linearly uncorrelated, and therefore it would be appropriate to model these as 
independent variables. ISVA was shown to perform best at capturing a known specific 
biological signature when compared to other adjustment methods (Teschendorff et al., 
2011). However that may not hold true for all datasets (Teschendorff et al., 2011), and the 
best method will be dependent on the tissue type under investigation, and whether the 
analysis is reference-based or reference-free (Teschendorff and Zheng, 2017). A thorough 
study compared each of the common methods (Houseman’s reference-based method, 
RefFreeEWAS, SVA, ISVA, EWASher and RUV) using extensive simulations. There was no 
method that performed perfectly for all parameters measured, however the authors 
concluded that SVA was the most robust (and ‘safest’) method (McGregor et al., 2016). In 
summary, there is support for both SVA and ISVA as high-performing adjustment methods, 
therefore both were utilised in these analyses.  
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 Exclusion criteria  
The 450K array relies on the specific hybridisation of genomic DNA to probes on the chip, 
and therefore alterations in the DNA such as SNPs, repetitive sequences or 
insertions/deletions can interfere with accurate measurement of DNAm (Chen et al., 2013). 
Known SNPs can be cross-referenced and removed prior to or post-analysis.  
It is also recommended to exclude identified non-specific probes to reduce the risk of false 
discovery, as these may not hybridise specifically. SNPs and non-specific probes (Chen et al., 
2013) were removed in epigenetic analyses.  
2.4.2 Measurement of DNA methylation in ARIES 
DNAm was quantified for the ARIES sub-sample using the 450K array (Illumina Inc., CA) 
according to the standard protocol. Cord and peripheral blood samples were collected using 
standard procedures and DNA was extracted. DNA was bisulfite-converted using the Zymo 
EZ DNA Methylation kit (Zymo, Irvine, CA) prior to hybridising DNA to the BeadChip. 
Sample handling, measurement of DNAm and quality control were carried out by the 
ALSPAC team at the University of Bristol. A semi-random approach was used to distribute 
samples across slides to ensure each time point was well represented, and to minimise 
potential confounding by batch effects. Samples failing quality control thresholds (average 
probe P-value ≥0.01) were repeated.  
ALSPAC methylation data were pre-processed with background correction and subset 
quantile normalisation in R (version 3.0.1), using the Touleimat and Tost pipeline (Touleimat 
and Tost, 2012, Relton et al., 2015). The data are processed prior to researcher use, primarily 
applying the following adjustments. Slide effects were regressed out on the raw betas before 
normalisation. Functional normalisation implemented in the R package meffil was used to 
normalise the data, which is a between-array normalization method and an extension to 
quantile normalisation (Fortin et al., 2014). This removes unwanted technical variation by 
regressing out the variation explained by control probes. Normalisation was applied 
separately by gender for the sex chromosomes, and there was also a background correction 
and a dye-bias correction applied. Many ARIES samples have been successfully genotyped, 
and any samples that failed genotype quality control due to sample swaps, gender 
mismatches, or relatedness issues between mothers and offspring were excluded. Gender 
mismatches (n=411) for individuals were assessed by comparing genotype probes to SNP-chip 
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data, or by assessing sex-chromosome methylation. Sample type, whether cells were from 
white cells from buffy coat or peripheral blood lymphocytes from whole blood, did not 
explain much variation in the child or adolescent samples. Any duplicates were removed 
(age 7, n=10; age 17, n=10) with retention of the sample with the highest number of 
detected probes. 
The proportions of CD8 T cells, CD4 T cells, NK cells, B cells, monocytes and granulocytes in 
the samples were estimated using the estimate CellCounts function (using the Houseman et 
al. method (Houseman et al., 2012)), in the minfi Bioconductor package in R by the ALSPAC 
team. Cell counts were corrected for in the linear adjusted models (see Figure 2.6). 
Sensitivity analysis was run with models without correction for cell counts to see if 
correction influenced results.  
DNAm levels are presented as ‘beta’ values (β-value), which represents the proportion of 
cells methylated at each individual locus, ranging from 0-1 (0-100% methylated).  
2.4.3 Statistical analysis  
There were three different analyses undertaken to examine the relationship between DNAm 
data (outcome) and early life exposures, including analysis of differentially methylation 
positions, differentially methylated regions, and differentially methylated positions in a 
subset of candidate loci. 
The significantly differentially methylated loci were analysed further with respect to 
phenotype; to determine if the loci were related to subsequent obesity; and via annotation 
of the gene region to highlight functional characteristics.  
 Differentially methylation positions  
An epigenome wide association study (EWAS) examines genome-wide epigenetic marks 
(DNA methylation) in order to determine differential sources of variation for a given 
exposure or phenotype. For example, this could be to distinguish between cases or controls, 
or between exposed and unexposed. It is also possible to conduct an EWAS on a continuous 
variable, thereby assessing the linear relationship between the exposure/phenotype and 
epigenetic marks. Using methylation data from the ARIES subset of the ALSPAC cohort, 
methylation at individual CpG sites was investigated for each exposure in individual EWAS’s. 
All EWAS and bioinformatics analyses were done in Rstudio version 3.3.2. 
88 
 
For the statistical analysis using the ALSPAC and ARIES data, the associations between 
exposures of interest and DNAm at 7 and 17 years, at more than 450,000 CpG sites were 
examined (for varying numbers of participants depending on exposure data availability (see 
Table 6.9)).  
The EWAS utilised a linear model, with DNAm as the outcome and the exposure of interest 
as the independent variable, as the baseline model. Age and cell type composition are 
important considerations in epigenetic analysis (although many of the DNAm changes that 
have been associated with age are actually due to age-related changes in cell composition) 
(Jaffe and Irizarry, 2014b). Therefore, models were adjusted for age, sex and cell 
proportions. Four models were run in total; unadjusted, adjusted for covariates, surrogate 
variable adjusted and independent surrogate variable adjusted (Figure 2.6). Cell counts 
included; B cells, CD4T cells, CD8 T cells, granulocytes, monocytes and NK cells. Analyses for 
each variable were done for complete cases. As sensitivity analysis, all models were also run 





Model 1 (no adjustment) 
DNAm = exposure 
 
Model 2 (adjusted for covariates) 
DNAm = exposure + age + sex + cell counts 
 
Model 3 (SVA) 
DNAm = exposure + age + sex + cell counts + surrogate variables 
 
Model 4 (ISVA) 
DNAm = exposure + age + sex + cell counts
+ independent surrogate variables 
Figure 2.6 EWAS adjustment models run using the Meffil R package  
 
All analyses were done in R, with the package Meffil (Min et al., 2017). The package employs 
SVA or ISVA methods which have been shown to successfully account for unmodelled or 
unknown confounding factors (such as batch) (Leek and Storey, 2007, Teschendorff et al., 
2011). Meffil simultaneously computes unadjusted, adjusted, SVA and ISVA models, thereby 
allowing results to be compared (Min et al., 2017) (Figure 2.6). Whilst all models are 
computed by the software, only SVA and ISVA models were considered, as the ‘none’ and 
‘all’ models will not capture the residual variation associated with technical (batch) effects.  
In order to minimise the influence of outliers in methylation data, beta values were 
winsorised at the level of 5% (95th percentile cut-off). Winsorising adjusts extreme values so 
that they are transformed to match the next closest value.  
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When computing multiple tests, there is the increased potential to find a significant result 
through chance, which would lead to a false positive. Correction for multiple testing was 
applied using a false discovery rate (FDR) threshold of p<0.05. The Benjamini-Hochberg 
method (FDR) determines the threshold for the expected proportion of false positives (type I 
errors) (Benjamini and Hochberg, 1995). In contrast to the more conservative Bonferroni 
correction (specified p value (i.e. p=0.05) divided by number of comparisons), which treats 
all p values as equal, the FDR assesses P values based on ranking. Bonferroni correction can 
lead to false negatives and runs the risk of discarding significant observations, whilst FDR 
adjustment aims to have the smallest number of false signals appearing as significant, but 
with potentially more type I errors. In summary, the Bonferroni cannot control for type II 
and the FDR cannot for type I, therefore, both the FDR and Bonferroni p values were 
assessed.  
Results of EWAS models were analysed using Q-Q plots. These show how well the specified 
distribution fit the results, and if the quantiles of theoretical and actual distributions agree, 
the points will lie on the line y=x. Departures from linearity indicate issues with the data. The 
Q-Q plots were visually inspected to determine the best fitting model. If the same loci 
appeared in different models, and the Q-Q plots for that variable were equivalent, then 
results from the SVA models were prioritised as it is more robust (McGregor et al., 2016). 
 Differentially methylated regions 
Instead of looking for changes at individual CpG loci, another means of identifying 
phenotypic differences in methylation is to analyse regions. DMRs, which are stretches of 
CpG loci, may have more of a functional effect on gene expression than individual CpG loci 
(Jones and Baylin, 2002). Additionally, if changes in DNAm are small but persistent across a 
region, there is more statistical power to detect them collectively as DMRs (Robinson et al., 
2014).  
DMRcate is an R package which uses Kernel smoothing (non-parametric estimation of the 
underlying curve/structure) for the estimation of DMRs, and allows adjustment for 
covariates (Peters et al., 2015). A study using simulated data found that DMRcate 
outperformed the other methods studied in terms of precision, but with a slightly lower 
sensitivity for change in betas (Martorell-Marugan et al., 2018). Its predictive performance 
was better than Bumphunter and Probe Lasso (two common methods used in DMR analysis), 
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and similar to that of comb-p, which often performs best but is implemented in python 
programming language (Peters et al., 2015). As the intention was to implement analyses 
using R in order to integrate the analysis with other Bioconductor tools, DMRs were analysed 
using the Bioconductor R package DMRcate (Peters et al., 2016).  
DMRcate utilises the limma R package to apply Bayesian linear model methods (Peters et al., 
2016). Similar to the models that were ran analysing single CpG loci, DNAm was the outcome 
and the exposure was the independent variable. However, when using DMRcate it is 
preferable to use M values (log logit transformed Beta values, M=log(beta/1−beta)), from a 
statistical standpoint to deal with any homoscedasticity (Du et al., 2010). Firstly, the t-
statistic for the linear model is computed, and then kernel smoothing is applied with a 
Gaussian kernel bandwidth for smoothed-function estimation (lambda), scaled by a scaling 
factor C (for bandwidth). DMRcate applies correction for multiple testing using the 
Benjamini-Hochberg method to determine the significant CpGs. DMRs are computed using 
the specified lambda for CpGs within that distance from one another, and the p value for the 
DMR is calculated using Stouffer’s method (Stouffer et al., 1949). For optimal prediction of 
DMRs using 450K array data, the recommended settings are (lambda=1000 and C=2); as the 
Gaussian kernel is calculated as lambda/C = sigma, this translates to one standard deviation 
of Gaussian kernel equal to 500 base pairs. Power in DMRcate increases when lambda is 
smaller or C is larger (Odom et al., 2018). 
DMRcate was executed using the recommended settings on the M-values, for each exposure 
and time point, and the models were run with and without adjustment for cell counts. 
Whilst ISVA and SVA have many benefits, unlike other methods such as ComBat (which 
adjusts for batch effects using an empirical Bayes framework (Johnson et al., 2007)), they do 
not directly adjust methylation data, meaning there are no adjusted data for downstream 
analyses. Therefore, in order to keep analysis in line with the previous models, the surrogate 
variables (that were calculated using meffil in the EWAS models) were included as covariates 
in the DMR models. The surrogate variables from the SVA model were used as this is 
deemed the ‘safest’ model (McGregor et al., 2016). Probes ≤2 nucleotides distance to a SNP 
with a minor allele frequency > 0.05, or probes in the list of cross-reactive probes, were 
filtered out (Chen et al., 2013, Pidsley et al., 2016). In this array, these steps filtered out 
approximately 15,518 of 453,723 (~3.3%) loci. In short, the analysis involved running model 
3 in Figure 2.6, both with cell counts and without.  
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 BMI-associated candidate loci approach 
The previous methods have focused on determining new loci primarily concentrated on the 
exposures. In order to narrow down loci to those suspected to be related to adiposity, a 
candidate gene approach was taken using CpG loci found to be associated with BMI. 
Therefore, instead of the 485,000 CpG loci (on the 450K), this BMI-associated, smaller subset 
of CpG loci were instead analysed as outcomes (n=187). This aims to increase the likelihood 
of finding a biomarker that is associated with adiposity, as well as the exposure. The 
candidate loci were selected from a robust, large-scale EWAS that utilised data from across 
multiple cohorts (Wahl et al., 2016). Epigenetic loci were investigated with respect to BMI in 
cohorts of European and Indian-Asian descent (Wahl et al., 2016), which were then validated 
in other population-based studies, and some loci via other methods (e.g. pyrosequencing, 
n=4). After validation, 187 genetic loci were identified as associated with BMI in adults 
(Appendix E).  
These loci were chosen as this was a powerful study that included multiple analytical 
components to produce robust findings. The results were: replicated in separate samples, 
robust to method of analysis, independent of cell heterogeneity and correlated with multiple 
tissue levels, and demonstrated some clinical significance. The study had a large sample size 
(EWAS n=5,387, replication n=4,874) with a diverse population. DNAm was primarily 
investigated in blood; as this is useful for clinical purposes, but there were also moderate to 
strong correlations between tissues (i.e. blood and adipose tissue). The candidate loci also 
mapped to genes with roles such as in lipid metabolism, inflammation, and metabolic, 
cardiovascular, respiratory and neoplastic diseases, suggesting functional roles in disease.  
The early life exposures studied here have been associated with subsequent changes in BMI. 
Therefore, it is plausible to hypothesise that if DNAm is a mediating mechanism between 
exposure and outcome, these early life exposures may influence methylation of those loci 
which are associated with BMI. 
Using the 187 loci as candidate loci, EWAS were run for individual exposures, at both time 
points using the Meffil R program (Min et al., 2017). This involved running the same models 
outlined in Figure 2.6, but in this case DNAm refers to the 187 individual loci.  
93 
 
 Phenotypic differences in methylation  
Methylation at specific, significant loci was examined graphically at the two time points (age 
7 and 17) by phenotype. Within the same individual, the change in methylation over time 
(from age 7 to 17), was also examined with respect to the exposure using the Student’s t-
test. 
To assess whether methylation varied by body composition, differentially methylated loci 
were also investigated with respect to both the exposure and outcome of interest (OWOB). 
A statistical method to test for differences between two or more groups is using an analysis 
of variance (ANOVA) test. A one-way ANOVA is appropriate when there is one independent 
variable. The first assumption of the ANOVA is that residuals are normally distributed. This 
can be determined by inspecting the residual plots. Homogeneity of variance is another 
important assumption of the one-way ANOVA. The Bartlett's test for equal variances can 
provide information as to whether this assumption holds true (the null hypothesis is that all 
groups are equal), however this test is based on the assumption that the samples are 
normally distributed. When there is violation of normality, a more robust test for 
homogeneity of variances is Levene’s test, which is less influenced by departures from 
normality. Similar to Bartlett’s test the null hypothesis is that the variance of all groups is 
equal. Another assumption of the ANOVA is that groups are independent (i.e. study 
members will belong to one group only).  
The null hypothesis for an ANOVA is sometimes referred to as the omnibus null hypothesis, 
as when it is rejected, the ANOVA test statistical indicates that group means are not equal, 
i.e. there is a difference between groups, however it does not indicate which group is 
different. Post-hoc analysis, can be used to identify where the differences lie, and can also 
take into account correction for multiple comparisons (e.g. Bonferroni or Benjamini-
Hochberg), and adjusting the accepted p value threshold. A caveat being, that when the 
estimates are conservative, adjusting for multiple testing increases the likelihood of type II 
errors (false negatives).  
For data that are not normally distributed, there is a non-parametric version of this test 
(Kruskal-Wallis, KW). Similarly, the KW test assumes that the groups have the same 
distributions, but it does not make the same strict assumptions as the ANOVA and is instead 
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rank-based. However, in substituting data to ranks, information is lost, which makes it a less 
powerful test than a one-way ANOVA. 
 
Figure 2.7 The ANOVA null hypothesis 
Visual inspection (box plots) of the data aided interpretation, and histograms of residuals 
were used to determine if the data fit the normality assumption. Bartlett’s test (Snedecor 
and Cochran, 1983) was used to test if groups had equal variances, or Levene’s test in the 
case of non-normality. If data fit the assumptions of normality and variance, a one-way 
ANOVA was used with Bonferroni adjustment for multiple testing, or in the case of non-
normality, the KW test was used. For the KW test, Dunn's multiple comparisons test using 
rank sums (Dunn, 1964) was applied using the user-written STATA program (Dinno, 2015). 
The package applies correction for multiple comparisons, and results were Bonferroni 
adjusted by multiplying the p-values in each pairwise test by the total number of pairwise 
tests. These analyses were done in STATA version 15.1 (StataCorp, College Station, Texas, 
USA) using standard commands aside from those specified. 
 
 Annotation of significant CpG loci 
The human reference genome (GRCh37/hg19 assembly) accessible on the UCSC Genome 
Browser was used for conceptualisation of the gene region (Kent et al., 2002). The genome 
browser is accessible online and allows interactive visualisation of sequence data and gene 
regions from many species, including all vertebrates and some invertebrates. The human 
GRCh37/hg19 assembly was used, which is compatible and consistent with bioinformatics 
tools for 450k analysis. Significant CpG loci were mapped to the genomic location (including 
nearest gene and associated CpG island) using the Illumina ilmn12.hg19 annotation (Hansen, 
2015). To examine if there was consistency in methylation within the CpG island, 
correlations between significant CpG loci (with the other CpG loci in the island) were 
investigated, including separately by exposure.  
If the CpG loci identified from the EWAS were located in proximity to a gene or within an 
island, any other CpG sites on the 450K which mapped to the gene and/or island were also 
examined (individually as outcomes) with respect to the exposure using linear regression 
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(adjusted for age, sex and white blood cells). Similarly, significant CpG loci were investigated 
at the alternative time point (i.e. DNAm in adolescence was also examined at the specified 
loci if in childhood DNAm changes were significant). 
 Examining associations for rapid thrive 
Due to the similarities between RT and RWG, and in an attempt to distinguish effects which 
may be partly due to birthweight, loci that were significant for RWG were analysed with 
respect to RT. This was done using a linear model, adjusted for age, sex, and the SVAs (from 
the RWG EWAS model), with separate models with or without cell counts. 
2.5 Methods for Lab analysis 
Loci of interest identified from EWAS’s in the ALSPAC cohort at age 7 (chapter 5) were 
investigated further in NTFS adults. There were no pre-existing DNA methylation array data 
for the NTFS samples, which is costly to obtain. Therefore, isolation and amplification of the 
loci of interest was achieved using DNA primers. Firstly, the surrounding gene regions were 
identified and checked for suitability. To differentiate the methylated positions, the samples 
underwent bisulfite modification, and the genetic material was amplified. Finally, the 
samples were sequenced to determine the proportion of methylated residues, and data 
were analysed statistically to examine the relationships between DNAm and the phenotype.    
2.5.1 Identification of epigenetic loci 
There were significant (PFDR<0.05) associations (in adjusted models) identified for RWG at 
two CpG loci. These loci were cg01379158 (NT5M) and cg11531579 (no associated gene) and 
were both associated with a 1% increase in methylation (p=0.02) in those who had RWG. 
Furthermore, at both CpG loci the highest methylation was in those with RWG and had 
OWOB. On these criteria, these loci were deemed good candidates for further investigation 





Box 2.2 Gene loci selection criteria 
 
2.5.2 In silico bisulfite conversion and primer design  
Firstly, the region of interest was identified using the UCSC genome browser (Hinrichs et al., 
2018). The CpG site was entered into the search box and the chromosomal location 
confirmed. A region of 1000 base pairs (bp), i.e. 500 bp both upstream and downstream of 
the target locus was used for primer design. The region also encompassed neighbouring CpG 
sites that do not feature on the 450K array.  
The region was inspected for SNPs and repeat elements, which could interfere with gene 
amplification and sequencing. This was done using the drop-down menus to display repeat 
elements and to display common SNPs (SNPs with >= 1% minor allele frequency (MAF) that 
map only once to the assembly), flagged SNPs (SNPs < 1% MAF, or unknown meaning they 
could be >1%) and multiple SNPs (SNPs that map to >1 place on the assembly).  
Gene loci selection criteria 
 A significant change in methylation at a CpG site associated with an early 
life exposure (False Discovery Rate (FDR) adjusted p≤ 0.05) 
 Significant changes in the adjusted (surrogate variable analysis or 
independent surrogate variable analysis adjusted) models (p<0.05) 
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The sequence of the 1000bp region was annotated further in Microsoft Word, this included 
denoting CpG sites, SNPs and primer placement (Box 2.3 and Figure 2.8). The primer 
sequence is based on the bisulfite-converted sequence. Methylated cytosines (methylated 
CpG sites) are resistant to bisulfite modification (overviewed in section 2.5.4). Therefore, 
after bisulfite conversion, all non-methylated cytosines are converted to thymine 
(represents the non-CpG sites and non-methylated CpG sites), and the only cytosine residues 
that remain are methylated cytosines (Figure 2.8). Therefore in order to design primers, the 
sequence must be transformed to the bisulfite sequence (replacing all potentially non-
methylated cytosine (C) with Thymine (T)) (i.e. the cytosine residues not adjacent to 
Guanine), using the method outlined in Box 2.3. 
 
Figure 2.8 Bisulfite conversion and primer placement around the region of interest. 
After bisulfite treatment of the genomic DNA strand and amplification, all non-methylated cytosines have been converted to 
thymine. The sequencing primer is a few bases upstream of the CpG of interest. The forward primer is 63 bases upstream of 
the sequencing primer, and the reverse primer is 80 bases after the last base. The region contains 3 CpG sites and a potential 
SNP. 
 
Primers were designed using Methprimer (Li and Dahiya, 2002), an online tool for designing 
1. The genomic sequence was extracted from the UCSC  
2. Using find and replace (CTRL+H), all spaces were removed by finding ‘^p’ and 
leaving replace clear 
3. Next, all CpG sites were found using the criteria: find ‘CG’, replace with ‘XG’ 
4. Next all non-CpG site C residues were replaced with T using: Find ‘C’, replace 
with ‘T’ 
5. Finally, the Cytosines adjacent to Guanine were converted back to C’s using: 
Find ‘X’, replace with ‘C’ 
Box 2.3 in silico bisulfite conversion 
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bisulfite-conversion-based Methylation primers. Primers for bisulfite sequencing should be 
non-specific regarding methylation status, i.e. the primers will bind whether the CpG is 
methylated or unmethylated (Li and Dahiya, 2002). Therefore, when designing primers, it is 
important to avoid CpG sites.  
The original genomic DNA sequence was entered as the input sequence, with the target 
specified as 500 base pairs (bp) along and 2 bp (CG) in length (e.g. 500,2) where the target 
CpG was located. In the initial primer design (Table 1), all parameters were set to default, 
including an optimum product size of 200 bases, a primer melting temperature (Tm) of 55oC 
(range 50-60 oC) and primer size of 25bp (range 20-30bp). An ideal product size is 150-
200bp, as larger fragments can be more difficult to amplify due to DNA fragmentation during 
bisulfite modification (Patterson et al., 2011). Similar annealing temperatures for the 
forward and reverse primer were also considered when choosing primer sets to minimise 
amplification bias (Shen et al., 2007). If no primers could be identified, then the ‘optimum 
criteria’ were ‘relaxed’ (Table 2.4). 
Primer sets from the Methprimer output were reviewed in turn with reference to the 
annotated bisulfite sequence. If the forward or reverse primer set contained any SNPs or 
repeat elements, then another primer set was selected and inspected. If no primers were 
identified that did not contain SNPs, then the SNP allele frequency was inspected.  
Table 2.4 The optimum and relaxed criteria utilised for primer design 
 Optimum criteria Relaxed criteria  




Primer length (bp) 25 16-25 
SNPs Does not contain SNPS Can contain low frequency SNPs 
 
Oligo nucleotides for the primers were obtained from IDT (Integrated DNA Technologies 
(IDT), IA, USA). The reverse primers were labelled with biotin, which allows for sepharose 
beads to bind when preparing the samples for pyrosequencing. 
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2.5.3 Sample storage and quality 
DNA was extracted from peripheral blood samples previously by Pearce et al. (2012c) using 
the Nucleon BACC2 kit (Tepnel Life Sciences, UK). DNA samples were stored at -80 °C in 
individual wells of four 96-well plates, in either Tris-EDTA (TE) buffer or water, with an 
adhesive plate seal. The sample quality, condition, freeze-thaw cycles, and previous 
treatment prior to retrieving samples was unknown. Therefore, the quality of all samples 
was assessed using a NanoDrop 2000 (Thermo Fisher Scientific, MA, USA) prior to use. As the 
samples had been stored for a long time, the seals had become brittle and did not appear 
airtight, meaning that for some samples there was minimal material left. In an attempt to 
salvage any remaining DNA, 10μL of warmed (37°C) nuclease free water was added to wells, 
the solution was agitated using pipetting, and samples were left for ~1 hour before removal. 
Although biological material can degrade over time, DNA is fairly robust. 
2.5.4 Bisulfite modification of genomic DNA 
First demonstrated by Frommer et al. (1992) and  CIark et al. (1994), bisulfite modification 
allows selective conversion of non-methylated cytosines in genomic DNA, for analysis of 
DNAm. It is considered the gold standard method for DNAm studies requiring resolution of 
single nucleotides (Clark et al., 2006). Bisulfite treatment deaminates (removal of the amine 
group) unmethylated cytosines converting to uracil in single stranded DNA, whilst 5-
methylcytosine (5-mC) remains unchanged (as the methyl group prevents conversion). 
Therefore, following gene amplification, the uracil residues will be amplified as thymine, and 
the 5-mC as cytosine, allowing differentiation between methylated and unmethylated bases 
upon sequencing (Clark et al., 2006). 
Genomic DNA was bisulfite converted using the EZ DNA Methylation Gold™ kit (Zymo 
Research, Cambridge Bioscience, UK) according to the manufacturers protocol. Using this kit, 
bisulfite conversion is quick, as DNA is denatured and bisulfite converted in a single step in 
individual reaction tubes. Using spin columns, the samples are desulphonated and cleaned 
up ready for downstream use. The kit states a conversion efficiency (of non-methylated C 
residues are converted to U) of >99%, and DNA recovery of 75% (Manufacturers handbook, 
Zymo EZ DNA Methylation Gold™ kit, Zymo Research). Generally, this kit performs well in 
terms of conversion (Holmes et al., 2014), and is one of the preferred options when high 
DNA recovery is required (Kint et al., 2018). Samples that were below the threshold of 95% 
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for bisulfite conversion efficiency (determined using the PyroMark software, see) were 
repeated. 
The manufacturer’s protocol recommends converting DNA in the range of 500 pg - 2μg. The 
samples ranged in concentration from 0-100 ng/μL. Therefore, all samples were diluted with 
water to contain either 50ng (or less in the low DNA samples, for which all material was 
used) or 100ng of starting genomic DNA (gDNA) in a volume of 20μL. 
To these samples, 130μL of prepared CT conversion reagent (containing sodium 
metabisulfite) was added and tubes placed in a Bio-Rad thermocycler S1000 (Hercules, CA, 
USA) using the following conditions: 98°C for 10 minutes, 64°C for 2.5 hours and a 4°C hold. 
To bind the sample to the column, the samples were transferred into columns with the 
addition of 600μL of M-Binding Buffer and centrifuged at full speed, and the flow through 
was discarded. Next, samples were washed with 100μL of M-Wash Buffer, and 
desulphonated using 200μL of Desulphonation Buffer for 20 minutes at room temperature, 
and then spun. The samples were then washed twice using 200 μL of M-Wash Buffer. Finally, 
the samples were eluted into a clean microcentrifuge tube using 12 μL of M-Elution buffer. 
2.5.5 PCR optimisation 
Polymerase chain reaction (PCR) is a molecular biology method used amplify stretches of 
DNA. PCR optimisation is required to determine the most appropriate annealing 
temperature (Ta) for the primer set that gives the best product. An optimised reaction was 
deemed as that which produced a clear, single band when visualised on the gel, with no 
secondary products (potential primer dimers). Optimisation was carried out using samples 
that were 50ng or 100ng (prior to bisulfite conversion) to ensure that the PCR would work at 
low DNA concentrations. PCR master mix was prepared in a PCR hood that had been treated 
with ultra-violet light (minimum 20 minutes) prior to use to minimise the risk of 
contamination. PCR master mix was prepared containing GoTaq® Hot Start Green Master 
Mix (Promega), forward and reverse primers, and nuclease free water in the volumes 
specified in Table 2.5. The volume of bisulfite DNA (bsDNA) was dependent on the sample 
concentration: for samples containing 50ng of gDNA 2μL of bsDNA was used, whilst 1μLof 
bsDNA was used for 100ng reactions (plus 9 and 8μL of water respectively). All assay 
validation steps used HEK293T (Human embryonic kidney) cell line DNA.  
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Table 2.5 PCR master mix composition, volume and reagent supplier 
Reagent Amount (μL) Supplier 
GoTaq® Hot Start Green Master Mix 12 Promega (WI, USA) 
Forward primer (10pmol/μL) =10µM 1 IDT (IA, USA) 
Reverse primer (10pmol/μL) 10µM 1 IDT (IA, USA) 
Nuclease free water 8 or 9 Qiagen (Hilden, Germany) 
bsDNA (100ng, 50ng) 1 or 2 Cell line DNA or NTFS DNA 
Total 23  
 
A no template control was included in all PCR assays, which substituted bsDNA for water, to 
detect the presence of any DNA contamination. Methylated controls were also included (0% 
and 100% methylated), ensuring primers could bind irrespective of methylation level. 
Sources of methylated and unmethylated bisulfite converted DNA were commercial 
(unmethylated EpiTect control genomic DNA, Qiagen, Hilden, Germany). 
All PCR reactions were carried out using the Bio-Rad thermocycler S1000 (Hercules, CA, 
USA). The estimated annealing temperature (Ta) was determined using the most respected 
theoretical primer Ta calculation by Rychlik et al. (1990) (Box 2.4). The average Ta (of the 
forward and reverse primers) was used as a mid-point to base the temperature range for 
gradient PCR. 
A temperature gradient PCR was carried out for assays using human cell-line bisulfite 
converted DNA (HEK 293T cell line) in order to determine the optimal Ta. For gradient PCR, 
the 8 rows of the thermocycler each have a different temperature setting for the annealing 
stage. The thermocycler determines the temperature settings based on the range inputted. 
The PCR reactions were then run with the reaction conditions outlined in Box 2.5. 
• Ta=0.3*Tm PRIMER + 0.7*Tm PRODUCT - 14.9 
• Forward = 0.3*49.5 + 0.7*68.4 -14.9                  = 14.85+32.98= 47.83 
• Forward(edit)=0.3*49.4 + 0.7*68.4 -14.9          = 14.82+32.98= 47.80 
• Reverse=0.3*52.3 + 0.7*68.4 -14.9                    = 15.69+32.98= 48.67 
Box 2.4 An example annealing temperature (Ta) calculation for the forward and reverse primers for cg11531579  
Calculations are according to the empirical formula by Rychlik et al,. (Rychlik et al., 1990) 





2.5.6 Gel electrophoresis 
PCR products were visualised on agarose gels. During the validation stage, this gave an 
indication of the amount of DNA (strength of the band), the PCR product size, and whether 
there was any contamination or secondary products.  
Agarose gels contained 1.5% agarose powder dissolved in 1X Sodium boric acid (SB) buffer, 
microwaved until dissolved. GelRed (Cambridge BioSciences, Cambridge, UK), a fluorescent 
nucleic acid dye, was added (2μL per 100ml gel) for staining, which fluoresces when exposed 
to ultra-violet light allowing visualisation. Fragments less than 100bp were likely a result of 
primer dimers.  
For the gels, 2μL of PCR product from each reaction was run alongside a 100bp DNA ladder 
(New England Biolabs, Ipswich, MA, USA), as a guide to fragment size. Gels were run at 90 
Volts for 30 minutes and were visualised using the Odyssey Fc viewer (Li-cor Biosciences Ltd, 
Lincoln, NE, USA).  
1. 1 cycle of 95 °C for 10 minutes  
2. 50 cycles of: 
95 °C for 40 seconds,  
Ta °C for 40 seconds,  
72 °C for 40 seconds; 
3. 1 cycle of 72 °C for 5 mins 
4. 4°C ∞ 
Box 2.5 PCR reaction conditions  
Ta, annealing temperature. 
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2.5.7 Pyrosequencing as a targeted approach for quantifying DNA methylation 
Measuring methylation: Cytosines can be either 
methylated or unmethylated and are therefore binary 
states. Methylation reflects an average across a whole 
sample.  
Pyrosequencing is a high-throughput CpG methylation 
analysis platform, which detects level of methylation 
at multiple, individual CpG sites. It is an accurate, 
reproducible method and considered the “gold 
standard” in DNAm analysis (Kurdyukov and Bullock, 
2016). 
It involves the real-time, sequence-based detection 
and quantification of DNAm. Using sequencing by 
synthesis, the sequential incorporation of nucleotides 
complementary to the template DNA leads to 
detection of nucleotide in the form of a light signal 
(Tost and Gut, 2007)(Figure 2.9).  
Prior to pyrosequencing, template bisulfite DNA must 
be amplified using a biotin-labelled primer. After 
denaturation the biotin-labelled single strand is 
isolated and hybridised to the pyrosequencing primer.  
The hybridised PCR product is incubated with the 
required enzymes (DNA polymerase, adenosine 
triphosphate (ATP) sulfurylase, luciferase, and 
apyrase) and substrates (adenosine 5' phosphosulfate 
(APS) and luciferin). One of the four 
deoxyribonucleotides (dATP, dCTP, dGTP and dTTP) is 
added to the reaction according to the dispensation 
order (determined by the pyrosequencing computer software). When complementary 
nucleotides are introduced, catalysed by DNA polymerase, pyrophosphate is released. The 
pyrophosphate along with APS, is enzymatically converted by ATP sulfurase to ATP. When 
Figure 2.9 Overview of pyrosequencing theory, reactions 
and measurement   
Image from (Qiagen, 2010)) 
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ATP is present, Luciferase converts luciferin to oxyluciferin, which releases visible light in 
proportion to the number of nucleotides incorporated. This light signal is detected by 
sensors in the pyrosequencer, and is emitted as a peak, the height of which is proportional 
to the number of nucleotides in the raw data output (pyrogram). Once unincorporated 
nucleotides have been degraded by Apyrase, the next nucleotide is added and continues 
until the DNA strand is elongated. The methylation level is quantified as the proportion of C 
to T as indicated by the peaks and presented as percentage methylation (Figure 2.10).  
2.5.8 Pyrosequencing assay design 
Pyrosequencing assays require an additional ‘sequencing primer’. This primer ideally would 
be ~10-15bp and start just before the CpG of interest, or a few bases upstream (<15bp). The 
sequence of the sequencing primer needs to avoid CpG sites to ensure binding whether the 
sequence is methylated or unmethylated. The sequencing becomes less reliable further 
away from the sequencing primer, hence it is beneficial to have the sequencing primer 
immediately before the CpG of interest. The sequencing entry (entered for the 
pyrosequencing assay) was the sequence (<100bp) that immediately follows the sequencing 
primer and includes the CpG of interest plus any additional CpGs in the region of interest (in 
this case this included 2 additional CpGs) (Table 2.6). CpG 2 and 3 in the analysis sequence 
are not featured on the 450K array. The sequencing entry also contained a low frequency 
SNP (rs190517174, A: 99.641% (4990 / 5008); G: 0.359% (18 / 5008)). This was entered into 
the PyroMark ID software as ‘R’ to denote either A or G. 
Table 2.6 Dispensation order for the cg11531579 assay.  
CpG Analysis sequence Dispensation order 
cg11531579 RGTTTGTTAAATTC/TGTC/TGTTAC/TGAGT TAGTGCTGATCAGTCGTGATCGAG 
C/T indicates the CpG sites in the sequence. Dispensation order (the sequence in which nucleotides are dispensed) is 
determined by the PyroMark software to maximise efficiency. 
2.5.9 Pyrosequencing protocol 
Both the binding buffer and annealing buffer solutions were prepared according to the 
protocol. The Binding Buffer Solution was prepared to a total of 70μL per sample (beads, 
binding buffer and Milli-Q H2O) as per the measurements in Table 2.7. This was added along 
with 10μL of PCR product to a 96 well plate. The plate was sealed and mixed (1400rpm) for 
10 minutes. To a PyroMark Q96 Plate Low, 40μL of Annealing Buffer Solution was added, 
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comprising of 38.4μL Annealing Buffer (20 mM Tris-Acetate - 2 mM MgAc2, Qiagen, Hilden, 
Germany) and 1.6μL Sequencing Primer (10pM)(Table 2.7). 
Table 2.7 Preparation of the binding buffer and annealing buffer solutions 
 Reagent  Per well (μL) Source 
Binding buffer solution   
1x Binding Buffer 40 Qiagen (Hilden, Germany) 
Streptavidin-sepharose beads 2 VWR International (Leicestershire, UK) 
Milli-Q Water 28  
Total per well 70  
Annealing buffer solution    
Annealing buffer  
(20 mM Tris-Acetate – 2 mM MgAc2) 
38.4 Qiagen (Hilden, Germany) 
Sequencing primer (10pM) 1.6 IDT (IA, USA) 
Total per well 40  
 
After 10 minutes of mixing, the 96 well plate was transferred to the PyroMark® Q96 ID 
Vacuum Workstation (Qiagen, Hilden, Germany). The sepharose beads in the binding buffer 
solution bind to the biotin labelled primer (in the samples). The sepharose-bound samples 
are then isolated and immobilised using the vacuum block tool. The bound-samples then 
undergo denaturation (to single stranded DNA) and washing in the wells of the vacuum 
workstation. Firstly, the samples were rinsed with 70% ethanol. Next, the samples were 
denatured in the denaturing buffer (0.2 M NaOH), and then washed in the wash buffer well 
(10X, pH 7.6 (10 mM Tris-Acetate)). Finally, the samples were released into the PyroMark 
Q96 Plate containing annealing buffer solution. The plate was sealed, the samples heated for 
2 minutes at 80oC, and then left to cool to room temperature for 10 minutes to allow 
annealing of the sequencing primer to the single stranded biotin-labelled PCR product. The 
reagent cartridge was loaded with nucleotides, enzyme and substrate according to the 
volumes calculated by the PyroMark software. 
Samples were run in duplicate from the same PCR reaction (section 2.5.10). Replicates that 
were not within 5% methylation of one another were repeated. Methylated controls (0% 
and 100%) were included in each plate and should be comparable between plates. To 
indicate the presence of contamination, negative controls from PCR (no template control) 
and pyrosequencing (binding buffer solution and no PCR product) were included on all 
plates. Pyrosequencing reactions were carried out using the PyroMark Q96 ID system 
(Qiagen, Hilden, Germany), in 96-well PyroMark Q96 plates (2 batches) on the same day.  
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The PyroMark software output also includes a bisulfite modification quality check (pass 
indicates conversion efficiency >95%), to check that all non-methylated cytosines have been 
converted to thymine. Furthermore, the software also includes a peak height quality check 
for all CpG sites. For any samples that did not pass the quality check, the pyrograms were 
visually inspected and if there were no apparent issues in the bases specified or the peak 
heights, were corrected to ‘passed’ status. Some samples had very low peak heights and 
noisy traces and therefore failed (n=11). This was likely due to low DNA concentrations as all 
the samples which failed due to low peak heights were those that had <50ng of starting 
DNA, therefore these were repeated with 3μL of bsDNA. An example of a pyrogram output 
from the PyroMark software is shown in Figure 2.10. 
 
 
Figure 2.10 Example pyrogram of cg11531579 assay.  
Peak height is presented on Y axis and dispensation order on the X-axis. The blue shaded areas show the CpG sites, with 
corresponding % methylation above. The yellow shaded indicates the bisulfite modification quality check. The peaks 
indicate that light was emitted when that nucleotide was added. CpG 1 is 45% methylated, CpG 2 is 67% methylated and 
CpG is 42% methylated. The n.a. corresponds to the potential SNP which was not a feature of this analysis. 
2.5.10 Pyrosequencing validation 
Pyrosequencing assays were validated across a known range of DNAm concentrations to 
ensure that DNAm is quantifiable across a range of values. Validation was done using DNA 
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methylated control DNA (Epitect, Qiagen, Hilden, Germany) between 0% and 100% 
methylation (Table 2.8). For each CpG, the expected vs observed methylation was plotted on 
a scatter graph, and the linear equation of the line and the correlation between values were 
determined.  











0 0 100 0 10 
5 5 95 0.5 9.5 
10 10 90 1 9 
25 25 75 2.5 7.5 
50 50 50 5 5 
75 75 25 7.5 2.5 
90 90 10 9 1 
95 95 5 9.5 0.5 
100 100 0 10 0 
 
2.5.11 How to define outliers in DNA methylation analysis  
There were some influential outliers in DNAm and therefore steps were taken to address 
these. The influence of outliers can be large when the sample size is relatively small, which 
can affect the mean and increase variability. In statistical models, many of which rely on 
mean differences, this can influence results and model validity. Statistical inference will rely 
on a standard deviation which measures normal spread of data, but extreme values at either 
side of the distribution increases the standard deviation and decreases the likelihood of 
finding a statistically significant difference, which increases likelihood of type II error 
(Cousineau and Chartier, 2010). There are various ways to define outliers and handle 
outliers; however there is no unanimous consensus.  
One route would be to determine if the values obtained are consistent with findings from 
other published studies. There has not been another study which has analysed DNAm at this 
locus using pyrosequencing, and it is acknowledged that alternative methods for quantifying 
DNAm (such as arrays) may differ in the values obtained. However, blood methylation levels 
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in adults have been investigated in a handful of cohorts with freely accessible 450K array 
data. CpG methylation at this locus has been measured in similar populations (European 
decent) in cohorts in Australia and in the Netherlands. In the Brisbane Systems Genetics 
Study (BSGS), DNAm was measured in 614 individuals from 117 families of European descent 
in Brisbane, Australia (Powell et al., 2012). Families consisted of adolescent monozygotic (n = 
67 pairs) and dizygotic (n = 111 pairs) twins, their siblings (n = 119), and their parents (n = 
139). The children were on average 14 years old (range 9-23), adults were 47 years old 
(range 33-75) (Figure 2.12), and beta values at this CpG were between 0.05-0.12 (Figure 
2.11). The authors state that any measurement greater than five interquartile ranges 
(determined/decided by comparing estimates with and without outliers) from its nearest 
quartile was set to missing in order to avoid the influence of outliers (Powell et al., 2012). 
Therefore, the range of methylation values at this CpG could have differed prior to 
adjustment. In the BSGS, methylation at this CpG (cg11531579) positively correlated with 
age (Pearson correlation =0.34, p<0.0001) (Figure 2.12).  
 
 
Figure 2.11. Histogram of methylation (beta values) at cg11531579 in the Brisbane Systems Genetics Study 
(BSGS). 





Figure 2.12 Plot of methylation (beta values) at cg11531579 by age in the Brisbane Systems Genetics Study (BSGS).  
 Line represents the linear fit with shaded 95% confidence intervals. Pearson correlation =0.34, p<0.0001. Age ranged from 
10-75 years. 
 
Another study examined methylation in elderly individuals. In the B-Vitamins for the 
PRevention Of Osteoporotic Fractures (B-PROOF) study, a randomised controlled trial which 
involved B12 and folic acid supplementation, methylation levels were quantified in 87 
individuals aged 65-75 years from the Netherlands using the 450K array (Kok et al., 2015). 
In the B-PROOF study, the range of methylation values was greater than those in the BSGS 
cohort, with beta values ranging from 0.05 to 0.3 (Figure 2.13). The data presented from the 
B-PROOF study are the filtered data, normalised using the Subset-quantile Within Array 
Normalization (SWAN) procedure (Maksimovic et al., 2012) (available in the R package minfi 
(Aryee et al., 2014)).  
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Figure 2.13 Methylation (beta values) at cg11531579 in the B-PROOF study. 
Betas were normalised betas using the SWAN normalisation procedure. Line represent Kernel density estimate. 
Methylation values ranged from 0.05-0.30, median methylation was 0.10. Baseline age ranged from 65-75. Methylation did 
not vary with age within this age range.  
Another option for defining outliers would be to use the statistical formula that defines 
outliers as greater than 1.5 x IQR. Using this formula on NTFS data would exclude data points 
with methylation greater than 11.2% (n=16), which is in line with methylation levels from the 
Brisbane study (max beta value was 0.12, aka 12%). However, this would exclude many 
values that could be valid, as seen in the B-PROOF study, whereby the upper observed 
methylation levels were 32% (beta value 0.32). The upper values in these two large studies 
are very dissimilar (12% - 32%) (Table 2.9) and choosing one of these values as part of the 
criteria would give notably different results. 
In NTFS, DNAm was centred around 3%, with a minority of samples that had very high 
methylation (Figure 2.14). Therefore, using a percentile cut-off (90th percentile, >13.4%) 
would exclude those with very high methylation, leaving observations that are more 
representative of the sample generally.  
Different cohorts adopt different methodological processes for dealing with outliers in their 
data, and different normalisation pipelines. This makes comparing the statistical outliers 
with values obtained in previous studies problematic, as the data presented are often 
processed data (such as with B-PROOF and BSGS), with limited information provided on the 
processing steps applied. 
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However, as there is consistency in the values specified using the statistical formula, 90th 
percentile and the Brisbane study, there is some agreement for an upper limit of 12% (Table 
2.9). Therefore, the definition of ‘high methylation’ utilised here was methylation >12%, 
which is reasonable considering the characteristics of the data. Methylation increases at this 
locus with age (Figure 2.12), which could explain some differences observed, and the 
Brisbane study included ages more similar to this cohort, whereas the B-PROOF study 
included older participants.  
Sensitivity analysis was done excluding the outliers. Outliers were defined as those with 
>12% methylation, in line with findings from previous studies (Table 2.9). Statistical analyses 
were repeated with outliers excluded to see how this influenced results.  
It is worth noting that other factors such as disease or lifestyle can influence methylation 
patterns (Robertson, 2005, Anderson et al., 2012). In NTFS, no variables (sex, smoking, 
exercise, SES, RWG, birthweight, alcohol intake) predicted whether an individual had outlier 
methylation. Sample sizes were too small to investigate whether high methylation levels 
were associated with disease (i.e. cancer or infection). 
 
Table 2.9 Threshold methylation values for the different approaches to defining outliers for cg11531579 
Method Study Threshold methylation value 
Statistical method (>1.5*IQR) NTFS 11.2 
90th percentile  NTFS 13.4 
Comparison with other data sets Brisbane 12 
B-PROOF 32 
ALSPAC  12 
Beta values are presented as % methylation for comparison. IQR, inter-quartile range.  
2.5.12 Statistical analysis 
Pyrosequencing results were analysed using STATA version 15 (STATA Corp., Texas, USA), 
and methylation values are reported as percentages (0-100%). Average (mean) DNAm was 
calculated at each individual CpG locus from the duplicate pyrosequencing reactions. From 
this, overall mean methylation (across the region spanning 3 CpG loci), was calculated as the 
average of the 3 values at the 3 loci. The correlation between CpG loci was assessed using 
Pearson’s correlation, and were also examined stratified by RWG.  
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There were outliers in DNAm values (very high methylation), which positively skewed the 
data, therefore the median was the preferred summary statistic. Outliers were detected 
across all CpG loci, and those which had high methylation at 1 CpG site tended to also have 
high methylation at the other loci. The impact of the outliers was addressed by using the 
statistical methods for non-parametric, positively skewed data. Furthermore, sensitivity 
analysis was carried out to assess the impact of the outliers.  
Summary statistics are presented for DNAm by RWG and by body composition (OWOB, OB). 
Phenotypic (RWG, OWOB, OB) differences in DNAm were compared using Wilcoxon signed-
rank test(s). DNAm between sub-phenotype groups (no RWG/RWG and OWOB/healthy 
weight) were compared using the non-parametric Kruskal-Wallis test. This test is less 
sensitive to outliers, or non-normal distributions, and therefore is a more appropriate test to 
use than the ANOVA. A post-hoc Dunn’s test was used to adjust for multiple comparisons. 
The association between DNAm and phenotype was assessed further in regression models 
(detailed methods in section 2.5.12.1), with adjustments for sex. Batch (i.e. pyrosequencing 
plate) was initially included as a factor variable in regression models, however inclusion did 
not affect estimates (<10% change in coefficients) and therefore batch was not considered a 
confounder in these analyses. Stratified analysis was carried out to examine methylation in 
only those who had RWG in childhood (the exposed group), with regards to adult OWOB.  
Analyses of the epigenetic datasets (to determine outliers) was done using R version 3.5.2, 
and reports methylation (beta values, ranging from 0-1). 
 Statistical models 
Both the relationship between the early life exposure (RWG) and later life DNAm, as well as 
the relationship between DNAm and outcome (body composition) were of interest, and 
were addressed using an adaptation of the ‘meet in the middle’ approach. This strategy has 
been proposed as a means to identify intermediary biomarkers related to both exposure and 
disease outcome (Vineis and Perera, 2007), and has been previously applied in the 
metabolomics literature (Chadeau-Hyam et al., 2011, Assi et al., 2015). In short, this 
approach evaluates the following relationship: exposure  intermediate biomarkers of 
exposure  disease. In this approach, omics data from prospective cohorts is used to 
identify molecules that represent intermediate markers of early effect, which are used to 
link exposures with disease endpoints (Vineis and Perera, 2007). The approach is flexible in 
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that it can utilise data from a prospective study, or can crossover between exposure 
biomarkers and disease risk markers from case-control studies. If searching for causal 
associations, the causal nature of an association is reinforced if it is found in all three steps, 
however causality is not justifiable without formal mediation analyses. 
Statistical models were utilised to examine the associations between the 
exposure(RWG)DNAm, and the DNAmoutcome (body composition) associations to 
gauge clues about DNAm as a possible intermediary. These models had to consider the 
characteristics of the data and the model assumptions, therefore a variety of models were 
utilised (Table 2.10). 
The relationship between body composition outcomes (OWOB, OB) and DNAm (exposure) 
were assessed using logistic regression. As sensitivity analysis, stratified analysis examined 
associations in the exposed (those who had RWG) population (Appendix F, Table XXIV) 
however associations did not differ. 
There were indications from the scatter plots that the relationship between BMI and DNAm 
was non-linear (outlined in section 2.5.12.1.1). Therefore, fractional polynomial models were 
used in order to determine the appropriate power transformation for these data. Median 
and Tobit regression models were used to examine the relationship between DNAm and 
RWG, to account for the positive skew in the dependent variable (DNAm).  
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a DNA methylation (DNAm) refers to separate models for the 3 individual CpG loci, and for average methylation.  
b Sensitivity analysis was done for CpG3 only (as it was the CpG of interest).  
2.5.12.1.1 Fractional polynomial terms 
Fractional polynomial (FP) models can be used to compare fit in regression models using 
non-linear functions (Royston and Altman, 1994). The combinations of powers (−2, −1, −0.5, 
0, 0.5, 1, 2, 3) are each fitted to the model until the best fitting model (lowest deviance) is 
achieved. The FP degree of the polynomial (the largest exponent) is termed m.  
Linear regression using the derived fractional polynomial terms was utilised with BMI as the 
outcome and DNAm as the predictor.  
2.5.12.1.2 Median regression model 
Standard linear regression uses the mean of the dependent variable (Y) to make inferences 
about the data, whereas quantile regression makes predictions for a given quantile of Y, 
such as the 50th (median). Median regression is a semi-parametric form of regression 
analysis which is more robust to outliers than standard linear regression (Koenker and 
Bassett Jr, 1978). It does not require the same assumptions as linear regression regarding a 
parametric distribution of the residuals or constant variance. Median regression was utilised 
to examine the relationship between methylation (age 50) with the exposure, RWG, 
adjusted for confounders (sex, birthweight). Robust estimates of standard error are 
reported, to account for heteroscedasticity (demonstrated using residual plots). These 
results were compared with those from the Tobit models. 
2.5.12.1.3 Tobit model 
A Tobit model was also used to estimate the linear relationship between methylation and 
RWG. The Tobit model is a censored regression model, which estimates linear relationships 
between variables when there is censoring in the outcome variable from either above or 
below (Tobin, 1958). Censored distributions are a mixture of both discrete and continuous 
distributions. Values above or below a threshold are censored (i.e. unknown above the 
upper or below lower limits), such that all values take on that specified value, even if the 
true value may be higher or lower. For example, the Tobit model will regard observations 
below the lower limit as lying somewhere between the limit and zero. 
Censoring from below would apply in this case to accommodate the many methylation 
values that equal 0 (Humphreys, 2013). The presence of many zeros in the dependent 
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variable causes issues when using an ordinary least squares model, as the data are positively 
skewed. However, it is assumed that these are true zeros in this case. Here the outcome 
(methylation) has both a lower and upper limit of detection (as identified in the assay 
validation), meaning methylation is frequently reported as 0% because the sensitivity of this 
assay (the smallest value of methylation that was observed at 0% methylation in the 
validation) was ~3% (Figure 2.14). In this case, a Tobit model would be appropriate, with 
lower censoring at 3%, which would mean that any observation less than 3% is not known 
exactly but then takes on that value. Upper censoring was also applied with the upper 
detection limit from the assay validation.  
 
Figure 2.14 Observed distribution of methylation values at CpG3 (cg11531579).  
If the lower limit of the assay is 3% (dashed line), then n=80 of these samples fall above the limit. Therefore, the 
distributions for samples with over 3% methylation is known, but only know the number of observations below 3% is 
known. Median regression and Tobit regression were utilised to address this issue.  
2.5.13 Potential effects of single nucleotide polymorphisms 
A potential explanation for the high methylation observed in some samples, is that SNPs 
either upstream or downstream could also influence methylation (Gibbs et al., 2010, Chen et 
al., 2013). In order to investigate if methylation patterns were being influenced by SNP 
effects, the region nearby the CpG of interest was sequenced. Samples were selected with 
high methylation (>12% methylation). There were 7 samples with high methylation, which 
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had DNA remaining. These were randomly matched (sex, RWG, BMI (age 50)) with other ‘low 
methylation’ (<5%) samples using the STATA program ccmatch (Cook, 2015).  
Genomic DNA primers were designed using the region 800 bp either side of the CpG of 
interest, forming a product size of 865 bp. PCR reactions were optimised as described 
previously (section 2.5.5) using a temperature gradient at both high (100ng) and low (50ng) 
amounts of DNA. Once optimised, PCR was carried out on the NTFS DNA samples, which for 
many samples used the remaining DNA. An estimated 20ng of gDNA (where available) was 
used for each PCR reaction in a total reaction volume of 24uL. Some samples failed (likely 
due to very low DNA concentrations), with no visible bands when visualised using gel 
electrophoresis, leaving 3 pairs (n=6) samples for sequencing.  
PCR clean up and sequencing (of the left and right strands) was carried out by the University 
of Sheffield Core Genomic Facility. After sequencing, the left and right reads need to be 
aligned, however all the left reads failed sequencing, and therefore the reverse complement 
of the right sequence was used for analysis.   
The sequence traces were visually inspected for quality. Sequences were aligned to the 
reference sequence using genescreen, a desktop program for alignment of multiple DNA 
sequences that highlights SNPs (Carr et al., 2011). The SNPs were compared between 
matched pairs. Linkage disequilibrium, when genetic variants are inherited in a non-random 
manner, was examined using the web-based tool: LDlink (Machiela and Chanock, 2015). 
Between two genetic variants, D prime (D') indicates the allelic segregation, and R squared 





Chapter 3. Exploring the relationship between early and 
later life exposures and obesity in middle-age  
3.1 Introduction 
This chapter addresses the first aim of the thesis and examines if early life factors and SES 
are associated with body composition in NTFS adults (aged 49-51 years), in order to 
determine which (if any) early life factors have a lasting effect into middle age, irrespective 
of various lifestyle and socioeconomic influences. The investigation of early life factors for 
obesity risk is a relatively recent concept, hence early life factors have been investigated in 
few pre-obesogenic cohorts so far. Additionally, the majority of the literature concentrates 
on childhood obesity, and there is limited data as to whether these are risk factors in adults, 
due to a lack of long-term follow-up data in many studies (Parsons et al., 1999). Data from 
NTFS, which commenced in 1947, provides the opportunity to investigate early life factors 
for in a pre-obesogenic, post-war cohort of middle-age adults to address these 
shortcomings.  
These are important questions to ask as they might direct whether interventions or 
resources should focus on addressing the early life exposures, or on modifying environment 
and lifestyle, in order to reduce the burden of obesity.  
3.2 Aims 
The analysis in this chapter utilises data from a pre-obesogenic environment cohort to i.) 
Determine if early life exposures were associated with adult body composition in the NTFS 
cohort; ii.) Examine if risk factors vary for different outcomes i.e. using proxy measures or 
direct measures of body composition and distribution; and iii.) Examine the relative 
contribution of early life factors, SES and lifestyle to adult BMI, as well as the relationships 
between these factors. 
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3.3 Participants and Methods 
3.3.1 Exposure and outcome data  
The NTFS dataset is described in detail in chapter 2.1.1. A large proportion of the cohort 
were traced at age 50 (n=866, 88%), with 113 lost to follow-up, which included those who 
died (after age 1), moved abroad or were untraceable.  
Early life exposures used in this analysis included birthweight (continuous and categorical), 
occupational social class at birth, maternal age (continuous and categorical), infant feeding 
(breastfeeding, exclusive breastfeeding and weaning age), bacterial infections, adverse 
events, and housing problems. Sex and gestational age were additional covariates.  
Data on lifestyle factors (smoking, physical activity) and socioeconomic position were 
derived from the self-completed questionnaire, and nutrient intake from the food frequency 
questionnaire, at age 50. Multiple dimensions of body composition were analysed as 
outcomes including; BMI and obesity (OB), body fat percentage (BF%) and waist-hip ratio 
(WHR). The coding of the early and late life factors is in section 2.1.1.2. 
3.3.2 Statistical methods  
Descriptive statistics are presented for each demographic, explanatory and outcome 
variable. A potential issue with longitudinal data is attrition (loss of participants over time), 
which reduces sample size and can leave a biased remaining sample. Apart from sex (fewer 
males), the cohort followed up at age 50 were shown to be representative of the original 
cohort for the early life factors examined in a previous study (Lamont et al., 2000). This was 
reassessed for the study members who had BMI measures at age 50, with respect to the 
early life variables of interest in this study (methods in section 2.3.2).  
Relationships between BMI and obesity (BMI>30kg/m2) and each of the early life and later 
life factors were examined using linear (BMI, WHR, %BF) and logistic (obese) regression 




3.4.1 Sample representativeness 
Questionnaires were returned by 574 members and 412 attended a full clinical assessment 
between ages 49-51. There were some differences between the original cohort and those 
who attended the clinic at age 50 (Table 3.1). There were a greater proportion of women 
(p<0.01), and fewer from the lower occupational social class group. Therefore, sex and SES at 
birth were included as covariates in adjusted models.  





Did not attend Attended 
Birthweight (z-score) -0.2 -0.1 0.57 
Maternal age (years) 28.3 28.7 0.28 
Housing problems (%) 58 52 0.06 
Duration Breastfed (days) 132.9 119.6 0.16 
Female (%) 44.6 56.5 <0.01 
 SES (birth, %) 
Least advantaged 33 27 
0.06 Mid 54 62 
Most advantaged 13 11 
P-values calculated from t-tests, chi-square tests or Mann-Whitney tests as appropriate 
3.4.2 Sex differences 
There were no a priori reasons to anticipate sex differences in early life exposures, however, 
socioeconomic differences between men and women have been observed when examining 
obesity (Wardle et al., 2002). Therefore, a Wald test was performed for each outcome for 
the socioeconomic variables (occupational SES at birth and middle age, education and 
income) to determine if there were significant differences between men and women. These 
results indicated that the models for WHR and BF% (but not BMI) should be stratified by sex. 
Furthermore, as there are sex-specific cut-offs for WHR (Table 1.1) and BF% (Table 3.2) for 
men and women, it is appropriate to stratify. There were also biological differences in 
support of stratifying by sex for these outcomes, whereby most men had an ‘at-risk’ WHR 
(82% men, only 21% women), and most men had obese levels of body fat (86%, compared to 





Table 3.2 Percentage BF cut-offs by sex for adults (aged 40-59) using the Gallagher classification 
Age (years) Category Sex   
Men Women 
40–59 Underweight <11.0% <23.0% 
Healthy 11.0%–22.9% 23.0%–34.9% 
Overweight 23.0%–28.9% 35.0%–40.9% 
Obese ≥29.0% ≥41.0% 
 
3.4.3 Descriptive characteristics 
 Outcome measures 
At age 50, the cohort had the same proportion of healthy weight (40%) and overweight 
(40%), with the remainder obese (20%) (Figure 3.1). These figures are in line with UK 1997 
averages (age 45-54) of 43.6% overweight and 22.1% obese (Health and Social Care 
Information Centre, 2014). There were significant differences in BMI categories between 
sexes; with 50% of NTFS men classed as overweight compared to 32% of women.  
 
 Healthy weight (n) (%) Overweight (n) (%) Obese (n) (%) Total 
P 
Males 54 31.2 86 49.7 33 19.1 173 0.001 
Females 103 46.2 73 32.7 47 21.1 223  
Figure 3.1 Proportion (%) of NTFS study members in each weight category at age 50 stratified by sex. 
Number of observations (n). Chi-square p value shown for differences in distributions between sexes 
 
BMI values for males followed a normal distribution, whilst the female values were skewed 
by some values greater than 40Kg/m2 increasing the range of values (Appendix B, Figure VII). 










and women (41.7%) (Figure 3.1) was in the category for greater risk of suffering from obesity 
related health conditions (Gallagher et al., 2000). As to be expected, women had a higher 
mean BF%, however males had a higher BMI and WHR (Table 3.3). Mean WHR in females 
was within healthy limits, whilst the average value for men was in the ‘at-risk’ category.  
Table 3.3 NTFS continuous outcome variables at age 50 stratified by sex 
Outcome  
variable 
Male  Female  
n Mean SD Min Max  n Mean SD Min Max P  
BMI 173 26.92 3.60 19.39 38.74  225 26.48 5.28 15.81 48.09 0.02 
Body fat 
(%) 
172 36.43 7.16 15.40 54.40  223 41.74 9.12 14.40 61.80 <0.001 
WHR 172 0.95 0.06 0.78 1.08  225 0.80 0.06 0.68 0.97 <0.001 
When testing for differences in distributions, parametric t-tests (WHR) were conducted or Mann-Whitney tests (BMI, BF%) 
were used for skewed distributions. Number of observations (n), standard deviation (SD), minimum (min) and maximum 
(max) values and P values for differences between sexes. 
 
 Correlations between adiposity outcomes 
Correlations between measures of adiposity were stronger for females than males (Figure 
3.2). The strongest correlation for both sexes was between BMI and body fat, suggesting 
that BMI is a good predictor of body fat in this population. There were also moderate 
positive correlations between WHR and body fat (Figure 3.2). There was a weak correlation 







A. WHR and BMI  
B. BMI and BF%  
 
C. WHR and BF%  
 
Figure 3.2 Correlations between NTFS outcome measures stratified by sex. 
A.) BMI z-score and body fat percentage (BF%).  
B.) waist-hip ratio (WHR) and BMI z-score.  
C.) WHR and body fat percentage. 









 Exposures  
Descriptive data are presented for all explanatory variables Table 3.4 (continuous or ordinal) 
and Table 3.5 (categorical variables). Aside from females having a higher birthweight z-score 
(Table 3.4), there were no other significant differences between males and females for the 
early life variables (Table 3.5).  
Mean birthweight z-score for this population was lower (-0.18) than the growth reference, 
which likely reflects the earlier date of birth (Cole et al., 1995). The average maternal age 
was 28 years old, with the majority of mothers aged 25-34.  
Most infants were in the normal birthweight category (Table 3.5). There were significant 
differences in birthweight z-score between males and females with significantly more 
females born LGA (12.5% compared to 4%). Around 42% of study members experienced a 
period of rapid growth from birth to twelve months.  
Around a third (30%) of study members who came to clinic at age 50 were breastfed for over 
6 months, whilst 19% were never breastfed (Table 3.5). Infant feeding was not related to SES 
(Appendix B, Figure VIII). Over half of the cohort experienced some form of housing 
problem, a third experienced an adverse event before they were three years old and 18% 




Table 3.4 Early life differences in continuous/ordinal variables between NTFS males and females 
Variable  All  Male  Female   
n Mean 
(SD) 
Min Max  n Mean 
(SD) 







1.93 4.88  173 3.41 
(0.47) 







-3.17 3.02  173 -0.28 
(0.93) 







33 44  171 39.94 
(0.81) 







17 45  173 28.44 
(5.70) 







0 443  168 121.88 
(118.68) 








0 291  170 65.70 
(61.81) 








15 345  168 157.17 
(43.95) 




in first year 
393 1.09 
(1.13) 
0 7  172 1.21 
(1.20) 
 219 1.01 
(1.07) 
0.11 
Number of observations (n), standard deviation (SD), minimum (min), maximum (max) values, and P values (p) for t-tests or 





Table 3.5 Descriptive statistics of categorical early life variables stratified by sex, for the NTFS age 50 sub-sample 
Maternal age at birth (n=398)  
Less than 25 (n=109) 27.2 27.6 27.4 0.99 
25-34 (n=217) 54.9 54.2 54.5  
35+ (n=72) 17.9 18.2 18.1  
Housing problems (n=396)  
None (n=192) 48 48.9 48.5 0.85 
Housing issues (n=204) 52 51.1 51.5  
Breastfeeding (n=219)  
None (n=42)      16.7 20.9 19.2 0.73 
<4 weeks (n=29)  15.6 11.6 13.2  
4 wks - 6 month (n=83) 36.7 38.8 37.9  
6 months+ (n=65) 31.1 28.7 29.7  
Occupational social class at birth (n=390)  
Least advantaged (n=107) 29.8 26.7 27.4 0.29 
Mid (n=240) 56.5 65.3 61.5  
Most advantaged (n=43) 13.7 9.0 11.0  
Bacterial infection in first year (n=301)  
No (n=248) 78.9 85.0 82.4 0.17 
Yes (n=53) 21.1 15.0 17.6  
Viral infection in first year (n=307)    
No (n=218)  42.2 57.8 71.0 0.80 
Yes (n=89) 43.8 56.2 29.0  
Any early life adverse event (first 12 months) (n=352)  
No (n= 303) 50.0 50.0 74.7 0.50 
Yes (n= 49) 44.9 55.1 25.3  
 Row sample sizes (n), column percentages (%) shown and Chi-square p-value (p) presented 
In terms of later life characteristics (Table 3.6), fewer women were educated, and 40% of 
women had no qualifications, compared to 27% of men. The majority of the cohort 
undertook light activity. At age 50, 27% of included NTFS participants smoked, 
corresponding to 28% of women and 25% of men (Table 3.6). This is inconsistent with 
national (PHE) figures which show higher proportions of male smokers (ONS, 2014), although 
differences were not significant (Table 3.6). Over three quarters of the cohort were married.   
Categorical variables Male (%) Female (%) Total (%) p 
Centile categories of birthweight (n=395)      
SGA (n=44) 11.7 10.7 11.1 0.014 
Normal (n=316) 84.2 76.8 80  
LGA (n=35) 4.1 12.5 8.9  
Weight categories of birthweight (n=398)      
LBW (n=10) 1.7 3.1 2.5 0.598 
Normal (n=382) 97.1 95.1 96  
HBW (n=6) 1.2 1.8 1.5  
RWG (n=163)      
No (n=95) 59.7 57.3 58.3 0.759 
Yes (n=68) 40.3 42.7 41.7  
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Table 3.6 Descriptive statistics of explanatory later life categorical variables related to growth stratified by sex, for the NTS 
age 50 sub-sample.  
 Later life variables Male (%) Female (%) Total (%) p 
Occupational social class at 50 (n=375)  
Least advantaged (n=52) 11.6 15.6 13.9 0.295 
Mid (n=132) 39 32.2 35.2  
Most advantaged (n=191) 49.4 52.1 50.9  
Education (n=382)  
None (n=131) 26.8 39.9 34.3 0.004 
O-level (n=131) 32.3 35.8 34.3  
A level (n=71) 25 13.8 18.6  
Degree (n=49) 15.9 10.6 12.8  
Educated past secondary school (n=382)  
No (n=262) 59.1 75.7 68.6 0.001 
Yes (n=120) 40.9 24.3 31.4  
Physical Activity (n=387)  
Inactive (n=43) 7.7 13.7 11.1 0.156 
Light Activity (n=191) 54.8 45.2 49.4  
Moderate (n=90) 21.4 24.7 23.3  
Heavy Activity (n=63) 16.1 16.4 16.3  
Current smoker at age 50 (n=395)  
No (n=288) 74.7 71.6 72.9  0.485 
Yes (n=107) 25.3 28.4 27.1  
Current marital status (n=393)  
Not married (n=79) 17.8 21.9 20.1 0.313 
Married (n=314) 82.2 78.1 79.9  
Row sample sizes (n), column percentages (%) shown and Chi-square p-value (p) presented 
 
3.4.4 Relationships between early life exposures and later life BMI and obesity 
In order to determine which early and later life factors might be predictive of middle-age 
BMI and obesity, each of these factors were examined individually (Table 3.7). In bivariate 
(unadjusted) analyses, study members were over twice as likely to be obese if they had a 
bacterial infection in the first year of life. However, there were no significant associations for 
viral infections. Those who smoked and participated in heavy physical activity were also 
significantly less likely to be obese. Current smokers had a significantly lower BMI. However, 
there were no significant differences in BMI or obesity likelihood between ex-smokers and 
non-smokers, or for number of pack years (Appendix B, Table VI). Those who did heavy 





Table 3.8).  
A lower BMI was associated with having an older mother (aged over 35), whilst being 
educated and married was associated with a higher BMI. Socioeconomic advantage was 
associated with lower BMI. There were no associations for birthweight, adversity, 




  BMI  OB 
  Coef CI p  OR CI p 
Sex Female -0.40 [-1.29,0.49] 0.38  1.12 [0.68,1.84] 0.66 
Birth 
Birthweight (z-score) -0.08 [-0.49,0.33] 0.71  1.10 [0.87,1.40] 0.42 
Gestation (weeks) 0.25 [-0.15,0.66] 0.22  1.18 [0.90,1.55] 0.23 
Maternal age 
Continuous  -0.07 [-0.14,0.00] 0.06  0.99 [0.94,1.03] 0.50 
<25 0.45 [-0.59,1.48] 0.40  1.37 [0.79,2.38] 0.26 
25-34 Ref  .  Ref  . 
35+ -1.46 [-2.63,-0.29] 0.01  0.75 [0.36,1.55] 0.44 
Infant feeding 
Never breastfed Ref  .  Ref  . 
<4 weeks 0.55 [-1.52,2.63] 0.60  2.29 [0.70,7.49] 0.17 
4 wk – 6 months 0.26 [-1.46,1.97] 0.77  1.53 [0.53,4.40] 0.43 
6 Months + 0.68 [-0.94,2.31] 0.41  1.52 [0.55,4.20] 0.42 
Breastfed (days) 0.00 [-0.00,0.01] 0.14  1.00 Ref 0.37 
Exclusive (days) 0.01 [-0.00,0.02] 0.15  1.00 [1.00,1.01] 0.29 
Weaning age (days) -0.01 [-0.02,0.01] 0.35  1.00 [0.99,1.00] 0.37 
Early life 
Rapid weight gain 0.76 [-0.44,1.97] 0.22  1.22 [0.51,2.91] 0.66 
Any infection 1.22 [0.33,2.10] 0.01  2.03 [1.21,3.39] 0.01 
Number of infections 0.42 [0.02,0.82] 0.04  1.36 [1.11,1.67] <0.01 
Bacterial infection 1.88 [0.53,3.23] 0.01  2.60 [1.34,5.02] 0.01 
Viral infection 0.29 [-0.82,1.39] 0.61  1.51 [0.83,2.73] 0.18 
SES (childhood) 
Least advantaged Ref  .  Ref  . 
Mid -0.92 [-1.93,0.08] 0.07  0.55 [0.32,0.95] 0.03 
Most advantaged -1.40 [-2.98,0.18] 0.08  0.35 [0.13,0.99] 0.05 
Housing score -0.02 [-0.43,0.38] 0.91  1.12 [0.89,1.39] 0.33 
Overcrowding 0.33 [-0.66,1.31] 0.52  1.65 [0.98,2.78] 0.06 
Adversity Any adverse event 0.16 [-2.02,2.33] 0.89  1.93 [0.66,5.61] 0.23 
SES  
(later life) 
Social class  Ref  .  Ref  . 
Mid -0.63 [-2.04,0.79] 0.39  0.53 [0.26,1.08] 0.08 
Most advantaged -0.59 [-1.95,0.76] 0.39  0.40 [0.20,0.80] 0.01 
Educated 0.51 [-0.46,1.48] 0.30  0.93 [0.53,1.62] 0.79 
No qualifications Ref  .  Ref  . 
GCSE/O-level -1.11 [-2.20,-0.02] 0.05  0.58 [0.31,1.08] 0.09 
A level 0.29 [-1.01,1.58] 0.67  0.86 [0.43,1.74] 0.68 
Degree -0.50 [-1.96,0.95] 0.50  0.54 [0.22,1.32] 0.18 
Income   -0.31 [-0.75,0.13] 0.17  0.79 [0.62,1.01] 0.06 
Married 1.01 [-0.11,2.12] 0.08  1.65 [0.82,3.29] 0.16 
Lifestyle 
Inactive Ref  .  Ref  . 
Light activity -1.25 [-2.75,0.24] 0.10  0.73 [0.35,1.52] 0.40 
Moderate activity -1.99 [-3.64,-0.35] 0.02  0.43 [0.18,1.01] 0.05 
Heavy activity -2.90 [-4.65,-1.15] <0.001  0.16 [0.05,0.52] <0.001 
Smoker -1.32 [-2.31,-0.34] 0.01  0.53 [0.28,0.99] 0.05 
Coefficients (coef) and odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of 
significance (p); Ref, reference group. Bold indicates significant at p<0.05. 
  
Table 3.7 Bivariate (unadjusted) associations between exposures of interest and outcomes obesity (OB) (logistic 
regression) and BMI (linear regression) in NTFS study members (age 50) 
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 Socioeconomic factors 
Those in the most advantaged socioeconomic group compared to the least at birth had a 
lower BMI in the unadjusted analysis (coef=-0.43, p=0.06)(Appendix B, Table III). Being 
educated to O-level was associated with a lower BMI compared to those with no 
qualifications (coefficient=-1.11, p<0.05), however, there was no trend across increasing 
educational attainment (Appendix B, Figure IX). 
As this cohort experienced great upward social mobility (previously reported by (Forrest et 
al., 2011)), this was investigated further regarding BMI. Social mobility was not associated 
with BMI, but those consistently in the mid advantaged occupational social class group had 
2.6 kg/m2 lower BMI (p=0.01) on average (Appendix, Table III). However, increasing social 
advantage was associated with lower odds of obesity across multiple levels (Appendix, Table 
III). Odds were lowest for those always in the most advantaged groups compared to always 
in the least (OR=0.09, p=0.005). 
There were no associations for other SES variables including experiencing adversity, housing 
issues or overcrowding (a composite of housing issues) in the first year, and any adiposity-
related outcome measures.  
3.4.5 Multivariable regression models for BMI and obesity 
The adjusted model for BMI shows that the significant early life exposures were older 
maternal age and bacterial infection in the first year, adjusted for sex, early and later life 





Table 3.8). Physical activity level (PAL), smoking and social class (age 50) were also 
independent significant predictors of BMI. These factors explained 17% of the variation in 
BMI. 
Adjusting for social class at birth attenuated the associations for sex, older maternal age, 





Table 3.8). The association between BMI and being married was attenuated by SES and was 





Table 3.8 Multivariable linear regression model for early and later life factors and BMI in NTFS study members age 50 
(n=262).   
BMI (age 50) Coef CI p 
Female -0.8 [-1.88,0.28] 0.147 
Maternal age    
<25 0.43 [-0.81,1.67] 0.498 
25-34 Ref  . 
35+ -1.52 [-2.96,-0.08] 0.038 
Social class (birth) Ref  . 
Mid -1 [-2.28,0.28] 0.125 
Most advantaged -0.78 [-2.88,1.32] 0.465 
Bacterial infection 2.12 [0.70,3.53] 0.003 
Duration breastfed (weeks) 0.03 [-0.00,0.06] 0.079 
PAL  Inactive Ref  . 
Light activity -2.30 [-4.17,-0.42] 0.017 
Moderate activity -3.09 [-5.14,-1.03] 0.003 
Heavy activity -3.89 [-6.18,-1.60] 0.001 
Smoker -2.31 [-3.57,-1.06] <0.001 
Social class (age 50) Ref  . 
Mid -2.02 [-3.74,-0.29] 0.022 
Most advantaged -1.58 [-3.27,0.11] 0.067 
Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p); Ref, 
reference group. Bold indicates significant at p<0.05. All covariates are presented.  
 
In multivariable analysis; infections, smoking and heavy PAL remained significant predictors 
of obesity (Table 3.9). SES at birth was no longer significant, and instead later life SES was a 
significant predictor of obesity.  
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Table 3.9 Multivariable logistic regression model for early and later life factors and obesity in NTFS study  
members age 50 (n=275) 
Obese (age 50) OR CI p 
Female 1.22 [0.62,2.40] 0.57 
Social class (birth) Ref  . 
Mid 0.55 [0.26,1.18] 0.13 
Most advantaged 0.52 [0.14,1.98] 0.34 
Bacterial infection 2.75 [1.30,5.79] 0.01 
PAL  Inactive Ref  . 
Mild 0.62 [0.24,1.57] 0.31 
Moderate 0.41 [0.13,1.24] 0.11 
High 0.06 [0.01,0.53] 0.01 
Smoker 0.35 [0.15,0.81] 0.01 
Social class (age 50) Ref  . 
Mid 0.29 [0.11,0.75] 0.01 
Most advantaged 0.36 [0.14,0.89] 0.03 
 Odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Ref, 
reference group. Bold indicates significant at p<0.05. All covariates are presented. 
 
In summary, bacterial infection was the only early life risk factor associated with both 
increased BMI and obesity in adjusted models. Being more advantaged in later life, and the 
lifestyle factors; smoking and heavy physical activity were associated with reduced odds of 
obesity and a lower BMI. 
3.4.6 Relationships between early life exposures and alternative measures of adiposity 
The relationships between risk factors and BF% and WHR were also considered. These were 
investigated separately by sex.  
 Body fat percentage analysis 
There were differences in associations between risk factors and BF% in males and females 
(Appendix B,Table IV). In bivariate models for men, social class at birth, income and smoking 
were all significantly associated with decreased body fat, whilst high social class at 50, being 
educated and being married were associated with higher body fat (Appendix B, Table IV).  
In females, there were significant, positive associations for duration breastfed and bacterial 
infection in the bivariate models, whilst moderate and heavy physical activity was associated 





In the multivariable model for males, social class at birth and smoking were significant 
predictors of lower BF% (Table 3.10). Father’s social class (birth) remained a significant 
predictor after adjustment for the study members own social class in middle age. The 
coefficients and strengths of the associations increased for social class at 50 and smoking 
after controlling for social class at birth. Income was no longer significant after controlling 
for occupational social class (age 50). Whilst higher social class at birth was associated with 
decreases in body fat, social class at time of measurement was associated with increased 
body fat (p=0.06), although the effects of SES at birth were more significant (p<0.001).  
In the multivariable model for females, bacterial infections were associated with increased 
body fat and heavy physical activity with decreased body fat in women (Table 3.10). These 
relationships were not influenced by social class and there was strong support for the model 
without SES at birth.  
 
Table 3.10 Multivariable linear regression model for associations between early and later life factors and BF% in NTFS males 
and females (age 50).  
BF% Males Coef CI p  BF% Females Coef CI p 
SES (birth) Ref  .  
Bacterial 
infection 
4.33 [0.36,8.30] 0.03 
Mid -3.74 [-6.17,-1.31] <0.001  
Breastfed 
(weeks) 
0.07 [-0.02,0.15] 0.13 
Most 
advantaged 
-5.88 [-9.39,-2.37] <0.001  PAL    
SES (age 50) Ref  .  Inactive Ref  . 
Mid 1.49 [-2.25,5.22] 0.43  Light activity -3.2 [-7.71,1.30] 0.16 
Most 
advantaged 
3.60 [-0.21,7.41] 0.06  
Moderate 
activity 
-3.49 [-8.46,1.47] 0.17 
Smoker -4.02 [-6.54,-1.49] <0.001  Heavy activity -6.31 [-11.82,-0.79] 0.03 
n 161    n 155   
Adjusted R2 0.12    Adjusted R2 0.06   
Reference category for SES was least advantaged. Coefficients (coef) are presented with 95% confidence intervals (CI) and 
the corresponding level of significance (p); Ref, reference group. Bold indicates significant at p<0.05. 
 
 
 Waist-to-hip ratio analysis 
Associations between risk factors and WHR in males and females are presented in Table V 
(Appendix B). There were differences in predictors of WHR by sex, with relatively few 
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significant risk factors for women. Similar to BF%, many socioeconomic variables were 
associated with WHR in males and some were also in females (Appendix B, Table V).  
Increasing social advantage at birth was associated with a lower WHR in males (b 
coefficient=-0.05, p=0.002). Birthweight was less significant after controlling for SES (age 50). 
Later life socioeconomic variables including high occupational social class at 50, income and 
university education were also associated with a decreased WHR. However, these factors 
were no longer significant after adjusting for social class at birth. Similar to results for BF%, 
father’s social class (birth) remained a significant predictor after adjustment for the study 
members own SES. In the adjusted model, higher social class at birth was the only significant 
predictor of decreased WHR in men and explained around 7% of the variation (adjusted 
R2=0.07). 
There were no early life and few later life exposures associated with WHR in women. In the 
bivariate analysis, there was a significant association for a decreased WHR for those in the 
mid social class group at 50 compared to low, and for household income (Table V). After 
adjusting for smoking, household income was not significant. There was a small, positive 
association between smoking and WHR. In the final model, the only significant predictor of 
WHR in women was mid-social class at age 50, however this explained little of the variation 
in WHR (adjusted R2=0.01) (Table 3.11).  
Table 3.11 WHR multivariable regression models for NTFS males (n=162) and females (n=210) 
WHR Males Coef CI p  WHR 
Females 
Coef CI p 
Social class 
(birth) Ref  . 
 Social class  
(birth) 
0 Ref . 
Mid -0.02 [-0.04,0.00] 0.053  Mid -0.01 [-0.03,0.01] 0.36 
Most 
advantaged -0.05 [-0.07,-0.02] 0.002 
 Most 
advantaged 
-0.02 [-0.05,0.02] 0.30 
Social class 
(age 50) Ref  . 
 Social class 
(age 50) Ref  . 
Mid -0.01 [-0.04,0.02] 0.342  Mid -0.03 [-0.05,-0.00] 0.04 
Most 
advantaged -0.01 [-0.04,0.02] 0.374 
 Most 
advantaged -0.01 [-0.03,0.01] 0.45 
Birthweight  
(z-score) -0.01 [-0.02,0.00] 0.081 
 
    
Reference category for SES was least advantaged. Coefficients (coef) are presented with 95% confidence intervals (CI) and 







 Summary of the associations across different outcome measures 
For BMI and obesity associations in adjusted models were similar and were significant for 
bacterial infection, later life SES, physical activity and smoking, with an additional association 
for older maternal age for BMI (Table 3.12). 
There were differences in the significant associations for BF% and WHR between men and 
women (Table 3.12). There was similarity in that later life occupational social class was 
associated with WHR in both sexes. Early life SES was associated with both WHR and BF% in 
males.  
Associations that were consistent across 3 or more outcome measures were: bacterial 
infection, later life SES, physical activity and smoking.  
Table 3.12 Summary of results across adiposity outcomes from adjusted regression models in NTFS study members  












Individual  Sex - -   
Maternal age Older mother ✓ - - - 
Birth Birthweight  - - - ✓(M) 
 Occupational social 
class 
- - ✓(M) ✓(M) 
 Breastfeeding - - ✓(F) - 
 Housing - - - - 
Childhood Bacterial infection ✓ ✓ ✓(F) - 
 Adversity  - - - - 
 Rapid weight gain - - - - 
Adulthood Education - - - - 
 Occupational social 
class 
✓ ✓ ✓(M) ✓(M, F) 
 Income  - - - - 
 Married - - - - 
 Physical activity ✓ ✓ ✓(F) - 
 Smoking  ✓ ✓ ✓(M) - 
Tick denotes significant association in bivariate regression. M; males, F; females. 
3.4.7 Pathways between early and later life factors and BMI 
The path models (Figure 3.3) demonstrate the relationships between each of the risk factors 
and BMI, as well as the relationships between the factors themselves.  
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In the path model, breastfeeding was associated with increased BMI. The model also shows 
that a longer duration breastfeeding was associated with reduced likelihood of bacterial 
infections. Those who were educated and more advantaged were less likely to be smokers. 
Occupational social class in middle age had a similar direct effect on BMI to father’s 
occupational social class at birth. 
Infection in the first year had the largest positive direct and total effect. The socioeconomic 
variables, education and occupational social class at 50, had direct effects on BMI until the 
lifestyle variables were considered. 
Lifestyle factors explained around half of the variation in BMI; when included in the path 
model the variation explained increases almost two-fold due to the indirect effects. Lifestyle 
factors (including PAL and smoking) were endogenous and predicted by socioeconomic 
variables. The effects of later life social class were mediated through lifestyle variables once 
they were included in the model, rather than being a direct predictor. The model explained 
13% of the variation in BMI, a lower value than the multivariable regression model, which 
may be due the use of binary variables. 
The path models indicate that early life and socioeconomic factors explain relatively small 
differences in BMI (7%), but similar in proportion to the lifestyle factors.  
In multivariable models, education was not directly associated with outcomes, although it 




A. Baseline model of early life factors and SES  
 
 





Figure 3.3 Path models of the relationship between early and later life variables, and BMI (age 50).  
Models are presented without (A) or with (B) adjustments for lifestyle. Arrows show the direction of the effect. 
Standardised coefficients are shown. All direct effects are represented by solid lines and are significant at p<0.05. Total 
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3.5 Discussion  
In summary, exposures that were consistently associated across different outcome measures 
were; bacterial infection, occupational social class (at birth and middle age), smoking and 
physical activity. There was some evidence for maternal age, birthweight and breastfeeding, 
although less consistent.  
Although prevalence of obesity was similar between the sexes there were more men who 
were overweight, therefore men on average had a higher BMI compared to females. This is 
consistent with findings for this age group by PHE (Health and Social Care Information 
Centre, 2014). Research suggests this could be due to the fact that men are less likely to 
recognise themselves as overweight or be dissatisfied with their weight (Sullivan and Brown, 
2013, Tsai et al., 2016). Alternatively, the value or awareness of the social ideals related to 
thinness may explain the lower rates of overweight in women (McLaren and Kuh, 2004, 
McLaren, 2007a).   
BMI correlated moderately with body fat and WHR, however different exposures were 
associated with different adiposity outcomes. BMI had the most significant explanatory 
variables and similar associations were observed when examining obesity. There were 
comparatively fewer exposures associated with measures of WHR and BF%, however SES 
emerged a consistent factor. There was a socioeconomic impact on adiposity that spanned 
across outcomes and varied by sex. SES at birth was not significantly associated with BMI or 
obesity in middle age, but was an important predictor of other later life factors (such as 
smoking, education and mid-life SES). Early life SES was an independent predictor of WHR in 
males, whereas SES in later life was a predictor of WHR in females. Similar to WHR, SES at 
birth also predicted body fat in males, as did SES in middle age. 
Those who had a bacterial infection in the first year of life were more likely to be obese and 
have a higher BMI or higher body fat (women only) at age 50. This association was 
independent of SES, amongst other potential confounding factors. Taking into account the 
era, infection in the first year could encompass some aspects of SES that occupational social 
class does not, such as adverse living conditions that increase susceptibility to infection.  
There was a weak association between birthweight and WHR in males. The standardised 
birthweight is similar to that of the National survey of Health and Development (NSHD), a 
larger UK birth cohort that commenced in 1946, thereby allowing comparisons to be made. 
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Similar findings from the NSHD support a small inverse association between birthweight and 
WC (Kuh et al., 2002) and higher lean mass (Bann et al., 2014). However, there was no 
associations for birthweight categories and adiposity outcomes. In NTFS, only 3% of study 
members were born LBW, which is dissimilar to current data from the office of national 
statistics which shows rates of low birthweight at ~7% in 2015 (ONS, 2015). Similarly, whilst 
figures for HBW were only 2% in NTFS, UK averages were around 11% in 2015. Therefore, 
perhaps the relatively low proportion of high and low birthweight could explain the lack of 
association. Furthermore, children born preterm or very low birthweight could possibly have 
lower odds of survival therefore reducing the proportion of children born LBW. 
In contrast to other studies, older maternal age was associated with a lower adult BMI and 
breastfeeding with a slightly higher BMI, which may be a peculiarity of the historic cohort 
(discussed further in section 5.5).  
Similar to other studies (Reiner et al., 2013), there was an inverse relationship between 
physical activity and obesity. Current smokers in NTFS had a lower BMI, which is in 
agreement with the literature (Eisen et al., 1993), however some studies find that heavy 
smoking is associated with increased weight (Chiolero et al., 2008). Additionally, NTFS men 
who were current or ex-smokers had larger WHR. This has also been noted in other studies 
(Canoy et al., 2005, Chiolero et al., 2008), and although similar findings are often observed 
for women, a study of older Dutch women also observed similar sex differences (Visser et al., 
1999b). NTFS women had relatively healthy WHR compared to the men, which may explain 
these differences.  
Thus far, there are indications that some factors in the peri- and post-natal period could 
affect obesity development. There were obvious differences in males and females in relation 
to body composition and also by exposure, which could suggest that sex-specific strategies 
are required for tackling overweight and obesity. The important exposures with respect to 
adult body composition were SES at birth, older maternal age, and bacterial infection in the 
first year, the latter of which requires further investigation. The early life exposures and 
lifestyle factors explained relatively a low percent of the variation in adult body composition, 
suggesting that other factors are contributing.   
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Chapter 4. The influence of early life exposures on 
childhood body composition  
4.1 Introduction 
This chapter will address the thesis aim of investigating the impact of early life exposures 
and SES on multiple indicators of childhood adiposity. The analysis will use data from the 
Gateshead Millennium study (GMS), a birth cohort from Gateshead that commenced in the 
year 2000. This cohort contains a wealth of early life data, and anthropometric data 
collected throughout childhood. There have already been a great deal of studies which 
examine multiple risk factors for childhood obesity from multiple cohorts (Fairley et al., 
2015a)(reviewed in section 1.3). As of yet, the early life factors associated with childhood 
OWOB in children in North East England have not been determined. The North East is the 
region with the highest proportion of children starting school with obesity in the UK (NHS 
Digital, 2017), and therefore it is important to understand the factors driving this early onset 
of obesity, and potentially if these factors are different to other parts of the UK. 
The previous chapter examined risk factors across different measures of adiposity (BMI, 
overweight and obesity, central obesity and body fat) in NTFS adults. Therefore, in keeping 
with previous analyses, this chapter will examine if early life risk factors are associated 
across similar components of body composition in GMS children.  
In the previous chapter, it was determined that lifestyle factors were important intermediate 
factors between SES and body composition. Therefore, in line with the previous analysis, this 
chapter will also examine whether lifestyle (physical activity) can modify the effect of an 
exposure that occurs during a critical developmental period. Lifestyle may act in a 
synergistic, antagonistic, clustered or independent manner (Jacob et al., 2015).  
4.2 Aims 
The aims of this chapter were to i.) Determine if early life exposures were associated with 
childhood overweight or obesity in the GMS cohort; ii.) Examine if risk factors vary for 
outcomes i.e. using proxy measures or direct measures of body composition and 
distribution; and iii.) Examine the relationship between early life risk factors and childhood 
body composition considering the impact of lifestyle (physical activity). 
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4.3 Participants and methods 
This analysis uses early life data from birth to 13 months, and outcome data from the age 6-
8 follow-up. The current cohort consists of all traceable study members who did not 
withdraw. At the follow-up between ages 6-8, anthropometric measures, physical activity, 
and food intake were measured. 
4.3.1 Anthropometric variables  
BMIz, waist-to-height ratio (WHtR) and fat mass index (FMI) at age 6-8 were analysed as 
outcomes, calculation of these is in section 2.2. 
4.3.2 Early life exposure data 
There were data on several early life risk factors in GMS including; birthweight, rapid weight 
gain (RWG), first-born, maternal age, adversity, infection and SES, and the covariates sex, 
gestation and physical activity (moderate–vigorous intensity physical activity (MVPA)). The 
definitions and measurement of these factors is outlined in section 2.2. 
Maternal education was chosen as the main SES indicator at birth as it represents economic 
resources and social characteristics related to knowledge and health literacy (Galobardes et 
al., 2006), and has been shown to have the strongest influence on pregnancy outcomes 
(Mortensen et al., 2008) (Parker et al., 1994). 
4.3.3 Statistical analysis 
SES, sex, birthweight categories, maternal age, first-born, adverse events, sleep issues, 
infection, RWG, and breastfeeding were categorical variables. All other variables were 
analysed as continuous or binary variables.  
It was not anticipated that there would be differences between genders in the relationships 
between early life risk factors and obesity in children (no strong correlations between sex 
and early life factors, Appendix B). However, to check this assumption, sex-exposure 
interactions were examined for each outcome, as outlined in section 2.3.2. There were no 
significant differences, and therefore the sample was not stratified by sex. 
Additionally, the impact of childhood physical activity was investigated, by adding MVPA to 





4.4.1 Sample representativeness 
There were data for 619 study members included at the age 6 to 8 follow-up, representing 
60% of the cohort. Study participants included in these analyses were comparable to the 
original cohort for most early life exposures (Table 4.1 and Table 4.2). There were 
differences in that the sample were more advantaged, in terms of Townsend score, higher 
achieved maternal education and less material deprivation (Table 4.2), leading to more even 
distribution across socioeconomic strata than the original sample (Parkinson et al., 2011). 
Those measured at age 6-8 had a significant longer gestational age, had slight older mothers, 
more experienced adversity, were breastfed for longer and were less likely to be formula fed 
(Table 4.1 and Table 4.2). These factors were likely related to the socioeconomic differences 
in the 6-8 sample (Appendix C, Table VII). 
Table 4.1 Differences in continuous and ordinal early life variables for GMS children with and without body composition 
data at age 6-8. 
Variable Without data  With data P value 
 n Mean SD min max  n Mean SD min max  
Birthweight 
(z-score) 




424 39.35 1.88 27 43  569 39.57 1.55 29 43 0.040 a 
Maternal 
age (years) 




269 14.49 3.42 3 33  479 14.59 3.2 5 42.5 0.67 a 
P values derived from tests for differences in means (T test a), median values (Rank-sum b)  n, sample size; SD, standard 






Table 4.2 Differences in categorical variables for GMS children with and without body composition data at age 6-8. 
 Early life variables All  Without data  With data P value 
  n %  n col %  n col %   
Sex 993   424   569   
Male 505 50.9  223 52.6  282 49.6 0.34 
Female 488 49.1  201 47.4  287 50.4  
First-born 991   423   568   
No 528 53.3  227 53.7  301 53  
Yes 463 46.7  196 46.3  267 47 0.83 
Gestation categories 993   424   569   
Pre-term 107 10.8  56 13.2  51 9  
Normal 823 82.9  338 79.7  485 85.2 0.061 
Post-term 63 6.3  30 7.1  33 5.8  
Birthweight 993   424   569   
SGA 89 9  36 8.5  53 9.3  
Normal 810 81.6  351 82.8  459 80.7 0.69 
LGA 94 9.4  37 8.7  57 10  
Caesarean 993   424   569   
No 844 85  365 86.1  479 84.2 0.41 
Yes 149 15  59 13.9  90 15.8  
Maternal age at birth 993   424   569   
Less than 25 326 32.8  164 38.7  162 28.5 
0.003 25-34 547 55.1  215 50.7  332 58.3 
35+  120 12.1  45 10.6  75 13.2 
Breastfeeding 953   405   548   
Never 468 49.1  232 57.3  236 43.1 <0.001 
<6wk 237 24.9  101 24.9  136 24.8  
>6wk  89 9.3  26 6.4  63 11.5  
>4m 159 16.7  46 11.4  113 20.6  
Exclusively breastfed  
(>4 months) 249   
 
262   
 
511   
 
No 468 91.6  232 93.2  236 90.1 0.21 
Yes 43 8.4  17 6.8  26 9.9  
Formula fed only 953   405   548   
No 485 50.9  173 42.7  312 56.9  
Yes 468 49.1  232 57.3  236 43.1 <0.001 
Rapid weight gain  813   282   531   
No 567 69.7  205 72.7  362 68.2 
0.18 
Yes 246 30.3  77 27.3  169 31.8 
Adversity 934   398   536   
No 719 77  327 82.2  392 73.1 
0.001 
Yes 215 23  71 17.8  144 26.9 
Sleep issues (8 months) 644   201   443   
No 532 82.6  162 80.6  370 83.5 
0.36 
Yes 112 17.4  39 19.4  73 16.5 
Infection (0-12 month) 994   425   569   
No 895 90  394 92.7  501 88 0.015 




 Socioeconomic  
variables 
All  Without data  With data  P 
  n %  n col %  n col %   
          
Townsend quintile 987   424   563   
1 Least advantaged 188 19.0  84 19.8  104 18.5 
0.021 
2 201 20.4  81 19.1  120 21.3 
3 221 22.4  94 22.2  127 22.6 
4 223 22.6  113 26.7  110 19.5 
5 Most advantaged 154 15.6  52 12.3  102 18.1 
Maternal education  
(birth) 
915   382   533   
None 142 15.5  78 20.4  64 12.0 
<0.001 
GCSE 534 58.4  227 59.4  307 57.6 
A level 111 12.1  41 10.7  70 13.1 
Degree 128 14.0  36 9.4  92 17.3 
Deprived at birth 991   422   569   
No 483 48.7  163 38.6  320 56.2 <0.001 
Yes 508 51.3  259 61.4  249 43.8  
Occupational social  
class (childhood) 
373   13   360   
Least advantaged 110 29.5  1 7.7  109 30.3 
0.21 Middle 133 35.7  6 46.2  127 35.3 
Most advantaged 130 34.9  6 46.2  124 34.4 
Upward mobility  
(0-8 years) 
994   425   569   
No 945 95.1  425 100  520 91.4 <0.001 
Yes 49 4.9  0 0  49 8.6  
Row sample sizes and column percentages (col %) shown.  P value represents the Chi-square test statistic. Bold indicates 
significant at p<0.05. 
 
4.4.2 Exposures 
Descriptive statistics for those measured at age 6-8, plus sex differences are presented in 
Table 4.3, Table 4.4 and Table 4.5. The mean age of the cohort was around 7.5 years. There 
was an even proportion of males and females. The majority had a normal birthweight, and 
there were 9.3% SGA and 10% LGA. In terms length of gestation, 85% of children were born 
normal term, 9% were pre-term and 5.8% post-term. In the sub-sample, 47% were first-born 
children, and mean maternal age was 29 years old. A large proportion of children were never 
breastfed (43.1%). Around a quarter of children experienced adversity in the first year and 
16.5% of children had sleep issues in the first 8 months. There was a fairly even split 
between parental socioeconomic groups at age 6-8, with 34.4% in the most advantaged 
group, 35.3% mid and 30.3% in the least advantaged group.  
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Males were weaned slightly earlier than females, on average spent more time doing MVPA 
(Table 4.3), and were more likely to have an infection in the first year (Table 4.4). There were 
no other significant differences between males and females, however there were some 
differences in socioeconomic variables that were borderline significant (p<0.1) (Table 4.5). 
 
Table 4.3 Summary statistics and differences in early life continuous variables stratified by sex for the GMS cohort (age 6-8) 
Variable Male  Female   
n mean SD min max  n mean SD min max p 
Age (years) 282 7.44 0.46 6.42 8.42  287 7.46 0.45 6.42 8.58 0.53 a 
Bwt (z-score) 282 -0.02 1.04 -2.74 3.45  287 -0.02 1.04 -3.48 3.51 0.98 a 
Gestation (weeks) 282 39.53 1.69 29 42  287 39.61 1.4 34 43 0.41 a 
Maternal age (years) 282 28.81 5.84 16.59 45.75  287 28.12 5.72 16.09 43.46 0.08 a 
Weaned (weeks) 379 14.31 3.12 3 32  369 14.81 3.42 4 42.5 0.04 a 
MVPA (%) 241 4.71 2.61 0.58 15.03  238 4.08 2.19 0.34 13.88 0.01 b 
Number of observations (N), mean, standard deviation (SD), minimum (min) and maximum (max) values and P values (p) for 
t-tests or Wilcoxon rank-sum tests for differences presented. a T-test or  b Ranksum tests for differences between males 




Table 4.4 Summary statistics and differences in categorical early life variables stratified by sex, for the GMS cohort (age 6-8) 
Binary variables All  
(n) 
% Yes Male  
(n) 
% Yes Female  
(n) 
% Yes p 
First-born 568 47 281 47 287 47 0.99 
Caesarean 569 15.8 282 15.6 287 16 0.89 
Exclusively breastfed  
(>4 months) 262 11.6 12 8.5 26 9.9 
0.41 
Formula fed 548 43.1 270 39.6 278 46.4 0.11 
RWG (0-12 months) 531 31.8 263 31.6 268 32.1 0.90 
Adversity (0-12 months) 536 26.9 267 29.6 269 24.2 0.15 
Sleep issues (8 months) 443 16.5 222 17.1 221 15.8 0.72 
Infection (0-12 months) 569 12 282 15.6 287 8.4 0.008 
Categorical variables  All (n) % Male  
(n) 
% Female  
(n) 
% p 







Pre-term 51 9 31 11 20 7 
 
Normal 485 85.2 231 81.9 254 88.5 
 
Post-term 33 5.8 20 7.1 13 4.5 
 







SGA 53 9.3 29 10.3 24 8.4 
 
Normal 459 80.7 225 79.8 234 81.5 
 
LGA 57 10 28 9.9 29 10.1 
 







Less than 25 162 28.5 81 28.7 81 28.2 
 
25-34 332 58.3 162 57.4 170 59.2 
 









Never 236 43.1 107 39.6 129 46.4 
 
<6wk 136 24.8 70 25.9 66 23.7 
 
>6wk 63 11.5 35 13 28 10.1 
 
>4m 113 20.6 58 21.5 55 19.8 
 
Season accelerometry 241   238   479    
Spring 56 23.2 56 23.5 112 23.4  
Summer 53 22 48 20.2 101 21.1 0.41 
Autumn 83 34.4 71 29.8 154 32.2  
Winter 49 20.3 63 26.5 112 23.4  
Sample sizes (n) and column percentages (col %), and Chi-square test statistic presented (p). Bold indicates significantly 








% Male (n) % Female (n) % p 







1 Least advantaged  46 16.5 58 20.4 104 18.5 
 
2 54 19.4 66 23.2 120 21.3 
 
3 61 21.9 66 23.2 127 22.6 
 
4 54 19.4 56 19.6 110 19.5 
 
5 Most advantaged  63 22.7 39 13.7 102 18.1 
 
Maternal education 269  264  533  0.44 
None  27 10 37 14 64 12 
 
GCSE 155 57.6 152 57.6 307 57.6 
 
A level 36 13.4 34 12.9 70 13.1 
 
Degree 51 19 41 15.5 92 17.3 
 







Least advantaged 46 26 63 34.4 109 30.3 
 
Mid 64 36.2 63 34.4 127 35.3 
 
Most advantaged 67 37.9 57 31.1 124 34.4 
 
Upward mobility  
(0-8 years) 
282  287  569  0.060 
No 264 93.6 256 89.2 520 91.4 
 
Yes 18 6.4 31 10.8 49 8.6 
 
Sample sizes (n) and column percentages (col %), and Chi-square test statistic presented (p).  
4.4.3 Infant feeding and SES 
There were significant differences between Townsend quintiles and the duration of 
breastfeeding, in that the most advantaged breastfed for longer and were less likely to be 
formula fed (Appendix C, Table VII). There was no statistically significant differences in 
weaning age between the Townsend quintiles (Kruskal-Wallis p = 0.07).  
4.4.4 Outcomes 
According to BMIz, at age 6-8 there were 116 (21%) children who were OWOB, and of those 
52 (9.3%) were obese (Table 4.7). Whilst for FMI, 5.2% of children had a fat mass index 
>=91st centile, and 1.1% had a FMI>=98th centile. Fewer were classified as obese using WHtR 
than using BMI (7%). There were no significant differences in outcomes between sexes. 




Table 4.7 Descriptive characteristics of body composition outcomes stratified by sex in the GMS cohort (age 6-8) 
Categorical 
outcomes 
All  Male  Female   
  n col %  n col %  n col %  P value 
All 562   278   284   0.56 
Healthy 
weight 
446 79.4  218 78.4  228 80.3   
OWOB 116 20.6  60 21.6  56 19.7   
Waist OB 505   488   993   0.98 
No 470 93.1  454 93  924 93.1   
Yes 35 6.9  34 7  69 6.9   
Continuous 
outcomes 
All  Male  Female   






 P value 














Proportion (%) of study members in each weight category with Chi2 test statistic for differences between sexes. Mean and 
standard deviation (SD) for BMIz and FMI, with p value for differences between sexes (T-test).  
  
There were strong correlations (r>0.7) between FMI with both BMIz and OWOB (Table 4.8). 
Whilst the weakest associations, although still moderate, were between FMI and BMIz and 
categorical OWOB (r<0.55). Waist OB showed the weakest correlations with the other 
measures, however again these were still modest (r>0.62). Overall, there was good 
correlation between the alternative measures of obesity.  
 
Table 4.8 Correlations between the body composition measures in the 
GMS cohort (age 6-8) 
 
BMIz FMI OWOB Waist OB 
BMIz 1 
   
FMI 0.749 1 
  
OWOB 0.763 0.701 1 
 
Waist OB 0.622 0.664 0.667 1 
 
Pearson correlation coefficients between outcome measures.  
All correlations p<0.0001. 
4.4.5 Relationship between early life exposures and childhood body composition  
In bivariate analyses, a higher birthweight and adversity were both associated with a higher 
BMIz and FMI and increased likelihood of OWOB (Appendix C,  
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Table XI ). RWG was associated with increased BMIz. MVPA was negatively associated with all 
outcomes.  
The exposures consistently significant across outcomes in bivariate analyses were 
birthweight and adversity ( 
Figure 4.1). Weaning was the only feeding-related variable that demonstrated significant 
associations in the bivariate models, albeit only for BMIz. Rapid weight gain also 
demonstrated significant associations with BMIz.  
The effects of these early life variables were investigated further in multivariable models 
adjusted for known confounders, including early and later life SES, and other early life 
exposures (Table 4.9).  
Anticipated confounding variables (Table 1.5) of the relevant exposures were included in the 
models. Including breastfeeding duration in the models made little difference to the 
estimates, and there was strong support for the models without breastfeeding (indicated by 
BIC), therefore it was not included. Using categorical maternal age rather than continuous 
explained more of the variation in outcomes. The impact of physical activity on the early life 









Figure 4.1 Forest plot of bivariate models for each outcome (x-axis) and exposure (y-axis) in GMS (age 6-8). 
Odds ratios presented for the outcomes OWOB and waist OB, and coefficients for BMIz and FMI,  
with respective 95% confidence intervals and the corresponding level of significance  
(* indicates p<0.05, ** p<0.01, ***p<0.001). Physical activity is adjusted for season.




Table 4.9 Multivariable regression models for early and childhood factors and all adiposity outcomes in GMS (age 6-8).  
 Variable  OWOB    BMIz    FMI    Waist OB  
  OR CI p  Coef CI p  Coef CI p  OR CI p 
Female 0.85 [0.42,1.71] 0.65  -0.03 [-0.27,0.20] 0.78  -0.06 [-0.49,0.38] 0.80  1.07 [0.48,2.42] 0.87 
Gestation length (wk) 1.30 [0.99,1.69] 0.055  0.04 [-0.04,0.11] 0.30  0.03 [-0.11,0.17] 0.66  0.92 [0.71,1.20] 0.54 
First-born 1 [0.48,2.09] 0.99  -0.01 [-0.27,0.24] 0.94  0.01 [-0.46,0.48] 0.97  1.05 [0.45,2.42] 0.92 
Maternal age 
Less than 25 0.27 [0.09,0.85] 0.025  -0.35 [-0.69,-0.00] 0.047  -0.65 [-1.28,-0.02] 0.043  0.29 [0.07,1.16] 0.080 
25-34 Ref  .  Ref  .  Ref  .  Ref  . 
35+ 0.63 [0.22,1.81] 0.39  -0.09 [-0.43,0.25] 0.60  -0.45 [-1.07,0.17] 0.16  1.18 [0.39,3.59] 0.77 
Adversity 2.59 [1.25,5.35] 0.010  0.31 [0.04,0.57] 0.023  0.64 [0.15,1.13] 0.010  1.06 [0.44,2.55] 0.90 
Birthweight z-score 2.61 [1.73,3.94] <0.0001  0.44 [0.31,0.57] <0.001  0.43 [0.19,0.68] 0.001  1.69 [1.09,2.64] 0.020 
Rapid weight gain  3.86 [1.69,8.82] 0.001  0.81 [0.52,1.10] <0.001  0.71 [0.18,1.24] 0.009  2.07 [0.79,5.48] 0.14 
Wean age 0.87 [0.75,1.03] 0.10  -0.06 [-0.11,-0.01] 0.012  -0.08 [-0.17,0.00] 0.061  0.82 [0.70,0.97] 0.023 
Maternal education 
None  Ref  .  Ref  .  Ref  .  Ref  . 
GCSE 1.47 [0.27,8.03] 0.66  0.4 [-0.11,0.92] 0.13  0.89 [-0.06,1.84] 0.066  2.61 [0.30,22.46] 0.38 
A level 1.3 [0.20,8.44] 0.78  0.42 [-0.16,1.00] 0.16  0.75 [-0.33,1.82] 0.17  1.11 [0.10,12.96] 0.93 
Degree 1.87 [0.30,11.82] 0.51  0.33 [-0.26,0.93] 0.27  0.39 [-0.70,1.49] 0.48  1.08 [0.10,11.82] 0.95 
SES (childhood)  
 Least advantaged Ref  .  Ref  .  Ref  .  Ref  . 
Mid 0.37 [0.14,0.97] 0.042  -0.23 [-0.54,0.09] 0.16  -0.65 [-1.24,-0.07] 0.028  0.54 [0.18,1.61] 0.27 
Most advantaged 0.44 [0.17,1.20] 0.11  -0.09 [-0.43,0.26] 0.61  -0.53 [-1.16,0.11] 0.10  0.89 [0.30,2.63] 0.84 
N 261    265    265    275   
pseudo R2/adjusted R2 0.207    0.219    0.104    0.111   
Coefficients (coef) or odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Ref indicates reference category for factor variables. 
Bold indicates significant at p<0.05.   
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4.4.6 Associations across different outcome measures 
There was consistency across measures in bivariate analyses (Appendix C,Table VIII). In 
bivariate analyses, birthweight z-score was positively associated with all outcome measures. 
MVPA was negatively associated with all outcomes. Whilst younger maternal age was 
associated with lower odds of OWOB, lower BMIz and FMI. Adversity was associated with 
increased odds of OWOB, increased BMIz and increased FMI (but not waist OB). The effects 
of adversity could be attributed to socioeconomic factors including debt and parental 
separation (Appendix C, Table IX). 
However, there were no associations for any other early socioeconomic factors (Appendix 
C,Table VIII) for any of the weight outcomes. Although, being in the mid socioeconomic 
advantaged group (compared to the least advantaged) in childhood was associated with 
lower odds of OWOB and a lower BMIz. There was no association for breast or formula 
feeding with any of the outcome measures, however weaning age was negatively associated 
with BMIz and lower odds of waist OB. For BMIz only, there was a positive association 
(p<0.1) between sleep issues in the bivariate model, however this was no longer present 
after adjustment.  
Overall, there was good agreement across OWOB, BMIz and FMI for the early life factors; 
younger maternal age, adversity, birthweight and rapid weight gain (Table 4.9). There were 
differences in associations for waist OB, whereby there were only significant associations for 
birthweight (increased odds) and weaning (decreased odds).  
 The influence of physical activity 
MVPA was negatively associated with all outcomes, with the most significant association 
being for FMI (Table 4.10). For BMIz, adjusting for MVPA did not lead to great changes in 
most significant coefficients. However, it removed the significant association for younger 
maternal age. Adjusting for MVPA removed any significant associations for SES. After 
adjustment, the coefficients for birthweight decreased across all outcomes, and birthweight 
was no longer significant associated with waist OB (Table 4.10). The association between 
weaning and lower odds of waist OB was no longer significant after controlling for MVPA. 
After adjustment for MVPA, the odds ratio notably increased for RWG and OWOB (OR=3.8 
in model without MVPA, compared to OR=4.8 in adjusted model).  
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Table 4.10 Multivariable regression models with and without adjustment for MVPA for outcomes in GMS (age 6-8). 
Models were additionally adjusted for covariates; sex, gestation and first-born, and MVPA models also for season. Coefficients (coef) or odds ratios (OR) are presented with 95% confidence intervals (CI) and the 
corresponding level of significance (p). Reference categories for factor variables were; least advantaged for SES; no maternal qualifications for maternal education; and maternal age 25-34.  Bold indicates significant at 
p<0.05. 
 
  OWOB  OWOB adjusted for MVPA   BMIz  BMIz  adjusted  for MVPA 
 Exposures OR CI p OR CI p  coef CI p coef CI p 
Maternal age                Less than 25 0.27 [0.09,0.85] 0.025 0.16 [0.04,0.66] 0.011  -0.35 [-0.69,-0.00] 0.047 -0.32 [-0.67,0.03] 0.07 
35+ 0.63 [0.22,1.81] 0.39 0.45 [0.12,1.68] 0.24  -0.09 [-0.43,0.25] 0.60 -0.16 [-0.49,0.18] 0.35 
Adversity 2.59 [1.25,5.35] 0.01 3.08 [1.32,7.18] 0.009  0.31 [0.04,0.57] 0.023 0.28 [0.02,0.54] 0.034 
Birthweight z-score 2.61 [1.73,3.94] <0.001 2.19 [1.38,3.49] 0.001  0.44 [0.31,0.57] <0.001 0.36 [0.23,0.50] <0.001 
Wean age 0.87 [0.75,1.03] 0.1 0.90 [0.76,1.07] 0.23  -0.06 [-0.11,-0.01] 0.012 -0.06 [-0.11,-0.02] 0.009 
Rapid weight gain  3.86 [1.69,8.82] 0.001 4.82 [1.78,13.09] 0.002  0.81 [0.52,1.10] <0.001 0.82 [0.53,1.11] <0.001 
Maternal education                 GCSE 1.47 [0.27,8.03] 0.66 1.21 [0.16,9.46] 0.85  0.4 [-0.11,0.92] 0.13 0.46 [-0.07,0.98] 0.09 
A level 1.3 [0.20,8.44] 0.78 1.04 [0.11,9.50] 0.97  0.42 [-0.16,1.00] 0.16 0.52 [-0.06,1.11] 0.08 
Degree 1.87 [0.30,11.82] 0.51 1.87 [0.22,15.53] 0.56  0.33 [-0.26,0.93] 0.27 0.44 [-0.16,1.04] 0.15 
SES (childhood)                        Mid 0.37 [0.14,0.97] 0.042 0.46 [0.15,1.39] 0.17  -0.23 [-0.54,0.09] 0.16 -0.11 [-0.42,0.21] 0.50 
Most advantaged 0.44 [0.17,1.20] 0.11 0.51 [0.16,1.66] 0.27  -0.09 [-0.43,0.26] 0.61 0.07 [-0.28,0.41] 0.71 
MVPA -   0.72 [0.58,0.90] 0.003  -   -0.07 [-0.12,-0.02] 0.007 
N 261   240                0.219   0.247              
R2/pseudo  R2 0.207   0.293                0.260   0.303              
  FMI  FMI  adjusted  for MVPA   Waist OB  Waist OB  adjusted  for MVPA 
  Exposures coef CI p coef CI p  OR CI p OR CI p 
Maternal age                Less than 25 -0.65 [-1.28,-0.02] 0.043 -0.67 [-1.30,-0.04] 0.037  0.29 [0.07,1.16] 0.08 0.3 [0.06,1.61] 0.16 
35+ -0.45 [-1.07,0.17] 0.16 -0.49 [-1.10,0.11] 0.11  1.18 [0.39,3.59] 0.77 1.37 [0.37,5.13] 0.64 
Adversity 0.64 [0.15,1.13] 0.01 0.63 [0.16,1.10] 0.009  1.06 [0.44,2.55] 0.90 1.04 [0.38,2.89] 0.93 
Birthweight z-score 0.43 [0.19,0.68] 0.001 0.26 [0.02,0.50] 0.033  1.69 [1.09,2.64] 0.020 1.39 [0.85,2.27] 0.20 
Wean age -0.08 [-0.17,0.00] 0.061 -0.08 [-0.16,0.01] 0.077  0.82 [0.70,0.97] 0.023 0.86 [0.72,1.02] 0.084 
Rapid weight gain  0.71 [0.18,1.24] 0.009 0.69 [0.17,1.21] 0.009  2.07 [0.79,5.48] 0.14 2.73 [0.89,8.35] 0.078 
Maternal education                  GCSE 0.89 [-0.06,1.84] 0.066 0.95 [0.00,1.90] 0.049  2.61 [0.30,22.46] 0.38 1.42 [0.15,13.18] 0.76 
A level 0.75 [-0.33,1.82] 0.17 0.94 [-0.11,2.00] 0.079  1.11 [0.10,12.96] 0.93 0.73 [0.06,9.68] 0.81 
Degree 0.39 [-0.70,1.49] 0.48 0.55 [-0.53,1.63] 0.32  1.08 [0.10,11.82] 0.95 0.79 [0.07,8.99] 0.85 
SES (childhood)                        Mid -0.65 [-1.24,-0.07] 0.028 -0.54 [-1.11,0.03] 0.062  0.54 [0.18,1.61] 0.27 0.51 [0.14,1.82] 0.30 
Most advantaged -0.53 [-1.16,0.11] 0.10 -0.44 [-1.07,0.18] 0.17  0.89 [0.30,2.63] 0.84 0.81 [0.23,2.95] 0.76 
MVPA -   -0.23 [-0.32,-0.13] <0.001  -   0.70 [0.53,0.93] 0.013 
N 265   243    275   246   
R2/pseudo R2 0.104   0.189    0.111   0.167   
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4.4.7 Sensitivity analysis for childhood FMI 
The model for FMI did not fit regression diagnostic criteria. There was a slightly positive 
skew of the residuals and the normal probability plot demonstrated deviation from 
normality towards the tails (Appendix C, Figure XI). The non-normal residuals suggested 
that this model does not explain all trends in the dataset.  
Model building was redone to find the best model for FMI (Table 4.11). Despite being 
confounding variables, there was support (BIC) for the model to not include the 
socioeconomic variables; maternal education, Townsend and occupation social class in 
childhood, or the feeding variables (Table 4.11).  
The skewed residuals could be due to the high values of FMI observed leading to positive 
skew in the values. Taking the definition of an outlier as greater than the upper quartile plus 
1.5 times the inter-quartile range (IQR) (>Q3 + 1.5*IQR), excluding outliers removed from 
the sample those with a FMI greater than 8.19 (n=16 in adjusted model). This appeared to 
correct the skewed residuals (Appendix C, Figure XI) which appeared more normally 
distributed, although statistically were not (Shapiro-Wilk p<0.005). Further investigation into 
which data points deviated from the mean (high leverage points using Cook’s distance), 
found no obvious, identifiable pattern. Therefore, the variables (Table 4.11) are a better 
model fit for those with a FMI within the middle of distribution for FMI, but not for those 




Table 4.11 Multivariable models for the FMI model and the model excluding the outliers in GMS (age 6-8). 
 FMI  FMI without outliers 
Exposures  coef CI p  coef CI p 
        
Female -0.14 [-0.46,0.19] 0.42  -0.15 [-0.41,0.10] 0.24 
Gestation (weeks) 0.04 [-0.06,0.15] 0.44  0 [-0.08,0.08] 0.94 
First-born 0.02 [-0.33,0.37] 0.90  0 [-0.28,0.27] 0.99 
Maternal age (years) 
 Less than 25 -0.25 [-0.66,0.16] 0.23  -0.22 [-0.54,0.10] 0.18 
25-34 Ref  .  Ref  . 
35+ -0.38 [-0.86,0.10] 0.12  -0.59 [-0.97,-0.20] 0.003 
Adversity 0.67 [0.30,1.04] <0.001  0.51 [0.22,0.80] 0.001 
Birthweight (z-score) 0.36 [0.19,0.53] <0.001  0.16 [0.03,0.30] 0.020 
RWG 0.56 [0.19,0.94] 0.004  0.30 [-0.00,0.59] 0.051 
N 499    473                  
Adjusted R2                 0.058    0.048                  
Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Ref 
indicates reference category for factor variables. Bold indicates significant at p<0.05. All covariates are presented.  
 
The study members with the greatest fat mass also had very high BMI and waist OB, 
therefore these data are probably valid measurements, and it would be incorrect to simply 
exclude those with high FMI. The models fit other regression diagnostic criteria (i.e. 
homoscedastic, no omitted variables, no collinearity) except for normality of residuals. This 
was due to skewed residuals, which were prone to non-normality at the tails (Appendix C, 
Figure XI). Therefore, to obtain reliable estimates without excluding data points, robust 
regression was used.  
The robust regression included the same variables as the basic model (model 1). The 
coefficients for birthweight, RWG and adversity were smaller and less significant when using 
robust regression compared to linear regression (Table 4.12). In addition, the coefficient for 
older maternal age was significant in the robust regression model. Other coefficients 
remained similar. Therefore, linear regression may lead to an overestimation of the 




Table 4.12 Comparison of the FMI adjusted linear regression model and the robust regression model in GMS (age 6-8). 
FMI Model 1 - Linear 
 
Model 1 - Robust  
coef CI p  coef CI p 
        
Female -0.14 [-0.46,0.19] 0.42  -0.23 [-0.50,0.04] 0.10 
Gestation length (wk) 0.04 [-0.06,0.15] 0.44  -0.02 [-0.10,0.07] 0.69 
First-born 0.02 [-0.33,0.37] 0.90  0.0 [-0.29,0.29] 0.98 
Adversity 0.67 [0.30,1.04] <0.001  0.50 [0.20,0.81] 0.001 
Birthweight z-score 0.36 [0.19,0.53] <0.001  0.17 [0.02,0.31] 0.021 
Rapid weight gain  0.56 [0.19,0.94] 0.004  0.34 [0.02,0.65] 0.037 
Maternal age   Less than 25 -0.25 [-0.66,0.16] 0.23  -0.20 [-0.54,0.14] 0.25 
25-34 Ref   .  Ref   . 
35+ -0.38 [-0.86,0.10] 0.12  -0.60 [-1.00,-0.20] 0.004 
N 499    499 
  
Adjusted R2 0.058    0.045 
 
              
Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Ref 
indicates reference category for factor variables. Bold indicates significant at p<0.05. All covariates are presented. 
 
4.4.8 Sensitivity analysis for demographic factors 
A small proportion of the age 6-8 sample with BMIz measures were ultra-Orthodox Jewish 
(n=9, 1.6%). As there are established differences in feeding practices within this group, any 
models that included feeding variables (BMIz, OWOB, waist OB) were re-run excluding ultra-
Orthodox Jewish (UOJ) study members. There were no significant differences in prevalence 
of OWOB or waist OB, or differences in the mean BMIz or FMI between this group and the 
remainder of the sample, however this may be due to the small sample size.  
Despite the low proportion, repeating analyses without ultra-Orthodox Jewish study 
members did have an impact on the regression coefficients and odds ratios. For the OWOB 
model, the odds ratios for younger maternal age and mid childhood SES decreased after 
excluding UOJ (Table 4.13). The model indicated that for OWOB, coefficients were 
underestimated, and therefore for the majority of the cohort there were larger associations 
for adversity, RWG and birthweight with childhood adiposity. Results remained similar for 
BMIz and waist OB. 
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Although sample sizes were too small to investigate the UOJ group separately, these results 
could suggest that early life risk factors are not the same for this group or have a smaller 
magnitude. 
Table 4.13 Multivariable regression models for UOJ sensitivity analysis for all outcomes in GMS (age 6-8). 
 BMI  without UOJ 
 Variable coef CI p  coef CI p 
Maternal age       Less than 25 -0.35 [-0.69,-0.00] 0.047  -0.40 [-0.76,-0.03] 0.032 
25-34 Ref  .  Ref  . 
35+ -0.09 [-0.43,0.25] 0.60  -0.07 [-0.42,0.28] 0.69 
Adversity 0.31 [0.04,0.57] 0.023  0.31 [0.04,0.58] 0.027 
Birthweight z-score 0.44 [0.31,0.57] <0.001  0.45 [0.32,0.59] <0.001 
Rapid weight gain  0.81 [0.52,1.10] <0.001  0.82 [0.51,1.12] <0.001 
Wean age -0.06 [-0.11,-0.01] 0.012  -0.06 [-0.11,-0.00] 0.036 
Maternal education  Ref  .  Ref  . 
GCSE 0.40 [-0.11,0.92] 0.13  0.48 [-0.07,1.03] 0.088 
A level 0.42 [-0.16,1.00] 0.16  0.49 [-0.12,1.11] 0.12 
Degree 0.33 [-0.26,0.93] 0.2  0.39 [-0.24,1.01] 0.23 
SES (childhood)  Ref  .  Ref  . 
Mid -0.23 [-0.54,0.09] 0.16  -0.24 [-0.57,0.09] 0.15 
Most advantaged -0.09 [-0.43,0.26] 0.61  -0.09 [-0.45,0.27] 0.63 
n 265    254   
R2 0.219    0.206   
 
 OWOB   without UOJ 
 Variable OR CI p  OR CI p 
Maternal age   Less than 25 0.27 [0.09,0.85] 0.025  0.25 [0.08,0.81] 0.021 
25-34 Ref  .  Ref  . 
35+ 0.63 [0.22,1.81] 0.39  0.68 [0.23,1.98] 0.48 
Adversity 2.59 [1.25,5.35] 0.01  2.87 [1.36,6.06] 0.006 
Birthweight z-score 2.61 [1.73,3.94] <0.001  2.67 [1.75,4.07] <0.001 
Rapid weight gain  3.86 [1.69,8.82] 0.001  4.32 [1.83,10.19] 0.001 
Wean age 0.87 [0.75,1.03] 0.10  0.88 [0.74,1.04] 0.12 
Maternal education  Ref  .  Ref  . 
GCSE 1.47 [0.27,8.03] 0.66  1.59 [0.28,8.93] 0.60 
A level 1.3 [0.20,8.44] 0.78  1.3 [0.20,8.63] 0.79 
Degree 1.87 [0.30,11.82] 0.51  1.9 [0.29,12.28] 0.50 
SES (childhood)  Ref  .  Ref  . 
Mid 0.37 [0.14,0.97] 0.042  0.33 [0.13,0.89] 0.028 
Most advantaged 0.44 [0.17,1.20] 0.11  0.39 [0.14,1.06] 0.066 
         
n 261    250   





 Waist OB  without UOJ 
 Variable OR CI p  OR CI p 
Maternal age     Less than 25 0.29 [0.07,1.16] 0.080  0.32 [0.08,1.29] 0.11 
25-34 Ref  .  Ref  . 
35+ 1.18 [0.39,3.59] 0.77  1.23 [0.40,3.76] 0.72 
Adversity 1.06 [0.44,2.55] 0.90  1.02 [0.41,2.54] 0.96 
Birthweight z-score 1.69 [1.09,2.64] 0.020  1.63 [1.04,2.55] 0.033 
Rapid weight gain  2.07 [0.79,5.48] 0.14  1.9 [0.69,5.21] 0.21 
Wean age 0.82 [0.70,0.97] 0.023  0.82 [0.69,0.97] 0.021 
Maternal education  Ref  .  Ref  . 
GCSE 2.61 [0.30,22.46] 0.38  2.59 [0.30,22.61] 0.39 
A level 1.11 [0.10,12.96] 0.93  1.11 [0.09,12.97] 0.93 
Degree 1.08 [0.10,11.82] 0.95  1.09 [0.10,12.13] 0.94 
SES (childhood)  Ref  .  Ref  . 
Mid 0.54 [0.18,1.61] 0.27  0.57 [0.19,1.75] 0.33 
Most advantaged 0.89 [0.30,2.63] 0.84  0.93 [0.31,2.81] 0.89 
         
n 275    263   
Pseudo R2 0.111    0.102   
Models included those with infant feeding variables, with and without ultra-orthodox Jewish (UOJ) study members for 
outcomes BMI, OWOB and waist OB. Models were additionally adjusted for sex, gestation and first born (for which all had 
non-significant p values) Coefficients (coef) or odds ratios (OR) are presented with confidence intervals (CI) and the 
corresponding level of significance (p). Ref indicates reference category for factor variables. No qualifications was the 
reference category for maternal education, and least advantaged for SES. . Bold indicates significant at p<0.05.   
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4.4.9 Path analysis 
In the path model, birthweight, adversity, RWG and physical activity had direct paths to 
BMIz. All but MVPA had positive coefficients. The direct effects of birthweight and RWG 
were similar in magnitude, however RWG had the largest total effect on BMIz of all the 
exposures. Cumulatively, the exposures in the model explained 23% of the variation in BMIz. 
Higher maternal education was associated with increased likelihood of being first-born and 
increased birthweight, independent of maternal age. Maternal education was not a direct 
predictor of BMIz, but had a small significant total effect, mediated through the early life 
exposures. Lower birthweights were observed for first-born children. Older maternal age 
was associated with lower likelihood of being first-born, as to be anticipated, however 
neither of these factors had significant total effects on BMIz.  
There was an interesting relationship between birthweight, RWG and BMIz. Whilst a higher 
birthweight was associated with a higher BMIz (age 6-8), higher birthweights were 
associated with decreased likelihood of RWG. However, the total effect of birthweight on 
BMIz remained significant despite the attenuating effect via RWG, suggesting this remains 
an important factor. As well as direct and total effects, birthweight also had a significant 
indirect effect on BMIz.  
Females spent less time doing MVPA compared to males. Removing MPVA and season from 
the model decreased the R2 by around 1% and minimally altered coefficients (less than 10% 
change). Therefore, the effects of MPVA on predicting BMIz in this model are minimal. When 
building the path model, including weaning age minimally altered coefficients and did not 
increase R2, and resulted in a direct path with BMIz (p<0.1) but no paths to other variables. 
As it was not significant at p<0.05 it did not meet criteria for inclusion in the path model. 




4.5.1 Summary  
Early life risk factors for childhood adiposity were examined for the outcomes BMIz, OWOB, 
waist OB and FMI in GMS children aged 6-8. For every outcome, there was an association for 
birthweight, and associations for young maternal age, adversity, and RWG across most 
outcomes (bar waist OB). These associations were evident even after adjusting for 
confounding factors including SES and physical activity. Age at weaning did not demonstrate 
consistent associations with body composition. Overall adversity, parental separation, 
money issues were significant predictors of adiposity even after adjustment for parental SES 
(Appendix C, Table IX). The low prevalence of specific adversity exposures (i.e. for death) 
may have affected the likelihood of finding associations.  
Further exploration of the pathways to BMIz demonstrated that RWG was an intermediate 
factor between birthweight and BMIz. Maternal education was associated with birthweight, 
Figure 4.2 Path model showing the relationships between early life and childhood variables with BMIz at age 6-8.  
Arrows show the direction of the effect. Standardised coefficients are shown. All direct effects are represented by solid 
lines and are significant at p<0.05. Total effects (if significant) are presenting in brackets with associated p values. There 
were significant indirect effects on BMIz for maternal education (0.05), female (0.01), season (0.03) and birthweight 
(0.14).   
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and parity, which were also both associated with RWG. Adversity and MVPA independently 
predicted BMIz.  
The associations noted for RWG were large, with 4 fold increased odds of OWOB and large 
increases in BMIz and FMI, with estimates increasing after adjusting for PAL. However, when 
excluding the FMI outliers and using robust regression, the estimates decreased suggesting 
that this relationship is stronger in children with higher fat mass.  
Decreases in adiposity were evident across all outcomes for physical activity. Adjusting for 
activity removed any significant associations between SES and outcomes, and no early life 
exposures predicted waist OB after adjusting for activity. When MVPA was included in the 
multivariable models, the model explained a much larger proportion of the variation in the 
outcome variables, more so for OWOB and FMI (R2 increased by 9%). Although in the path 
model, when activity was excluded it made little difference to estimates or overall variation 
explained. This may suggest that although activity is an important factor for obesity and fat 
mass, the early life and maternal factors and the pathways between them are the main 
influences on childhood BMIz.  
There were no associations for caesarean birth, which is in contrast to systematic reviews 
and meta-analyses, which generally find a positive association (Darmasseelane et al., 2014, 
Kuhle et al., 2015). Findings from the Pelotas study from Brazil (Barros et al., 2017), and a 
matched sibling-pair design study (Rifas-Shiman et al., 2018) have attributed the association 
to unmeasured confounding. Differences might also arise when distinguishing between 
elective and emergency c-sections, for example considering underlying issues related to an 
emergency c-section such as maternal pre-pregnancy BMI or macrosomic infants. The 
underlying biological mechanism for caesarean birth is yet to be determined, but may be 
related to the microbiome (Masukume et al., 2018), which demonstrates great 
interindividual variation and could create heterogeneity in results (Kuhle and Woolcott, 
2017).  
There were null associations for sleep problems, which may be due to the definition of sleep 
problems used. The majority of studies analysing sleep problems use sleep duration, which 
was not measured in this cohort. There is also the possibility that higher BMI precedes sleep 
problems (Wang et al., 2019).  
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There were no associations for early life infection, however this was a rather crude measure 
extrapolated from questionnaire data. More accurate infection data could come from data 
linkage with NHS records.  
4.5.2 Sensitivity analyses 
Sensitivity analyses based on religion revealed some differences. Previous research in this 
group in GMS has found differing growth patterns, including weight faltering in infancy 
(Wright et al., 2010b). This was attributed to delayed introduction of solids and longer 
duration breastfeeding (Wright et al., 2010b). Excluding this demographic also meant the 
exposures; adversity, birthweight, and RWG corresponded to higher odds of OWOB and 
increased FMI and BMIz. This suggests that the effect sizes were underestimated, and 
perhaps implies that these risk factors may not be risk factors in different populations. 
Despite previous findings that ultra-orthodox infants were lighter at age 13 months, the 
prevalence of overweight or adiposity in childhood (age 6-8) was not different between 
ultra-orthodox children and the rest of the cohort. It was not possible to discern if early life 
risk factors differed between groups, and due to the small sample size results should be 
interpreted with caution.  
4.5.3 Choice of outcome measure  
There were strong correlations between all outcome measures, more so between BMIz, FMI 
and OWOB, whilst waist OB had slightly weaker correlations with the other outcomes 
(however all Pearson r>0.6). Studies have found that correlations between body fat and BMI 
in children can range vastly (from 0.22 to 0.9) and are stronger in those with higher fat mass 
(Wells, 2000, Freedman et al., 2005b).  
Despite the strong correlations, there were some differences between risk factors and 
outcomes (Figure 4.3). In accordance with the work of Basterfield et al (2012), there were 
differences in early life risk factors based on choice of outcome measure. However, contrary 
to their work, in these analyses there was good consistency in associations for exposures for 
BMIz, FMI and OWOB. The risk factors for increased BMIz (maternal age, birthweight, 
adversity and RWG) also correspond to increased odds of OWOB, which is perhaps not 
surprising as BMIz and OWOB are based on the same measures. 
Height is a confounding factor when determining childhood adiposity. The outcome 
measures accounted for height, however there still may be residual correlation. The use of 
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FMI in addition to primary outcomes allows greater sensitivity to detect early life exposures 
associated with adiposity.  Although, in the study by Steiberger et al. (2005), the correlations 
between BMIz and body fat quantified by DXA were stronger among children with a higher 
percentage of body fat (r = 0.9) than among leaner children (r = 0.5) (Steinberger et al., 
2005). This suggests that BMI is more reflective of body fat in children with higher fat mass.   
Ideally studies would use direct measures of body fat. Whilst BIA has its limitations, many of 
the other sophisticated methods for determining body fat are less suitable for small children 
as they require subjects to lie still for an amount of time. In this cohort the risk factors for 
FMI were the same as those for OWOB, suggesting that BMI (for determining OWOB) may be 
an adequate proxy measure.  
Overall these results indicate that the risk factors; birthweight, RWG, adversity and maternal 
age were consistently associated with adiposity in this cohort, with some support for early 
weaning and low SES.  Physical activity was associated with reduced adiposity across all 
outcomes.  
 
Figure 4.3 Venn diagram for significant associations (p<0.05) in multivariable models across outcomes.  
Associations are from the multivariable models not adjusted for PAL and outliers not excluded for FMI. BWT, birthweight, 




Chapter 5. The influence of early life factors and the 
environment on childhood obesity over time in two regional 
birth cohorts 
5.1 Introduction 
Increases in childhood obesity in the last 20 years have been somewhat attributed to social 
change and a changing environment. All of the environmental influences and conditions of 
life that encourage OWOB have been termed the obesogenic environment (Lake et al., 
2011). Over this time, there has also been widening social inequalities in childhood 
overweight (NHS Digital, 2016, Bann et al., 2018), and changes in the social patterning of 
obesity (Knai et al., 2012).   
Early life risk factors for childhood obesity have mostly been examined in modern cohorts. 
However, multiple early life risk factors have not previously been examined in children in a 
historic (i.e. pre-obesity epidemic) cohort. Therefore, it is unknown whether these early life 
risk factors are only risk factors in conjunction with an obesity-promoting environment or 
are distinct, biologically embedded risk factors.  
This chapter addresses the second aim of the thesis and investigates the regional temporal 
changes on obesity, and the impact of modern environmental and socioeconomic factors. 
The analysis uses data from both the 1947 Newcastle Thousand Families Study (NTFS) and 
the 2000 Gateshead Millennium Study (GMS)), two cohorts from the same region- North 
East of England born over 50 years apart. Using cohorts from the same region controls for 
some baseline area-level differences. The cohorts had data collected on body composition at 
various ages throughout childhood, and both cohorts had measures of body height and 
weight at ages 9 and 13. The analysis in this chapter focused on body composition at age 9, 
due to a lower level of missing data, and to minimise the bias of puberty on results (which 
typically begins between around age 11 and 12 years for girls and boys respective (Marshall 
and Tanner, 1969, Marshall and Tanner, 1970)).   
The previous chapters determined that the early risk factors for childhood body composition 
(in GMS) were birthweight, maternal age, adversity and rapid weight gain (RWG). 
Breastfeeding was associated with BMI in NTFS adults. SES had indirect effects in both adults 
and children. Therefore, these were the exposures investigated in this analysis. Whilst there 
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were other associations found (bacterial infection (NTFS adults), physical activity (NTFS 
adults and GMS children)), comparable data were not available for these exposures for both 
cohorts.  
This chapter will investigate and compare the relationship between early life and societal 
factors on childhood body composition in the two cohorts. Using cohorts from the same 
area but at different time points provides a unique opportunity to investigate if, and how the 
escalating obesogenic environment may have transformed early life risk factors for obesity.  
5.2 Aims 
The first aim of this chapter was to determine if an increasingly obesogenic environment has 
altered the impact of early life factors and societal factors on BMI and the likelihood of being 
overweight/obese (OWOB) in childhood. The analysis will examine if risk factors have 
changed over time, in two regional birth cohorts that were not subject to the same 
confounding and environmental influences. 
Secondly, this chapter aimed to assess the relative importance of each of the early life 
factors and SES on childhood BMI by understanding the pathways between them.  
5.3 Participants and methods 
Details on the two cohorts utilised in this chapter are outlined in sections 2.1.1 (NTFS) and 
2.1.2 (GMS). Anthropometric measures were taken at around age 9 for participants from 
both cohorts and were used to calculate BMIz and OWOB (for details see methods section 
2.2.1). There were several early life factors directly comparable across the two cohorts and 
measured at similar time points (Table 5.1). These included; SES, maternal age, birthweight, 
breastfeeding, adversity and RWG (in the first year). Due to the large difference in 
birthweight z-scores between the cohorts, weight gain conditional on birthweight was also 
considered (rapid thrive). Recoding of the variables was similar for both, except for SES and 
adversity (Table 5.1). 
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Table 5.1 Description of the earlexposures and any differences between the cohorts 
Time 
point 





Maternal age Years and groups (<25, 25-34, 35+) Continuous and categorical No 
Birthweight  
Birthweight z-score, using the British 1990 
growth reference  
Continuous  No 
Gestation  
Weeks (continuous) and categorised as; pre-
term, <38 wks; post-term >41 wks 
Continuous and categorical  No 
Socioeconomic 
status (SES) 
In NTFS Social class based on occupation  
In GMS Townsend score (quintiles) 
Categorical,  
5 categories with 1 being 







If experienced a 0.67 SD change in weight 
for age z-score 
Dichotomous  No 
Rapid thrive 
(RT) 
If experienced a 0.67 SD change in 
conditional weight gain (z-score12m − r × z-
scorebirth) 
Dichotomous  No 
Breastfeeding 
Predefined categories (GMS) of never, <4 
weeks, 4 week-6 months and 6 months+ 
For NTFS, weeks were transformed into the 
same categories to match GMS 
Categorical  No  
Adversity 
Experiencing any of the following;  
parental separation, police involvement, 
abuse, debt, death or illness in the family; 
- In the first year in NTFS (0-12 months) 
- From 8 months pre-natal to 4 months 
post-natal in GMS 
Dichotomous  Yes 
SD, standard deviation.  
Statistical analysis 
Sex, SES, adverse events, RWG, RT and breastfeeding were analysed as categorical variables. 
Maternal age and birthweight were analysed as both categorical and continuous variables, 
and gestation as a continuous variable. Outcomes were BMIz and OWOB at age 9. 
The statistical analysis is outlined in section 2.4.3. Briefly, this included testing cohort 
representativeness of sub-sample of participants at age 9 and examining baseline 
differences in the cohorts, using t-test, chi-squared or Wilcoxon rank-sum tests as 
appropriate. Variation between socioeconomic groups and body composition (OWOB, BMIz 
and height), were analysed using Chi-square tests or one-way ANOVA. Logistic (OWOB) and 
linear (BMIz) regression analyses were carried out as described in section 2.3.5. Associations 
between exposures and outcomes were estimated, with separate analyses for each cohort, 
and with adjustment for SES.  
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Although BMI assesses weight independent of height, it remains correlated with height in 
children (Metcalf et al., 2011b)(residual correlation). In GMS, there was a moderate 
correlation (r=0.4, p<0.0001) between height and BMIz (age 9), whereas there was no 
correlation in NTFS (p=0.3). Furthermore, as there was a notable height difference between 
the cohorts, height was included as a covariate in the multivariable models.  
Odds ratios (OR) with corresponding 95% confidence intervals for OWOB and explanatory 
variables were estimated using logistic regression. Multivariable analysis was possible only in 
the GMS cohort due to few OWOB study members in NTFS. 
5.4 Results 
5.4.1 Sample differences in early life exposures 
For the children in the original cohorts (NTFS n=1142, GMS n= 1029), measures of height and 
weight were available for 734 members of NTFS and 481 of GMS at age 9. Study members 
measured at age 9 differed significantly from the remainder of the original study members in 
both cohorts (Table 5.2). In GMS those with BMI measures (age 9) had a higher mean 
maternal age, were more advantaged at birth, had a longer duration of breastfeeding and a 
greater proportion had experienced an adverse event, compared to the original sample. The 
NTFS age 9 sample also had a higher mean maternal age, the sample was less advantaged 




Table 5.2 Descriptive statistics and sample representativeness of those with BMI measures at age 9 in the NTFS and GMS 






























































  NTFS  GMS 
Categorical Total Measured 
Not 
measured 




  N Col % Col %   N Col % Col %  
Sex 1,097 363 734   988 507 481  
Male 561 54.5 49.5 
0.11 
 501 51.7 49.7 
0.53 
Female 536 45.5 50.5  487 48.3 50.3 
Birthweight 973 246 727   987 506 481  
SGA 111 15 10.2 
0.10 
 87 8.7 8.9 
0.77 Normal 784 78 81.4  806 82.4 80.9 
LGA 78 6.9 8.4  94 8.9 10.2 
Gestation categories 983 250 733   987 506 481  
Pre-term  34 7.2 2.2 
<0.001 
 105 11.9 9.4 
0.32 Normal 907 87.2 94.0  819 81.2 84.8 
Post-term  42 5.6 3.8  63 6.9 5.8 
RWG (0-12 months) 354 17 337   808 354 454  
No 213 58.8 60.2 
0.91 
 562 70.9 68.5 
0.46 
Yes 141 41.2 39.8  246 29.1 31.5 
RT (0-12 months) 354 17 337   808 354 454  
No 219 58.8 62 
0.79 
 572 72.9 69.2 
0.25 
Yes 135 41.2 38  236 27.1 30.8 
Maternal age at 
birth 
978 244 734   987 506 481  
Less than 25 272 36.5 24.9 
<0.001 
 322 39.1 25.8 
<0.001 25-34 544 54.5 56  545 50.6 60.1 
35+ 162 9 19.1  120 10.3 14.1 
Breastfeeding 
categories 
460 114 346   948 483 465  
None 65 8.8 15.9 
0.004 
 465 56.1 41.7 
<0.001 
<6 weeks 73 21.1 14.2  237 25.1 24.9 
>6wk 143 21.9 34.1  89 6.8 12.0 
>4m 179 48.2 35.8  157 12.0 21.3 
Adversity 346 97 249   928 475 453  
No 298 89.7 84.7 
0.23 
 715 80.8 73.1 
0.005 
Yes 48 10.3 15.3  213 19.2 26.9 
SES at birth 1021 310 711   981 506 475  
Least advantaged 158 11.3 17.3   186 20.2 17.7  
2nd to least 162 15.8 15.9   200 18.2 22.7  
Mid advantaged 577 52.6 58.2 <0.001  221 23.1 21.9 0.001 
2nd to most 92 14.5 6.6   222 26.5 18.5  
Most advantaged 32 5.8 2.0   152 12.1 19.2  
Number of study members in each category (n) and corresponding column percentage (Col %) or mean and 
standard deviation (SD). P values shown for Chi-square test for significant differences between the those with 
data (BMI measured) and those without for categorical variables, and t-tests for continuous variables. SGA, Small 
for gestational age; LGA, Large-for-gestational age; RWG, rapid weight gain; RT, rapid thrive; SES, socioeconomic 
status.  
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5.4.2 Cohort differences in outcome measures 
GMS children on average had a significantly (p<0.001) higher BMIz (+0.52 z-score) and were 
taller (+8.4cm) than NTFS children (Table 5.3). Of the 734 study members, there were few 
children with overweight (5%) or obesity (3%) in the NTFS in 1956, with the majority (93%) 
having a healthy weight. Of the 481 in GMS sample, 33% were OWOB, of these 11% were 
obese (Table 5.3).  
5.4.3 Descriptive characteristics of socioeconomic groups and weight outcomes 
In both cohorts, there were no significant differences in the prevalence of children with 
OWOB by socioeconomic group (at each time point), and no trend for BMIz (ANOVA p>0.05) 
(Table 5.3). Although there were no significant differences, in both cohorts the 2nd to most 
advantaged group (at birth) had the highest mean BMIz (age 9).   
There were socioeconomic differences in height in NTFS, which were significant (after 
Bonferroni correction) at birth between the least advantaged and both the mid (+3.0cm, 
p<0.001), and the most advantaged (+5.9cm, p=0.04)(Table 5.3). There were no differences 
for childhood SES. Whereas in GMS, height was associated with childhood SES with 
significant differences between the least and most advantaged (+2.1, p=0.056). However, 
there were no significant height and SES interactions on BMIz within the cohorts.  
When examining SES groups in childhood, in GMS the least advantaged group (at age 9) had 
a greater proportion of children with OWOB (32%), although this was not significant (p=0.07) 
(Table 5.3). In contrast, in NTFS the most advantaged group (at age 9) had the highest 
proportion of OWOB (8.5%); and this was comprised exclusively of children with obesity.  
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Table 5.3 Body composition measures (age 9) by SES categories at birth and age 9 in the GMS and NTFS cohorts 




















(SD) (SD)     (SD) (SD) 
All 
 
734 93.1 6.9 0.08 127.4   481 76.5 23.5 0.60 135.8 
      (-0.88) (7.40)         (1.06) (6.34) 
SES at birth                       
Least 
advantaged 
123 91.9 8.1 
0.07 125.2  84 76.2 23.8 0.63 135.7 
(-0.90) (7.31)     (1.04) (5.82) 
2nd to least 
advantaged 
113 98.2 1.8 
-0.01 126.6  108 78.7 21.3 0.58 136.5 
(-0.82) (7.26)     (1.07) (6.03) 
Mid 414 92 8 
0.11 128.2  104 76 24 0.61 135.9 
(-0.89) (7.31)     (1.1) (6.63) 
2nd to most 
advantaged 
47 91.5 8.5 
0.18 127.7  88 70.5 29.5 0.72 135.0 
(-0.98) (7.59)     (1.05) (6.68) 
Most 
advantaged 
14 92.9 7.1 
-0.03 131.1  91 80.2 19.8 0.5 135.4 
(-0.87) (6.66)     (1.02) (6.53) 
Total 711      475 
  
  
P value  0.22 a 0.66 b 0.001 b  
 0.59 a 0.74 b 0.52 b 
SES at 9                      
Least 
advantaged 
250 94 6 
0.04 127.4  87 67.8 32.2 0.63 134.9 
(-0.92) (6.78)     (1.13) (5.88) 
Mid 379 92.9 7.1 
0.08 127.9  110 80.9 19.1 0.53 136.0 
(-0.85) (7.31)     (1.01) (6.34) 
Most 
advantaged 
47 91.5 8.5 
0.17 128.6  105 79 21 0.70 137.0 
(-0.85) (6.73)     (0.99) (6.32) 
Total 676      302 
    
P value   0.77 a 0.63 b 0.50 b     0.07 a 0.49 b 0.06 b 
Category totals (N); corresponding row percentages (row %); Standard deviation (SD); Socioeconomic status at 
birth (SES) was fathers occupational social class in NTFS or Townsend quintile in GMS. Bold indicates p<0.05.  
a Chi-square test p value presented for differences between socioeconomic group and weight categories  
b ANOVA p value for differences between socioeconomic groups  
 
5.4.4 Cohort differences in early life exposures 
Descriptive statistics for all variables are shown in Table 5.4, with tests for significant 
differences between cohorts. Mean birthweight was higher in GMS children and length of 
gestation was marginally longer in NTFS (Table 5.4). There were no differences in the 
distribution of birthweight categories (SGA, LGA) between the cohorts. In GMS there were 
more children who were never breastfed and there was overall shorter duration of 
breastfeeding: just under half of GMS children were never breastfed (49%), whereas 
breastfeeding for over 4 months was more commonplace in NTFS (39%). Rapid growth (RWG 
and RT) was more common in NTFS than in GMS. In GMS there were fewer older mothers 
(35+) and a greater proportion of younger mothers (<25 years).  
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There were few in the most advantaged socioeconomic groups in NTFS at both birth and age 
9 (Table 5.4). The composition of socioeconomic groups was notably different between the 
cohorts at age 9 (occupational social class): only 6.8% of the NTFS cohort were in the highest 
occupational group, compared to 34.9% in GMS (p<0.0001) (Table 5.4).  
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Table 5.4 Descriptive statistics for early life exposures and covariates and baseline differences between the cohorts   
Cohort   
  NTFS  GMS   
Continuous variables n Mean (SD)  n Mean (SD) P value 
Birthweight (z-score) 1,002 -0.15 (1.06)  993 -0.02 (1.02) 0.009 
Maternal age (years) 995 28.48 (5.80)  993 27.92 (5.97) 0.035 
Gestation (weeks) 990 39.82 (1.28)  993 39.48 (1.70) <0.0001 





Male 570 51.2  506 50.9 
0.905 
Female 544 48.8  488 49.1 
Gestation categories 990   993   
Pre-term  34 3.4  107 10.78  
Normal 914 92.3  823 82.88 <0.0001 
Post-term  42 4.2  63 6.34  





SGA 115 11.6  89 9.0 
0.10 Normal 796 80.4  810 81.6 






No 218 60.6  567 69.6 
0.002 
Yes 142 39.4  246 30.4 
RT 360   813   
No 227 63.1  577 71.0 
0.007 
Yes 133 36.9  236 29.0 





Less than 25 276 27.7  326 32.8 
0.004 25-34 554 55.7  547 55.1 
35+ 165 16.6  120 12.1 
Breastfeeding categories  469 
 
 993   
Never 68 14.5  468 49.1 
<0.0001 
 
<6 weeks 75 16.0  237 24.9 
>6 weeks 143 30.5  89 9.3 






No 303 86.1  719 77.0 
<0.0001 
Yes 49 13.9  215 23.0 





Least advantaged 158 15.3  188 19.1 
<0.0001 
 
2nd to least advantaged 165 15.9  201 20.4 
Mid 589 56.9  221 22.4 
2nd to most advantaged 92 8.9  223 22.6 
Most advantaged 32 3.1  154 15.6 





Least advantaged 265 36.9  110 29.5 
<0.0001 Mid 404 56.3  133 35.7 
Most advantaged 49 6.8  130 34.9 
Number of study members in each category (n) and corresponding column percentage (Col %) or mean and 
standard deviation (SD). P values shown for Chi-square test for significant differences between NTFS and GMS 
for categorical variables, and t-tests for continuous variables. Bold indicates p<0.05. SGA, Small for gestational 
age; LGA, Large-for-gestational age; RWG, rapid weight gain; RT, rapid thrive; SES, socioeconomic status.  
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5.4.5 Relationship between childhood BMI, early life risk factors and SES 
Similar to descriptive analyses, there were no significant direct linear associations between 
early life or childhood SES and BMIz at age 9 in either cohort (Table 5.6, unadjusted model). 
In NTFS unadjusted regression models, females had a significantly lower BMIz. RWG and RT 
were associated with an increased BMIz, each to a similar degree. Higher maternal age was 
associated with a small decrease in BMIz. These associations remained after adjustment for 
SES at birth and at age 9. No other variables demonstrated significant (P<0.05) associations 
with BMIz in NTFS.  
In the GMS cohort, birthweight and adversity were associated with an increased BMIz, with 
adjustment for SES at both time points attenuating these effects (Table 5.6). Both RWG and 
RT were also associated with increased BMIz, however the coefficient for RT was much 
larger (RWG b=0.32, p<0.05; RT b=0.70, p<0.001). After adjusting for SES, older maternal age 
was significantly associated with a lower BMIz in GMS.  
There was no evidence for interactions between explanatory variables and SES at birth for 
pooled data from both cohorts (all p values >0.1). Interactions between SES at birth and 
explanatory variables were also investigated separately by cohort. In NTFS, there was a 
significant interaction between maternal age (continuous) and those in the 2nd to most 
advantaged group at birth compared to the least advantaged (-0.07 reduction in BMIz, 
p=0.02), which remained after adjustment for SES at age 9, however there was no overall 
trend (Table 5.5). This indicates that the slopes of the best-fitting regression lines between 
maternal age and childhood BMI are not parallel for every socioeconomic group. Group sizes 
were too small to investigate adversity, categories of birthweight and maternal age in NTFS. 
There were no significant interactions between SES and exposures in GMS. 
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Table 5.5 The significant exposure-socioeconomic status interaction(s) from the unadjusted and adjusted for SES (age 9) 
bivariate regression models in the NTFS cohort (age 9) 
SES (at birth) & exposure interaction effects     
 
        
NTFS Unadjusted  Adjusted for SES (age 9) 
 Coef CI p  Coef CI p 
Maternal age        
*Least advantaged Ref    Ref   
*2nd to least advantaged -0.01 (-0.05,0.03) 0.60  -0.01 (-0.05,0.03) 0.48 
*Mid 0.02 (-0.01,0.05) 0.15  0.02 (-0.01,0.05) 0.28 
*2nd to most advantaged -0.07 (-0.13,-0.01) 0.020  -0.06 (-0.12,-0.00) 0.036 
*Most advantaged 0.08 (-0.05,0.21) 0.21  0.08 (-0.05,0.21) 0.22 
n 711    657   
* p<0.05, ** p<0.01, *** p<0.001. Coef, coefficient; CI, 95% confidence interval; Ref, reference category. 





Table 5.6 Linear regression associations for the early life exposures and BMIz at age 9 years with unadjusted, adjusted for SES (birth) and adjusted for SES (age 9) estimates  presented for the 
NTFS and GMS cohorts 
NTFS            
 Unadjusted 
 Adjusted for SES (birth)  Adjusted for SES (age 9) 
Exposure Coef CI p  Coef CI p  Coef CI p 
Female -0.23 (-0.36,-0.11) <0.001  -0.24 (-0.37,-0.11) <0.001  -0.25 (-0.38,-0.11) <0.001 
Birthweight z-score 0.05 (-0.01,0.11) 0.092  0.05 (-0.01,0.11) 0.134  0.04 (-0.02,0.11) 0.20 
Birthweight 
categories 
SGA -0.14 (-0.35,0.07) 0.20  -0.15 (-0.37,0.08) 0.20  -0.18 (-0.41,0.05) 0.13 
Normal Ref  .  Ref  .  Ref  . 
LGA 0.09 (-0.15,0.32) 0.46  0.08 (-0.15,0.32) 0.49  0.04 (-0.21,0.29) 0.75 
Maternal age (years) -0.01 (-0.02,-0.00) 0.035  -0.01 (-0.02,-0.00) 0.023  -0.01 (-0.03,0.00) 0.022 
Maternal age 
categories 
< 25 0.09 (-0.06,0.24) 0.26  0.11 (-0.05,0.27) 0.19  0.15 (-0.02,0.31) 0.079 
25-34 Ref  .  Ref  .  Ref  . 
35+ -0.13 (-0.30,0.04) 0.14  -0.13 (-0.30,0.04) 0.13  -0.11 (-0.29,0.07) 0.22 
Adverse events -0.09 (-0.39,0.21) 0.55  -0.03 (-0.35,0.30) 0.88  0.07 (-0.29,0.43) 0.71 
RWG 0.29 (0.10,0.48) 0.002  0.27 (0.08,0.46) 0.006  0.27 (0.08,0.47) 0.005 
RT 0.23 (0.04,0.42) 0.01  0.21 (0.01,0.40) 0.021  0.20 (-0.00,0.40) 0.031 
Breastfeeding 
categories 
Never Ref    Ref    Ref   
<6 weeks 0.19 (-0.17,0.54) 0.30  0.18 (-0.16,0.52) 0.30  0.18 (-0.16,0.52) 0.30 
>6 weeks 0.12 (-0.17,0.42) 0.41  0.11 (-0.18,0.39) 0.47  0.11 (-0.18,0.39) 0.47 
>4 months 0.08 (-0.22,0.38) 0.60  0.08 (-0.20,0.36) 0.58  0.08 (-0.20,0.36) 0.58 
SES at birth            
Least advantaged     Ref    Ref   
2nd to least advantaged     -0.07 [-0.30,0.16] 0.53  -0.01 [-0.25,0.23] 0.92 
Mid     0.04 [-0.14,0.22] 0.65  0.05 [-0.16,0.26] 0.61 
2nd to most advantaged     0.11 [-0.19,0.41] 0.48  -0.02 [-0.36,0.32] 0.90 
Most advantaged     -0.07 [-0.58,0.44] 0.78  -0.28 [-0.90,0.34] 0.38 
SES age 9            
Least advantaged         Ref   
Mid         0.02 [-0.14,0.18] 0.82 
Most advantaged         0.25 [-0.11,0.61] 0.17 
Height (age 9) 0 (-0.00,0.01) 0.29 
 0 (-0.01,0.01) 0.46  0.01 (-0.00,0.02) 0.12 
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GMS            
 Unadjusted 
 Adjusted for SES (birth)  Adjusted for SES (age 9) 
Exposure Coef CI p  Coef CI p  Coef CI p 
Female -0.03 (-0.22,0.16) 0.78  -0.05 (-0.24,0.15) 0.64  -0.15 (-0.39,0.09) 0.23 
Birthweight z-score 0.21 (0.12,0.30) <0.001  0.23 (0.13,0.32) <0.001  0.22 (0.10,0.33) <0.001 
Birthweight 
categories 
SGA -0.2 (-0.53,0.13) 0.23  -0.19 (-0.53,0.15) 0.28  -0.15 (-0.61,0.30) 0.51 
Normal Ref  .  Ref  .  Ref  . 
LGA 0.22 (-0.09,0.53) 0.16  0.25 (-0.07,0.57) 0.12  0.25 (-0.14,0.64) 0.21 
Maternal age (years) 0 (-0.02,0.01) 0.72  0 (-0.02,0.02) 0.88  -0.02 (-0.04,0.01) 0.18 
Maternal age 
categories 
< 25 -0.12 (-0.34,0.10) 0.30  -0.14 (-0.37,0.10) 0.25  -0.11 (-0.41,0.20) 0.50 
25-34 Ref  .  Ref  .  Ref  . 
35+ -0.28 (-0.56,-0.00) 0.049  -0.27 (-0.55,0.01) 0.055  -0.44 (-0.77,-0.10) 0.011 
Adverse events 0.42 (0.20,0.64) <0.001  0.43 (0.21,0.65) <0.001  0.34 (0.07,0.61) 0.014 
RWG 0.36 (0.16,0.57) 0.001  0.37 (0.16,0.58) 0.001  0.32 (0.05,0.59) 0.019 
RT 0.63 (0.43,0.83) <0.001  0.65 (0.44,0.86) <0.001  0.70 (0.45,0.96) <0.001 
Breastfeeding 
categories 
Never Ref    Ref    Ref   
<6 weeks -0.05 (-0.30,0.19) 0.67  -0.04 (-0.29,0.21) 0.75  -0.04 (-0.29,0.21) 0.75 
>6 weeks -0.28 (-0.59,0.04) 0.085  -0.24 (-0.57,0.10) 0.17  -0.24 (-0.57,0.10) 0.17 
>4 months -0.16 (-0.42,0.09) 0.21  -0.17 (-0.45,0.10) 0.22  -0.17 (-0.45,0.10) 0.22 
SES at birth            
Least advantaged     Ref    Ref   
2nd to least advantaged     -0.09 (-0.39,0.22) 0.58  -0.21 (-0.61,0.18) 0.29 
Mid     -0.06 (-0.36,0.25) 0.72  -0.29 (-0.69,0.10) 0.15 
2nd to most advantaged     0.07 (-0.25,0.38) 0.68  -0.21 (-0.61,0.19) 0.30 
Most advantaged     -0.18 (-0.50,0.14) 0.27  -0.18 (-0.59,0.23) 0.38 
SES age 9            
Least advantaged         Ref   
Mid         -0.09 (-0.40,0.22) 0.57 
Most advantaged         0.05 (-0.27,0.37) 0.76 
Height (age 9) 0.07 (0.05,0.08) <0.001  0.07 (0.05,0.08) <0.001  0.07 (0.05,0.08) <0.001 
The unadjusted model is the relationship between the exposure and BMIz, with models further adjusted for SES at birth, and then SES age 9.  
Coef, coefficient; CI, 95% confidence interval; p, p value; Ref, reference category. SES, socioeconomic status; RWG, rapid weight gain; RT, rapid thrive. 
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The multivariable analyses were stratified by cohort, and RT (rather than RWG) was used as 
it controls for some of the differences in birthweight. In the stratified multivariable model 
for NTFS, females had a lower BMIz (-0.22, CI -0.41,-0.02) and those who experienced RT in 
the first year had a higher BMIz (0.20, CI 0.01,0.40) (Table 5.7). Those from the most 
advantaged group at birth had a significantly lower BMIz, however there was no overall 
trend by SES. There was no significant interaction between maternal age and SES after 
adjustment for the other covariates.  
The significant predictors of BMIz in GMS were RT, birthweight and adversity, adjusted for 
covariates; maternal age, gestation, SES and first-born (Table 5.7). RT was associated with 
greater increases in BMIz in GMS. The early life factors explained a greater proportion of the 
variation in BMIz in GMS (GMS R2=17%, NTFS R2=3%, Table 5.7). There were no significant 
interactions between early life exposures and SES at birth in the adjusted model for either 
cohort.  
Adjusting for height attenuated the effects (by 10-30%) for all significant associations in 
GMS. Whilst adjusting for height made little difference to estimates for early life variables in 
NTFS. The variance inflation factors were low (<2.5) for all variables, therefore this is less 
likely to be due to multi-collinearity. This may be because height is a mediator on the 
pathway for early life factors and BMIz in GMS (Figure 5.1) 
  
Table 5.7 Multivariable fully adjusted linear regression models for BMIz (age 9) by cohort 
 NTFS  GMS 
 coef CI p  coef CI p 
Female -0.22 (-0.41,-0.02) 0.029  -0.16 (-0.39,0.06) 0.16 
RT 0.22 (0.01,0.43) 0.038  0.50 (0.23,0.76) <0.001 
Birthweight z-score 0.02 (-0.08,0.11) 0.72  0.17 (0.05,0.29) 0.006 
SES at birth        
 Least advantaged Ref  .  Ref  . 
2nd to least 0.05 (-0.31,0.41) 0.79  -0.24 (-0.62,0.14) 0.22 
Mid advantaged 0.1 (-0.21,0.41) 0.54  -0.34 (-0.73,0.05) 0.084 
2nd to most 0.04 (-0.45,0.53) 0.88  -0.19 (-0.58,0.19) 0.33 
Most advantaged -0.93 (-1.87,0.01) 0.052  -0.18 (-0.57,0.22) 0.39 
Height (cm) 0 (-0.02,0.01) 0.59  0.04 (0.02,0.06) 0.019 
Adversity     0.30 (0.05,0.55) <0.001 
Adjusted R2 0.022    0.212   
n 313    269   
Models were additionally adjusted for height, maternal age, gestation and SES at age 9.  
* p<0.05, ** p<0.01, *** p<0.001. Bold indicates p<0.05. Coef, coefficient; CI, 95% confidence interval; Ref, 
reference category.; n, number of observations. RT, rapid thrive; SES, socioeconomic status. 
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5.4.6 Early life predictors of childhood overweight/obesity 
In addition to BMIz, early life exposures were examined as risk factors for childhood OWOB. 
In terms of socioeconomic factors, in NTFS there were lower odds of OWOB between the 
second to least advantaged group (compared to the least at birth) (p<0.05), but there was no 
overall trend (Table 5.8). Whilst in GMS, mid-socioeconomic advantage (age 9) corresponded 
to 50% lower odds of OWOB compared to the least advantaged.  
Birthweight, adversity, RT and RWG were associated with higher odds of OWOB in GMS 
children in unadjusted models (Table 5.8). In NTFS, the only early life exposure significantly 
associated with OWOB was RT (unadjusted model, Table 5.8).  
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Table 5.8 Bivariate (unadjusted) logistic regression models for overweight/obese (age 9) by cohort 
 NTFS  GMS 
 Unadjusted  Unadjusted 
Variable OR CI p  OR CI p 
SES at birth        
 Least advantaged Ref .   Ref .  
2nd to least 0.20 (0.04,0.95) 0.043  0.87 (0.44,1.71) 0.68 
Mid advantaged 0.98 (0.47,2.05) 0.95  1.01 (0.52,1.99) 0.97 
2nd to most 1.05 (0.31,3.53) 0.94  1.34 (0.68,2.65) 0.40 
Most advantaged 0.87 (0.10,7.35) 0.90  0.79 (0.38,1.62) 0.52 
SES at age 9        
Least advantaged Ref .   Ref .  
Middle 1.2 (0.63,2.31) 0.58  0.50 (0.26,0.96) 0.036 
Most advantaged 1.46 (0.46,4.60) 0.52  0.56 (0.29,1.07) 0.079 
Female 1.02 (0.58,1.80) 0.95  0.96 (0.63,1.47) 0.86 
Birthweight z-score  1.17 (0.90,1.53) 0.25  1.28 (1.04,1.57) 0.020 
Birthweight categories        
SGA 0.75 (0.26,2.15) 0.59  0.75 (0.34,1.67) 0.48 
Normal Ref . .  Ref . . 
LGA 1.17 (0.44,3.08) 0.75  1.31 (0.68,2.54) 0.43 
Maternal age (years) 0.97 (0.92,1.02) 0.23  0.98 (0.95,1.02) 0.37 
Maternal age categories        
<25 1.36 (0.72,2.60) 0.35  0.89 (0.54,1.45) 0.63 
25-34 Ref  .  Ref  . 
>35 0.86 (0.38,1.94) 0.72  0.5 (0.24,1.03) 0.06 
Adversity 0.85 (0.18,3.91) 0.83  1.78 (1.12,2.85) 0.015 
RWG 1.71 (0.77,3.75) 0.19  1.65 (1.04,2.60) 0.033 
RT 2.24 (1.01,4.96) 0.046  2.38 (1.51,3.75) <0.001 
Breastfeeding categories        
None Ref .   Ref .  
<6 weeks 2.36 (0.41,13.46) 0.19  0.93 (0.55,1.58) 0.80 
6 weeks-4 months 2.72 (0.58,12.74) 0.12  0.47 (0.21,1.05) 0.067 
>4 months 2.58 (0.55,12.05) 0.13  0.85 (0.48,1.49) 0.57 
OR, Odds ratio; CI, 95% confidence interval; Ref, reference category. * p<0.05, ** p<0.01, *** p<0.001.  Bold 
indicates p<0.05. SGA, Small for gestational age; LGA, Large-for-gestational age; RWG, rapid weight gain; RT, 
rapid thrive; SES, socioeconomic status. 
OWOB was examined further in GMS as group sizes were too small to sufficiently estimate a 
multivariable model for NTFS. The associations of increased odds of OWOB with higher 
birthweight and RWG, and reduced odds with increasing SES remained significant after 
adjustment (Table 5.9). RWG had the greatest effect on OWOB at age 9. There were no 
significant interactions between exposures and SES, with OWOB in GMS. Adjusting for height 
increased the variation explained and removed significant associations for birthweight.  
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Table 5.9 Multivariable fully adjusted logistic regression models for OWOB (age 9) in GMS 
 GMS (RWG)  GMS (RT) 
 RT, adjusted for height 
 OR CI p  OR CI p 
 OR CI p 
Bwtz 2.12 (1.47,3.04) <0.001  1.72 (1.25,2.38) 0.001  1.35 (0.95,1.94) 0.098 
RWG 3.65 (1.73,7.70) 0.001         
RT     3.98 (2.06,7.68) <0.001  2.12 (1.02,4.40) 0.044 
Adversity 1.84 (0.96,3.53) 0.066  1.84 (0.95,3.56) 0.071  1.63 (0.81,3.27) 0.17 
SES  
(age 9) 
           








       1.14 (1.07,1.22) <0.001 
n 269    269    269   
Pseudo 
R2 0.107 
   0.126    0.186   
BIC’ 36.8    31.3    19.7   
OR, Odds ratio; CI, 95% confidence interval; Ref, reference category; N, number of observations.. * p<0.05, ** p<0.01, ***, 
p<0.001. Bold indicates p<0.05. Bwtz, birthweight z-score; RWG, rapid weight gain; RT, rapid thrive; SES, socioeconomic 
status; ht, height.  Models are additionally adjusted for sex, SES at birth, gestation, maternal age. SES reference category is 
least advantaged. A difference of 5.5 in BIC' provided positive support for the model with rapid thrive rather than RWG.   
 
5.4.7 Path analysis of the predictors of childhood BMI  
Figure 5.1 illustrates the adjusted path models for BMIz. In both cohorts, rapid thrive was 
directly associated with increased BMIz, but no variables were associated with RT. Sex was 
associated with decreased BMIz in NTFS, however, similar to the multivariable regression 
model (Table 5.7), there were no other exposures directly or indirectly associated with BMIz 
in NTFS.  
In GMS, there were direct relationships between birthweight, RT, adversity and height with 
BMIz. All exposures had significant total effects (the sum of direct and indirect effects) on 
BMIz except SES at birth. Increasing SES was positively associated with birthweight z-score. 
RT and birthweight z-score demonstrated positive associations with height. Adversity, RT 
and birthweight z-score all had similar positive, direct effects on BMIz. Dissimilar to NTFS, 
the largest total effect came from height in GMS. The GMS model explained 24% of the 
variation in BMIz, whilst the NTFS model explained a very small proportion of the variation 
(3%). For the GMS path model there was strong support for the model without SES at age 9 
and without breastfeeding, neither of which altered estimates, improved model fit, or 
increased overall variance explained.  
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A – NTFS 
B - GMS 
 
Figure 5.1 The path models for early life factors and BMIz (age 9) for NTFS (A) and GMS (B) cohorts.  
Arrows show the direction of the effect. Standardised coefficients are presented, which represent partial regression 
coefficients between connected variables, controlling for all prior variables (Garson, 2008). All direct effects are represented 
by solid lines and are significant at p<0.05. Total effects (if significant) are presenting in brackets with associated p values. 
The NTFS model was additionally adjusted for height, birthweight, maternal age, gestation length, SES (birth) however these 
had no significant paths that improved model fit (informed by modification indices). The GMS model was additionally 
adjusted for sex and maternal age (no significant paths). There were significant (p<0.05) indirect paths to BMIz for gestation 
(-0.04), RT (0.11), birthweight z-score (0.09). Gest, gestation length; SES, socioeconomic status (birth); RT, rapid thrive.  
 
5.4.8 Investigating rapid thrive 
 
RT was the risk factor associated with increased odds of OWOB and higher BMIz in both 
cohorts. There were no variables that predicted RT (Figure 5.1) in the cohorts.  
The effects of RT on mean BMI z-scores over time were examined further by cohort (Figure 
5.2). By definition, those with RT show a sizeable increase in z-score from birth to 12 
months. Within cohorts, those who had RT tended to have higher BMI z-scores throughout 
childhood than those who did not. However, in NTFS, at age 13 (the last available time point 
before adulthood) although the z-score was greater, there was no significant difference 
between those who had RT and those who did not. Similar to NTFS, in GMS those who had 
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RT had a large initial increase in z-score (0-12 months) (albeit to a lower average z-score), 
however subsequently they have a higher BMIz throughout childhood and an overweight 
BMIz (z-score>=1).  
Those who did not have RT demonstrate a decrease in z-score after birth, which over time 
stabilises around the average (z-score of 0) in NTFS, but in GMS gradually increases. 
 
Figure 5.2 The change in average z-score over by cohort and RT 
Error bars represent 95% confidence intervals. Average values were used for the interval ages for GMS. 
5.5 Discussion 
These data provided an opportunity to analyse how early life factors influencing BMI have 
changed over a long time period in one geographical area. There were more early life 
exposures significantly associated with childhood body composition and they explained 
more variation in BMIz in the modern (GMS) cohort.  
Early life and childhood experiences of NTFS study members were vastly different to those of 
GMS children and warrant further discussion to provide context for the results. Food was 
heavily regulated due to state enforced rationing leading to reductions of sugar, meat and 
fats and individuals were entitled to their fair share (Zweiniger-Bargielowska, 2000). 
Rationing did not cease immediately after the war but continued until 1954. This reduced 
disparities of the previous decade between the social classes regarding energy and nutrient 
intakes, with calorie and protein intakes between working and middle classes stable 
between 1944-1956 (Zweiniger-Bargielowska, 2000). This period of time also saw an 














No rapid growth NTFS Rapid growth NTFS
No rapid growth GMS Rapid growth GMS
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reduced vehicle usage as a result of petrol rationing. These factors will have impacted both 
the mother during pregnancy and also the offspring during the first few years of life. 
A comparison between two of the British birth cohorts found those born in 1958 were not 
heavier than those born in 1946 until adolescence, when the weight trajectories for the later 
cohort had a faster rate of gain (Li et al., 2008). Further differences emerged by mid-
adulthood in measures of waist and hip circumferences, with higher rates of obesity in the 
1958 cohort. Compared to modern day, this cohort experienced the obesity epidemic at a 
later age (around mid-thirties) meaning a shorter exposure to an obesogenic environment. 
This is consistent with results here, whereby obesity did not emerge until later life (chapter 
3). This coincides with a time of technological change, whereby households and industry 
were shifting toward labour-saving devices (Lakdawalla and Philipson, 2009), therefore 
lifestyles became more sedentary. This additional time also meant more women could take 
up employment, and with this came a change in what was deemed traditional home cooking 
and diet.  
Post-war was a time of rising affluence in Britain, which was seen here in the social mobility 
of NTFS. The boom of the economy was associated with increased travel due to decreases in 
transport costs and the accompanying introduction of new, cheaper foods. The food 
environment shifted; with the focus was no longer solely on sustenance, and restaurant and 
fast food chains began to emerge. These factors could partly explain the latency in obesity 
onset.   
Early life factors previously explained a relatively small proportion of the variation in BMI 
(2% in NTFS compared to 22% in GMS), suggesting that early life factors in combination with 
modern environments, have become more important over time in determining childhood 
body composition.  
5.5.1 Summary of results 
At baseline, the two cohorts differed in birthweight, maternal age, gestation length, RWG, 
duration breastfed, adversity, and SES. On average birthweight increased, there were fewer 
older mothers and more young mothers, RT was less likely, breastfeeding duration was 
shorter and more experienced adversity. Height has also increased vastly between the two 
cohorts, and in the modern cohort was associated with increased BMI and odds of OWOB (in 
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GMS). The social class differences in height seen in NTFS have diminished over time. 
However, in the modern cohort socioeconomic differences in OWOB have emerged. 
There were large differences in birthweight between the cohorts, and birthweight was 
negatively associated with RWG (section 4.4.9), therefore RT was also analysed to further 
understand the effects of conditional weight gain. RT corrected for some of the effects of 
catch-up growth (from low birthweight), suggesting that RWG encompassed some of the 
indirect, and potentially developmental programming effects of birthweight. RT was 
associated with increased BMIz in both cohorts, however in GMS the effects were greater. 
There were socioeconomic gradients in height in NTFS, in accordance with earlier 
observations by Wright and Parker (2004). These differences were much smaller in GMS.  
Indeed, socio-economic differences in height, which have decreased over, time (Bann et al 
2018). Height modulated the effects of many exposures on BMIz (notably for NTFS), which 
may suggest that some of these associations were related to lean mass rather than fat mass. 
Other studies have suggested that the relationship between RWG and subsequent adiposity 
is merely a marker of fast growth and later height (Wright et al., 2012). This analysis instead 
suggests instead that the effects of rapid growth were previously unrelated to height (NTFS), 
but are now somewhat mediated through height (GMS). 
Both higher birthweights and RT were associated with increased height in GMS, which may 
suggest they are important growth-related factors on the pathway to obesity, however it is 
difficult to untangle the complex relationships between height, BMI and SES. Adjusting for 
height could also introduce bias, if it lies on the causal pathway. There is a lack of 
consistency as to whether other body composition measures (such as height) should be 
further adjusted for (Tu et al., 2005).  
Although anthropometric measures were utilised at age 9 to minimise the bias from puberty, 
there are reports of children entering puberty as young as age 6 years (Herman-Giddens et 
al., 1997), therefore some children may have been more developed. Early onset of puberty 
may be more likely in children with a higher BMI (Freedman et al., 2002, Kaplowitz, 2008, Li 
et al., 2017b), therefore it may not be appropriate to adjust for pubertal status if BMI is 
causally related to early puberty (Mumby et al., 2011).  
As there were few OWOB study members in NTFS it was not possible to analyse OWOB in a 
multivariable model. However, this highlights that one of the main differences between the 
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cohorts is the relatively low levels of OWOB in the historical cohort. In spite of this, the 
bivariate analyses suggested that RT that was associated with OWOB in NTFS, which is in line 
with findings for BMIz.  
Rapid infancy growth was the prominent factor in these analyses, due to the positive 
associations with BMIz, and also OWOB in the modern cohort, suggesting that despite the 
changing environment, RT has remained a consistent risk factor over time. Whereas 
adversity and birthweight may perhaps be risk factors exacerbated by modern-day 
obesogenic environments.   
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Chapter 6. The Avon Longitudinal study of parents and 
children (ALSPAC) 
6.1 Introduction  
The previous chapters determined the risk factors for childhood and adult obesity in the 
North East cohorts. The risk factors, which were consistently associated with adiposity across 
both cohorts, were birthweight, RWG, maternal age, and SES. It was necessary to examine 
RWG conditional on birthweight (rapid thrive), in the cohort comparison due to the large 
differences in birthweight, although findings were similar. Adversity was associated with 
multiple outcome measures in GMS. Recorded bacterial infection was associated with 
increased odds of obesity in adults in NTFS, however the GMS questionnaire data on 
infections was unreliable, therefore it remains uncertain whether the association was 
present in GMS children.  
A strength of the North East region cohorts is that despite the time differences between 
them, there were similarities in the early life influences on childhood BMI (Chapter 5). 
Although they include comprehensive data, a limitation of the North East cohorts is that 
they are relatively small samples in comparison to the larger epidemiological cohorts. 
Replication of the findings in a larger cohort, from another part of the UK, would reinforce 
that these exposures are indeed early life risk factors for subsequent obesity. To address 
these shortcomings, this chapter used data from the ALSPAC cohort, a large, longitudinal 
birth cohort from the South West of England with vast exposure data (Boyd et al., 2013). 
This chapter addresses the third aim of the thesis and focuses on the analysis of early life risk 
factors in the ALSPAC cohort to identify gene-specific methylation differences in relation to 
focal early life exposures. Firstly, the epidemiological associations between focal early life 
exposures and body composition outcomes in childhood and late adolescence were 
examined. For consistency in methods and exposures, the exposures studied in NTFS and 
GMS were harmonised with ALSPAC data. The ALSPAC cohort also has epigenetic data, 
thereby allowing early life exposures to be investigated with respect to changes in DNAm. 
The second section of this chapter examines the hypothesis that epigenetics is a mechanism 
linking early life factors and later life obesity. Whilst DNAm biomarkers have been identified 
for some exposures, others have either; not been investigated, have been measured 
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differently, or not been validated (section 1.5.3). Less is known regarding whether these 
early life exposures leave lasting, measurable effects on DNAm in later life. Thereby these 
data provide the opportunity to determine the focal early life exposures, harmonised across 
cohorts, and examine these with respect to methylation in childhood and adolescence. This 
analysis could elucidate whether these risk factors are mediated through epigenetic 
programming and if the epigenetic marks are stable over time.  
6.2 Aims  
The first aim of this chapter was to establish whether early life risk factors for subsequent 
obesity in the North East cohorts are also risk factors in the ALSPAC cohort. To address this 
aim, early life exposures were investigated with respect to body composition in childhood 
and adolescence, using statistical regression methods. 
The second aim addresses the overall thesis aim 3(i); to determine which of the focal early 
life exposures (from the analyses in NTFS and GMS cohorts) demonstrate a relationship with 
DNAm childhood or adolescence. This was addressed using epigenome-wide analyses at 
individual CpG loci for each exposure. 
6.3 Participants and methods  
6.3.1 Data selection and recoding  
The ALSPAC data dictionary was used to identify and match the exposures with the variables 
from NTFS and GMS. For the early life variables, data from mother-focused questionnaires at 
18 and 32 weeks prenatal, and 8 weeks postnatal were used, along with data from the child-
focused questionnaires at 4 weeks, 15 months and age 17. Partner questionnaire data were 
used at age 8 for childhood SES. Clinic data from ages 7 and 17 were used for body 
composition measures.  
BMIz and OWOB were utilised as outcomes in these analyses, in line with the outcomes that 
were comparable across all three cohorts and time points. These were coded as described in 
section 2.2.1.  
There were several early life risk factors with demonstrated consistent associations in GMS 
and NTFS, and for which data were available in the ALSPAC cohort. These included; 
birthweight, RWG, RT, infant feeding, parity, maternal age, adversity, antibiotics exposure 
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(proxy for bacterial infection), and SES. The definitions and measurement of these factors is 
outlined in 2.2.3. 
Social class in childhood were based on partner’s self-reported data at age 8 using the 1991 
British Office of Population and Census Statistics (OPCS) classification (see section 2.1.3 for 
details), as there were no maternal data at this time point.  
 ARIES recoding  
ALSPAC collected blood at multiple time points. DNA was extracted and DNAm was 
measured for 1000 mother-child pairs for those who had DNA available at birth, age 7 and 
ages 15 (TF3) or 17. The age 7 sample was used to represent childhood methylation levels. 
The age 17 sample was used as this sample was more representative of adults, and study 
members are likely to have finished the majority of their childhood growth (whereas the TF3 
sample included those as young as 14.6 years).  
EWAS were run using the meffil R program (detailed in the next section), which allows binary 
or continuous variables as inputs in models, and therefore some categorical explanatory 
variables were recoded. The variables: RWG, antibiotic exposure (0-6 months), prenatal 
adversity and postnatal adversity remained coded as previously described (section 6.3.1). 
Birthweight was associated with outcomes across the cohorts, however this exposure has 
been studied previously in the ALSPAC cohort and no significant loci (for childhood 
methylation) were identified (Simpkin et al., 2015). As birthweight was not examined as an 
independent exposure, both RWG and RT were examined which may somewhat 
differentiate birthweight effects. There was a lower risk of adiposity for mid and most 
advantaged compared to the least, therefore SES was recoded to a binary variable for “least 
advantaged” (increased risk of adiposity). Maternal age was examined as a separate binary 
variables of either young (<25 years), or advanced (>45 years) maternal age (compared to 
the reference category of 25-34 years).  
6.3.2 Statistical analysis  
The ALSPAC epidemiological data was analysed using the same statistical approach as in the 
cohort comparison (of GMS and NTFS) (see section 2.3.1). Briefly, this firstly involved 
examining bivariate relationships for all focal early life risk factors. The effects of SES on the 
coefficients were examined sequentially. Then, the same multivariable models were run as 
that for the cohort comparison (chapter 5) for means of comparison. However, this resulted 
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in models that did not meet regression criteria. Therefore, to find the best predictive model 
for the explanatory variables under investigation, regression models were re-estimated 
using stepwise regression. The BIC was used as a decisive factor for model selection, with 
lower model BIC preferred. The aim was to form a parsimonious model, i.e. a model that has 
the greatest explanatory ability, using the least number of variables necessary.  
6.4 Results 
6.4.1 ALSPAC sample characteristics  
 Outcomes 
There were a total of 7,868 (50.5% female) participants at the age 7 follow-up, and 4,858 
(43.8% female) at age 17 with body composition measurements (Table 6.1). Using BMIz to 
determine weight categories, 13% of study members had an OWOB BMIz at age 7, and 21% 
at age 17 (Table 6.1). Accordingly, mean BMIz was also higher at age 17. 
Table 6.1 Descriptive characteristics of body composition outcomes for ALSPAC participants age 7 and 17 
Proportion (%) of study members in healthy weight or overweight/obese (OWOB) and mean BMIz and standard deviation 
(SD). n, sample size; %, column percentage. 
 
 Exposures 
Descriptive statistics for those with data available at each follow-up are shown in 
  Age 7   Age 17 
 n Mean (SD)  n Mean (SD) 
BMIz 7,868 0.19 (1.01)   4,858 0.47 (1.13) 
 n %  n % 
Healthy weight 6,841 86.95  3,827 78.78 
OWOB 1,027 13.05  1,031 21.22 
Total 7,868     4,858   
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Table 6.2. Compared to the original cohort, at both ages 7 and 17; there were more females, 
more first-born children, fewer younger mothers and more who experienced adversity. 
There were also more SGA and fewer LGA, however overall mean birthweight z-score and 
gestational length was greater. The sample was also more advantaged at both time points. 
At age 17, there were fewer who had antibiotics compared to the original cohort. There 
were no differences for RWG at either time point or antibiotics at age 7.  
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Table 6.2 Summary characteristics of ALSPAC participants (all) and those with body composition measures (age 7 and 17) 
 All   Age 7   Age 17 
Continuous variable n 
Mean  
(SD)   n 
Mean  





Birthweight (z-score) 13457 
0.09   








Gestation (weeks) 14178 
38.39  








Categorical variable All    Age 7    Age 17   
 n col %  n col % Chi
2 p  n col % Chi
2 p  
Sex 14409     7868   0.050   4858   <0.001 
Male 7387 51.3  3975 50.5   2127 43.8  
Female 7022 48.7  3893 49.5   2731 56.2  
First-born 11356     6953   0.002   4262   <0.001 
No 6277 55.3  3763 54.1   2211 51.9  
Yes 5079 44.7  3190 45.9   2051 48.1  
Birthweight categories 13457     7336   <0.001       0.004 
SGA 1467 10.9  852 11.6   529 11.8  
Normal 10913 81.1  6008 81.9   3637 81.1  
LGA 1077 8  476 6.5   320 7.1  
Gestation categories 14178     7428   <0.001       <0.001 
Pre-term 2027 14.3  728 9.8   445 9.8  
Normal 11116 78.4  6147 82.8   3770 83.1  
Post-term 1035 7.3  553 7.4   323 7.1  
RWG 1184     853   0.76       0.67 
No 822 69.4  590 69.2   375 68.8  
Yes 362 30.6  263 30.8   170 31.2  
RT 1,184    853   0.51  545   0.69 
No 813 68.7  581 68.1   371 68.1  
Yes 371 31.3  272 31.9   174 31.9  
Maternal age at birth 13641     7428   <0.001   4538   <0.001 
Less than 25 3309 24.3  1180 15.9   706 15.6  
25-34 8981 65.8  5341 71.9   3243 71.5  
35+ 1351 9.9  907 12.2   589 13  
Adversity pre-natal 14997     7868   <0.001   4858   <0.001 
No 10347 69  5183 65.9   3232 66.5  
Yes 4650 31  2685 34.1   1626 33.5  
Adversity post-natal 14997     7868   <0.001   4858   <0.001 
No 11415 76.1  5628 71.5   3553 73.1  
Yes 3582 23.9  2240 28.5   1305 26.9  
Pre and post-natal 14997     7868   <0.001   4858   0.001 
No 12960 86.4  6645 84.5   4132 85.1  
Yes 2037 13.6  1223 15.5   726 14.9  
Antibiotics (0-6 months) 11016     6923   0.48   4243   0.031 
No 7460 67.7  4705 68   2925 68.9  
Yes 3556 32.3  2218 32   1318 31.1  
SES at birth 10540     6678   <0.001   4115   <0.001 
Least Advantaged 589 5.6  273 4.1   163 4  
Mid 4058 38.5  2324 34.8   1323 32.2  
Most advantaged 5893 55.9  4081 61.1   2629 63.9  
SES in childhood 3553     3038   0.007   2069   <0.001 
Least Advantaged 413 11.6  333 11   215 10.4  
Mid 1079 30.4  920 30.3   595 28.8  
Most advantaged 2061 58   1785 58.8     1259 60.9   
Differences between the original sample (all), and either the age 7 and 17 samples, assessed using T-tests for continuous 
variables, and Chi-square (Chi2) tests for differences between the whole sample and those measured at either age 7 or 17. 
n, sample size; col %, column percentage; SD, standard deviation. Bold indicates significant at p<0.05.
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6.4.2 Associations between early life factors and adiposity outcomes 
In bivariate analyses, birthweight z-score and LGA were associated with increased BMIz and 
increased odds of OWOB at both time points (Appendix E, 
Table XI). SGA was negatively associated, and gestation length positively associated with 
BMIz at age 7, but there were no associations for OWOB or outcomes at age 17. RWG was 
positively associated with BMIz at age 7 and 17, and OWOB at age 7. Younger maternal age 
(<25 years) was associated with higher BMIz (0.24, p<0.001) and 50% increased odds of 
OWOB at age 17. Whilst older maternal age (35+) was associated with a lower BMIz at age 
17.  
Interestingly, pre-natal and pre and post-natal adversity (collectively) were associated with 
BMIz at age 7 and 17, and OWOB at age 17, but not OWOB at age 7 (Appendix E, 
Table XI). At age 7, the coefficients were small, almost doubling by age 17. The effect sizes 
were greater for pre- and post-natal adversity combined. There were no associations for 
post-natal adversity alone.  
SES at birth and in childhood were not directly associated with BMIz (age 7), but the most 
advantaged group (both time points) was associated with lower BMIz and OWOB at age 17, 
with similar effect sizes. In addition, the association for childhood SES and OWOB was also 
seen at age 7.  
Table 6.3 Summary of ALSPAC bivariate associations for early life exposures and outcomes (age 7 and 17) 
Early life exposures  Outcome measures 
 BMI  OWOB 
 Age 7 Age 17  Age 7 Age 17 




 - ✓ 
(young) 
Birth Birthweight ✓ ✓  ✓ ✓ 
 Occupational social class - ✓  - ✓ 
Early life Antibiotics (0- 6 months) - -  ✓ ✓ 
 Adversity Prenatal ✓ ✓  - ✓ 
 Postnatal - -  - - 
 Pre and postnatal ✓ ✓  - ✓ 
 Rapid weight gain ✓ ✓  ✓ - 
 Rapid thrive ✓ ✓  ✓ - 
Childhood Occupational social class - ✓  ✓ ✓ 
Tick represents a significant association between exposure and specified outcome measure in the (unadjusted) bivariate 
model
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 Multivariable cohort-comparative models  
In order to compare models with those in GMS and NTFS cohort comparison, RT was used in 
the multivariable models (for models with RWG see Appendix E). In the multivariable 
analyses, the combined pre and post-natal adversity variable was used as it had the largest 
coefficient and was most significant in the bivariate models. As a sensitivity test, additional 
models were estimated with the other adversity variables as controls, however they were 
not significantly associated and did not improve model fit. Similar to analyses in the cohort 
comparison, the impact of childhood SES on the early life factors was investigated further.  
At age 7 the associations for RT decreased but remained after adjustment for SES at both 
time points. Associations for birthweight were similar but were not significant for OWOB 
(age 7) after adjustment for childhood SES. After adjustment, RT was the only early life 
factor associated with both outcomes in childhood. 
The combined multivariable models including early life factors and SES explained more the 
variation in adiposity outcomes in childhood. All age 7, BMI models fit regression criteria 
(regression diagnostic plots in Appendix E). However, the model for BMIz (age 7) had 
slightly positively skewed residuals, therefore ordinal regression (OWOB age 7 multivariable 
model) results which do not assume normality of residuals may be more valid. 
All models for OWOB (age 17) had non-significant p values and very low pseudo R2 value 
which indicates that the early life factors included were poor at predicting OWOB in 
adolescence.  
There was also very strong support for all models without adjustment for SES in childhood 
(informed by BIC). There was also a large decrease in sample size, which may be also result 
in poor model specification. Therefore, instead parsimonious models were estimated 
(section 6.4.2.2).
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Table 6.4 Multivariable linear and logistic regression for BMIz and OWOB at ages 7 and 17, adjusted for SES 
Age 7  
 BMIz 
Unadjusted  Adjusted for SES (birth)  Adjusted for SES (childhood) 
Coef CI p  Coef CI p  Coef CI p 
Female -0.06 [-0.19,0.07] 0.37  -0.06 [-0.20,0.07] 0.34  -0.05 [-0.25,0.14] 0.61 
Gestation  0.01 [-0.03,0.06] 0.56  0.01 [-0.03,0.06] 0.6  0.01 [-0.05,0.08] 0.69 
Birthweight z-score 0.19 [0.12,0.26] <0.001  0.18 [0.11,0.26] <0.001  0.16 [0.06,0.27] 0.003 
Maternal age 
Less than 25 -0.04 [-0.25,0.16] 0.68  0.06 [-0.17,0.29] 0.60  0.35 [-0.07,0.77] 0.10 
35+ -0.13 [-0.32,0.06] 0.17  -0.13 [-0.33,0.07] 0.20  0.02 [-0.26,0.29] 0.90 
First-born 0.07 [-0.07,0.21] 0.31  0.05 [-0.09,0.19] 0.48  0.12 [-0.09,0.34] 0.26 
RT 0.77 [0.63,0.91] <0.001  0.77 [0.62,0.91] <0.001  0.67 [0.46,0.87] <0.001 
Adversity  0.02 [-0.15,0.19] 0.83  -0.03 [-0.22,0.15] 0.72  0.04 [-0.25,0.32] 0.80 
SES (birth) 
Mid     0.27 [-0.08,0.61] 0.13  -0.17 [-0.81,0.47] 0.60 
Most advantaged     0.28 [-0.06,0.62] 0.11  -0.06 [-0.70,0.57] 0.85 
SES childhood 
Mid         0.13 [-0.24,0.51] 0.49 
Most advantaged         -0.01 [-0.38,0.35] 0.94 
n 825    772    382   
Adjusted R2 0.158    0.154    0.112   
            
  OWOB 
Unadjusted  Adjusted for SES (birth)  Adjusted for SES (childhood) 
OR CI p  OR CI p  OR CI p 
Female 0.66 [0.42,1.02] 0.063  0.66 [0.42,1.04] 0.076  0.77 [0.38,1.54] 0.46 
Gestation 1.01 [0.87,1.16] 0.92  1.02 [0.88,1.18] 0.82  1.01 [0.80,1.26] 0.95 
Birthweight z-score 1.41 [1.11,1.80] 0.005  1.31 [1.02,1.68] 0.035  0.97 [0.66,1.41] 0.86 
Maternal age 
Less than 25 0.85 [0.43,1.69] 0.65  1.14 [0.55,2.36] 0.72  1.77 [0.53,5.83] 0.35 
35+ 0.62 [0.29,1.31] 0.21  0.56 [0.26,1.24] 0.15  0.29 [0.07,1.28] 0.10 
First-born 1.15 [0.73,1.83] 0.55  1.09 [0.68,1.76] 0.71  1.11 [0.53,2.36] 0.78 
RT 3.93 [2.54,6.08] <0.001  3.77 [2.41,5.89] <0.001  3.01 [1.54,5.88] 0.001 
Adversity 0.99 [0.55,1.77] 0.97  0.93 [0.49,1.74] 0.81  1.61 [0.67,3.88] 0.29 
SES (birth) 
Mid     1.33 [0.36,4.89] 0.66  0.38 [0.06,2.58] 0.32 
Most advantaged     1.67 [0.46,6.07] 0.44  0.64 [0.10,4.32] 0.65 
SES childhood 
Mid         1.08 [0.33,3.58] 0.90 
Most advantaged         0.6 [0.19,1.93] 0.40 
n 825    772    382   
Pseudo R2 0.091    0.086    0.085   
 
     196 
Age 17      
BMIz  Unadjusted  Adjusted for SES (birth)  Adjusted for SES (childhood) 
 Coef CI p   Coef CI p  Coef CI p 
Female -0.08 [-0.27,0.12] 0.43  -0.1 [-0.30,0.10] 0.33  -0.08 [-0.35,0.20] 0.59 
Gestation  0 [-0.06,0.07] 0.91  0 [-0.07,0.07] 0.98  0.01 [-0.09,0.10] 0.91 
Birthweight z-score 0.06 [-0.05,0.17] 0.30  0.05 [-0.07,0.16] 0.42  0.09 [-0.07,0.24] 0.27 
Maternal age 
Less than 25 0.2 [-0.12,0.51] 0.23  0.27 [-0.09,0.63] 0.14  0.45 [-0.24,1.15] 0.20 
35+ -0.11 [-0.39,0.18] 0.47  -0.08 [-0.38,0.22] 0.59  0.04 [-0.35,0.44] 0.83 
First-born 0.04 [-0.17,0.25] 0.72  0.01 [-0.21,0.24] 0.90  0.11 [-0.19,0.41] 0.48 
RT 0.21 [0.00,0.43] 0.05  0.23 [0.00,0.45] 0.045  0.18 [-0.11,0.47] 0.22 
Adversity - Pre and post-natal 0.31 [0.03,0.59] 0.03  0.26 [-0.04,0.56] 0.088  0.19 [-0.22,0.61] 0.36 
SES (birth) Mid     0.42 [-0.14,0.98] 0.14  -0.15 [-1.13,0.83] 0.77 
  Most advantaged     0.29 [-0.26,0.84] 0.29  -0.46 [-1.43,0.52] 0.36 
SES (childhood) 
Mid         -0.22 [-0.79,0.35] 0.44 
Most advantaged           -0.1 [-0.64,0.44] 0.71 
n 527      498     270     
Adjusted R2 0.011         0.009     0.001     
            
OWOB   Unadjusted   Adjusted for SES (birth)  Adjusted for SES (childhood) 
 OR CI p 
 OR CI p   OR CI p 
Female 0.98 [0.63,1.52] 0.93  0.94 [0.60,1.47] 0.79 
 0.94 [0.49,1.81] 0.86 
Gestation  1.02 [0.88,1.19] 0.77  1.02 [0.88,1.19] 0.81 
 0.99 [0.80,1.24] 0.96 
Birthweight z-score 1.18 [0.92,1.51] 0.19  1.16 [0.90,1.49] 0.25 
 1.15 [0.79,1.67] 0.47 
Maternal age Less than 25 1.13 [0.56,2.27] 0.74  1.2 [0.56,2.59] 0.64 
 1.34 [0.30,5.94] 0.70 
  35+ 1.38 [0.75,2.53] 0.30  1.43 [0.77,2.66] 0.26 
 1.93 [0.83,4.54] 0.13 
First-born 0.97 [0.60,1.57] 0.91  0.96 [0.59,1.58] 0.88 
 1.11 [0.54,2.28] 0.77 
RT 1.54 [0.97,2.45] 0.066  1.6 [1.00,2.56] 0.05 
 1.34 [0.69,2.63] 0.39 
Adversity - Pre and post-natal 1.79 [1.02,3.14] 0.044  1.61 [0.88,2.94] 0.12 
 1.38 [0.56,3.41] 0.48 
SES (birth) Mid     1.64 [0.44,6.18] 0.46 
 1.41 [0.14,14.34] 0.77 
  Most advantaged     1.48 [0.40,5.47] 0.56 
 0.78 [0.08,8.05] 0.83 
SES (childhood) Mid         1.05 [0.28,3.87] 0.94 
  Most advantaged          1.13 [0.32,3.94] 0.85 
n 527      498     270    
Pseudo R2 0.02       0.02       0.026     
Coefficients (coef) and Odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p).Bold indicates p<Reference categories were; the least advantaged 
group for SES; and age 25-34 for maternal age. n, sample size; Bwtz, birthweight z-score; SES, socioeconomic status; RT, rapid thrive. The overall model p value was no longer significant for BMIz (age 17) 
and OWOW (age 7) after controlling for SES in childhood. There were indications that the models for OWOB at age 7 and 17 did not meet logistic regression criteria and were poorly specified models. 
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 Multivariable cohort-specific models 
In the previous section, models were estimated to harmonise with those in chapter 4. 
However, these models did not meet regression criteria, suggesting that using these 
variables did not result in a good predictive model for the ALSPAC cohort. Models were 
refitted using a stepwise procedure, informed by goodness of fit statistics (BIC) to create 
parsimonious models (Table 6.5 and Table 6.6). Model BIC provided strong support for 
models (BMIz7 and BMIz17) without SES at either time point. In the BMIz17 model, prenatal 
adversity had better model fit than when using the pre- and post-natal adversity variable, 
and postnatal adversity was not a significant predictor. For regression diagnostic plots for 
these models see Appendix E, Figure XVI. 
In the parsimonious adjusted models (Table 6.5 and Table 6.6), birthweight was positively 
associated with outcomes at age 7. RT was associated with increased BMIz (at both ages), 
and increased odds of OWOB at age 7. Pre-natal adversity was associated with BMIz at age 
17, but not with outcomes at age 7 or OWOB at age 17.  
There were few differences for the models using RWG, and similar to RT, RWG was the most 
significant factor associated with body composition (for RWG models see Appendix E).  
Early life factors explained greater variation in body composition in childhood, particularly 
for BMIz at age 7 (R2=0.16). 
Table 6.5 Multivariable parsimonious linear regression models for BMIz at ages 7 and 17 in ALSPAC participants 
        
   BMIz7      BMIz17   
  Coef CI p  Coef CI p 
        
Female -0.06 [-0.19,0.07] 0.36  -0.09 [-0.28,0.10] 0.36 
Gestation length (weeks) 0.01 [-0.03,0.06] 0.57  0 [-0.07,0.07] 0.98 
First-born 0.07 [-0.07,0.20] 0.32  0.03 [-0.18,0.24] 0.78 
Maternal age (categories)        
Less than 25 -0.04 [-0.24,0.16] 0.68  0.2 [-0.12,0.51] 0.22 
35+ -0.13 [-0.32,0.06] 0.17  -0.1 [-0.38,0.19] 0.51 
Birthweight z-score 0.19 [0.12,0.26] <0.001  0.05 [-0.06,0.16] 0.35 
RT 0.77 [0.63,0.91] <0.001  0.23 [0.02,0.45] 0.03 
Adversity - prenatal     0.33 [0.12,0.54] 0.002 
                
n 825    527   
Adjusted R2 0.159       0.021     
Coefficients (coef) presented with 95% confidence intervals (CI) and the corresponding level of significance (p). The 
reference category was age 25-34 for maternal age. n, sample size; RT, rapid thrive. All variables included in the model are 
presented. Bold indicates p<0.05. 
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Table 6.6 Multivariable parsimonious logistic regression models for OWOB at ages 7 and 17 in ALSPAC study members 
   OWOB7                 OWOB17   
  OR  CI p  OR CI p 
Female 0.66 [0.42,1.02] 0.063  0.95 [0.50,1.82] 0.88 
Gestation length (weeks) 1.01 [0.88,1.16] 0.91  1 [0.80,1.24] 0.96 
First-born 1.15 [0.73,1.83] 0.54  1.1 [0.54,2.27] 0.79 
Maternal age (categories)        
Less than 25 0.85 [0.43,1.69] 0.65  1.43 [0.33,6.30] 0.63 
35+ 0.62 [0.29,1.31] 0.21  1.98 [0.85,4.63] 0.12 
Birthweight z-score 1.41 [1.11,1.80] 0.005  1.14 [0.79,1.66] 0.48 
RT 3.93 [2.54,6.08] <0.001   1.37 [0.70,2.67] 0.36 
Adversity - prenatal     0.92 [0.46,1.87] 0.82 
SES at birth        
Mid     1.47 [0.14,15.25] 0.75 
Most advantaged     0.79 [0.08,8.32] 0.85 
SES in childhood        
Mid     1.08 [0.29,3.98] 0.91 
Most advantaged     1.14 [0.33,3.97] 0.83 
n 825     270   
Pseudo R2 0.091       0.024     
Odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Bold 
indicates p<0.05. Reference categories were; the least advantaged group for SES; and age 25-34 for maternal age.  
n, sample size; SES, socioeconomic status; RT, rapid thrive. All variables included in the model are presented.  
 
 
 Sensitivity analysis 
Maternal BMI and maternal smoking during pregnancy are two factors known to influence 
offspring body composition and health. Data on these two important factors were not 
available in NTFS or GMS, therefore the ALSPAC dataset provided an opportunity to assess 
how these factors could influence the associations between early factors and BMI or OWOB 
(Table 6.7 and Table 6.8). 
Adjusting for smoking made little difference to most estimates. Adjusting for smoking 
increased the OR for RT for OWOB (age 7), but the coefficient for BMI remained similar. 
Therefore, without adjustment the effect was underestimated.   
Although the literature suggests that maternal BMI and smoking can affect birthweight, 
adjusting for these factors had no effect on the estimates for birthweight on the models at 
age 7.   
Models including maternal BMI and smoking explained 8% and 14% more of the variation in 
BMIz, and 6% and 13% more variation in OWOB, at ages 7 and 17 respectively (Table 6.7).  
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Table 6.7 Sensitivity analyses including maternal factors for the multivariable linear regression (parsimonious) models for 
BMIz at ages 7 and 17 in ALSPAC study members 
  BMIz (age 7)    BMIz (age 17) 
 coef     CI p  coef  CI p 
Female -0.06 [-0.19,0.06] 0.33  -0.06 [-0.25,0.13] 0.51 
Gestation length (weeks) 0 [-0.04,0.05] 0.90  -0.03 [-0.09,0.03] 0.36 
First-born 0.06 [-0.07,0.20] 0.35  0.08 [-0.13,0.28] 0.45 
Maternal age (categories)        
Less than 25 -0.09 [-0.30,0.12] 0.39  0.11 [-0.21,0.44] 0.49 
35+ -0.12 [-0.31,0.07] 0.21  -0.09 [-0.37,0.19] 0.52 
Birthweight z-score 0.18 [0.11,0.25] <0.001  0.02 [-0.09,0.13] 0.71 
RT 0.76 [0.62,0.90] <0.001  0.22 [0.02,0.43] 0.033 
Adversity - prenatal - - -  0.32 [0.12,0.52] 0.002 
        
Pre-pregnancy BMI 0.06 [0.05,0.08] <0.001  0.10 [0.08,0.12] <0.001 
Maternal smoking 0.07 [-0.11,0.24] 0.46   -0.23 [-0.51,0.06] 0.12 
n 763    492   
Adjusted R2 0.237    0.158   
Coefficients (coef) presented with 95% confidence intervals (CI) and the corresponding level of significance (p). The 
reference category was age 25-34 for maternal age. n, sample size; SES, socioeconomic status; RT, rapid thrive. 
Table 6.8 Sensitivity analyses including maternal factors for the multivariable logistic regression (parsimonious) models for 
OWOB at ages 7 and 17 in ALSPAC study members 
  OWOB (age 7)   OWOB (age 17) 
 OR     CI p  OR  CI p 
        
Female 0.60 [0.37,0.98] 0.039  1.12 [0.54,2.31] 0.76 
Gestation length 
(weeks) 0.95 [0.82,1.10] 0.47  0.91 [0.71,1.15] 0.43 
First-born 1.18 [0.72,1.94] 0.51  1.01 [0.45,2.25] 0.98 
Maternal age 
(categories)        
Less than 25 0.66 [0.30,1.46] 0.31  1.31 [0.23,7.48] 0.76 
35+ 0.65 [0.30,1.43] 0.29  1.35 [0.50,3.66] 0.55 
Birthweight z-score 1.39 [1.07,1.80] 0.012  0.91 [0.60,1.39] 0.67 
RT 4.53 [2.82,7.29] <0.001   1.40 [0.66,2.95] 0.38 
Adversity - prenatal     0.98 [0.44,2.16] 0.96 
SES at birth     2.96 [0.17,52.75] 0.46 
Mid     2.2 [0.12,39.43] 0.59 
Most advantaged        
SES in childhood     1.13 [0.27,4.80] 0.86 
Mid     0.9 [0.23,3.50] 0.88 
Most advantaged        
Pre-pregnancy BMI 1.14 [1.09,1.20] <0.001  1.27 [1.15,1.39] <0.001 
Maternal smoking 1.12 [0.58,2.16] 0.74  0.27 [0.04,1.70] 0.16 
n 763       257     
pseudo R2 0.147       0.154     
Odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Reference 
categories were; the least advantaged group for SES; and age 25-34 for maternal age. n, sample size; SES, socioeconomic 
status; RT, rapid thrive. 
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6.4.3 ARIES sample characteristics  
Demographic characteristics of the ARIES sample are shown for the total sample and for 
each exposure. Sample sizes varied according to the exposure investigated (ranged from 
n=116 to 873, at age 7 with cells counts included) and were smaller at age 17 due to 
attrition. 
Table 6.9 Descriptive statistics for all early life exposures in ARIES at ages 7 and 17, for models either 
with or without cell counts. 
  
Models adjusted for cell counts 
 
Models not adjusted for cell counts 
Age Variable Total No % Yes % 
 
Total No % Yes % 
7 RWG 116 75 64.7 41 35.3  125 84 67.2 41 32.8 
 RT 116 65 56.0 51 44.0  125 73 58.4 52 41.6 
  Low SES (birth)  817 785 96.1 32 3.9  907 871 96.0 36 4.0 
  AB 836 581 69.5 255 30.5  927 639 68.9 288 31.1 
  Younger mother 860 634 73.7 105 12.2  822 707 86.0 115 14.0 
  Older mother 860 634 73.7 115 13.4  829 707 85.3 122 14.7 
  Prenatal 
adversity 873 569 65.2 304 34.8  966 620 64.2 346 35.8 
  Postnatal 
adversity 873 618 70.8 255 29.2  966 676 70.0 290 30.0 
  Pre and post-
natal adversity 873 736 84.3 137 15.7   966 810 83.9 156 16.1 
17 RWG 89 54 60.7 35 39.3  96 61 63.5 35 36.5 
 RT 89 50 56.2 39 43.8  96 56 58.3 40 41.7 
  Low SES (birth)  660 632 95.8 28 4.2  677 649 95.9 28 4.1 
  AB 617 591 95.8 26 4.2  688 474 68.9 214 31.1 
  Younger mother 592 506 85.5 86 14.5  540 458 84.8 82 15.2  
Older mother 606 506 83.5 100 16.5  551 458 83.1 93 16.9 
  Prenatal 
adversity 651 420 64.5 231 35.5  713 457 64.1 256 35.9 
  Postnatal 
adversity 651 457 70.2 194 29.8  713 494 69.3 219 30.7 
  Pre and post-
natal adversity 651 546 83.9 105 16.1  713 594 83.3 119 16.7 
Exposed (yes) or not exposed (No) and proportion (%).  
SES, socioeconomic status; RWG, rapid weight gain; RT, rapid thrive; AB, Antibiotics. 
6.4.4 EWAS results  
There were significant (PFDR<0.05) associations at individual CpG sites for the exposures; RWG 
and pre-natal adversity (Table 6.10) at age 7. Across the various adjustment models there 
were 4 significant hits for RWG (PFDR<0.1) corresponding to 3 unique CpG sites.  
In the model which did not include cells counts, two of the loci (cg01379158, cg11531579) 
associated with RWG had p values that were also were also below the Bonferroni p value 
threshold (1.04x10-7). The two significant loci (cg01379158, cg11531579) were investigated 
further. Methylation at these loci was also associated with RT, however the coefficient was 
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smaller and less significant than for RWG (Appendix E, Table XIX). The loci that was 
significantly associated with adversity (cg00397179) was located in the vicinity (7bp 
upstream) of a high frequency SNP (rs12811501) flagged in the Infinium HD Methylation SNP 
list and was not significant at PFDR<0.05, and was therefore not analysed further. There were 
no other significant associations (PFDR <0.1), and no associations with DNAm at age 17.  
 
Table 6.10 Significant (FDR p<0.1) associations between individual CpG sites (n=482,855) and the 
early life exposures in models with or without cell counts.  




CpG island name Coef PFDR PBonf Model 
With cell counts         
RWG cg01379158 17 NT5M TSS200 
chr17:17206527-
17207306 
0.011 0.02 2.91x10-7 ISVA 
Without cell counts         
RWG cg01379158 17 NT5M TSS200 
chr17:17206527-
17207306 
0.011 0.01 2.33x10-8 ISVA 
RWG cg11531579 12 CHFR Island 
chr12:133484658-
133485739 
0.011 0.02 4.16x10-8 SVA 
RWG cg11531579 12 CHFR Island 
chr12:133484658-
133485739 
0.011 0.03 1.26 x10-7 ISVA 
Pre-natal 
adversity 
cg00397179 5 BTF3 3'UTR - 0.009 0.09 8.97x10-6 SVA 
Bonferonni threshold= < 1.0355076 × 10-7. Chr, chromosome; PFDR, FDR p value; PBonf, Bonferonni p value, Coef, coefficient; 
TSS200, transcription start site; 3'UTR, 3’ untranslated region; RWG, rapid weight gain. 
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Figure 6.1 Bidirectional Manhattan plots for the EWAS linear regression models.  
Models are ISVA (top) and SVA (bottom) for methylation at age 7 with RWG as the independent variable, without cell 
counts. The plots show the chromosomal location of significant CpG loci. The red line indicates the Bonferroni significance 
threshold. 
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 Methylation changes at the cg01379158 locus 
Those who experienced RWG on average had 1% greater methylation at cg01379158. RWG 
was associated with a 1% increase in methylation at this locus (FDR adjusted p value=0.02) in 
the ISVA model with cell counts, and also the ISVA model without cell counts (FDR adjusted p 
value=0.01) (Table 6.10). Methylation at this loci at age 17 was not associated with RWG.  
The significant CpG locus; cg01379158 was located upstream of the transcriptional start site 
in a CpG island (chr17:17206527-17207306). There were 10 CpG loci on the 450K also 
located in this island (Figure 6.2).   
Probes in the island were not necessarily concordantly correlated (Figure 6.2). In those who 
had RWG, the CpG of interest (cg01379158) demonstrated stronger (moderate) correlations 
with 3 CpG sites within the island (cg21614420, cg08693337, cg09810313), compared to 
those who did not experience RWG (Figure 6.2).  
  








Figure 6.2 Correlations between CpG sites on the 450K array located within the CpG island (chr17:17,206,527-17,207,306). 
The CpG of interest (cg01379158), associated with RWG is located on the horizontal bottom row. Red indicates strong 
positive correlation, whilst purple indicates strong negative, proportionate to the colour intensity.   
The nearest gene to cg01379158 is NT5M, also known as 5',3'-Nucleotidase, Mitochondrial. 
This probe is a type II probe with nearby SNPs. The other CpG loci which also mapped to the 
NT5M gene (n=12) and to the chr17:17,206,527-17,207,306 island (n=12) on the 450k array 
were also examined using linear regression (adjusted for age, sex and WBCs). There were 2 
significant (p<0.05) CpG loci, however the beta coefficients were less than 0.01 and these 
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loci would not have been significant after correction for multiple comparisons (Appendix E, 
Table XVIII).  
 
Figure 6.3 Annotated region of the CpG (cg01379158). 
Chromosomal (17) position, the nearest gene and the downstream region for CpG (cg01379158) annotated using the 
(GRCh37/hg19) assembly. 
 
6.4.4.1.1 Age-related changes in methylation 
At the cg01379158 loci, within individuals who had RWG, methylation decreased from age 7 
to 17. Whilst in those who did not have RWG, methylation increased (Figure 6.4).  
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Figure 6.4 Change in methylation at the cg01379158 loci within individuals from age 7 to 17 by RWG. 
Those who did not have RWG (n=60) demonstrated small mean increases (+0.63%) in methylation, whereas those who had 
RWG (n=34) demonstrated small (-0.45%) decreases in methylation between ages 7 and 17 (p=0.09, using the students t-
test). 
6.4.4.1.2 Relationship between methylation and adiposity outcomes 
Methylation at this locus was not associated with BMIz at age 7 or 17. There were too few 
OWOB to sufficiently execute a logistic regression model (n=19 OWOB at age 17 for those 
with rapid weight gain data available), however phenotype group differences were 
examined. Highest methylation was in those who experienced RWG and were OWOB both in 
childhood (9.1% methylation) and adolescence (8.8% methylation) (Appendix E,  
Table XXI and Figure XIX).  
 
 Methylation changes at the cg11531579 loci 
The other significant CpG loci (cg11531579), was positively associated with RWG in both the 
ISVA and SVA models (pFDR<0.05) (Table 6.10). The association p values were not below the 
accepted Bonferroni threshold.  
p=0.09 
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At age 7, cg11531579 methylation ranged from 0 to 12%, with median value around 3%. This 
CpG was also a significantly associated with RWG in the DMRcate analysis, however the fold 
change was very small (max beta fold change=0.01) and the Stouffer p value was non-
significant (p=0.48). 
This CpG (cg11531579) is located within a CpG island on chromosome 12 (Table 6.10). 
Correlations between the CpG of interest and other CpG sites in the island were generally 
positive and tended to be stronger in those who did not experience RWG (Figure 6.5). In 
those who did experience RWG, this particular CpG site was an anomaly in the island in that 
it demonstrated by very low correlation with the other CpG sites in the island, whereas 
generally speaking the rest of the CpG sites were mostly positively correlated to various 
degrees (Figure 6.5). Cg24459893 showed the greatest ‘disagreement’ with the rest of the 
island, with strong negative correlations in both those who had RWG and those who did not. 
Upon closer inspection, although this CpG maps to the island (using the 450K annotation file) 
located at chr12:133,484,658-133,485,739, its actual location is much further downstream at 
133,488,122, which may explain this discordance.   
The other CpG loci which also mapped to the chr12:133484658-133485739 island (n=10) on 
the 450k array were also examined using linear regression (adjusted for age, sex and WBCs). 
There was 1 significant CpG site, however the beta coefficient was less than 0.01 (Appendix 
E, Table XVIII).  








Figure 6.5 Correlations between CpG sites on the 450K array located within the CpG island (chr12:133484658-
133485739).  
The CpG of interest (cg11531579), associated with RWG is located on the horizontal bottom row. Red indicates strong 
positive correlation, whilst purple indicates strong negative, proportionate to the colour intensity.  
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The CpG of interest (cg11531579) was not located near to any protein-coding genes. 
Upstream 30,000+ bases is the protein coding gene; Checkpoint With Forkhead And Ring 
Finger Domains (CHFR) (Figure 6.6). Whilst 558 base pairs downstream, is a small (2 exons) 
non-coding region (AK055957), for which there is limited information. 
 
Figure 6.6 Annotated region of the CpG (cg11531579). 
Chromosomal (12) position, the region, and nearest genes region for CpG (cg11531579) annotated using the 
(GRCh37/hg19) assembly. 
6.4.4.2.1 Age-related phenotypic changes in methylation 
Using methylation data at ages 7 and 17 shows that in those with RWG, on average 
methylation decreases from age 7 to 17 (p<0.01) (Figure 6.7). Whereas in those who did not 
experience RWG, on average methylation tends to increase between the time points.  
 
Figure 6.7 Change in methylation from age 7 to 17 within individuals by RWG. 
Those who did not have RWG (n=60) demonstrated small mean increases (+1.3%) in methylation, whereas those who had 
RWG (n=34) demonstrated small (-0.58%) decreases in methylation between ages 7 and 17. This difference (1.8%) was 
significant (p=0.001, determined using the student t- test).  
 
p=0.001 
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6.4.4.2.2 Relationship between methylation and adiposity outcomes 
There were median differences in methylation level according to phenotype (Appendix E, 
Table XXII, Figure XX). There was some suggestion that methylation was higher in those who 
had RWG and were OWOB at the time (age 7) or subsequently (age 17). However, the 
sample size for these group were small and therefore these results are suggestive. 
6.4.5 Candidate gene analysis results 
As there were few significant probes found, which may have been due to the strict 
correction for multiple tests, an alternative approach was taken utilising a smaller, candidate 
set of epigenetic loci. The aim of the analyses was to isolate CpG loci already known to be 
associated with the outcome phenotype of interest (body composition). The candidate gene 
analysis utilised findings from a consortium, which integrated data from 4 discovery cohorts 
and replicated findings in 9 cohorts, and found 187 validated methylation markers 
associated with BMI (Wahl et al., 2017).  
Using a smaller subset of loci as candidates has the advantage of reducing the stringent p 
values threshold imposed by correcting for multiple testing. The associations between these 
loci and the early life exposures were examined using the ALSPAC methylation childhood and 
adolescent data, however there were no significant associations identified (Bonferroni p 
value=3x10-4). 
6.4.6 Differentially methylated regions results 
Whilst some significant individual probes were identified using DMRcate in unadjusted 
models for some exposures at age 7 (adversity all (no cells), low SES (cells and no cells), RWG 
(no cells) and younger mum (no cells)) and age 17 (low SES with and without cells), there 
were no overall DMRs identified. All Stouffer corrected p values were non-significant, which 
may be due to a lack of consistency in the direction of methylation in the region.  
6.4.7 DNA methylation analysis 
To investigate DNAm biomarkers of early life exposures, methylation changes in children and 
adolescents in response to early life exposures were investigated. To do so, epigenome-wide 
association studies (EWAS) were run for each exposure to determine methylation changes at 
individual CpG sites in response to the exposure(s). To further investigate the hypothesis 
that DNAm changes that are associated with adiposity are also associated with early life 
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exposures, a subset of CpG loci with confirmed associations with BMI were investigated with 
respect to each exposure. The EWAS methods and statistical methods are described in 
section 2.4. 
 EWAS regression diagnostic plots 
Meffil simultaneously computes estimates for all 4 models (Figure 2.6). Q-Q plots were 
consulted, which allow graphical assessment of whether the data are derived from a normal 
distribution. Q-Q plots demonstrated that ISVA adjustment was most effective in correcting 
the data best so that it satisfies the assumptions of normality (Appendix E, Figure XVII). 
These plots indicate loci which deviate from the expected distribution, i.e. those that are 
above the p value threshold are significantly associated with the exposure.  
All models were additionally run without adjustment for cell counts, for each exposure and 
for both methylation outcome time points. The p value distributions display greater 
deviation from normality than those from the adjusted models, however the SVA model 
performed well (Appendix E, Figure XVIII).  
6.5 Discussion 
The exposures that were important factors for childhood OWOB in the North East cohorts 
were investigated further in the larger, South West cohort; ALSPAC. The aim was to 
investigate exposures using the same models as done in the previous chapter (the cohort 
comparison) for consistency. However, in ALSPAC, this led to ill-fitting models that did not 
meet regression criteria, and instead the parsimonious models were more informative.  
Birthweight, RWG, RT, and adversity were all positively associated with adiposity outcomes. 
Birthweight was consistently associated across all outcomes and time points. RT was 
consistently associated with body composition measures in childhood.  
The sensitivity analyses revealed that maternal BMI was an important factor which predicted 
offspring body composition across all measures, similar to findings in many longitudinal birth 
cohorts (Baker et al., 2004, Harvey et al., 2007, Wright et al., 2010a, Bammann et al., 2014, 
Fairley et al., 2015b). Other analyses in the ALSPAC cohort found that children of obese 
parents had a greater fat mass at 7 years and larger increases in fat mass up to 11 years 
(Wright et al., 2010a), perhaps be due to a shared environment as well as genetic influences. 
Maternal obesity can affect multiple aspects of offspring health, which is accompanied by 
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changes in neuroendocrine, metabolic and immune system processes, increasing risk of 
multiple diseases and all-cause mortality, and thereby has great public health implications 
(Reynolds et al., 2013a, Godfrey et al., 2017).  
Maternal smoking during pregnancy did not demonstrate direct associations with offspring 
body composition, however adjusting for smoking removed significant associations for 
birthweight for outcomes in adolescence, perhaps suggesting a latent indirect effect.  
Factors that were associated with body composition across three cohorts; birthweight, RT, 
RWG, SES (at birth), and adversity, were all good candidates for further investigation. 
Birthweight was previously examined in this cohort with regards to DNAm, however no 
significant associations were identified, and therefore birthweight was not explored here. 
RWG was associated with BMIz in children in all three cohorts, and with OWOB in GMS and 
ALSPAC, and was therefore a robust exposure. As there were also some weak associations 
observed for maternal age and bivariate associations for antibiotic exposure (which were 
both also seen in GMS and NTFS respectively), these were also investigated further in the 
epigenetic analysis.  
The exposures were examined with regards to DNAm in childhood and adolescence. Two 
CpG sites (cg1379158 and cg11531579) were identified which exhibited differential 
methylation in childhood, in association with RWG. No other early life factors were 
significantly associated with changes in DNAm.  
Cg11531579 is located downstream of CHFR, an E3 ubiquitin-protein ligase that regulates 
the cell cycle at the antephase checkpoint, by delaying progression into mitosis in response 
to microtubule stress (Scolnick and Halazonetis, 2000). This achieved by preventing cyclin B1 
access to the nucleus prior to chromosome condensation (Summers et al., 2005). Decreased 
expression has been exhibited in certain cancers as a result of promoter hypermethylation 
(Sanbhnani and Yeong, 2012, Derks et al., 2014), confirmed with treatment with the 
methyltransferase inhibitor; 5-aza-2'-deoxycytidine (Sakai et al., 2005). Silencing may also be 
a result of deacetylation of histones in the promoter region (Oh et al., 2009), however it is 
unclear whether silencing is a consequence or cause of cancer. However, as cg11531579 is 
located far (20,538 bases upstream) from the gene CHFR, it is perhaps speculative to discuss 
a role methylation at this locus could have in relation to the CHFR gene. 
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Upstream of cg11531579 is AK055957, a small non-coding RNA regulatory sequence. Its 
biological role is uncharacterised. Recently, this CpG (in combination with others) has been 
identified as a potential DNAm biomarker for use in detection panels for hepatocellular 
carcinoma (Kisiel et al., 2019) and pancreatic ductal adenocarcinoma (Majumder et al., 
2019). The CpG site, AK055957, is located near a H3K27Ac histone mark, which is often 
found near regulatory elements in many cell types. The H3K27Ac histone mark is the 
acetylation of lysine 27 of the H3 histone protein and is thought to be a transcription 
enhancer. It is located near a DNAse I hypersensitivity cluster, which may suggest a 
transcription factor binding region. In a study in children diagnosed with acute myeloid 
leukaemia, cg11531579 was found to be differentially methylated in marrow after 
chemotherapy compared to baseline (-0.24 change in beta, p=0.004) (Gore et al., 2017). In 
summary, this locus may have a role in carcinogenesis, and therefore exists a tenuous link 
between RWG, DNAm and uncontrolled growth. 
The cg01379158 locus is located in the TSS of the NT5M gene, which encodes a 5' 
nucleotidase (a hydrolytic enzyme that catalyses the hydrolysis of a nucleotide to a 
nucleoside and a phosphate) that is subcellularly located within the mitochondrion. This 
enzyme (dNT-2) dephosphorylates the 5'- and 2'(3')-phosphates of uracil and thymine 
deoxyribonucleotides, hence protecting mitochondrial DNA replication from excess dTTP 
(Rampazzo et al., 2000). It has associated pathways of pyrimidine metabolism and 
metabolism, and annotations relating to nucleotide binding and nucleotidase activity. The 
gene is located on chromosome 17 in the Smith-Magenis syndrome-critical region, and 
therefore could potentially play a role in this disease aetiology. Smith-Magenis syndrome is a 
rare condition characterised by inverse circadian rhythm and disturbed sleep, factors which 
have also been linked to obesity (Froy, 2010, Woo Baidal et al., 2016). Furthermore, an 
EWAS on sleep found a cluster of differentially methylated positions in this Smith-Magenis 
region of chromosome 17 (Lahtinen et al., 2019) suggesting methylation could play a role in 
regulation of sleep and circadian rhythm. 
In the epidemiological analysis, RWG was a mediator between birthweight and adiposity 
outcomes, and therefore was closely linked with birthweight. DNAm differences related to 
birthweight are frequently related to growth control (Turan et al., 2012). For example, a 
panel of 23 genes explained 70-87% of the variation in birthweight in human or mouse 
models, and 6 of these genes had roles closely related to growth (Turan et al., 2012). 
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Therefore, as associations were stronger for DNAm and RWG (rather than RT), it is plausible 
that methylation at these loci reflect a combination of birthweight and postnatal growth.  
Whole blood represents a mixed cell population with varying proportions of white blood 
cells. For cg01379158, the association remained with or without adjustment for cell 
composition. In the adjusted analysis, cg11531579 did not emerge as a significant CpG locus. 
Therefore, it is possible that RWG-linked differences in cell proportions could somewhat 
account for this association.  
Whilst the cg01379158 was associated with RWG in both adjusted models, it did not 
demonstrate potential to be predictive of subsequent OWOB (age 17). However, the 
cg11531579 locus showed more promise as a predictive marker, as the highest levels of 
methylation were in those who had RWG and were subsequently OWOB.  
Early life RWG was associated with changes in childhood methylation, however it is unclear 
how methylation at these CpG loci may change over the life course. There was not 
persistence of methylation differences through direct associations with RWG in adolescence, 
which could have been partly due to a smaller sample size. Alternatively, these methylation 
changes could exert effects throughout childhood, rather than persistence into adolescence. 
This is consistent with the epidemiological findings, whereby RWG was associated with 
changes in body composition in childhood, but not adolescence (OWOB in ALSPAC) or 
adulthood (BMI in NTFS). Individuals who had infancy RWG had higher childhood 
methylation (cg11531579), which decreased over time. The initial high methylation followed 
by the decrease over time mirrors the growth pattern seen with rapid infancy growth 
(Chapter 5, Figure 5.2), therefore the decrease over time may reflect the ‘recovery’ of DNAm 
levels similar to the normalisation of BMIz. 
There were null findings for many exposures in this analysis. Recently, Houtepen et al,. ran a 
similar analyses looking at ACEs and maternal DNAm in ALSPAC and in a replication cohort, 
and also did not identify any individual CpG sites which replicated across cohorts (Houtepen 
et al., 2018a). However they did find some DMRs associated with parental health including 
parental mental or physical illness, and death (Houtepen et al., 2018a), suggesting that 
perhaps some of the more ‘severe’, hereditary or genetic factors could have persistent 
DNAm changes. Another recent ALSPAC study deemed very early childhood (0-3 years) as a 
critical period in establishment of DNAm patterns (Dunn et al., 2019), therefore perhaps the 
time period examined here (0-1 year) was too narrow.    
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In an ALSPAC EWAS, socioeconomic position during pregnancy was associated with DNAm 
signatures at three stages across the life course, with maternal education level as the most 
important socioeconomic variable (Alfano et al., 2018), whereas this study used occupational 
social class. 
When studying exposures with small effect sizes there is less power to detect changes that 
span multiple CpG loci, which may explain why no significant DMRs were identified.  
There were also no associations when using the consortium CpG loci as candidates, which 
could be for various reasons. Firstly, that these specific exposures are not associated with 
changes in DNAm (except for RWG). Secondly, the candidate loci mapped to genes with 
specific roles, which could be different to the roles and pathways of the exposures 
examined. The early life exposures studied here have been associated with subsequent 
changes in BMI (chapters 2-5). Whereas, in the consortium paper, using Mendelian 
Randomization it was determined that the majority of the significant CpGs were a 
consequence (rather than a cause) of changes in BMI (Wahl et al., 2016). Thereby BMI is the 
mediator in this hypothesis, and if any exposures were associated with DNA changes in this 
subset of CpG loci, this in theory would have been a result of BMI. Finally, although some of 
the associations have been replicated in pre-school children (Rzehak et al., 2017), primarily 
the candidate loci were relevant to an adult population, whereas this cohort were much 
younger. 
The strengths and limitations of the Illumina 450K array should be considered. Whilst the 
array gives highly reproducible measures of DNAm at many loci, it only allows investigation 
of the predefined probes on the array. The CpG sites on the array cover 99% of RefSeq genes 
and 96% of CpG islands, which were selected because they were of particular interest and 
are not equally distributed across the genome (Bibikova et al., 2011). Whilst the array has 
good overall coverage for protein coding genes, it only covers 1.7% of CpG sites on the 
human genome, located mostly in promoter regions. This approach could neglect sites that 
could be markers for the investigated exposures.  
Batch effects are a source of heterogeneity when analysing arrays and were dealt with using 
adjustment techniques. There are issues in probe design in that many of the probes cross 
hybridise to regions that were not the intended target loci, however this was dealt with by 
removing the probes known to cross-hybridise. The array does not encompass simultaneous 
analyses of SNPs and CpG sites, and loci which contain SNPs affect quantification of DNAm 
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levels. Furthermore, the relative contribution of genetics cannot be disregarded, for 
example, it is possible that some study members were genetically predisposed to obesity, 
and this could interact with epigenome.   
The EWAS served as a starting point to identify potentially important candidate sites, which 
could be the focus of further investigation. Validation (in another independent cohort) 
would be required to determine if CpG loci are consistently, differentially methylated in 
different populations, time points, ages and disease-states.
217 
Chapter 7. Investigating methylation in the Newcastle 
Thousand Families Study 
7.1 Introduction 
This chapter further addresses the third aim of the thesis and examines the gene-specific 
methylation differences identified (in children) in an adult population, many years after the 
exposure and when obesity has occurred.  
The EWAS outlined in chapter 5 identified two differentially methylated CpG loci at age 
seven, in association with rapid weight gain (RWG) in the first year of life. RWG, was a focal 
exposure, as it was strongly associated with childhood body composition in all the cohorts 
(NTFS, GMS and ALSPAC). The Newcastle Thousand Families Study (NTFS) provided an 
opportunity to investigate if early life RWG has a transient or enduring impact on DNAm, in 
an older population.  
This chapter describes the quantification of DNAm at these specific loci at age 50 in the NTFS 
cohort, to investigate if DNAm at these loci are biomarkers of early life RWG and subsequent 
adiposity in adults. If methylation at the RWG-associated locus is subsequently associated 
with obesity in adulthood, it is plausible that methylation could be used as a biomarker to 
predict those at higher risk of obesity in later life. 
7.2 Aims 
This chapter addresses the second part of the 3rd aim of the thesis; To investigate the 
methylation differences in relation to the early life exposure(s) found to influence obesity in 
an adult population. 
The aims were addressed with the following objectives: i.) Develop locus-specific DNAm 
assays (Bisulfite polymerase chain reaction (PCR) and pyrosequencer-based) for the 
detection and quantification of methylation at identified CpG loci, and ii.) Analyse 
methylation at the CpG sites of interest in the NTFS cohort, and iii.) Determine if RWG in 
infancy is associated with altered DNAm at specific loci in adults. 
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7.3 Participants and methods 
7.3.1 Study design and samples 
DNAm (age 49-51) was investigated with respect to early life RWG, and both current (age 49-
51) and subsequent (age 60) body composition (BMI). Early life data were collected 
prospectively for study members and participants of the NTFS were invited to the clinic to be 
measured around age 49-51 (n=412, including measurements of body composition and 
blood samples taken)(detailed in section 2.1.1.2). Participants had similar body composition 
measures taken again in a clinical assessment at age 60 (n=354). DNA was previously 
extracted (Pearce et al., 2012b) from the peripheral blood samples (age 49-51) and stored at 
-80oC in the Newcastle University Biobank. Further details on the NTFS participants (at age 
49-51) can be found in section 2.1.1. 
Bisulfite-PCR and pyrosequencing assays were designed for the two epigenetic loci identified 
from the ALSPAC EWAS (see chapter 5). Of the two assays designed only one was viable 
(detailed in section 7.4.1), and therefore one target was analysed in peripheral blood DNA in 
NTS adults (age 50) NTFS.  
The loci of interest were investigated in the DNA extracted from NTFS blood samples, and 
DNAm was quantified using pyrosequencing (section 2.5.9).  
DNAm levels were analysed with respect to RWG in infancy, and weight-related outcomes 
(BMI and OWOB at ages 50 and 60) using statistical methods (detailed in section 2.5.12.1). 
The approaches taken to address the impact of outliers and potential SNPs are outlined in 
sections 2.5.11 and 2.5.13. 
7.4 Results 
7.4.1 Assay for cg01379158 (NT5M) 
Primer design for the loci, cg01379158, was problematic. The region was CG rich and no 
primers could be identified for the genomic DNA, even with relaxed criteria. Therefore, the 
reverse complement sequence was trialled as the input sequence. This resulted in some 
primer matches, however it was still not possible to design a forward primer without any 
SNPs or of adequate length (the forward primer was 17bp). Multiple primer sets were 
examined (Appendix F, Table XXIII); either matching the original sequence (including SNPs) or 
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with degenerate primers using International Union of Pure and Applied Chemistry (IUPAC) 
nucleotide pairing in the forward primer. This would allow ‘wobble’ base pairing, in this case 
annealing whether the base was either Purine (A or G), by denoting an R nucleotide. No sets 
of primers gave clear, consistent bands of the expected size when visualised by gel 
electrophoresis, with either fragmentation or numerous primer dimers.  
It was not possible to validate the assay for cg01379158 to a sufficient standard for 
sequencing. The presence of secondary bands meant that pyrosequencing reactions failed 
(due to low peak heights). Various PCR conditions were trialled in an attempt to increase the 
band size and reduce secondary structures. Firstly, Dimethyl sulfoxide (DMSO), used in 
reactions to inhibit formation of secondary products, at concentrations of 3% and 5%. Next, 
the number of PCR cycles was increased from 50 to 55. Finally, a touchdown PCR protocol 
(using a higher Ta, and gradually decreasing the Ta over successive cycles until ‘touchdown’ 
temperature is reached) was trialled. However, none of these methods were successful in 
inhibiting secondary structures or improving bands sufficiently for pyrosequencing. Overall, 
these results suggested that primer specificity was the issue. Primers were redesigned and 
all avenues of exploration re-trialled, however these also failed, and no there were further 
attempts to validate this assay.  
There were also 3 SNPs within the vicinity of this CpG (cg01379158) (Table 7.1), which could 
have potentially impacted methylation array results if present in the population under study.  
All further results will be in reference to the assay designed for cg11531579. 
Table 7.1 Known common SNPs near to cg01379158, distance to CpG and the minor allele frequency of the SNP 
SNP Distance (bp) 
from CpG 
Minor allele  
frequency 
rs151107219 16 0.004600 
rs8071972 18 0.020417 
rs6502575 35 0.213047 
 
7.4.2 Assay design for cg11531579 
There were many SNPs in the region for the loci, cg11531579, which meant having to 
compromise on primer design. All viable primers contained a SNP (Appendix F, Table XXIII), 
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with the selected primer set containing a SNP of unknown frequency (observed A/G, 
rs867052755) in the forward primer. In order to ensure correct primer annealing, two 
forward primers were trialled during assay validation, one set with the wild-type base (A), 
and one set with IUPAC base pairing (R). The ‘R’ primer set produced the clearest, strongest 
bands visualised with gel electrophoresis. Furthermore, a benefit of using this set is that 
primer binding will occur whether the base is A or G (if the individual has the SNP), and thus 
was used in analyses. 
Clear bands were observed at all the temperatures in the range of Ta (42-52oC) for the 
gradient PCR for cg11531579. The band at 52oC was marginally clearer (Appendix F, Figure 
XXII), therefore this was selected as the Ta. 
7.4.3 Sample processing 
Figure 7.1 shows a flow diagram for the samples included for methylation analysis in NTFS. 
There were 366 DNA samples remaining for NTFS study members at age 50 (Figure 7.1). Due 
to missing data, only 153 of these had early life RWG data. After quantifying DNA, six 
samples contained no DNA and were excluded. There were two samples which failed 
bisulfite conversion (incomplete conversion), and had no DNA remaining to repeat. Eleven 
samples failed pyrosequencing due to low peak heights. Repeating these samples did not 
lead to improvements and these samples were discarded. This left 134 samples for analysis.  
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7.4.4 Pyrosequencing results 
 Validation of pyrosequencing assays 
The validation results using the methylated controls are presented in Figure 7.3. Validation 
was performed in duplicate for 9 different methylation percentages ranging from 0-100%. 
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Participants with DNA samples 
(n = 366) 
Figure 7.1 Flow diagram of sample processing and analysis for NTFS samples (age 50) 
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methylation, and the trend line and R2 value determined. R2 values for all CpG loci were 
close to 1, indicating that using this assay, observed values of methylation are in agreement 
with the actual values, and that the assay is able to accurately detect the range of 
methylation values. This provided confirmation that the assay was adequately detecting 
methylation levels in this region. Validation at different concentrations provided an 
opportunity to determine the optimum way in which perform duplicate experiments. Route 
A utilised 1 PCR reaction (total volume of 24μL), split over two pyrosequencing reactions 
(10μL in each). Whereas route B involved 2 PCR reactions, with 1 pyrosequencing reaction 
from each individual PCR (Figure 7.2). The hypothesis was that route B, dividing the bisulfite 
DNA across 2 PCRs, would lead to more variation in methylation due to the precision 
required when pipetting small volumes prior to amplification. However, both replication 
methods were comparable, with high R2 values (for both methods the R2 for mean 
methylation and individual CpG methylation was >0.99) (Figure 11). Therefore, route A was 









Figure 7.2 Replication methods tested to determine most accurate measure of DNA methylation. 
Route A used the same PCR products with duplicate pyrosequencing plates, whereas route B used 
two PCR reactions and separate pyrosequencing reactions from these PCR products. BS mod, 
bisulphite modification; Pyro, pyrosequencing run. 
A                                                                            B 
A                                                                     B 
BS mod
PCR










Figure 7.3 Validation (route A) curves for overall average methylation and each of the CpG loci in the pyroassay.  
The solid lines represent the linear relationship, with the equations of the line shown, along with the R2 values to demonstrate the degree of concordance between the observed and 
expected values (an R2 close to 1 signifies exact correlation). Error bars represent standard error. 



































































































7.4.5 Distribution of DNAm data 
DNAm was successfully quantified in 134 samples. The range of methylation detected in the 
NTFS samples by pyrosequencing was wide, ranging from 0-99% (Table 7.2). Average 
(median) methylation level across the 3 CpGs measured was 3.1%. From inspection of the 
histograms, mean methylation was much higher because it was skewed by high values 
(Figure 7.4). Most individuals had low methylation (<7%).  
 
Table 7.2 Methylation levels at each CpG and the average methylation in the NTFS samples.  
Mean methylation (%) N Mean p50 p25 p75 Min Max Range SD 
Average 134 7.13 3.11 1 5.19 0 95.46 95.46 14.35 
Cpg1 134 6.91 2.81 0 5.88 0 99.3 99.3 14.89 
Cpg2 134 7.66 3.59 1.19 7.12 0 95.81 95.81 14.43 
Cpg3 134 6.83 2.81 0 4.49 0 91.27 91.27 14.41 
Median (p50), lower quartile (p25), upper quartile (p75), standard deviation (SD) minimum (min) and maximum (max) 




Figure 7.4 Distribution of average methylation (%) and methylation at each CpG loci determined by pyrosequencing
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7.4.6 The relationship between RWG and DNAm (age 50)  
Of the 3 CpG sites present in the region examined, CpG3 was the original target 
(cg11531579). Correlations between the CpG sites were examined with Pearson correlation 
coefficients (Table 7.3), with all loci demonstrating strong, positive correlations (p<0.0001). 
Correlations were also similar between those who had RWG compared to those who did not 
(Table 7.3). 
 
Table 7.3 Pearson correlation coefficients between the CpG loci examined in the NTFS samples stratified by RWG 
Significance level for all p<0.0001 
 
Overall, average (median) methylation was lower in those who had RWG (Figure 7.5). At 
CpG3, this difference was statistically significant (Wilcoxon ranksum, p=0.03). 
  
 All  No RWG  RWG 
 
Cpg1 Cpg2 Cpg3  Cpg1 Cpg2 Cpg3  Cpg1 Cpg2 Cpg3 
Cpg1 1 
  
 1    1   
Cpg2 0.97 1 
 
 0.98    0.97 1  
Cpg3 0.92 0.97 1  0.92 0.97 1  0.94 0.97 1 
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n p50 Min max p25 p75 
 
n p50 min max p25 p75 p 
Average 78 3.12 0 95.46 1.22 6.05 
 
56 2.37 0 69.53 0 4.98 0.077 
Cpg1 78 2.81 0 99.3 0 5.86 
 
56 2.92 0 72 0 5.89 0.55 
Cpg2 78 3.72 0 95.81 1.5 7.49 
 
56 2.88 0 70.59 0 6.15 0.082 
Cpg3 78 3.17 0 91.27 0.91 5.33 
 
56 1.54 0 66.01 0 3.87 0.027 
Figure 7.5 DNA methylation (%) at the CpG loci by RWG.  
Median (p50), lower quartile (p25),upper quartile (p75), minimum (min) and maximum (max) values shown for all CpG 
stratified by RWG. Comparison between the two groups performed by Wilcoxon rank-sum test (p).  
 
Median regression was used to examine the relationship between methylation (age 50) and 
RWG, adjusted for confounders (sex and/or birthweight z-score) (Table 7.4). Methylation 
was significantly lower (-1.6%, p=0.03) for the target loci (CpG3, Table 7.4). RWG remained 
significantly associated after adjustment, with 1.9% lower methylation in the adjusted (age, 








Adjusted for sex 
 
Adjusted for  
birthweight z-score  
Coef CI p 
 
Coef CI p 
 
Coef CI p             
Average -0.66 [-2.32,1.00] 0.43 
 
-0.88 [-2.56,0.80] 0.30 
 
-0.83 [-2.62,0.97] 0.37 
CpG1 0.33 [-1.78,2.43] 0.76 
 
0.81 [-1.38,2.99] 0.47 
 
-0.22 [-2.60,2.17] 0.86 
CpG2 -0.81 [-3.04,1.42] 0.48 
 
-1.0 [-2.93,0.93] 0.31 
 
-1.13 [-3.09,0.84] 0.26 
CpG3 -1.51 [-3.11,0.09] 0.065 
 
-1.84 [-3.44,-0.24] 0.024 
 
-1.89 [-3.65,-0.13] 0.035 
Methylation at each individual CpG loci was the outcome and RWG the exposure (n=134). Models were unadjusted, 
adjusted for sex, adjusted for sex & birthweight z-score (bwtz). Birthweight and sex were not-significant predictors of 
methylation. Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level of significance 
(p). 
 
The assay was not able detect methylation in the full range of 0-100%. The upper and lower 
levels of detection of percent methylation observed from the assay validation are presented 
in Table 7.5. 
 
Table 7.5 Tobit upper and lower censoring cut-offs from the calibration curves for each CpG loci 
CpG Lower level (%) Upper level (%) 
1 4.2 86.7 
2 3.6 83.0 
3 3.4 77.2 
 
A Tobit model was utilised to take into consideration the assay upper and lower detection 
limits in the observed values. There were no significant associations between RWG and 
DNAm in the Tobit models (Table 7.6). A large proportion of observations were left censored 
on the basis of their methylation values (left censored <3-4%, n=80; uncensored, n=53; right 
censored, n=1). The estimates were higher for the Tobit model (non-significant), which may 
be due to the censoring at 3%, which is the lower detection level whereby DNAm is not 
quantifiable. In this case, censoring should produce less biased estimates.  





Adjusted for sex 
 
Adjusted for bwtz  
coef CI p 
 
Coef CI p 
 
coef CI p             
CpG 1 -3.8 [-15.44,7.83] 0.52 
 
-3.61 [-15.20,7.98] 0.54 
 
-4.96 [-17.52,7.59] 0.44 
CpG 2 -4.65 [-12.98,3.68] 0.27 
 
-4.63 [-12.94,3.68] 0.28 
 
-5.49 [-14.41,3.43] 0.23 
CpG 3 -5.85 [-15.91,4.22] 0.26 
 
-5.85 [-15.93,4.22] 0.26 
 
-5.90 [-16.75,4.96] 0.29 
Upper and lower censoring values determined from calibration curves.  
Coefficients for sex and birthweight z-score (bwtz) were not significant. N=134. 
Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). 
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Methylation at CpG3 was significant associated with RWG in the median regression model 
after adjustment (Table 7.4) but was not in the Tobit model (Table 7.6). As Tobit regression 
predicts the mean, and median regression the median, results are not directly comparable. 
Although estimates were in the same direction, median regression gave lower estimates, 
with concise confidence intervals that were significant, whilst Tobit regression had higher 
coefficients that did not reach statistical significance.  
 
7.4.7 The relationship between DNAm and body composition (age 50) 
Methylation levels were examined in participants with obesity, compared to those without 
obesity (i.e. a healthy weight or overweight BMI), and in study members with OWOB 
compared to healthy weight (Figure 7.6). Methylation levels at CpG1 and CpG3 were lower in 
study members with OWOB and OB, compared to healthy weight, whilst median 
methylation at CpG2 was similar across the body composition categories.  
  
Although methylation levels were lower in participants with obesity compared to those not 
obese, there were no significant differences between the groups (Table 7.7). This could have 
been due to the small proportions with obesity in this sample. To include a larger sample, 
methylation levels in those OWOB were also analysed. Again, methylation was lower in 
OWOB participants, but these differences were not statistically significant. Likewise, there 
were no significant differences for age 60 body composition outcomes. 
 
Figure 7.6 Median % DNA methylation at each CpG loci and the average, by body composition (age 50).  
There were no significant differences in methylation between body composition groups.  
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 Table 7.7 Median % methylation levels at each CpG by body composition outcome (age 50) in NTFS 
 Not Obese  Obese   
 
N p50 min max p25 p75  n p50 min max p25 p75  
Ranksum 
p value 
                
Average 114 3.09 0 95.46 0.81 5.3  18 2.68 0 65.12 1.15 3.85  0.76 
Cpg1 114 3.03 0 99.3 0 5.88  18 1.06 0 66.34 0 4.02  0.25 
Cpg2 114 3.61 0 95.81 1.18 7.01  18 3.59 0 64.75 1.23 9.29  0.73 
Cpg3 114 2.97 0 91.27 0 4.45  18 1.44 0 64.28 0 3.79  0.59 
 Healthy weight  OWOB   
 
N p50 min max p25 p75  n p50 min max p25 p75  
Ranksum 
p value 
                
Average 58 3.08 0 95.46 1.08 4.8  74 3.08 0 65.12 0.95 6.05  0.71 
Cpg1 58 3.01 0 99.3 0 4.58  74 2.59 0 66.34 0 7.37  0.82 
Cpg2 58 3.52 0 95.81 0.94 5.24  74 3.66 0 64.75 1.23 7.54  0.39 
Cpg3 58 3.11 0 91.27 0 4.36  74 1.72 0 64.28 0 4.67  0.53 
Median (p50), lower quartile (p25), upper quartile (p75), minimum (min) and maximum (max) values shown for all CpG 
stratified by body composition. Ranksum p value for differences in methylation between obese and not obese, or OWOB 
and healthy weight. 
 
In multivariable analyses, methylation at either loci was not associated with weight 
outcomes: obesity, OWOB or BMI at age 50 (Table 7.8). Whilst methylation was lowest in 
those who had RWG and were OWOB (age 50) in the sub-phenotype groups, however these 
differences were not significant (Appendix F, Figure XXIII). 
 









OR CI p 
 
OR CI p 
 
coef CI p             
Average 1 [0.96,1.03] 0.86 
 
1 [0.98,1.03] 0.89 
 
0.01 [-0.04,0.06] 0.76 
Cpg1 0.99 [0.96,1.03] 0.76 
 
1 [0.98,1.03] 0.70 
 
0.01 [-0.04,0.05] 0.78 
Cpg2 1 [0.97,1.04] 0.99 
 
1 [0.98,1.03] 0.79 
 
0.01 [-0.04,0.06] 0.68 
Cpg3 1 [0.96,1.03] 0.83 
 
1 [0.97,1.02] 0.81 
 
0.01 [-0.04,0.05] 0.83 
Weight outcome was the dependent variable and DNAm the independent variable. Healthy weight was the reference 
category for the OWOB and OB logistic regression models. Adjusted for sex. Odds ratios (OR) and coefficients (coef) are 
presented with 95% confidence intervals (CI) and the corresponding level of significance (p) 
7.4.8 The relationship between DNA methylation and subsequent body composition (age 
60)  
There was a positive relationship between methylation (CpG3) at age 50 with BMI at age 60 
(Pearson r=0.25, Figure 7.7). Additionally, there was a slightly stronger positive association 
between methylation (age 50) and the change in BMI from age 50 to 60 (Pearson r=0.31).  
231 
 
Figure 7.7 Scatter plot for DNAm (age 50) and BMI (age 60) and change in BMI (age 50-60).  
Pearson correlation (r) and associated p value.  
 
For outcomes at age 60, there were no significant differences in methylation between 
phenotype groups (RWG and healthy weight/OWOB) (Appendix F). CpG methylation at this 
locus explained an additional 3% of the variation in DNAm after controlling for current body 
composition (Table 7.9).  
 
Table 7.9 Linear associations between BMI (age 60) with % methylation (age 50) and BMI (age 50) in NTFS study members 
BMI  
(age 60) 
% methylation BMI (age 50) Adjusted model 
 
coef CI p coef CI p coef CI p 
DNAm 
(%) 
0.08 (0.156,0.14) 0.015    0.065 (0.02,0.09) 0.03 
BMI  
(age 50) 
   0.97 (0.83,1.12) <0.001 0.96 (0.81,1.10) <0.001 
n 91   90   90   
Adj R2 0.05   0.67   0.70   
 All models adjusted for sex (non-significant). Coefficients (coef) are presented with 95% confidence intervals (CI) and the 
corresponding level of significance (p) and adjusted R2 of the model. 
 
Whilst there appeared to be a relationship between DNAm and BMI (age 60), because of the 




nature (linear or non-linear) of the association was uncertain. Therefore, a fractional 
polynomial (FP) model was used to examine the relationship between methylation and 
subsequent BMI. The initial model was skewed by a recognisable outlier with methylation 
greater than 80% (circled, Figure 7.8). When fractional polynomial linear model was re-run 
without the outlier, there was no relationship between methylation and BMI at methylation 
levels <15%, but between 15-60% methylation there was a positive relationship between 
methylation and BMI (age 60) (Figure 7.8). This suggests that this association could be driven 
by high methylation outliers, with less certainty at higher values (wider confidence intervals, 
Figure 7.8B). 
Generally, for a FP model, the best model is that with the lowest deviance. The best-fitting 
fractional polynomial had 1 exponent to the power 2 (squared term) and deviance 518.9, 
forming a curved relationship.  There was no FP model that fit these methylation data for 






Figure 7.8 Fractional polynomial model plots for CpG3 methylation and BMI (age 60). 
Models are adjusted for sex (not a -significant predictor), with all data points (A), and without the outlier (>80% 
methylation, circled) (B). For model A; Coefficient for methylation=0.08, CI 0.00-0.17; p=0.05, n=90. For model B; 
Coefficient for methylation=0.24, CI 0.09-0.38; p=0.001, n=90. Confidence intervals shown as shaded area around 




7.4.9 Data validity 
The range of methylation values obtained for the CpG loci of interest was unusual in that 
genome-wide methylation has a bi-modal distribution, whereby methylation levels at a 
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single locus are usually either high or low. In this case, this raises the question as to whether 
the high levels of methylation are valid.  
Pyrosequencing assays were run in duplicate and replicates were within 5% methylation, 
which would imply the pyrosequencing results are precise. This phenomenon was 
investigated further to determine whether this represented measurement error or a SNP 
effect, and the extent of the effect of the outliers.  
 Assay measurement error 
The high methylation samples all had low DNA concentrations (n=12, shaded points on 
Figure 7.9). It is likely that the low concentration samples had low total amounts of DNA. 
However, many samples had low DNA concentrations and there were some samples which 
had low methylation and a low DNA concentration (n=32). Therefore, it does not appear to 
be likely that the assay preferentially amplified based on methylation in low DNA 
concentration samples.  
 
 
Figure 7.9 Plot of methylation at CpG3 (%) and DNA concentration (ng/μL) of the sample.  
Shaded are the high methylation samples, which have a DNA concentration <5ng/μL. 
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 Understanding any potential SNP effects on DNA methylation 
The CpG loci of interest was located at the start of the 450K probe (Table 7.10). The region 
up- and down-stream of this loci was sequenced in a matched experimental design to 
highlight any nearby SNPs that could influence methylation.   
 
Table 7.10 450K array probe characteristics for cg11531579 
Probe details  Chromosome 
Probe ID Forward genomic sequence CpGs   No. Start  
position        
End  





2  12 133,484,743 133,484,792 133,484,743 
The CpG (cg11531579) is underlined in the probe sequence. 
 
The right strand for each sequencing reaction was sequenced successfully, with some drop 
off in quality towards the end. There were a handful of SNPs within the sequences, however 
no clear pattern that distinguished high and low methylation samples, or paired samples. 
The CpG loci of interest was at position 110 in the sequence. There were some differences 
between high and low methylation samples at positions 90, 339 and 424 (Appendix F, 
Figure XXV). Pair B showed consistent SNP patterns for the matched samples, but there were 
differences in SNPs for the matched pairs A and C (Appendix F, Figure XXV).  
There were nucleotide differences observed for the pairs (A and C) with characteristics of 
RWG and a BMI>25kg/m2 (overweight category), whereas there was no difference between 
the pair (B) which had no RWG/healthy weight. This could suggest that genetic variation is 
occurring in a phenotypic-dependent manner. However, with the small sample size this 
cannot be said with great certainty.  




Matched pairs A B C 
Sample ID TFS55 TFS314 TFS59 TFS296 TFS270 TFS152 
RWG Yes No Yes 
Sex Female Female Female 
BMI 29 25 27 
Methylation Low High Low High Low Very high 





Position 90 G A* HZ HZ G HZ 
Position 339 C * T C* C* C* HZ 
Position 424 T* C C C T* C 
Pair differences  ✓ X ✓ 
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sequences 
Diff, differences in matched pairs; Pos, position in sequence read; %, percent methylation; HZ, heterozygous; * indicates 
major allele. 
 
The SNPs at positions 90 and 424 were known SNPs, whereas position 339 was not a known 
SNP (Table 7.12). The known SNPs (rs2873193, rs4758916) were examined for linkage 
disequilibrium, however evidence suggested that these genetic variants occur independent 
of one other (Appendix F, Figure XXVI).  
Table 7.12 SNPs identified in the sequenced region in NTFS paired samples and SNP characteristics  
SNP name Position in 
aligned 
sequence 








Unknown 339 chr12:133,484,970 C>T -  




Allele frequencies were determined from (phase3 release V3+)(Sudmant et al., 2015). 
 
 Sensitivity analysis  
Sensitivity analysis was done to examine if the extreme values (>12% methylation) affected 
the results. This was done for CpG3 only, as this was the CpG loci of interest and the only loci 
that demonstrated any significant associations with exposures and outcomes. With outliers 
excluded, the mean was closer to median, and the standard deviation decreased (Table 
7.13).  
Table 7.13 Descriptive statistics for CpG3 methylation with (all) and without outliers, stratified by RWG 
All N Mean p50 p25 p75 Min Max SD 
Total 134 6.83 2.81 0.00 4.49 0.00 91.27 14.41 
No RWG 78 8.10 3.17 0.91 5.33 0.00 91.27 16.01 
RWG 56 5.08 1.54 0.00 3.87 0.00 66.01 11.75 
Excluding outliers N Mean p50 p25 p75 Min Max SD 
Total 118 2.40 1.88 0.00 3.82 0.00 10.34 2.45 
No RWG 67 2.79 2.65 0.00 4.36 0.00 9.87 2.52 
RWG 51 1.90 1.19 0.00 3.77 0.00 10.34 2.28 
Outliers n=16. N, sample size; p50, median, p25, lower quartile; p75, upper quartile; min, minimum; max, maximum; SD, 
standard deviation.  
 
In the median regression model when outliers were excluded, the coefficient for RWG 
increased and the p value was smaller (Table 7.14). Therefore, in the range of methylation 
from 0-12%, there was a stronger association between DNAm and RWG, than in the original 
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(wider) range of values. Most individuals exhibited methylation in the range 0-10%, 
suggesting that for the majority of the cohort, RWG was associated with -2% methylation.  
Excluding the outliers did not result in any changes in significance in the Tobit model.  
Table 7.14 Comparison between Tobit and median regression model results for the models with and without outliers 
excluded.  
Model Adjusted for sex and bwtz 
Tobit regression coef CI p 
Original -5.85 [-15.91,4.22] 0.26 
Outliers removed -2.41 [-24.57,19.74] 0.83 
Median regression coef CI p 
Original -1.89 [-3.65,-0.13] 0.035 
Outliers removed -1.95 [-3.36,-0.54] 0.007 
Methylation at CpG3 was the outcome and RWG was the main explanatory variable. Models were additionally adjusted for 
sex and birthweight z-score (bwtz). The original model included all the data points, whilst the outliers model excludes 
methylation values >12%. Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level 
of significance 
Methylation at CpG3 was not associated with body composition outcomes (at age 50) with 
or without outliers, in linear or logistic models (Table 7.15).  
Table 7.15 Outlier analysis with body composition outcomes (age 50) using logistic and linear regression models, for all and 
stratified by RWG. 
Outcome  OB    OWOB    BMI  
 OR CI p  OR CI p  Coef CI p 
All study members, n=118                    
Original 1 [0.96,1.03] 0.83  1 [0.97,1.02] 0.81  0.01 [-0.04,0.05] 0.82 
Outliers 
removed 
1.04 [0.85,1.28] 0.71  0.98 [0.85,1.15] 0.84  0.01 [-0.04,0.05] 0.83 
Models are adjusted for sex. Sample sizes refer to the sample without the outliers. Odds ratios (OR) and coefficients (coef) 
are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). 
 
When outliers were excluded, there was an association between DNAm and subsequent 
body composition measures (age 60), as determined using a fractional polynomial model 
(Figure 7.10). The best fitting model was a with a cubic term (Coefficient = 5.5, CI 0.05-10.9, 
p=0.05). Both models had widening confidence intervals at higher values (Figure 7.10).  
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Figure 7.10 Fractional polynomial model for BMI (age 60) and methylation at CpG3 (age 50), for models with and without 
outliers.  
The model with the original data is to power (2) whilst the model without outliers is to power (3).  
The outlier model had coefficient = 5.5, CI 0.05-10.9, p=0.05. 
 
Furthermore, from the FP model it appeared that BMI was only associated with the outliers 
(i.e. a change in slope at methylation >20%). To examine this, a linear regression model was 
run with BMI age 60 as the outcome, and outliers (>12% methylation) as a binary 
explanatory variable (study members with methylation >12% vs <12%) (Table 7.16). Having 
DNAm levels greater than 12% was associated with a 3.11kg/m2 increase in BMI at age 60. 
High methylation remained associated with subsequent BMI after controlling for current 
BMI, however current BMI explained much more of the variation in BMI (age 60) and was 
therefore a better predictor.  
 
Table 7.16 Linear associations between outlier DNAm (>12% methylated) and BMI (age 60) 
BMI (age 60) Unadjusted  Adjusted for BMI (age 50)  
coef CI p  coef CI p 
Outliers (>12% methylation) 3.11 [0.30,5.91] 0.03  1.96 [0.27-3.64] 0.02 
n 91 
  
 90   
R2 0.06 
  
 0.69   
Both models additionally adjusted for sex. Coefficients (coef) are presented with 95% confidence intervals (CI) and the 
corresponding level of significance (p) 
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7.5 Discussion 
An assay was successfully developed to measure DNAm at the CpG site associated with RWG 
in the ALSPAC cohort (cg11531579). DNAm levels in the region of interest were quantified in 
134 viable samples from the NTFS cohort. Median DNAm at the cg11531579 locus was 2.8% 
and was lower on average in those who had RWG (3.2% vs 1.5%). Median regression 
revealed that RWG was associated with 2% lower methylation after adjustment for 
confounders. Whilst methylation tends to increase over time at this locus (BSGS, section 
7.3.1), on average in NTFS adults those who had RWG had lower methylation.  
There were differences when analysing the outliers, which suggested that RWG was more 
significantly associated with reduced methylation in the lower range of methylation values. 
There were also differences observed when utilising a censored regression model, which 
questions the accuracy of the results that lie outside the (lower) range of detection of the 
assay, perhaps due to the uncertainty introduced from many censored values, or due to 
reduced statistical power. 
A wide range of methylation values were observed, including some very high values. It is 
possible that outliers could come from technical artefacts, however this seems unlikely in 
this as repeats were within 5% of each other, and some high methylation samples were re-
run and values were similar. White et al,. found that low concentrations of template DNA 
(<10ng) can affect absolute quantification due to introduction of PCR bias (White et al., 
2006). Increasing the number of technical replicates, or bisulfite sequencing could have been 
potential options to investigate further if there was abundant DNA remaining. Ideally if there 
was more DNA available, then all samples would have had greater starting material, and 
samples could have been run in PCR triplicate.  
The DNAm changes identified here were small, particularly considering that technical 
replicates can often have methylation differences up to 10% (Dedeurwaerder et al., 2014). 
Here, replicates were only accepted if within 5% of one another. There is the possibility that 
methylation could be due to random technical variations rather than true biological 
differences (Dedeurwaerder et al., 2014). For individual CpG sites the pyrosequencer 
detection limit is approximately 5% (Mikeska et al., 2011), therefore meaningful differences 
may be too small to accurately quantify. Ideally differentially methylated loci should be 
confirmed using an independent assay and technique (i.e. next generation sequencing which 
is costly) in the same population.   
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Statistical methods were used which are appropriate for the data (without excluding points), 
as if this is a ‘true’ event, then removing the data points would generate a selection bias. On 
the other hand, an argument to exclude outliers would be in that the utility of a biomarker is 
that it applicable for most of the population, hence sensitivity analysis was done to examine 
the impact of outliers. Outliers could be a result of a difference in measurement method, 
genetic variation, cell composition, or disease state (discussed further in section 8.7). 
The range of methylation values detected by pyrosequencing in the samples was higher than 
those observed in the epitect control DNA samples for a given methylation level. A possible 
explanation for this could be that the epitect control DNA, which uses whole-genome 
amplification (0% methylated) and SssI treatment (CpG Methyltransferase which methylates 
all cytosine residues), does not result in 0 or 100% methylation at all CpG loci (Choi et al., 
2011). In another study which used the epitect control DNA, the values obtained for 
supposed 0% methylation at various CpG loci ranged from 0-23% (Nishitani et al., 2018). The 
methylation detection limit of the assay by the pyrosequencing machine also had a lower 
and upper threshold, and therefore relying on the control DNA to determine will impact on 
the specified detection ability of the assay and would invalidate the Tobit model results.  
The high methylation levels were investigated further to determine if SNP patterns were 
driving differences between high and low methylation. There is literature on the two 
identified SNPs. Sequencing results were suggestive of a phenotypic (RWG and OWOB) 
pattern of methylation related to SNPs. As there were few samples with sequencing data 
and with very high methylation, these results could be spurious findings. If the results are 
not by chance, then high levels of methylation could be driven by SNP effects or be 
indicative of future body composition in those with high BMI. However, as there were few 
samples with high methylation, and only 3 matched pairs were successfully sequenced, 
these results are inconclusive, but this could be the focus of future research.  
There was a wide range of methylation values could indicate a high degree of heterogeneity 
at this locus. For example, this could occur if the majority of cells (blood is comprised of 
numerous cell types) exhibit low levels of methylation but some exhibit very high levels. 
Outliers could arise from abnormal methylation patterns from white blood cells (e.g. from 
infection or cancer), or could be influenced by disease status or lifestyle (Alegría-Torres et 
al., 2011).  
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DNAm did not distinguish between healthy weight and OWOB (age 50), regardless of 
previous RWG. However, there was a positive association between DNAm and subsequent 
BMI (age 60), which on further inspection appeared to be non-linear. Those who had very 
high methylation also happened to have a greater BMI at age 60. The CpG methylation at 
loci improved prediction of subsequent BMI (age 60) over and above the use of current BMI 
(age 50). A 1% increase in CpG methylation at this 1 locus was associated with a 0.07 Kg/m2 
increase in subsequent BMI and explained around 3% of the variation in NTFS participants. 
However, this may have limited use as a biomarker in this age group, as BMI at age 50 was 
more predictive of BMI at age 60 than DNAm, but CpG methylation could be used to 
improve predictive models alongside BMI. This could also suggest that similar to findings in 
ALSPAC, relative increases in methylation are reflective of subsequent growth.  
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Chapter 8. Discussion  
This final chapter is a discussion of the main findings of results chapters, and how the 
findings compare with the published literature. The chapter will also include the study 
strengths and limitations, and the public health implications and future directions. 
8.1 Summary of the main findings 
Early life exposures were primarily investigated in North East populations of children and 
adults, in two cohorts that commenced over 50 years apart. Over this time, the prevalence 
of obesity has vastly increased, from what were very low numbers in 1947.  
Despite the change over time to a more obesogenic environment, early life weight gain was 
consistently associated with a higher BMIz in both NTFS and GMS cohorts, even when 
accounting for birthweight. RWG is characterised by initial rapid growth, and generally BMI 
z-scores decrease and ‘normalise’ over time. However, in the modern cohort those who had 
RWG had a higher, sustained BMIz throughout childhood. 
The exposures that were important factors for childhood OWOB in the North East cohorts 
were investigated further in the larger, South West cohort; ALSPAC. Again, there were 
consistent associations for early life weight gain, both dependent and independent of 
birthweight. However, when examining long-term effects, the relationship between early life 
weight gain and BMI in adolescents weakened over time in ALSPAC and was non-existent in 
NTFS adults. Thereby questioning whether there are long-term effects, or if other factors 
become more important predictors of body composition.  
The programming effect of early life risk factors on childhood BMI may arise through 
epigenetic marks laid down at an early developmental stage, which then elicit effects at a 
later stage (Mathers and McKay, 2009). Like the epidemiological findings with RWG and 
childhood BMI, there was a positive association between RWG and DNAm. DNAm changes 
were associated with RWG, but less so with RT, which may suggest that this includes some of 
the effects of birthweight. To examine if there were latent effects of RWG on DNAm, 
methylation at the significant locus (cg11531579) was verified by pyrosequencing in NTS 
adults. Interestingly, DNAm at this locus was negatively associated with RWG in NTFS (age 
50), suggesting variability. In childhood, the highest levels of methylation were in those who 
had RWG and were subsequent OWOB. At age 50, methylation was positively associated 
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with subsequent BMI (age 60). Therefore, DNAm at this locus may reflect patterns of 
growth; increased methylation associated with increased subsequent growth. However, due 
to the differences in age, time period, and methods of measurement, direct comparisons are 
inadvisable. Furthermore, the methylation differences observed were small and findings 
need to be replicated. 
There were other important early life risk factors identified in the epidemiological analyses, 
including birthweight, adversity, infection, maternal age and SES. There were more early life 
factors related to childhood body composition in the modern (GMS) cohort, which may 
suggest these factors have become more important over time, or that there is now greater 
variability in early life environments.  
8.2 Discussion of the epidemiological findings 
8.2.1 Birthweight 
The positive associations between birthweight and adiposity outcomes in children in the 
modern cohorts agrees with the literature (Reilly et al., 2005a, Yu et al., 2011). In contrast, 
there was no association in NTFS children, and a protective effect of higher birthweights in 
adults, which could be due to time period effects. NTFS study members were in utero during 
a time of rationing in Britain, whereby it is generally accepted that the nation’s health 
improved, which could have reduced numbers of LBW infants. Particularly rationing will have 
benefited less advantaged groups more and mothers were less likely to be undernourished. 
Similarly, theories around a mismatched intrauterine and postnatal environment do not 
apply to this cohort, as the period of rationing extended throughout early childhood, 
meaning a consistency in nutrient intake throughout pregnancy and early life. Furthermore, 
considering the time period there will have been fewer obese mothers due to lower 
prevalence of obesity generally, therefore findings in the modern cohort could reflect the 
cycle of higher birthweights and obesity across generations (Cnattingius et al., 2011). 
8.2.2 Adversity 
The components of adversity that were significantly associated with body composition in 
GMS had socioeconomic implications (Appendix C, Table IX). Whilst in NTFS, neither 
adversity nor early life SES were associated with any outcome measures in childhood or mid-
life, which could indicate that the effects of adversity on BMI impact via SES. 
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An alternative explanation could be the timing, as in NTFS the adversity exposure was 
postnatal, whereas significant associations in ALSPAC and GMS were identified for prenatal 
adversity. This may support an intrauterine mechanism of altered stress responses, leading 
to disturbances in metabolism (Entringer et al., 2012, Johnson et al., 2013). However, early 
life stress could also impact on the development and calibration of the neuroendocrine-
immune network, and have downstream effects on various social, economic, academic and 
behavioural aspects of a child’s life, which could also influence likelihood of obesity (Johnson 
et al., 2013). 
Another potential explanation could be that the effects of adversity do not persist to 
adulthood, although this was the case in ALSPAC, whereby associations were stronger over 
time (in adolescence). Furthermore, a large systematic review and meta-analysis found weak 
to moderate associations for adverse childhood experience (ACEs) and obesity in adulthood 
(OR 1·39 (95% CI 1·13–1·71) when examining multiple ACES (>4), which may be indicative of 
more severe childhood adversity (Hughes et al., 2017). A recent methodological approach 
has exploited the high dimensionality of the ALSPAC data to derive ACE scores and 
constructs from the numerous adversity questionnaires (Houtepen et al., 2018b). These 
scores which utilise multiple measures can also deal with missing data, and could be used in 
future analyses. 
8.2.3 Infections 
In NTFS bacterial infection was associated with OB and also with body fat in women. There 
was a lack of robust infection data in GMS, however, there were some indications in ALSPAC 
that antibiotic exposure in the first 6 months (as a proxy for bacterial infection) was 
associated with OWOB until adjustment for early life growth (correlated with antibiotic 
exposure). This could suggest a link between early life infection, antibiotics, and subsequent 
growth. The antibiotic growth effect is observed in farm animals who are given antibiotics to 
increase their weight, but has also been observed in humans (Haight and Pierce, 1955). 
Research seems to suggest that the mechanism linking antibiotics and growth could be via 
the microbiome (Cox and Blaser, 2014, Forrest et al., 2017).  
A longitudinal study that compared infants with infections who either did or did not receive 
antibiotics found no difference in obesity risk up to 18 years (Li et al., 2017a). However, the 
number of infections was significantly associated with increased risk of obesity in those who 
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did not have antibiotics. Thereby the authors concluded that the exposure to infection 
rather than the antibiotics was the important factor.  
The timing of antibiotic exposure could also be important, as early‐life post-natal exposure 
was associated with increased child BMI, but not pre-natal (Poulsen et al., 2017). In support 
of this, in a large sample of mother-child pairs (n=53,320) also found that maternal antibiotic 
exposure during pregnancy was not associated on childhood BMI-z at 5 years (Heerman et 
al., 2019).  
Furthermore, this study supports that bacterial, rather than viral infection is associated with 
increased BMI, however this could be due to the types of viruses and bacterial infections 
examined in NTFS, some of which are rare now.  
8.2.4 Maternal age 
Although maternal age has been related to detrimental birth outcomes, in these cohorts 
maternal age was not directly associated with an unfavourable body composition or 
birthweight. Instead, the association of older (NTFS) and younger (GMS) maternal age with 
decreased offspring BMI is an interesting observation and is opposite to previous findings 
(Myrskyla and Fenelon, 2012). However, maternal age may not be causally linked to body 
composition but could have indirect route (for example via parity, Figure 4.2), or could be 
confounded by SES. 
This positive effect of older maternal age was not seen in ALSPAC, and therefore could be an 
oddity of the North East cohorts, or a spurious finding due to smaller sample sizes. In other 
studies, maternal age above 40 (Fuchs et al., 2018) or 45 (Myrskylä and Fenelon, 2012) has 
been associated with adverse offspring health outcomes. As the maximum maternal age in 
NTFS was 45, it is plausible that there were no any adverse associations, as the ‘older’ 
maternal age group were relatively young. Although, aside from for birthweight or length of 
gestational, other adverse offspring outcomes have been shown to remain fairly stable after 
a maternal age in the mid-30s (Carslake et al., 2017). 
These results may suggest that in older mothers, whilst intrauterine conditions may be less 
optimum, the life experiences and enhanced childhood environment may confer certain 
advantages. 
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8.2.5 Infant feeding 
In these cohorts, there was no evidence of a protective effect of breastfeeding on obesity, 
independently or after adjustment for socioeconomic factors. In contrast, breastfeeding was 
associated with small increases in BMI in NTFS adults. Whilst studies have found long-term 
benefits of breastfeeding (such as reductions in OWOB) in developed countries, studies in 
low and middle income countries have not shown such great effects, which could suggest 
differences in social and cultural structures, selection bias or confounding could in part 
explain some of the association (Kramer et al., 2009, Brion et al., 2011).  
Previous analyses in the GMS cohort have shown there is a clear relationship between SES 
and breastfeeding duration (Wright et al 2005), with those in the most affluent quintile 3x 
more likely to breast-feed initially and 5x more likely to continue breastfeeding past 4 
months (Wright et al., 2006a). Wright et al,. also found greater rapid weight gain (0-13 
months) in those who stopped breastfeeding earliest, although this is likely a result of 
reverse causation; that starting solids and ceasing breastfeeding is a response to RWG 
(Wright et al., 2006b). They conclude that babies genetically destined to be larger make 
greater demands on their mother for breastmilk; and this greater demand increases 
likelihood of earlier cessation. 
A study which utilised structural equation modelling found that shorter breastfeeding 
duration was associated with increased infant weight gain and subsequent higher childhood 
BMIz, however these estimates were not adjusted for SES (Lamb et al., 2010). Similar 
associations between weight gain and breastfeeding have been observed in other studies, 
with suggestion that any beneficial effect is obtained by 12 months of age (Scholtens et al., 
2007). These analyses primarily examined the duration of breastmilk rather than the 
composition, however formula and other milks have been associated with greater dose-
response in weight gain through infancy (first year) (Kramer et al., 2004).  
There was a negative association between age at weaning and some outcomes in the GMS 
cohort (waist OB, BMIz). This is consistent with the literature on early weaning and could be 
related to the types of foods that are introduced (Pearce and Langley-Evans, 2013), and may 
explain a lack of association in NTFS. This association for waist OB was no longer significant 
after controlling for physical activity, which could suggest that this was operating through a 
shared pathway. Perhaps the families which introduce weaning foods later are generally 
healthier (more active) or with greater health literacy. Accordingly, a systematic review 
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determined that low maternal education was an important factor in early weaning 
(Wijndaele et al., 2009b), and is supported by findings in GMS (Wright et al., 2004). 
8.2.6 Physical activity 
In GMS and NTFS, there was a negative association between increased physical activity and 
most adiposity outcomes. These results are similar to other studies in adults (Reiner et al., 
2013). Whereas studies on childhood obesity have found mixed results, with associations 
perhaps influenced by biological or social gender differences (Prentice-Dunn and Prentice-
Dunn, 2012). In GMS, physical activity began to decline in both sexes from age 7 years 
(Farooq et al., 2018), therefore the effect sizes exhibited here may change over time. 
Females were also less likely to participate in activity and were more sedentary (King et al., 
2011). The results here are in agreement (Figure 4.2), suggesting that girls are less likely to 
take part in MVPA, which could then impact on BMI.  
There is also the possibility of bidirectionality between body composition and activity, which 
is supported by recent findings from GMS suggesting that adiposity influences levels of 
physical activity (Tanaka et al., 2018). 
8.2.7 Socioeconomic status 
As rationing reduced disparities in NTFS, we might expect more pronounced inequalities to 
be in GMS. However, SES at birth was not associated with outcomes in the modern cohorts, 
but higher social class at birth was negatively associated with BF% and WHR in NTFS males. 
The fact that SES was not associated with factors in females could be partly attributable to 
the fact that the UK Registrar General’s classification was developed for male workers and 
may transfer poorly to females. Although in pooled analyses (both sexes), social mobility was 
associated with drastically decreased odds of obesity in NTFS adults, and those who were 
always in the most advantaged group had very low odds of obesity.  
National level data find a relationship between childhood SES and childhood obesity (Health 
and Social Care Information Centre, 2016). Similarly, GMS results suggested that SES in 
childhood is more predictive of OWOB than SES at birth. There was no evidence for 
increasing upward mobility, which may be because it was basic measure using ownership 
and employment, rather than encompassing multiple aspects of social mobility. 
Furthermore, deprivation measured using home ownership is perhaps less informative over 
time with the resurgence of private renting (Kemp, 2015).  
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There were no socioeconomic differences in OWOB in ALSPAC either, which is in contrast to 
other studies. This could be due to the use of occupational social class or Townsend score, 
rather than parental education, which is most frequently associated with lower odds of 
obesity (Brophy et al., 2009, Shrewsbury and Wardle, 2012, Ruiz et al., 2016). However, the 
effects of maternal education appeared to be indirect in GMS, via other factors such as 
birthweight or parity or lifestyle (Figure 4.2). Similarly in NTFS, early life SES had indirect 
effects on BMI via later life SES and lifestyle factors (Figure 3.3). Brophy et al,. suggest that 
the relationship between maternal education and obesity could be a result of more 
protective health behaviours and empowerment for people to modify their own health. In 
pregnant women, this could influence health-related behaviours that affect birthweight, 
which may explain the relationships exhibited.  
A potential limitation when comparing results is the difference in the socioeconomic 
variables available in each of the cohorts, which may limit interpretations.  
8.2.8 Infant and childhood growth  
This study is one of many to show a relationship between RWG and childhood adiposity 
(Stettler et al., 2003, Ong and Loos, 2006b, Druet et al., 2012). In these analyses, this 
association was observed across cohorts and time points, and therefore suggests this is a key 
exposure regardless of the modern obesogenic environment. Similarly, a 2005 systematic 
review investigating infant weight gain in populations born between 1945-94, found 
consistent associations across various time periods and ages (5-20 years)(Baird et al., 2005). 
Furthermore, findings from low and middle-income countries also support that early life 
weight gain is associated with subsequent BMI (Joglekar et al., 2007, Fernandes et al., 2009). 
Collectively these findings suggest that RWG is a consistent risk factor regardless of 
environmental influences.  
Genetic markers support that early infancy gains in weight and length are on the pathway to 
adult obesity risk (Elks et al., 2010b). The path analyses attempted to disentangle the direct 
and indirect pathways and determined that a direct path between RWG and BMI existed, 
and that no factors predicted RWG, supporting a direct relationship. However, obesity is the 
result of the interplay and balance between multiple contributing and intermediary factors. 
Therefore, whilst this is a plausible risk factor, it is unlikely to be a sole determining factor. 
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An important consideration is that infancy RWG per se may not be causal, but could reflect 
an individual’s predestined growth trajectory, or an antecedent to childhood obesity. 
However, previous systematic reviews have found weight gain in the first year (specifically, 
rather than periods greater or less than 1 year) to be most predictive of childhood obesity 
(Zheng et al., 2018). This does not rule out RWG as an antecedent, but suggests that the first 
year is a critical period.  
 
However, many children with rapid infancy weight gain do not go on to have increased 
adiposity in childhood (Wright et al., 2012). Using data from three longitudinal growth 
cohorts, excess weight in in infancy had a moderate positive predictive value for becoming 
overweight in mid‐childhood, but not necessarily for becoming obese (Wright et al., 2018). 
This therefore highlights the need for a means to detect those most at-risk (i.e. a biomarker). 
The entire childhood period, rather than the first year, could also be a critical period for 
growth and development of obesity (Cole, 2004).  
 
Previous studies which have used BMI are unable to determine whether this reflects changes 
in fat mass. This study examined multiple outcomes and determined that RWG was also 
related to FMI, and the relationship was stronger in those with very high fat mass. RWG in 
infancy has been associated with higher concentrations of insulin-like growth factor I (Ong et 
al., 2002a) which could increase growth and lean mass. This may explain the relationship 
between RT and height (which contributes to lean mass), which was also noted in a Swedish 
cohort of young adults (age 17 years) (Ekelund et al., 2006). They found that RWG in the first 
6 months was associated with both fat and fat free mass (measured using air-displacement 
plethysmography) and WC in adolescence (Ekelund et al., 2006).  
In GMS, those with early RT had consistently higher weights throughout childhood; therefore 
infancy may be a key time to intervene. Children with early increasing BMI diverge from 
other growth trajectories as early as two years (Robinson et al., 2019), therefore rapid early 
growth may set infants on a higher weight trajectory over the life course. This also suggests 
that BMI measurements taken in the NCMP at school-age (age 4-5) will miss some high risk 
children (Robinson et al., 2019).  
Although RWG is associated with increased childhood BMIz, in the historic cohort BMIz 
normalised over time and RWG was not associated with adult body composition. This could 
be interpreted as either; factors determining early life fat mass manifest in childhood BMI 
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and not adult BMI; the obesogenic environment is key; or that RWG is associated with adult 
BMI through changes in lean mass. Regarding the latter, a Finnish study examined the 
relationship between early life growth and body composition in adults aged 56-70, and 
determined that rapid gains in BMI (from 0-1 or 1-2 years) were associated with lean rather 
than fat mass (Ylihèrsilè et al., 2008).  
Similar to findings from ALSPAC (Ong, 2006), early postnatal growth rates were a 
compensatory mechanism for lower birthweight or growth restriction. LBW infants are more 
likely to have catch-up growth, which increases CVD risk (Kelishadi et al., 2015). This 
supports the DOHaD and Barker hypotheses regarding the interaction between intrauterine 
conditions, environmental factors, and increased risk of metabolic disorders. Interestingly, 
although waist obesity has been specifically related to metabolic disorders (Hirschler et al., 
2005), RWG was not significantly associated with waist OB.  
Although LBW makes catch-up growth more likely, Druet et al. (2012) found that the effects 
of infant weight gain on childhood obesity were similar regardless of birthweight status. This 
was reiterated when analysing rapid thrive, which accounts for catch-up growth due to LBW. 
Factors which influence birthweight will impact on likelihood of RWG. For example, maternal 
smoking during pregnancy has been shown to be associated with increased risk of RWG 
(Mine et al., 2017). However, adjusting for maternal smoking in the ALSPAC analysis did not 
notably affect associations. Whilst it was not possible to adjust for maternal BMIz in GMS 
and NTFS, the associations for birthweight and rapid growth remained in the ALSPAC 
analyses, and in another ALSPAC study on childhood obesity which adjusted for parental 
obesity amongst other factors (Reilly et al., 2005a).  
Aside from birthweight no factors predicted rapid weight gain in this study. Factors could be 
related to appetite regulation, feeding behaviour or breastmilk composition. Traffic pollution 
has also been considered a cause (Fleisch et al., 2015). In GMS, appetite at 6 weeks and 12 
months was positively associated with weight gain at 12 months (Wright et al., 2006b). 
Accelerated growth in infancy could be due to increased intake of nutrients, in particular 
protein, which has been shown to increase levels of insulin-like growth factor 1 and 
promotes growth in the first 6 months of life (Socha et al., 2011). RWG is less likely in 
breastfed infants, which could also be related to the lower protein content of human breast 
milk compared to formula (Koletzko et al., 2013).  
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Overall, the findings in this thesis support previous findings that early life growth is an 
independent, persistent factor related to subsequent body composition. 
8.3 The potential causal impact of RWG and future work 
Before we can address the question of causation, it is important to establish that a valid 
association exists. Firstly, it must be determined that there is valid association between the 
exposure and the outcome. If the association is valid and is not due to bias or confounding, 
then causality can be addressed. The analysis undertaken here was not intended to 
determine causal factors, and thus this research design is not able to ascertain causality 
which is often only possible in randomised controlled trials. Although, in epidemiological 
studies, the Bradford Hill criteria are often used to assess the strength of a causal 
relationship and can be considered in this context. These criteria include plausibility, 
consistency, temporality, strength, specificity, change in risk factor, coherence, analogy and 
experiment.  
Applying these criteria to the principle findings in this thesis, RWG would meet the criteria of 
plausibility, consistency and temporality. The strength of the association was not 
investigated here, however others have found that very rapid weight gain, equivalent to 
crossing 2 growth centile bands was associated with even higher risk of childhood obesity 
(Druet et al., 2012), which supports a dose-response relationship. There is plausibility in that 
there is a reasonable pathway to link excess weight gain and obesity. Epigenetics is also a 
plausible mechanism, however these findings would need to be replicated. There is 
temporality in that the exposure precedes the outcome. No single study is sufficient to 
determine causality, however this study is consistent with the previous literature and 
aetiology. There was also consistency when RWG was analysed in several populations, and 
across different outcome measures of obesity. Regarding specificity, thus far RWG has not 
been linked to other diseases and therefore its effects may be specific to obesity. Whether 
the mechanism is via epigenetic changes (specific), rather than another mechanism (non-
specific), remains to be determined. 
8.4 Strengths and limitations of the epidemiological analysis 
There are several strengths to this study. The three birth cohorts had reasonable sample 
sizes and prospectively collected early life exposures and body composition measures. Data 
and methods were harmonised as thoroughly as possible to allow comparison between 
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studies. Trained professionals collected anthropometric data; therefore, there was no 
reliance on self-reported measures of adiposity outcomes. Another strength is the 
comprehensive analyses of multiple outcome measures allowing greater sensitivity to detect 
early life exposures associated with adiposity.  
Whilst a range of exposures and factors were measured routinely in the cohorts, inevitably, 
the data collection for some variables was limited, and therefore there is potential for 
unmeasured confounding. Data were not available for other risk factors or confounding 
factors. For example, maternal smoking (Newnham, 1991) and maternal BMI (Harvey et al., 
2007, Wright et al., 2010a, Bammann et al., 2014, Fairley et al., 2015a) are known to 
influence birthweight in opposing directions. Additionally, the associated risk factors for LGA 
infants include pre-pregnancy obesity, excessive GWG, maternal or GDM (Jolly et al., 2003). 
This was addressed partly in the sensitivity analyses in ALSPAC, which confirmed that the key 
associations remained. 
In NTFS, the questionnaire used to collect retrospective data is vulnerable to recall bias and 
inaccurate responses. To reduce this bias, information was only taken on present habits in 
the age 50 follow-up questionnaire. Additionally, data considered unreliable (such as those 
on energy intake) were not utilised.  
A main limitation of this study was the small sample sizes in the North East cohorts at follow-
up relative to larger birth cohort studies. There was insufficient power to detect small effect 
sizes. However, a key strength of the project overall is through integrating results from 
several different approaches (triangulation). Each approach may have specific sources of 
bias, but by comparing cohorts from different times and geographical locations strengthens 
confidence in the findings. It is also reassuring that the main findings for rapid growth in 
infancy are in agreement with findings from large-scale meta-analyses.  
8.4.1 Generalisability and attrition  
Loss to follow-up is an important issue as it can result in biased estimates. As with most 
longitudinal population studies there has been attrition related to SES. Attrition could lead to 
underestimations, particularly of inequality when SES is the exposure of interest (Howe et 
al., 2013). However, in GMS, as more affluent families were initially underrepresented, this 
has led to a sample that is more now more representative of the region. There were missing 
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data for some exposures, notably for RWG, however this supports the utility of a biomarker 
when early life data are not available. 
As cohorts situated in the North East of England, GMS and NTFS may not be representative 
of the rest of the UK. However, key findings were replicated using ALSPAC data (South West 
England). Furthermore, in NTFS the inclusion of study members who had moved away 
increased representativeness of the original cohort (shown for all early life factors bar 
gender (Lamont et al., 2000)).  
Generalisability of these findings to other populations is limited by the predominantly white 
ethnicity of study members, and risk factors for other ethnic minorities may differ. However, 
research from the more diverse Born in Bradford birth cohort did not find strong evidence 
that risk factors for childhood obesity varied by ethnicity (Fairley et al., 2015b), and an Asian 
cohort also found similar risk for RWG (Aris et al., 2017). Other factors that may limit 
generalisability are inter-individual variation, transgenerational effects and genetic factors.  
Due to the long-term nature of the Thousand Families cohort, findings may not be entirely 
generalisable to present-day populations. The influence of time-period effects cannot be 
overlooked, as the early years of NTFS study members will have been very different (section 
5.5), even to adults age 50 today. However, despite these differences and the lesser impact 
of environmental factors, some early life exposures and lifestyle factors predicted adult body 
composition. 
Adiposity is a complex trait and may not adequately captured by a single measurement, 
therefore multiple outcomes were analysed. Although a proxy measure, BMI was the only 
measure consistent across all of the cohorts in childhood. While there is a strong correlation 
between BMIz and fat mass, this alone is not enough to make inferences about individuals. 
For example, exercise can lead to reductions in fat mass and increases in lean mass (Prentice 
and Jebb, 2001), however if weight remains the same, BMIz will also stay the same. It could 
be argued that estimates obtained when using BF%, a direct measure of adiposity that is 
independent of bone mass, would more reliably depict adiposity. A study in GMS found that 
FMI was a more sensitive measure than BMI (Basterfield et al., 2012a), and proxy measures 
of adiposity were inferior (Basterfield et al., 2012b). In NTFS and GMS there was a high 
correlation between BMI and BF%/FMI, suggesting that BMI is a good proxy measure of 
body fat in these populations.  
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Risk factors for BMI were also risk factors for measures of body fat and waist obesity, which 
may imply that additional measures have little added value. Generally, there were more risk 
factors associated with BMI, which may suggest some risk factors may be related to total 
(both fat and lean) mass. However, due to the different cardiovascular consequences 
associated with waist obesity, and the consistent associations for birthweight and waist 
obesity (in both NTFS men and GMS children), there is definite value in this measure, and 
findings were in agreement with the DOHaD hypothesis (Barker, 1995). Furthermore, only 
analysing BMI misses those with normal weight but waist OB, who are at risk of higher 
mortality (Cerhan et al., 2014, Sun et al., 2019) 
The validity of the 0.5 threshold for WHtR to identify cardiometabolic risk in children has 
been questioned (Hara et al., 2002, Yan et al., 2007). Although values vary by ethnicity, 
generally estimates are around the 0.5 value for children from: South Africa (Matsha et al., 
2013), Australia (Nambiar et al., 2010) and the UK (McCarthy and Ashwell, 2006), and 
therefore this probably was an appropriate cut-off in this study. Tybor et al. (2008) found 
that there was a residual correlation between WHtR and height in children during periods of 
growth; therefore, it is possible that WHtR does not completely control for the effect of 
height and the effect sizes for WHtR here are underestimations. On the other hand, 
adjusting indices to be independent of height does not appreciate that taller children are 
fatter than their shorter peers (Metcalf et al., 2011), and that there is cross-over in genetic 
variants related to weight and height (Elks et al., 2010a). 
The UK90 reference was consistently used to normalise BMI in all the cohorts, as prevalence 
of obesity should be relative to reference data at a fixed time point (Prentice, 1998). 
Although NTFS children were born before the reference, it is the most appropriate growth 
reference for these analyses. An alternative is the UK-WHO growth charts (Cole et al., 2011), 
which have been found to classify more children as obese, and could lead to 
misinterpretation of risk (Johnson et al., 2012). When growth in ALSPAC and GMS were 
compared to the WHO standard, more were classified as overweight in the pre-school years, 
and as it uses a breastfed child as a model for growth, may not be appropriate for a UK 
population (Wright et al., 2008a). The GMS and ALSPAC cohorts have been shown to be 
similar to the UK90 reference, with very similar weights and heights at times of overlap in 
childhood (Wright et al., 2008a).  
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Findings from this cohort support that when investigating early life risk factors of childhood 
obesity, BMI or categorical OWOB are adequate measures, but studies might be enhanced 
by the inclusion of a body fatness outcome measure (e.g. FMI) when examining SES.  
8.5 Conclusion 
In summary, this study provides evidence for early life weight gain as an important risk 
factor for multiple measures of childhood body composition, consistent across all three 
cohorts (time periods and regions). Some of these effects may be a consequence of lower 
birthweight, which can be influenced by many factors. The associations for rapid growth did 
not persist into adulthood and may represent a more important factor for childhood BMI 
and on the pathway to adult BMI.  
Since early life, lifestyle and socioeconomic factors have emerged as important factors in the 
development of obesity, multi-component interventions have emerged (Lanigan, 2018). The 
path models support that a multi-component intervention may be the best approach and 
demonstrate the complexity and interrelated nature of risk factors (Figure 3.3, Figure 4.2).  
8.6 Summary of the epigenetic findings 
This study used a discovery cohort (ALSPAC) to determine loci associated with early life 
exposures, and a validation cohort (NTFS) to verify methylation. Robust associations were 
found for RWG and childhood and adult methylation, but for no other exposures. As 
described in the literature review (section 1.5.3), so far, only a handful of differentially 
methylated positions have been identified for early life risk factors of obesity. This study 
used stringent criteria and adjustment methods to identify specific CpG sites meaning that 
perhaps only the most robust associations were identified.  
There were missing data for exposures, and smaller sample sizes reduce the likelihood of 
finding a statistically significant result, especially when the changes in methylation exhibited 
are small. Large differences in methylation are often found in cancer, but generally, small 
effect sizes (2-10%) are common when examining environmental influences (Breton et al., 
2017). Both the sample size and effect sizes were small for RWG, which could support that 
this CpG is robustly associated, although there is always the possibility that the finding was a 
false positive.   
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Replication by an independent technique and dataset were used to examine methylation in 
adults. Although the direction of the association was different between the cohorts, the 
association was still significant. The findings may suggest that methylation is dynamic, has 
specific cohort or age effects, or that disparities are due to sample or phenotype differences.  
8.6.1 Persistence of methylation over time 
It is interesting that RWG was positively associated with DNA methylation in childhood at the 
specific loci identified, but was negatively associated with methylation in adults1. A similar 
phenomenon was seen in a paper by (Richmond et al., 2015) examining maternal smoking 
and offspring methylation. This ‘recovery’ of methylation could represent the adaptability of 
methylation to environmental cues. However, as there were no longitudinal data available 
(in the same individuals) it is unsure whether DNAm was also negatively associated in NTFS 
adults. 
Simpkin et al. (2015) noted that lower birthweights and shorter gestational age were 
associated with a phase of rapid ‘catch-up’ in methylation differences. As RWG includes 
some of the impact of catch up growth from lower birthweights, this could be the case in 
ALSPAC, where catch-up growth (RWG) is mirrored by a ‘catch-up’ in methylation. Whilst the 
opposite, ‘catch-down methylation’, could be reflective of slowed growth and the 
normalisation of BMI over time in NTFS adults. Taken together, one hypothesis could be that 
methylation at this locus represents growth more generally; increases in methylation in 
response to growth, but relative decreases later in order to return to ‘normal’ methylation.  
In terms of changes in methylation over the life course, this study identified that in ALSPAC, 
those who had RWG (ALSPAC) have higher levels of methylation in childhood (age 7), but 
then methylation decreases slightly in adolescence (age 17). If considering age 17 as adults, 
similar overall trends were observed in NTFS adults (age 50), in that those who had RWG 
                                                     
 
1 It is granted that beta (β) values from the Infinium, and percentage methylation from 
pyrosequencing may not be interchangeable, therefore when comparing the two datasets 
the descriptions were focused on the size (small/large) and direction (increases/decreases) 
of change in methylation, in relation to the exposure.  
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have lower methylation levels compared to those who did not have RWG (Figure 8.1). This 
could suggest that the hypermethylation in those with RWG at age 7 may be ‘corrected’ over 
time from childhood to adolescence to middle age. Again, one could speculate that this 
could reflect growth patterns, as the majority of childhood growth will have happened by 
age 17.  
These specific epigenetic changes detected in childhood might have downstream effects 
throughout childhood and adolescence rather than persistence across the life course, 
however currently there are a limited number of studies examining the variation and 
stability of methylation changes over the life course (Richmond et al., 2014, Simpkin et al., 
2015). As there were no longitudinal methylation measurements, the patterns of 
methylation cannot be discerned in NTFS. There is also the possibility that other lifestyle 
factors, or pleiotropy (where one gene affects multiple characteristics) could influence 
DNAm at this locus. 
 
Figure 8.1 Summary of DNAm by RWG in ALSPAC AND NTFS. 
Median DNAm (%) at ages 7 and 17 (ALSPAC) and age 50 (NTFS). 
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8.7 Strengths and Limitations of the epigenetic analysis 
There are a number of strengths and limitations of the epigenetic analysis. These relate to 
sample representativeness, statistical power, cell heterogeneity, EWAS methodology, and 
specific limitations of the technologies and comparing methylation values across studies. 
8.7.1 Sample representativeness  
The ARIES sub-sample are more affluent than those not included (Alspac Study Team, 2001, 
Relton et al., 2015), and therefore there if mechanistic pathways in which SES impacts on 
DNAm exist this could introduce bias. However, the NTFS validation cohort was also biased 
in the same direction. 
Some of the analyses will have been underpowered, it would be worth using other large 
cohorts with larger sample sizes, such as the PACE consortium, although despite the small 
sample size robust associations were still identified.  
8.7.2 Cell types and tissue specificity 
There is variability in methylation across cell types and the possibility for tissue specific 
methylation effects. Many studies have utilised blood DNAm in relation to obesity (van Dijk 
et al., 2015, Wahl et al., 2017), which is reflective of changes in other tissues (Dick et al., 
2014). As biopsies from relevant tissues (such as adipose tissue) are more difficult to obtain, 
surrogate tissues (i.e. peripheral blood) are often used. However, for the determination of a 
biomarker, a surrogate, accessible tissue such as blood is ideal for diagnostic purposes and 
for use in a clinical setting.  
Furthermore, blood may be a physiologically relevant tissue due to the close contact with all 
cells, tissues and organs, and therefore reflects the interactions of changes at the molecular 
level via internal (hormones) and external (such as nutrients or drug interactions) stimuli. 
This idea was proposed by Liew et al. and is referred to as the “Sentinel Principle”, whereby 
blood cells respond to changes occurring in the micro- and macro-environments in the 
body’s systems, therefore are acting as “sentinels” (Liew et al., 2006).  
8.7.3 EWAS methodology 
The EWAS serves as a starting point to identify potentially important candidate sites which 
can be the focus of further investigation, however this is essentially a ‘needle in a haystack’ 
approach. Methylation levels at time of measurement can only provide a snapshot, not how 
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methylation changes over the life course (without multiple measurements). Generally 
speaking, bar the limitations imposed by the technology (i.e. the CpG loci selected for the 
array), the EWAS approach is an unbiased method to identify novel CpG loci associated with 
exposures. An unbiased alternative is whole genome sequencing, however currently this 
technology is costly. Another approach could have been to use candidate genes associated 
with exposures from the literature, however there are no DNAm biomarkers associated with 
RWG and hence this would not have been feasible for all exposures. A limitation of the 
methodology employed here was using significance over effect size, i.e. using p values which 
do not consider the magnitude of the CpG-trait association. However, this is a trade off, and 
all associations with an FDR p value<0.1 were considered, and any less stringent criteria 
could increase the likelihood of false positive findings.  
 
8.7.4 Differences in methods of measuring DNA methylation 
The range of methylation values observed were vastly different when comparing values from 
pyrosequencing and the 450K array. Current methods to quantify DNAm are not always 
directly comparable, and the results presented here reflect fundamental difficulties with 
DNAm analyses. Even when comparing β values at the same CpG site and from the same 
platform (450K) from different studies (B-PROOF, BSGS), a wide range of DNAm values were 
observed (section 2.5.11), which may be due different normalisation methods. Others have 
observed that even when data are normalised using the same methods, there is 
disagreement in methylation values between the 450K and EPIC array platforms, and many 
(55%) sites exhibit low correlation due to low variability in methylation (Logue et al., 2017). 
They found that CpGs with a low range, had low correlation (r<0.2) across the arrays. 
Examining their data, cg11531579 was a locus with a low range, which could be because the 
ratio of the true variability relative to the measurement error is low. 
The normalisation procedures utilised by these studies may in part explain some of the 
different methylation levels obtained in this study. Different normalisation procedures are a 
known source of heterogeneity in DNAm studies, particularly when changes observed are 
small or less significant (Wu et al., 2014a). The ALSPAC methylation levels were much lower 
than some of the NTFS samples. It is probable that if such high levels of methylation existed 
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in the 450K data, those points may be filtered out and removed as noise prior to statistical 
analysis (as per normalisation techniques), although they could be valid data points.  
Differences could also arise from the technology utilised. Overall, there is good concordance 
between 450K and pyrosequencing data (Roessler et al., 2012). However, several validation 
studies show that β values are not equal to % methylation (e.g. 0.1 =10%) for the majority of 
loci examined, and although there is a trend of high and low between those data sets, 
differences between 450K assay values and sequencing values can vary wildly (Bibikova et 
al., 2011, Roessler et al., 2012). Roessler et al. (2012) similarly noted that in a cross 
validation study of the 450K array and whole-genome bisulfite sequencing (Bibikova et al., 
2011), many measurements differed by 30-40%. As an unprocessed method that directly 
measures methylation, pyrosequencing may more closely reflect the true value. 
Furthermore, the use of bisulfite pyrosequencing for region-specific DNAm analysis is 
considered the gold standard. 
Common SNPs could result in discrepancies between pyrosequencing and the 450k array, 
and the ‘high methylation’ samples could have underlying genetic differences. SNPs can 
account for 22-80% of the variability in DNAm between individuals (Birney et al., 2016). 
Further investigation of the region of interest using Sanger sequencing (section 7.4.9.2), 
indicated SNPs may be influencing methylation, perhaps in a phenotypic fashion (consistent 
patterns observed for RWG and high BMI). However, the effects of proximal or distal SNPs 
cannot be discerned using this small sample, but could be the focus of future work. There 
may still be purpose in biomarkers that can capturing both genetic and environmental 
influences on DNAm. 
Additionally, for all methods, the influence of sampling, storage and processing on the 
methylation measures must be considered, as the variation due to these measures may well 
exceed the signal level. 
8.7.5 The direction of the associations between DNAm and BMI 
A recognised limitation is that many EWAS’s are unable to distinguish causal or 
consequential epigenetic changes in the disease process (Baylin and Bestor, 2002, Bell et al., 
2010). There is the potential for reverse causation, in that BMI alters methylation rather 
than vice versa (Wahl et al., 2017). Although childhood methylation was higher in ALSPAC 
participants who were OWOB in adolescence, these individuals could also have had a higher 
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BMI at age 7. When examining childhood methylation by phenotype and age (Figure ), higher 
methylation levels were evident in those who had RWG, and then were OWOB in either 
childhood or adolescence, but also in those who were healthy weight in childhood and then 
OWOB in adolescence. This does not rule out reverse causality entirely, but suggests that 
regardless of childhood body size, if an individual had RWG and is then subsequently OWOB 
in adolescence their methylation was higher in childhood than someone of normal weight, 
supporting this locus as a predictive biomarker. The aim of the analysis was to determine 
biomarkers rather than causal DNAm changes. However, there are genotype data available 
for ALSPAC, and therefore causal inference methods such as Mendelian Randomization 
could be used to determine if changes were causal, if valid instrumental variables for RWG 
exist.   
8.8 Remaining questions and future directions 
These findings amongst others provide further evidence of the clinical importance of a fine 
balance between adequate weight gain to support neurodevelopment and ensuring infants 
with lower birthweights experience ‘healthy’ catch-up growth. Future developments could 
be to have closer monitoring of infant weight gain and personalised advice by health care 
professionals, to ensure weight gain is within accepted healthy limits for a given birthweight. 
In epidemiological studies, if the disease risk decreases following an intervention or removal 
of the exposure, this provides strong support for causal inference. There is limited capacity 
to assess causality in studies of early life exposures through randomised controlled trials, 
partly due to ethical issues of potentially causing harm. Instead, to further investigate 
causality, an intervention study or natural experiment could be used. When analysing the 
BMI trajectories in the two cohorts (chapter 4), it was the cohort exposed to an obesogenic 
environment in combination with RWG that had the most detrimental phenotype. 
Therefore, an intervention would need to alter the environment of those who had RWG 
(potentially through a diet or physical activity intervention, or perhaps in a rural population 
with reduced exposure to an obesogenic environment), or prevent the initial RWG. 
There have been limited studies aimed at preventing RWG through interventions. Gungor et 
al. (2010) found that 1/3 of at-risk (those who had RWG) infants go on to become 
overweight children, whilst the 2/3 that do not: had parents that were more educated, had 
lower weight gain between 18-24 months, were exclusively breastfed for longer and had a 
later introduction of solid foods. Therefore interventions could focus on modifying these 
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factors. An intervention focusing on feeding alone, which utilised a theory-based behavioural 
intervention in formula milk-fed infants to promote responsive feeding, did not reduce the 
prevalence of RWG (Moorcroft et al., 2011). However, a multi-component intervention by 
Savage et al (2016) was more successful and therefore may be an effective strategy. The 
intervention was implemented via posted educational materials on infant feeding, sleep 
hygiene, active social play, emotional regulation and recording growth and involved 
numerous visits by research nurses between 3 and 48 weeks (Savage et al., 2016). Fewer 
than 6% of infants in the intervention group were overweight at age 1 year compared with 
13% of control group infants, which is a relatively low prevalence (controls) compared to 
other studies (Zheng et al., 2018) therefore it would be interesting to see if these results 
extrapolate to populations with higher prevalence of RWG. If this critical period has passed 
and infancy weight is not monitored then there is utility for a biomarker of RWG to identify 
those at later risk.  
 
An individual’s current BMI alone will always be very predictive of future BMI, however 
DNAm could improve model prediction along with other known factors such as SNPs and 
environmental factors. For example, in older individuals from two European cohorts, 
methylation profiles explained 3.6 to 4.9% of the variation in BMI (Shah et al., 2015). 
Genome-wide association studies have found over 30 SNPs associated with BMI, which 
explain around 1.5% of the inter-individual variation in BMI when combined (Speliotes et al., 
2010). The minor allele of FTO which is associated with obesity-related traits is associated 
with 1.2 fold risk of obesity and to 0·39 kg/m2 increases in BMI (Loos and Yeo, 2014). 
Therefore, as the effect sizes for individual CpG loci are much larger than effect sizes for 
individual SNPs, even from relatively small studies, there may be scope in future for larger 
studies to identify predictive changes in DNAm.  
 
Our ability to identify methylation biomarkers will likely improve as the arrays increase in 
size and as more sophisticated bioinformatics methods are developed. The methylation 
differences identified were small, if biomarkers are to be useful then assays need to be able 
to detect these small differences accurately, which will likely become more commonplace 
with technological advancements. The investigation of methylation in this region was limited 
to a short region for pyrosequencing, however as whole genome sequencing becomes less 
expensive there will be future opportunities to examine larger regions.  
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These results suggest that the relationship between RWG and DNAm may change over the 
life course, or that it might be different in different cohorts or populations. Validation is 
required to determine if CpG loci are consistently differentially methylated in different 
populations, time points, ages and disease-states. The focus of future work could be to 
analyse DNAm at the locus of interest using pyrosequencing in a younger population. This 
was the original intent; however, the age 6-8 GMS DNA samples could not be traced. As 
there have been no other EWAS on RWG to date it was not possible to replicate the DNAm 
results. Additionally, if looking for causal epigenetic changes, gene expression and 
functionality will also need to be assessed.  
8.9 Overall conclusions 
Using two regional birth cohorts born 50 years apart, factors influencing obesity and how 
these have changed over time were investigated in the region with the highest rates of 
obesity in England (Health and Social Care Information Centre, 2014). The important finding 
from this study is that rapid infancy weight gain conditional on birthweight or not, was 
associated with increased childhood BMI. There is the potential for development of a CpG 
biomarker of RWG, which could be of use when early life data are not available in order to 
identify high-risk individuals for preventative intervention. However, whether this biomarker 
would be a useful predictor of future adiposity, or if methylation marks persist is unsure, and 
needs to be investigated in a younger population where a predictive biomarker of 
subsequent OWOB would be useful.  
The life course path analysis approach allowed examination of the effects of exposures on 
prospective outcomes, and the results provide important insights into the multi-dimensional 
aetiology of obesity. Taken together, these results suggest that the combination of 
environmental insults at a critical developmental periods, combined with a multi-faceted, 
high-risk environment increases adiposity in childhood, which may track in adulthood. 
Understanding of the interactions and pathways between exposures and socioeconomic 
factors could be used to develop a risk-score for intervention purposes. 
This work highlights the dynamic nature of methylation and contributes to the literature on 
life course changes in methylation in relation to early life exposures. This study provides a 
proof of concept and establishes a motive for further research to identify novel biomarkers 
of early life rapid weight gain in longitudinal studies. 
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Directed Acyclic Graph (DAG) of the hypothesised relationships from the literature review 
 
Figure I The hypothesised pathways between exposures, covariates and obesity outcomes across the lifecourse 
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Energy intake data for NTFS participants (age 50) 
Overall, there was a small negative correlation (r=~-0.1) between daily energy intake and 
BMI. When stratified by sex there was no relationship for males, and a negative correlation 
between energy intake and BMI in females (Figure II).  
 
Figure II Scatter plot showing the relationship between BMI and energy intake in males and females.  
Correlation in males, r=0.02, p=0.8; females, r=-0.18, p=0.01.  
 
In women, mean energy intake decreased as weight category progressed from healthy 
weight to overweight to obese. Mean energy intake in overweight men was lower compared 
to healthy weight men (Table I). These results state that those who are overweight or obese 
on average have a lower calorie intake according to FFQ data. This may be due to the cross-
sectional nature of the data, which could suggest that those with the highest BMI or BF% are 
on weight loss diets. Underreporting has also been noted in smokers (Johansson et al., 








N Mean EI SD N Mean EI SD 
Healthy 54 2319 801 103 1947 543 
Overweight 84 2100 626 68 1921 586 
Obese 31 2346 708 46 1789 563 
Standard deviation (SD) and group size (N) 
 
In order to investigate further, basal metabolic rate (BMR) was calculated using the Harris 
Benedict equation (Harris and Benedict, 1918) which takes into account height, weight, sex 
and age, revised by Mifflin (1990). 
 
Total daily energy expenditure (TDEE) was calculated using the physical activity data 
according to the calculation factors in Table II.  
Table II Calculation factor for varying levels of physical activity 
Little to no exercise Daily kilocalories needed = BMR x 1.2 
Light exercise  Daily kilocalories needed = BMR x 1.375 
Moderate exercise  Daily kilocalories needed = BMR x 1.55 
Heavy exercise  Daily kilocalories needed = BMR x 1.725 
 
Using these equations, TDEE was determined and the difference between this value and the 
value calculated from the food intake data was calculated. Negative values indicate a calorie 
deficit (i.e. more calories expended than ingested) and positive values an energy surplus 
(more energy ingested than expended). These results show that those with the highest BMI 
report an energy deficit (Figure III). Similar results were seen for BF% (Figure IV) and WHR 
 
𝐹𝑜𝑟 𝑚𝑒𝑛, 
𝐵𝑀𝑅 =  9.99  x  weight (kg) +  6.25 x height (cm) −  4.92 x age (years)  +  5 
 
𝐹𝑜𝑟 𝑤𝑜𝑚𝑒𝑛, 
𝐵𝑀𝑅 =   9.99  x  weight(kg)  +  6.25 x height (cm) −  4.92 x age (years)  −  161 
 
Equation I BMR equations for men and women revised by (Mifflin et al., 1990) 
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(Figure V). For each outcome there was a negative correlation in females, which is moderate 
and significant for BMI, with a weak negative correlation and borderline significant for BF% 
and WHR. Relationships between the difference in energy intake and anthropometric 
outcomes were less prominent for males.  
 
Figure III Scatter plot of the relationship between BMI and differences in energy intake. 
Scatter plot with linear fit showing the relationship between BMI and the differences in energy intake (reported calorie 
intake-TDEE) in males and females. Correlation in males, r=-0.14, p=0.07; females, r=-0.35, p<0.001. 
 
Figure IV Scatter plot of the relationship between BF% and difference in energy intake.  
Scatter plot with linear fit showing the relationship between BF% and the differences in energy intake (reported calorie 




Figure V Scatter plot of the relationship between WHR and difference in energy intake.  
Scatter plot with linear fit showing the relationship between WHR and the differences in energy intake (reported calorie 
intake-TDEE) in males and females. Correlation in males, r=-0.01, p=0.8; females, r=-0.11, p=0.1. 
 
These differences could have been due to those with higher body weights endeavouring to 
reduce their calorie intake. Many studies report that that overweight and obesity are factors 
in underreporting of energy intake (Johnson et al., 1998, Johansson et al., 2001). Additionally 
there is evidence that underreporting is more likely in women (Pikholz et al., 2004). 
Reversing the calculations in Table II (using energy intake divided by BMR as an estimate of 
physical activity level) gives values ranging from 0.42 to 3.92 for study participants. Taking a 
physical activity level (PAL) value of 1.2 to indicate bed-bound and a value of 2.4 as 
strenuous activity, values that fall outside of this range would be outliers. Removing these 
observations would lead to the exclusion of 135 study members from analyses.  
On this basis of these issues with the data, the energy intake data were not used in these 
analyses. Firstly, it would give biased estimates if the variables were inaccurately measured, 
and secondly the direction of the association (between energy intake and body weight) 
cannot be discerned with these cross-sectional data and endogeneity bias. As energy intake 
was not analysed in NTFS, for coherence this was also not analysed in GMS.  
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Figure VI Correlations between explanatory variables in NTFS 
Appendix B 







































































































































































0.08 0.08 -0.17 1.00
0.008 0.009 <0.001
RWG 0.00 -0.14 0.11 -0.36 1.00
0.969 0.010 0.031 <0.001
RT 0.07 -0.08 0.07 0.00 0.67 1.00
0.164 0.127 0.185 0.982 <0.001
0.03 0.04 -0.03 0.11 -0.29 -0.24 1.00
0.528 0.388 0.603 0.022 <0.001 0.002
0.06 -0.05 -0.04 0.08 -0.20 -0.22 0.66 1.00
0.214 0.318 0.418 0.092 0.006 0.004 <0.001
Wean age 0.03 0.07 -0.09 -0.05 0.05 0.03 -0.05 0.10 1.00
0.588 0.162 0.076 0.349 0.550 0.679 0.336 0.034
-0.04 0.05 0.00 0.00 -0.01 -0.06 -0.12 -0.09 -0.02 1.00
0.256 0.166 0.912 0.926 0.854 0.342 0.026 0.103 0.665
-0.02 0.04 0.00 -0.01 -0.07 -0.05 -0.08 -0.08 0.01 0.02 1.00
0.596 0.306 0.891 0.877 0.271 0.427 0.152 0.151 0.864 0.513
-0.06 0.01 0.06 0.03 -0.12 -0.08 -0.12 -0.17 -0.03 0.29 0.23 1.00
0.077 0.688 0.057 0.413 0.023 0.111 0.013 0.001 0.551 <0.001 <0.001
Adversity 0.04 -0.01 0.02 -0.09 -0.05 0.02 -0.01 -0.10 0.12 -0.01 0.08 0.10 1.00
0.495 0.839 0.740 0.076 0.584 0.807 0.867 0.223 0.165 0.926 0.191 0.067
0.00 -0.08 0.04 -0.01 -0.11 -0.12 0.02 -0.01 -0.13 0.06 0.02 0.08 0.07 1.00
0.951 0.015 0.169 0.690 0.035 0.028 0.631 0.909 0.009 0.117 0.542 0.012 0.172
-0.02 0.08 0.04 0.02 0.03 0.06 0.07 0.04 0.09 -0.07 -0.03 -0.10 -0.14 -0.31 1.00
0.605 0.009 0.280 0.522 0.602 0.268 0.188 0.434 0.077 0.049 0.385 0.004 0.011 <0.001
0.00 -0.03 -0.02 0.06 -0.03 0.08 0.05 0.03 0.06 -0.04 0.05 -0.05 -0.06 -0.19 0.32 1.00
0.938 0.564 0.664 0.180 0.613 0.218 0.351 0.591 0.215 0.395 0.306 0.263 0.452 <0.001 <0.001
-0.21 -0.01 0.04 0.03 0.00 0.03 0.15 0.12 -0.02 -0.11 -0.08 -0.09 -0.16 -0.20 0.35 0.42 1.00
<0.001 0.823 0.347 0.427 0.989 0.614 0.003 0.017 0.744 0.026 0.115 0.053 0.028 <0.001 <0.001 <0.001
-0.01 0.03 -0.02 0.01 -0.10 -0.04 0.00 -0.01 0.02 -0.10 0.03 -0.06 -0.15 -0.09 0.12 0.24 0.20 1.00
0.846 0.532 0.680 0.889 0.224 0.642 0.944 0.810 0.746 0.080 0.580 0.209 0.078 0.068 0.024 <0.001 <0.001
-0.18 0.06 0.03 0.01 0.08 -0.03 0.02 0.00 -0.09 0.00 0.01 0.00 -0.01 -0.02 0.01 -0.11 0.01 -0.02 1.00
<0.001 0.140 0.481 0.810 0.229 0.615 0.671 0.967 0.086 0.963 0.872 0.919 0.863 0.640 0.738 0.015 0.782 0.769
0.05 0.02 0.07 -0.03 0.10 0.04 -0.01 0.03 -0.06 -0.03 0.03 0.00 0.14 0.13 -0.19 -0.22 -0.25 -0.26 0.02 1.00
0.206 0.623 0.104 0.548 0.124 0.526 0.858 0.595 0.274 0.546 0.513 0.950 0.053 0.003 <0.001 <0.001 <0.001 <0.001 0.731
-0.02 -0.05 0.00 -0.04 -0.01 0.06 0.04 0.00 -0.07 0.01 0.00 0.04 -0.09 -0.02 -0.03 0.09 -0.07 0.08 -0.06 -0.17 1.00



































Figure VII Distribution of continuous outcome measures (from top: BMI, BF%, WHR) stratified by sex. 
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Social mobility (birth to age 50) and body composition (age 50) in NTFS 
Table III Linear (BMI) and logistic (OB) regression models for social mobility from birth to age 50 in NTFS 
    BMI    Obesity  
  n % Coef CI p  OR CI p 
Always  
least advantaged 24 7.0 Ref  .  Ref  . 
Least--> 
 mid 43 12.5 -0.15 [-2.34,2.04] 0.892  0.68 [0.24,1.90] 0.457 
Least-->   
most advantaged 40 11.6 -1.26 [-3.48,0.96] 0.265  0.20 [0.06,0.69] 0.011 
Always mid 77 22.4 -2.55 [-4.56,-0.54] 0.013  0.10 [0.05,0.48] 0.001 
Mid-->  
most advantaged  128 37.2 -1.19 [-3.10,0.72] 0.223  0.36 [0.14,0.89] 0.028 
Always 
most advantaged  32 9.3 -2.12 [-4.44,0.20] 0.073  0.09 [0.02,0.48] 0.005 
n 344   344    344   
Adjusted R2     0.021    0.063   
 Coefficients (coef) and odds ratios (OR) are presented with 95% confidence intervals (CI) and the 




Socioeconomic differences in breastfeeding in NTFS 
In the UK, socioeconomic differences in breastfeeding are often described. In NTFS, the most 
advantaged group had higher median values for duration breastfeeding, exclusive 
breastfeeding and introduction of solids compared to lower groups however these 
differences were not significant (Figure VIII).  
 
 Least advantaged  Middle  Most advantaged 
Statistics p25 p50 p75  p25 p50 p75  p25 p50 p75 
Duration breastfed 12.5 74 163  21 83 237  17.5 137 257 
Exclusively breastfed 20 42 126  16 42 120  15 91 140 
Solid foods 126 153 181  135 153 183  140 159 210 
Figure VIII Box plot of infant feeding by SES at birth in NTFS study members. 
Table of values (rounded) for lower quartile (p25), median (p50) and upper quartile (p75).  
There were no significant differences in infant feeding by occupational social class (Kruskal-Wallis equality-of-populations 






Weight categories and qualifications in NTFS (age 50) 
 
 
Figure IX Proportion of weight categories by education level achieved at age 50 in NTFS study members. 
A large proportion of those without qualifications had obesity, whereas those educated to degree level had the lowest 
proportion with obesity. However around half of those with A level qualifications and degrees were overweight (Figure IX). 




Models for bivariate associations in NTFS for weight outcomes (age 50) 
Table IV Bivariate linear associations between exposures and BF%, stratified by sex, in NTFS study members (age 50) 
  Males  Females 
  coef CI p  coef CI p 




-0.52 [-1.67,0.63] 0.37  -0.23 [-1.31,0.86] 0.68 
Gestation (weeks) 0.48 [-0.84,1.80] 0.48  0.08 [-1.02,1.18] 0.89 
Maternal 
age 
Continuous  -0.09 [-0.28,0.10] 0.34  -0.12 [-0.32,0.07] 0.22 
<25 -0.88 [-3.39,1.63] 0.49  0.57 [-2.21,3.35] 0.69 
25-34 Ref  . 
 Ref  . 
35+ -2.23 [-5.12,0.66] 0.13  -2.83 [-6.08,0.42] 0.09 
Infant 
feeding 
Never breastfed Ref  . 
 Ref  . 
<4 weeks 0.88 [-4.03,5.78] 0.73  -1.39 [-6.77,4.00] 0.61 
4 wk – 6 months 1.05 [-3.25,5.36] 0.63  -0.09 [-4.30,4.12] 0.97 
6 Months + 0.38 [-3.69,4.45] 0.85  2.78 [-1.24,6.80] 0.18 
Breastfed (days) 0.01 [-0.00,0.02] 0.27  0.01 [0.00,0.03] 0.03 
Exclusive (days) 0.00 [-0.02,0.02] 0.96  0.03 [0.00,0.05] 0.02 
Weaning age 
(days) 
0.00 [-0.02,0.03] 0.78  0.00 [-0.03,0.03] 0.92 
Early life 
Rapid weight gain -0.34 [-3.99,3.31] 0.85  1.99 [1.90,5.88] 0.317 
Any infection 1.26 [-0.86,3.39] 0.24  1.84 [-0.59,4.27] 0.14 
Number of 
infections 
0.40 [-0.48,1.27] 0.37  0.22 [-0.93,1.36] 0.71 
Bacterial infection 0.29 [-2.67,3.26] 0.85  4.48 [0.70,8.27] 0.02 
Viral infection -1.53 [-4.10,1.03] 0.24  1.47 [-1.56,4.49] 0.34 
SES  
(childhood) 
Least advantaged Ref  . 
 Ref  . 
Mid -2.56 [-4.97,-0.14] 0.04  -1.09 [-3.89,1.71] 0.45 
Most advantaged -4.24 [-7.78,-0.70] 0.02  -1.61 [-6.26,3.04] 0.50 
Housing score 0.53 [-0.46,1.53] 0.30  0.43 [-0.68,1.54] 0.45 
Overcrowding 1.04 [-1.30,3.37] 0.39  2.25 [-0.40,4.91] 0.10 
Adversity Any adverse event 1.04 [-3.93,6.01] 0.68  -0.45 [-5.85,4.95] 0.87 
SES  
(later life) 
Social class  Ref  . 
 Ref  . 
Mid 1.78 [-1.80,5.36] 0.33  -0.61 [-4.47,3.26] 0.76 
Most advantaged 3.82 [0.33,7.31] 0.03  -2.28 [-5.88,1.31] 0.21 
Educated 3.25 [1.10,5.39] <0.001  -0.87 [-3.70,1.95] 0.55 
No qualifications Ref  . 
 Ref  . 
GCSE/O-level -0.78 [-3.55,1.98] 0.58  -1.93 [-4.72,0.86] 0.18 
A level 2.82 [-0.14,5.77] 0.06  -0.25 [-4.03,3.52] 0.90 
Degree 2.81 [-0.55,6.18] 0.10  -3.81 [-7.98,0.37] 0.07 
Income   1.17 [0.12,2.23] 0.03  -1.12 [-2.33,0.10] 0.07 
Married 3.60 [0.85,6.35] 0.01  1.78 [-1.10,4.66] 0.23 
Lifestyle 
Inactive Ref  . 
 Ref  . 
Light activity -0.91 [-5.00,3.18] 0.66  -3.13 [-6.82,0.57] 0.10 
Moderate activity -1.48 [-5.95,2.98] 0.52  -4.36 [-8.40,-0.31] 0.04 
Heavy activity -1.72 [-6.38,2.94] 0.47  -6.53 [-10.91,-2.15] <0.001 
Smoker -4.02 [-6.40,-1.65] <0.001  0.05 [-2.62,2.71] 0.97 
Coefficients (coef) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p); Ref, 




Table V Bivariate linear associations between risk factors and WHR in NTFS males and females (age 50) 
  Males  Females 
  coef CI p  coef CI p 
Early life 
Birthweight (z-score) -0.01 [-0.02,-0.00] 0.045  0.00 [-0.01,0.01] 0.91 
Gestation (weeks) 0.00 [-0.01,0.01] 0.93   0.00 [-0.01,0.01] 0.93 
Maternal age 
Continuous  0.00 [-0.00,0.00] 0.14   0.00 [-0.00,0.00] 0.48 
<25 0.02 [-0.00,0.04] 0.12  0.01 [-0.01,0.02] 0.52 
25-34 Ref  .  Ref  . 
35+ 0.00 [-0.02,0.02] 0.99  0.00 [-0.02,0.02] 0.95 
Infant feeding 
Never breastfed Ref  .   Ref  . 
<4 weeks 0.01 [-0.03,0.04] 0.67   0.03 [-0.01,0.06] 0.14 
4 wk – 6 months 0.02 [-0.01,0.05] 0.26   -0.01 [-0.04,0.02] 0.61 
6 Months + 0.00 [-0.03,0.03] 0.87   0.00 [-0.02,0.03] 0.84 
Breastfed (days) 0.00 [-0.00,0.00] 0.96  0.00 [-0.00,0.00] 0.80 
Exclusive (days) 0.00 [-0.00,0.00] 0.11   0.00 [-0.00,0.00] 0.51 
Weaning age (days) 0.00 [-0.00,0.00] 0.22  -0.00 [-0.00,0.00] 0.09 
Early life 
Rapid weight gain -0.02 [-0.05,0.01] 0.14   0.00 [-0.02,0.02] 0.96 
Any infection 0.00 [-0.01,0.02] 0.73  0.01 [-0.00,0.03] 0.07 
Number of infections 0.00 [-0.01,0.01] 0.63   0.00 [-0.00,0.01] 0.20 
Bacterial infection 0.01 [-0.02,0.03] 0.53  0.02 [-0.01,0.04] 0.13 
Viral infection -0.02 [-0.04,0.00] 0.09   0.02 [-0.00,0.04] 0.06 
SES (childhood) 
Least advantaged Ref  .  Ref  . 
Mid -0.02 [-0.04,-0.00] 0.02  -0.01 [-0.03,0.01] 0.46 
Most advantaged -0.05 [-0.08,-0.02] <0.001  -0.01 [-0.05,0.02] 0.34 
Housing score 0.00 [-0.00,0.01] 0.25   0.00 [-0.01,0.01] 0.88 
Overcrowding 0.01 [-0.01,0.03] 0.22  0.01 [-0.01,0.03] 0.29 
Adversity Any adverse event 0.01 [-0.02,0.05] 0.50   0.00 [-0.04,0.04] 0.91 
SES  
(later life) 
Social class  Ref  .   Ref  . 
Mid -0.02 [-0.05,0.01] 0.15   -0.03 [-0.05,-0.00] 0.03 
Most advantaged -0.03 [-0.06,-0.00] 0.047   -0.01 [-0.04,0.01] 0.24 
Educated -0.01 [-0.03,0.00] 0.10  -0.01 [-0.02,0.01] 0.47 
No qualifications Ref  .   Ref  . 
GCSE/O-level -0.02 [-0.04,0.00] 0.06   -0.01 [-0.03,0.00] 0.14 
A level -0.02 [-0.04,0.01] 0.12   -0.02 [-0.04,0.01] 0.16 
Degree -0.04 [-0.07,-0.02] 0.002   -0.01 [-0.03,0.02] 0.60 
Income   -0.01 [-0.02,-0.00] 0.03  -0.01 [-0.02,-0.00] 0.02 
Married 0.00 [-0.02,0.02] 0.96   0.00 [-0.02,0.02] 0.71 
Lifestyle 
Inactive Ref  .  Ref  . 
Light activity 0.00 [-0.03,0.04] 0.79  0.00 [-0.03,0.02] 0.78 
Moderate activity -0.03 [-0.06,0.01] 0.14  0.00 [-0.03,0.02] 0.72 
Heavy activity -0.02 [-0.06,0.01] 0.19  -0.02 [-0.05,0.01] 0.14 
Smoker 0.00 [-0.02,0.02] 0.72   0.02 [0.00,0.04] 0.02 
Reference category for SES was least advantaged. Coefficients (coef) are presented with 95% confidence intervals (CI) and 
the corresponding level of significance (p); Ref, reference group. Bold indicates significant at p<0.05. 
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Smoking sensitivity analyses 
Table VI Regression sensitivity analyses for categories of smoking and pack years and body composition outcomes in NTFS 
study members (age 50) 
Unadjusted All Males Females 











BMI Never Ref  .       
 Ex 0.71 [-0.33,1.75] 0.18       
 Current -1.02 [-2.10,0.07] 0.066       
 Pack years 0 [-0.03,0.03] 0.90       
Obese Never Ref  .       
 Ex 1.02 [0.58,1.79] 0.94       
 Current 0.56 [0.29,1.09] 0.088       
 Pack years 1 [0.98,1.01] 0.76       
WHR Never Ref  . Ref  . Ref  . 
 Ex 0.05 [0.03,0.07] <0.001 0.03 [0.01,0.05] 0.003 0.01 [-0.01,0.03] 0.38 
 Current 0.03 [0.01,0.05] 0.012 0.02 [-0.00,0.04] 0.094 0.02 [0.01,0.04] 0.008 
 Pack years 0.00 [0.00,0.00] <0.001 0.00 [0.00,0.00] 0.006 0.00 [0.00,0.00] 0.004 
BF% Never Ref  . Ref  . Ref  . 
 Ex 0.43 [-1.58,2.43] 0.68 0.67 [-1.67,3.01] 0.58 1.98 [-0.97,4.93] 0.19 
 Current -1.25 [-3.35,0.84] 0.24 -3.89 [-6.53,-1.25] 0.004 0.89 [-1.92,3.70] 0.54 
 Pack years -0.04 [-0.09,0.01] 0.15 -0.04 [-0.09,0.02] 0.19 0.07 [-0.03,0.17] 0.17 
Adjusted model All Males Females 











BMI Never 0 Ref .       
 Ex 0.81 [-0.25,1.87] 0.14       
 Current -1.19 [-2.32,-0.05] 0.041       
 Pack years 0 [-0.03,0.03] 0.86       
Obese Never 1 [1.00,1.00] .       
 Ex 0.94 [0.53,1.69] 0.84       
 Current 0.49 [0.24,0.98] 0.042       
 Pack years 0.99 [0.98,1.01] 0.39       
WHR Never Ref  . Ref  . Ref  . 
 Ex 0.05 [0.03,0.07] <0.001 0.03 [0.01,0.05] 0.008 0.01 [-0.01,0.03] 0.28 
 Current 0.02 [-0.00,0.05] 0.052 0.01 [-0.01,0.04] 0.30 0.02 [-0.00,0.03] 0.086 
 Pack years 0.00 [0.00,0.00] <0.001 0.00 [0.00,0.00] 0.023 0.00 [0.00,0.00] 0.02 
BF% Never Ref  . Ref  . Ref  . 
 Ex 0.46 [-1.62,2.53] 0.67 0.76 [-1.63,3.15] 0.53 2.18 [-0.90,5.25] 0.17 
 Current -1.62 [-3.85,0.62] 0.16 -3.22 [-6.03,-0.40] 0.025 0.25 [-2.76,3.25] 0.87 
 Pack years -0.04 [-0.10,0.02] 0.17 0 [-0.07,0.06] 0.88 0.06 [-0.05,0.17] 0.28 
Unadjusted models (top) and adjusted (for adult SES, bottom) presented for each outcome. Coefficients (coef) for linear 
outcomes or odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance 




Figure X Correlations between all explanatory variables in GMS and p values 
Appendix C 




































































































































Maternal age -0.06 1.00
0.083
First-born 0.01 -0.36 1.00
0.659 <0.001
Caesarean 0.00 0.19 0.06 1.00
0.968 <0.001 0.053
Gestation 0.03 -0.04 0.08 -0.18 1.00
0.412 0.236 0.012 <0.001
Bwt-z 0.00 0.13 -0.12 0.08 -0.10 1.00
0.983 <0.001 <0.001 0.011 0.001
RWG -0.02 -0.07 0.15 -0.02 0.12 -0.38 1.00
0.664 0.040 <0.001 0.510 0.001 <0.001
RT 0.01 -0.01 0.14 0.03 0.07 -0.03 0.66 1.00
0.860 0.690 <0.001 0.465 0.053 0.333 <0.001
-0.03 0.31 0.03 0.04 0.05 0.10 -0.07 -0.02 1.00
0.351 <0.001 0.432 0.193 0.144 0.001 0.056 0.618
-0.01 0.21 -0.13 -0.01 0.05 0.10 -0.09 -0.09 1.00 1.00
0.821 <0.001 0.004 0.793 0.262 0.022 0.061 0.068 <0.001
Formula-fed 0.03 -0.26 -0.10 -0.04 -0.05 -0.08 0.02 -0.02 -0.82 -1.00 1.00
0.321 <0.001 0.002 0.247 0.114 0.015 0.586 0.601 <0.001 1.000
Wean age 0.08 0.13 -0.07 0.01 -0.04 -0.02 -0.06 -0.04 0.20 0.34 -0.14 1.00
0.036 <0.001 0.066 0.778 0.267 0.678 0.098 0.260 <0.001 <0.001 <0.001
Any infection -0.06 0.04 -0.08 0.02 -0.04 -0.01 0.07 0.05 0.05 0.00 0.00 -0.04 1.00
0.068 0.235 0.009 0.525 0.231 0.695 0.059 0.148 0.096 0.983 0.948 0.299
Adversity -0.03 0.02 0.07 0.05 0.03 0.00 0.04 0.03 0.03 -0.03 -0.04 -0.13 0.07 1.00
0.440 0.451 0.040 0.156 0.423 0.901 0.222 0.413 0.436 0.582 0.192 0.001 0.041
Sleep issues -0.01 -0.03 0.02 0.00 0.02 0.02 0.00 -0.03 -0.07 -0.10 0.04 -0.10 -0.01 -0.02 1.00
0.815 0.526 0.651 0.911 0.603 0.684 0.924 0.466 0.074 0.074 0.281 0.016 0.734 0.660
Townsend -0.06 0.18 -0.06 0.02 0.04 0.07 -0.06 -0.03 0.23 0.14 -0.20 0.08 -0.01 0.00 -0.07 1.00
0.078 <0.001 0.074 0.556 0.171 0.020 0.083 0.472 <0.001 0.001 <0.001 0.028 0.672 0.881 0.084
-0.04 0.29 0.09 0.10 0.08 0.16 -0.02 0.04 0.42 0.35 -0.36 0.05 0.01 0.13 0.01 0.22 1.00
0.218 <0.001 0.010 0.004 0.016 <0.001 0.642 0.332 <0.001 <0.001 <0.001 0.231 0.743 <0.001 0.901 <0.001
Deprived 0.05 -0.38 -0.08 -0.04 -0.05 -0.15 0.07 -0.01 -0.30 -0.13 0.30 -0.10 -0.01 -0.05 0.02 -0.23 -0.38 1.00
0.090 <0.001 0.008 0.257 0.118 <0.001 0.045 0.724 <0.001 0.003 <0.001 0.008 0.711 0.160 0.574 <0.001 <0.001
SES (age 8) -0.09 0.34 -0.03 0.08 -0.05 0.12 -0.02 0.05 0.27 0.12 -0.20 0.10 0.08 -0.02 -0.01 0.15 0.37 -0.42 1.00
0.088 <0.001 0.592 0.128 0.357 0.023 0.742 0.313 <0.001 0.124 <0.001 0.082 0.104 0.687 0.891 0.004 <0.001 <0.001
0.06 -0.04 -0.03 0.05 -0.01 -0.01 0.03 -0.01 0.01 0.00 -0.02 -0.06 0.03 0.00 -0.05 -0.04 -0.03 0.22 -0.04 1.00
0.042 0.236 0.396 0.135 0.643 0.745 0.427 0.720 0.687 0.961 0.534 0.084 0.300 0.883 0.250 0.203 0.308 <0.001 0.489
%MVPA -0.13 -0.07 0.10 -0.04 0.04 -0.10 0.12 0.11 -0.09 -0.11 0.08 0.05 0.00 0.03 0.01 -0.06 -0.04 0.05 0.00 0.02 1.00
0.003 0.113 0.031 0.418 0.353 0.024 0.013 0.014 0.059 0.103 0.070 0.350 0.967 0.501 0.903 0.160 0.348 0.229 0.948 0.616
Season 0.04 0.01 -0.04 -0.02 0.06 0.02 -0.06 -0.07 0.05 0.00 -0.01 -0.07 0.03 0.06 -0.06 0.11 0.03 -0.07 -0.01 0.05 -0.21 1.00










SES and early life factors 
Table VII Categorical early life factors that differed by Townsend quintile in the age 6-8 sub-sample.  









                    
 n % n % n % n % n % n %  
Maternal age 987  188  201  221  223  154  <0.001 
Less than 25 324 32.8 102 54.3 38 18.9 72 32.6 97 43.5 15 9.7  
25-34 543 55 77 41 133 66.2 124 56.1 101 45.3 108 70.1  
35+ 120 12.2 9 4.8 30 14.9 25 11.3 25 11.2 31 20.1  
Formula-fed 947  180  191  212  215  149  <0.001 
No 481 50.8 48 26.7 120 62.8 101 47.6 101 47 111 74.5  
Yes 466 49.2 132 73.3 71 37.2 111 52.4 114 53 38 25.5  
Total              
Breastfeeding 947  180  191  212  215  149  <0.001 
Never 466 49.2 132 73.3 71 37.2 111 52.4 114 53 38 25.5  
<6wk 235 24.8 34 18.9 58 30.4 54 25.5 56 26 33 22.1  
>6wk 88 9.3 3 1.7 25 13.1 18 8.5 16 7.4 26 17.4  
>4m 158 16.7 11 6.1 37 19.4 29 13.7 29 13.5 52 34.9  
Adversity 929  174  193  206  204  152  0.761 
No 715 77 135 77.6 151 78.2 152 73.8 161 78.9 116 76.3  
Yes 214 23 39 22.4 42 21.8 54 26.2 43 21.1 36 23.7  




Models for bivariate associations for outcomes (age 6-8) in GMS 
Table VIII Bivariate (unadjusted) associations between explanatory variables and all body composition outcomes in GMS (age 6-8) 
Early life factors OWOB BMIz FMI  Waist OB 
 OR CI p coef CI p coef CI p OR CI p 
Female 0.89 [0.59,1.34] 0.56 0.02 [-0.16,0.20] 0.85 -0.11 [-0.43,0.20] 0.47 1.01 [0.62,1.64] 0.98 
First-born 0.85 [0.57,1.29] 0.45 -0.08 [-0.26,0.11] 0.412 -0.07 [-0.38,0.25] 0.68 0.87 [0.53,1.42] 0.58 
Gestation (wk) 1.13 [0.98,1.30] 0.10 0.03 [-0.03,0.09] 0.31 0.02 [-0.08,0.12] 0.66 1.03 [0.89,1.19] 0.71 
Preterm 0.64 [0.28,1.47] 0.29 -0.12 [-0.44,0.20] 0.46 -0.14 [-0.69,0.42] 0.63 0.92 [0.41,2.08] 0.85 
Normal Ref   . Ref   . Ref   . Ref   . 
Post term 1.67 [0.77,3.63] 0.19 0.07 [-0.33,0.46] 0.74 0.32 [-0.36,1.00] 0.36 0.89 [0.31,2.55] 0.83 
Bwtz 1.53 [1.25,1.88] <0.001 0.26 [0.17,0.34] <0.001 0.22 [0.07,0.37] 0.004 1.37 [1.09,1.73] 0.007 
Categories of 
birthweight              
SGA 0.63 [0.27,1.44] 0.27 -0.30 [-0.62,0.01] 0.060 -0.06 [-0.62,0.49] 0.82 1.24 [0.55,2.83] 0.60 
Normal Ref   . Ref   . Ref   . Ref   . 
LGA 1.67 [0.91,3.08] 0.10 0.25 [-0.06,0.55] 0.11 0.2 [-0.33,0.73] 0.45 1.74 [0.85,3.54] 0.13 
Caesarean 1.07 [0.61,1.86] 0.81 0.03 [-0.22,0.28] 0.80 0.25 [-0.18,0.69] 0.26 1.64 [0.90,2.99] 0.11 
Maternal age 1.02 [0.98,1.06] 0.27 0 [-0.01,0.02] 0.63 0.01 [-0.02,0.03] 0.64 1.02 [0.98,1.06] 0.30 
Less than 25 0.59 [0.36,0.97] 0.038 -0.15 [-0.35,0.06] 0.16 -0.28 [-0.65,0.08] 0.13 0.63 [0.35,1.12] 0.16 
25-34 Ref   . Ref   . Ref   . Ref   . 
35+ 0.67 [0.35,1.28] 0.23 -0.23 [-0.50,0.04] 0.091 -0.39 [-0.87,0.10] 0.12 0.82 [0.37,1.78] 0.61 
Categories of breastfeeding            
Never Ref   . Ref   . Ref   . Ref   . 
<6wk 1.2 [0.72,2.00] 0.47 0.11 [-0.12,0.34] 0.35 0.33 [-0.08,0.74] 0.12 1.53 [0.85,2.75] 0.16 
>6wk 0.65 [0.30,1.40] 0.27 -0.19 [-0.49,0.12] 0.23 -0.22 [-0.76,0.31] 0.41 0.74 [0.25,2.16] 0.58 
>4m 1.19 [0.69,2.04] 0.54 -0.09 [-0.34,0.16] 0.48 -0.18 [-0.62,0.25] 0.41 1.52 [0.78,2.96] 0.22 
Exclusive  0.92 [0.33,2.57] 0.88 -0.18 [-0.59,0.23] 0.38 -0.24 [-0.92,0.44] 0.49 1.09 [0.31,3.92] 0.89 
Formula fed 0.93 [0.61,1.41] 0.74 0.02 [-0.16,0.21] 0.82 -0.03 [-0.36,0.30] 0.85 0.73 [0.44,1.20] 0.22 
Wean age 0.97 [0.91,1.05] 0.47 -0.03 [0.06,0.00] 0.086 -0.02 [0.07,0.04] 0.54 0.97 [0.90,1.06] 0.56 
RWG  1.52 [0.98,2.36] 0.060 0.47 [0.27,0.67] <0.001 0.23 [-0.12,0.58] 0.20 1.46 [0.86,2.49] 0.16 
Adversity 2.01 [1.28,3.13] 0.002 0.39 [0.18,0.61] <0.001 0.62 [0.25,0.98] 0.001 1.49 [0.85,2.61] 0.17 
Sleep issues  1.37 [0.77,2.46] 0.28 0.25 [-0.03,0.53] 0.076 0.22 [-0.25,0.69] 0.36 1.30 [0.65,2.62] 0.46 
Infection  1.3 [0.71,2.37] 0.40 0.06 [-0.22,0.34] 0.67 -0.05 [-0.53,0.44] 0.85 1.59 [0.79,3.22] 0.20 
MVPA (%) 0.82 [0.73,0.91] <0.001 -0.05 [-0.09,-0.01] 0.016 -0.19 [-0.25,-0.12] <0.001 0.82 [0.70,0.95] 0.008 
327 
Socioeconomic and lifestyle 
variables 
OWOB BMIz FMI Waist OB 
 OR CI p coef CI p coef CI p OR CI p 
T score quintile for N region             
Least advantaged  Ref   . Ref   . Ref   . Ref   . 
2nd to least advantaged 1.24 [0.62,2.47] 0.54 -0.02 [-0.31,0.27] 0.89 0.04 [-0.47,0.54] 0.88 0.7 [0.30,1.65] 0.42 
Mid  1.67 [0.86,3.23] 0.13 0.21 [-0.08,0.49] 0.16 0.33 [-0.17,0.83] 0.20 1.49 [0.73,3.04] 0.28 
2nd to most advantaged 1.46 [0.73,2.91] 0.28 0.22 [-0.08,0.52] 0.15 0.35 [-0.17,0.86] 0.19 1.04 [0.49,2.22] 0.92 
Most advantaged  1.28 [0.63,2.61] 0.50 -0.07 [-0.37,0.23] 0.65 -0.18 [-0.71,0.34] 0.49 0.74 [0.30,1.83] 0.51 
Maternal education (birth)             
None  Ref   . Ref   . Ref   . Ref   . 
GCSE 0.99 [0.51,1.94] 0.98 -0.01 [-0.31,0.29] 0.95 -0.13 [-0.64,0.38] 0.61 1.04 [0.51,2.14] 0.92 
A level 0.98 [0.42,2.28] 0.96 0.02 [-0.36,0.40] 0.93 -0.19 [-0.83,0.45] 0.56 1.03 [0.39,2.69] 0.96 
Degree 1.01 [0.46,2.24] 0.97 0.02 [-0.34,0.38] 0.91 -0.42 [-1.03,0.18] 0.17 0.76 [0.28,2.07] 0.60 
Parental occupational social class (childhood)           
Least advantaged Ref   . Ref   . Ref   . Ref   . 
Mid 0.83 [0.44,1.55] 0.56 -0.1 [-0.38,0.17] 0.46 -0.38 [-0.88,0.12] 0.14 1.02 [0.47,2.23] 0.96 
Most advantaged 0.76 [0.40,1.44] 0.41 -0.04 [-0.32,0.24] 0.78 -0.43 [-0.94,0.07] 0.093 0.83 [0.37,1.87] 0.65 
Upward mobility 0-8 1.01 [0.49,2.10] 0.97 0.11 [-0.22,0.43] 0.53 -0.1 [-0.66,0.47] 0.74 1.95 [0.80,4.76] 0.14 
For outcomes of overweight/obesity (OWOB) and waist obesity (OB) (logistic regression), BMIz, and FMI (linear regression). Coefficients (coef) and odds ratios (OR) are presented with 95% 
confidence intervals (CI) and the corresponding level of significance (p). Ref indicates reference category for factor variables. Bold indicates significant at p<0.05.  
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FMI regression model outlier analysis 
Before removing outliers 
 
Shapiro-Wilk test for normal data  




After removal of outliers 
 





Figure XI Regression diagnostic plots for FMI outlier sensitivity analysis. 
Plots are for models before (a) and after (b) removal of outliers. The histogram represents the distribution of residuals, 
whilst the normal probability (pnorm) plot shows the distribution relative to the specified distribution (straight line). Using 
the Shapiro-Wilk W test for normal data, a p-value less than 0.05, means the null hypothesis that the data are normally 





In order to determine which factors could be driving the associations between adversity and 
adiposity outcomes, each of the components of adversity was investigated individually.  
Parental separation and debt were associated with increased odds of OWOB and increased 
BMI, and debt was also associated with increased FMI (Table IX). Adversity was not 
associated with waist OB in any capacity. There were relatively low numbers for some 
exposures, in particular for death in the family (n=12, 2.2%). 
 
Table IX The associations between individual components of adversity and adiposity outcomes (age 6-8). 
 
n % OWOB  BMI  
  OR CI p  coef CI p 
       
   
Adversity (all) 144 26.9 2.37 [1.29,4.33] 0.01  0.33 [0.06,0.61] 0.02 
Parental 
separation 
33 6.2 3.19 [1.16,8.79] 0.02 
 
0.55 [0.04,1.07] 0.04 
Police involvement 28 5.2 1.09 [0.34,3.50] 0.89  0.00 [-0.52,0.52] 0.99 
Debt 93 17.4 2.68 [1.37,5.25] <0.001  0.45 [0.13,0.78] 0.01 
Death in the 
family 
12 2.2 1.80 [0.15,21.28] 0.64 
 
0.35 [-0.79,1.50] 0.54 
          
 n % FMI  Waist OB 
   coef CI p  OR CI p 
          
Adversity (all)   0.68 [0.19,1.16] 0.01  1.23 [0.56,2.69] 0.61 
Parental 
separation 
  0.85 [-0.07,1.77] 0.07 
 
2.86 [0.88,9.25] 0.08 
Police involvement   0.25 [-0.67,1.18] 0.59  1.74 [0.46,6.59] 0.41 
Debt   0.75 [0.18,1.32] 0.01  1.20 [0.48,2.98] 0.70 
Death in the 
family 
  1.21 [-0.82,3.24] 0.24  2.20 [0.17,29.40] 0.55 
Models are adjusted for sex, gestation, maternal age, Townsend score and maternal education at birth, and parental 
occupational social class in childhood. Coefficients (coef) or odds ratios (OR) are presented with confidence intervals (CI) 
and the corresponding level of significance (p). Ref indicates reference category for factor variables. N, number of 





Inverse probability weighting (IPW) for the cohort comparison models 
Table X IPW weighing on adjusted models for BMIz for NTFS and GMS 
 
NTFS - original 
 
NTFS - IPW 
 
GMS - original 
 







coef CI             
Female -0.22* [-0.42,-0.03]  -0.20* [-0.40,-0.01]  -0.16 [-0.39,0.06]  -0.18 [-0.40,0.05] 
Rapid 
thrive 
0.24* [0.04,0.45]  0.24* [0.04,0.44]  0.50*** [0.23,0.76]  0.49*** [0.23,0.75] 
Bwtz 0.02 [-0.07,0.12]  0.01 [-0.08,0.11]  0.17** [0.05,0.29]  0.17** [0.06,0.29] 
Height (cm) 0 [-0.02,0.01]  -0.01 [-0.02,0.01]  0.04*** [0.02,0.06]  0.04*** [0.02,0.06] 
SES (at 
birth) 
           
1 Least 
advantaged 
Ref .  Ref .  Ref .  Ref . 
2 0.04 [-0.32,0.39]  0.04 [-0.30,0.39]  -0.24 [-0.62,0.14]  -0.23 [-0.59,0.14] 
3 0.09 [-0.22,0.40]  0.1 [-0.23,0.42]  -0.34 [-0.73,0.05]  -0.37 [-0.77,0.03] 
4 0.03 [-0.46,0.52]  0.12 [-0.46,0.70]  -0.19 [-0.58,0.19]  -0.19 [-0.57,0.19] 
5 Most 
advantaged 
-0.93 [-1.87,0.00]  -0.91* [-1.62,-0.20]  -0.18 [-0.57,0.22]  -0.18 [-0.57,0.21] 
Adversity       0.30* [0.05,0.55]  0.30* [0.04,0.56] 
Adjusted R2 0.026   0.033   0.212   0.217  
n 313   313   269   269  
NTFS model was weighted using SES at birth and maternal age, whilst the GMS model was additionally weighted for 
adversity as well. Models were adjusted for gestation, maternal age and SES (age 9). Those in most advantaged group had a 
lower BMIz in NTFS after weighting was applied. However, this may be a spurious finding as this was a small group size (n=5, 









Correlations between exposure variables in GMS 
 
 





















































































































Gestastion length 0.04 1.00
<0.001
BWT-z 0.00 -0.16 1.00
0.593 <0.001
Firstborn 0.01 0.00 -0.17 1.00
0.203 0.651 <0.001
Antibiotics (6 months) -0.08 -0.04 0.04 -0.13 1.00
<0.001 <0.001 <0.001 <0.001
Maternal age -0.02 0.00 0.11 -0.27 0.00 1.00
0.007 0.606 <0.001 <0.001 0.737
Old maternal age -0.02 -0.02 0.02 -0.11 -0.01 0.72 1.00
0.020 0.026 0.051 0.000 0.220 <0.001
Smoked during pregnancy -0.02 -0.04 -0.16 -0.01 0.02 -0.24 -0.03 1.00
0.010 <0.001 <0.001 0.581 0.035 <0.001 0.001
Pre-pregnancy BMI -0.01 0.02 0.16 -0.06 0.03 0.02 0.03 -0.01 1.00
0.282 0.046 <0.001 <0.001 0.013 0.094 0.013 0.141
Breastfeeding categories 0.01 0.07 0.05 0.03 -0.04 0.27 0.08 -0.20 -0.10 1.00
0.112 <0.001 <0.001 0.004 <0.001 <0.001 <0.001 <0.001 <0.001
Adversity (pre) -0.01 0.14 0.01 -0.03 0.02 0.00 0.01 0.11 0.03 -0.03 1.00
0.530 <0.001 0.214 <0.001 0.055 0.981 0.416 <0.001 0.003 0.006
Adversity (post) 0.00 0.12 0.01 -0.02 0.02 0.03 0.01 0.06 0.02 0.00 0.31 1.00
0.912 <0.001 0.374 0.011 0.032 <0.001 0.167 <0.001 0.014 0.647 <0.001
Adversity (pre + post) -0.01 0.08 0.01 -0.03 0.02 0.02 0.01 0.09 0.03 0.00 0.59 0.71 1.00
0.334 <0.001 0.375 0.001 0.044 0.065 0.276 <0.001 0.005 0.621 <0.001 <0.001
RWG -0.03 0.15 -0.38 0.18 0.04 -0.05 -0.02 0.06 -0.04 -0.05 -0.04 -0.04 -0.04 1.00
0.238 <0.001 <0.001 <0.001 0.238 0.088 0.603 0.053 0.217 0.088 0.178 0.150 0.207
RT -0.0455 0.0322 -0.0198 0.138 0.0758 -0.0517 -0.0475 0.0333 0.0248 -0.0539 0.0057 0.0181 -0.0033 0.6623 1
0.118 0.268 0.496 <0.001 0.011 0.076 0.132 0.262 0.420 0.068 0.843 0.534 0.910 <0.001
SES (birth) 0.00 0.01 0.04 0.07 0.00 0.27 0.08 -0.19 -0.09 0.26 -0.07 -0.04 -0.04 0.02 -0.02 1.00
0.642 0.479 <0.001 <0.001 0.675 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.480 0.515
SES (age 8) 0.01 0.00 0.03 0.06 -0.01 0.19 0.07 -0.13 -0.11 0.20 -0.03 -0.02 -0.03 0.02 0.03 0.43 1.00
0.509 0.908 0.061 <0.001 0.769 <0.001 <0.001 <0.001 <0.001 <0.001 0.065 0.216 0.038 0.680 0.496 <0.001
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Models for bivariate associations in ALSPAC 
Table XI Bivariate associations between early life factors and adiposity outcomes (BMIz, OWOB) at ages 7 and 17 in ALSPAC study members  
  Age 7 
 
Age 17 
 Exposures  BMIz       OWOB       BMIz       OWOB    
 Coef CI p   OR CI p  Coef CI p  OR CI p 
Female 0 [-0.05,0.04] 0.83 
 
0.95 [0.83,1.08] 0.42 
 
0.03 [-0.03,0.10] 0.31  0.98 [0.85,1.12] 0.75 
Gestation (weeks) 0.02 [0.01,0.03] 0.005 
 
1.02 [0.98,1.06] 0.37 
 
0 [-0.02,0.02] 0.86  1.01 [0.96,1.05] 0.80 
Pre-term -0.03 [-0.10,0.05] 0.489 
 
1.12 [0.89,1.40] 0.33 
 
0.08 [-0.03,0.19] 0.14  1.2 [0.95,1.51] 0.12 
Post-term 0.06 [-0.03,0.14] 0.21 
 
1.08 [0.84,1.40] 0.54 
 
-0.08 [-0.20,0.05] 0.25  0.91 [0.68,1.22] 0.53 
Bwt z-score 0.18 [0.16,0.21] <0.001 
 
1.30 [1.21,1.39] <0.001 
 
0.12 [0.08,0.15] <0.001  1.20 [1.12,1.30] <0.001 
Bwt categories       SGA -0.23 [-0.33,-0.14] <0.001 
 
0.86 [0.64,1.17] 0.35 
 
-0.04 [-0.17,0.09] 0.56  0.93 [0.69,1.24] 0.62 
LGA 0.35 [0.28,0.42] <0.001 
 
1.73 [1.43,2.09] <0.001 
 
0.30 [0.20,0.40] <0.001  1.64 [1.33,2.01] <0.001 
Maternal age                
Less than 25 0.04 [-0.03,0.10] 0.24 
 
1.09 [0.90,1.31] 0.39 
 
0.24 [0.15,0.33] <0.001  1.50 [1.24,1.80] <0.001 
35+ 0.01 [-0.06,0.08] 0.83 
 
1.04 [0.84,1.28] 0.72 
 
-0.11 [-0.21,-0.01] 0.033  0.83 [0.66,1.05] 0.12 
First-born 0.02 [-0.02,0.07] 0.31 
 
1.08 [0.94,1.25] 0.27 
 
0.01 [-0.06,0.08] 0.73  0.95 [0.82,1.10] 0.51 
RWG 0.52 [0.37,0.66] <0.001 
 
2.04 [1.36,3.06] 0.001 
 
0.25 [0.04,0.45] 0.020  1.25 [0.80,1.96] 0.32 
RT 0.77 [0.63,0.90] <0.001  3.82 [2.53,5.76] <0.001  0.26 [0.05,0.46] 0.014  1.55 [1.00,2.39] 0.051 
Adversity 
Pre-natal 0.05 [0.00,0.09] 0.045 
 
1.06 [0.92,1.21] 0.42 
 
0.12 [0.05,0.19] <0.001  1.28 [1.11,1.47] 0.001 
Post-natal 0.02 [-0.03,0.07] 0.34 
 
1.02 [0.88,1.18] 0.79 
 
0.03 [-0.04,0.10] 0.42  1.03 [0.88,1.20] 0.75 
Pre and 
post 0.08 [0.02,0.14] 0.012 
 
1.08 [0.91,1.29] 0.39 
 
0.14 [0.06,0.23] 0.001  1.38 [1.15,1.65] 0.001 
Antibiotics 0.02 [-0.03,0.07] 0.39  0.12 [0.05,0.19] 0.002  0.98 [0.84,1.14] 0.80  1.19 [1.02,1.40] 0.028 
SES at birth                
Mid 0.01 [-0.12,0.13] 0.90 
 
0.92 [0.64,1.32] 0.66 
 
-0.1 [-0.29,0.08] 0.26  0.76 [0.53,1.10] 0.14 
Most advantaged -0.03 [-0.15,0.10] 0.68 
 
0.78 [0.55,1.11] 0.17 
 
-0.25 [-0.43,-0.08] 0.005  0.52 [0.37,0.74] <0.001 
SES in childhood                
Mid -0.01 [-0.13,0.11] 0.85 
 
0.78 [0.54,1.11] 0.17 
 
-0.11 [-0.28,0.05] 0.18  0.71 [0.49,1.03] 0.070 
Most advantaged -0.05 [-0.16,0.07] 0.42   0.65 [0.46,0.91] 0.012   -0.20 [-0.36,-0.05] 0.010   0.58 [0.41,0.81] 0.001 
Coefficients (coef) or odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Bold indicates significant at p<0.05. Reference categories were 
normal term for gestational age categories; the least advantaged group for SES; and age 25-34 for maternal age. SES, socioeconomic status; Bwt, birthweight; RWG, rapid weight gain.   
333 
Table XII Multivariable regression models for adiposity outcomes in ALSPAC using RWG and adjusted for SES  
Age 7           BMIz                       OWOB           
  Adjusted for early life 
 Adjusted for SES (birth)   Adjusted for SES (childhood)   Adjusted for early life  Adjusted for SES (birth)  Adjusted for SES (childhood) 
 Coef CI p 
 Coef CI p  Coef CI p  OR CI p  OR CI p  OR CI p 
 
                       
Female -0.07 [-0.20,0.06] 0.27 
 -0.07 [-0.21,0.06] 0.27  -0.08 [-0.28,0.12] 0.43  0.63 [0.41,0.98] 0.039  0.63 [0.40,0.99] 0.047  0.71 [0.36,1.40] 0.32 
Gestation (weeks) 0 [-0.04,0.05] 0.87 
 0 [-0.04,0.05] 0.97  0 [-0.07,0.07] 0.99  1 [0.87,1.15] 0.98  1.01 [0.87,1.17] 0.91  1.02 [0.81,1.28] 0.87 
Bwtz  0.35 [0.27,0.42] <0.001 
 0.35 [0.27,0.42] <0.001  0.30 [0.18,0.42] <0.001  1.86 [1.43,2.42] <0.001  1.72 [1.31,2.26] <0.001  1.09 [0.73,1.62] 0.67 
Maternal age  
                      
<25 -0.01 [-0.21,0.20] 0.94 
 0.09 [-0.14,0.32] 0.45  0.40 [-0.03,0.82] 0.066  0.9 [0.46,1.76] 0.76  1.18 [0.58,2.43] 0.64  2.06 [0.65,6.46] 0.22 
35+ -0.18 [-0.37,0.01] 0.065 
 -0.17 [-0.37,0.02] 0.086  -0.04 [-0.32,0.24] 0.77  0.56 [0.27,1.17] 0.13  0.51 [0.23,1.11] 0.089  0.26 [0.06,1.15] 0.076 
First-born 0.09 [-0.04,0.23] 0.19 
 0.06 [-0.08,0.21] 0.38  0.12 [-0.10,0.34] 0.28  1.24 [0.79,1.96] 0.35  1.15 [0.72,1.85] 0.55  1.13 [0.54,2.38] 0.74 
RWG 0.79 [0.63,0.94] <0.001 
 0.81 [0.65,0.96] <0.001  0.62 [0.38,0.86] <0.001  3.36 [2.05,5.52] <0.001  3.15 [1.90,5.23] <0.001  1.36 [0.63,2.96] 0.43 
Adversity            
            
Pre and post-natal 0.09 [-0.09,0.26] 0.34  0.03 [-0.16,0.22] 0.76  0.1 [-0.19,0.39] 0.50 
 1.1 [0.62,1.96] 0.74  1.03 [0.55,1.92] 0.93  1.7 [0.71,4.04] 0.23 
SES at birth 
                       
Mid 
    0.23 [-0.11,0.58] 0.19  -0.23 [-0.88,0.42] 0.48      1.25 [0.34,4.53] 0.74  0.38 [0.06,2.40] 0.31 
Most  
advantaged 
    0.25 [-0.09,0.60] 0.15  -0.09 [-0.74,0.55] 0.77      1.57 [0.44,5.64] 0.49  0.71 [0.12,4.36] 0.71 
SES in childhood 
                       
Mid 
        0.11 [-0.27,0.50] 0.56          1.03 [0.32,3.30] 0.96 
Most advantaged 
        0.02 [-0.36,0.39] 0.93          0.62 [0.20,1.93] 0.41 





    0.143 
  




0.066     
  
0.061     
  




Age 17           BMIz                       OWOB           
 Adjusted for early life 
 Adjusted for SES (birth)   Adjusted for SES (childhood)  Adjusted for early life  Adjusted for SES (birth)   Adjusted for SES (childhood) 
 Coef CI p 
 Coef CI p  Coef CI p  OR CI p  OR CI p  OR CI p 
 
                       
Female -0.08 [-0.27,0.11] 0.42  -0.1 [-0.31,0.10] 0.32  -0.09 [-0.36,0.18] 0.53  0.98 [0.63,1.51] 0.92  0.94 [0.60,1.46] 0.78  0.93 [0.49,1.77] 0.82 
Gestation (weeks) 0 [-0.07,0.06] 0.88  -0.01 [-0.08,0.06] 0.74  0 [-0.10,0.09] 0.92  1.01 [0.87,1.17] 0.88  1.01 [0.86,1.17] 0.94  0.99 [0.79,1.23] 0.93 
Bwtz  0.12 [0.01,0.24] 0.040  0.12 [-0.01,0.24] 0.063  0.15 [-0.02,0.31] 0.084  1.31 [1.00,1.71] 0.051  1.28 [0.98,1.69] 0.075  1.19 [0.80,1.78] 0.39 
Maternal age                        
<25 0.19 [-0.13,0.51] 0.24  0.26 [-0.10,0.62] 0.15  0.41 [-0.28,1.11] 0.24  1.12 [0.56,2.26] 0.75  1.19 [0.55,2.56] 0.66  1.33 [0.30,5.92] 0.71 
35+ -0.12 [-0.41,0.17] 0.41  -0.09 [-0.39,0.21] 0.54  0.03 [-0.37,0.42] 0.89  1.35 [0.73,2.47] 0.34  1.41 [0.75,2.62] 0.28  1.91 [0.81,4.48] 0.14 
First-born 0.04 [-0.18,0.25] 0.74  0.01 [-0.21,0.23] 0.93  0.11 [-0.19,0.41] 0.47  0.99 [0.62,1.60] 0.98  0.99 [0.61,1.62] 0.97  1.14 [0.56,2.33] 0.72 
RWG 0.34 [0.10,0.57] 0.006  0.36 [0.11,0.60] 0.005  0.31 [-0.03,0.65] 0.072  1.65 [0.97,2.81] 0.066  1.64 [0.95,2.81] 0.073  1.17 [0.53,2.61] 0.69 
Adversity                        
Pre and post-natal 0.33 [0.05,0.61] 0.021  0.28 [-0.02,0.58] 0.068  0.21 [-0.20,0.63] 0.31  1.84 [1.05,3.25] 0.034  1.66 [0.91,3.03] 0.10  1.43 [0.58,3.50] 0.44 
SES at birth                        
Mid     0.42 [-0.13,0.98] 0.16  -0.18 [-1.16,0.80] 0.72      1.59 [0.42,5.96] 0.49  1.42 [0.14,14.36] 0.77 
Most advantaged     0.28 [-0.26,0.83] 0.31  -0.51 [-1.48,0.47] 0.31      1.41 [0.38,5.21] 0.60  0.78 [0.08,8.05] 0.84 
SES in childhood                        
Mid         -0.22 [-0.78,0.35] 0.45          1.04 [0.28,3.83] 0.95 
Most advantaged         -0.06 [-0.60,0.47] 0.82          1.15 [0.33,3.99] 0.83 
N   527       498       270       527       498       270              
Adjusted/ 
pseudo R-sq 
0.018     
  
0.017     
  
0.008     
  
0.02     
  
0.018     
  
0.024              
Coefficients (coef) or odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Reference categories were; normal term for gestational age 
categories; the least advantaged group for SES; and age 25-34 for maternal age. 
SES, socioeconomic status; RWG, rapid weight gain
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Multivariable parsimonious models in ALSPAC 
Table XIII  Multivariable linear regression parsimonious models for BMIz at ages 7 and 17 
   BMIz7      BMIz17   
  Coef CI p  Coef CI p 
        
Female -0.07 [-0.20,0.05] 0.26  -0.09 [-0.29,0.10] 0.35 
Gestation (weeks) 0 [-0.04,0.05] 0.90  -0.01 [-0.07,0.06] 0.80 
First-born 0.09 [-0.05,0.23] 0.20  0.03 [-0.18,0.24] 0.81 
Maternal age        
Less than 25 -0.01 [-0.21,0.20] 0.95  0.19 [-0.12,0.51] 0.23 
35+ -0.18 [-0.37,0.01] 0.066  -0.11 [-0.40,0.17] 0.44 
Birthweight z-score 0.35 [0.27,0.42] <0.001  0.12 [0.00,0.24] 0.043 
RWG 0.78 [0.63,0.94] <0.001  0.35 [0.12,0.59] 0.004 
Adversity - prenatal     0.34 [0.14,0.55] 0.001 
                
n 825    527               
Adjusted R2 0.142       0.028                
Coefficients (coef) presented with 95% confidence intervals (CI) and the corresponding level of significance (p). The reference category was age 25-34 for maternal age.  




Table XIV Multivariable logistic regression parsimonious models for OWOB at ages 7 and 17 
   OWOB7                 OWOB17   
  OR  CI p  OR CI p 
        
Female 0.63 [0.40,0.97] 0.037  0.81 [0.64,1.03] 0.081 
Gestation (weeks) 1.00 [0.87,1.15] 0.99  1.03 [0.95,1.11] 0.45 
First-born 1.24 [0.79,1.95] 0.36  1.04 [0.81,1.33] 0.75 
Maternal age         
Less than 25 0.90 [0.46,1.77] 0.76  1.42 [0.97,2.09] 0.073 
35+ 0.56 [0.27,1.17] 0.13  0.98 [0.70,1.38] 0.93 
Birthweight z-score 1.86 [1.43,2.42] <0.001  1.26 [1.10,1.43] 0.001 
RWG 3.35 [2.04,5.50] <0.001                 
Adversity - prenatal     1.43 [1.12,1.82] 0.004 
SES at birth        
Mid     0.50 [0.25,0.97] 0.041 
Most advantaged     0.39 [0.20,0.76] 0.006 
SES in childhood        
Mid     0.74 [0.50,1.09] 0.12 
Most advantaged     0.67 [0.45,0.98] 0.039 
n 825    1952   
pseudo R-sq 0.066     0.026     
Odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Reference categories were; the least advantaged group for SES; and age 25-34 for 
maternal age. n, sample size; SES, socioeconomic status; RWG, rapid weight gain. 
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Table XV Multivariable regression models for adiposity outcomes in ALSPAC using RWG and adjusted for SES  
Age 7           BMIz                       OWOB           
  Adjusted for early life 
 Adjusted for SES (birth)   Adjusted for SES (childhood)   Adjusted for early life  Adjusted for SES (birth)  Adjusted for SES (childhood) 
 Coef CI p 
 Coef CI p  Coef CI p  OR CI p  OR CI p  OR CI p 
                        
Female -0.07 [-0.20,0.06] 0.27  -0.07 [-0.21,0.06] 0.27  -0.08 [-0.28,0.12] 0.43  0.63 [0.41,0.98] 0.039  0.63 [0.40,0.99] 0.047  0.71 [0.36,1.40] 0.32 
Gestation 
(weeks) 
0 [-0.04,0.05] 0.87  0 [-0.04,0.05] 0.97  0 [-0.07,0.07] 0.99  1 [0.87,1.15] 0.98  1.01 [0.87,1.17] 0.91  1.02 [0.81,1.28] 0.87 
Bwtz  0.35 [0.27,0.42] <0.001  0.35 [0.27,0.42] <0.001  0.30 [0.18,0.42] <0.001  1.86 [1.43,2.42] <0.001  1.72 [1.31,2.26] <0.001  1.09 [0.73,1.62] 0.67 
Maternal age                        
<25 -0.01 [-0.21,0.20] 0.94  0.09 [-0.14,0.32] 0.45  0.40 [-0.03,0.82] 0.066  0.9 [0.46,1.76] 0.76  1.18 [0.58,2.43] 0.64  2.06 [0.65,6.46] 0.22 
35+ -0.18 [-0.37,0.01] 0.065  -0.17 [-0.37,0.02] 0.086  -0.04 [-0.32,0.24] 0.77  0.56 [0.27,1.17] 0.13  0.51 [0.23,1.11] 0.089  0.26 [0.06,1.15] 0.076 
First-born 0.09 [-0.04,0.23] 0.19  0.06 [-0.08,0.21] 0.38  0.12 [-0.10,0.34] 0.28  1.24 [0.79,1.96] 0.35  1.15 [0.72,1.85] 0.55  1.13 [0.54,2.38] 0.74 
RWG 0.79 [0.63,0.94] <0.001  0.81 [0.65,0.96] <0.001  0.62 [0.38,0.86] <0.001  3.36 [2.05,5.52] <0.001  3.15 [1.90,5.23] <0.001  1.36 [0.63,2.96] 0.43 
Adversity                        
Pre and 
post-natal 0.09 [-0.09,0.26] 0.34  0.03 [-0.16,0.22] 0.76  0.1 [-0.19,0.39] 0.50 
 1.1 [0.62,1.96] 0.74  1.03 [0.55,1.92] 0.93  1.7 [0.71,4.04] 0.23 
SES at birth                        
Mid     0.23 [-0.11,0.58] 0.19  -0.23 [-0.88,0.42] 0.48      1.25 [0.34,4.53] 0.74  0.38 [0.06,2.40] 0.31 
Most  
advantaged 
    0.25 [-0.09,0.60] 0.15  -0.09 [-0.74,0.55] 0.77      1.57 [0.44,5.64] 0.49  0.71 [0.12,4.36] 0.71 
SES in 
childhood 
                       
Mid         0.11 [-0.27,0.50] 0.56          1.03 [0.32,3.30] 0.96 
Most 
advantaged 
        0.02 [-0.36,0.39] 0.93          0.62 [0.20,1.93] 0.41 





    0.143 
  




0.066     
  
0.061     
  




Age 17           BMIz                       OWOB           
 Adjusted for early life 
 Adjusted for SES (birth)   Adjusted for SES (childhood)  Adjusted for early life  Adjusted for SES (birth)   Adjusted for SES (childhood) 
 Coef CI p 
 Coef CI p  Coef CI p  OR CI p  OR CI p  OR CI p 
 
                       
Female -0.08 [-0.27,0.11] 0.42  -0.1 [-0.31,0.10] 0.32  -0.09 [-0.36,0.18] 0.53  0.98 [0.63,1.51] 0.92  0.94 [0.60,1.46] 0.78  0.93 [0.49,1.77] 0.82 
Gestation (weeks) 0 [-0.07,0.06] 0.88  -0.01 [-0.08,0.06] 0.74  0 [-0.10,0.09] 0.92  1.01 [0.87,1.17] 0.88  1.01 [0.86,1.17] 0.94  0.99 [0.79,1.23] 0.93 
Bwtz  0.12 [0.01,0.24] 0.040  0.12 [-0.01,0.24] 0.063  0.15 [-0.02,0.31] 0.084  1.31 [1.00,1.71] 0.051  1.28 [0.98,1.69] 0.075  1.19 [0.80,1.78] 0.39 
Maternal age                        
<25 0.19 [-0.13,0.51] 0.24  0.26 [-0.10,0.62] 0.15  0.41 [-0.28,1.11] 0.24  1.12 [0.56,2.26] 0.75  1.19 [0.55,2.56] 0.66  1.33 [0.30,5.92] 0.71 
35+ -0.12 [-0.41,0.17] 0.41  -0.09 [-0.39,0.21] 0.54  0.03 [-0.37,0.42] 0.89  1.35 [0.73,2.47] 0.34  1.41 [0.75,2.62] 0.28  1.91 [0.81,4.48] 0.14 
First-born 0.04 [-0.18,0.25] 0.74  0.01 [-0.21,0.23] 0.93  0.11 [-0.19,0.41] 0.47  0.99 [0.62,1.60] 0.98  0.99 [0.61,1.62] 0.97  1.14 [0.56,2.33] 0.72 
RWG 0.34 [0.10,0.57] 0.006  0.36 [0.11,0.60] 0.005  0.31 [-0.03,0.65] 0.072  1.65 [0.97,2.81] 0.066  1.64 [0.95,2.81] 0.073  1.17 [0.53,2.61] 0.69 
Adversity                        
Pre and post-natal 0.33 [0.05,0.61] 0.021  0.28 [-0.02,0.58] 0.068  0.21 [-0.20,0.63] 0.31  1.84 [1.05,3.25] 0.034  1.66 [0.91,3.03] 0.10  1.43 [0.58,3.50] 0.44 
SES at birth                        
Mid     0.42 [-0.13,0.98] 0.16  -0.18 [-1.16,0.80] 0.72      1.59 [0.42,5.96] 0.49  1.42 [0.14,14.36] 0.77 
Most advantaged     0.28 [-0.26,0.83] 0.31  -0.51 [-1.48,0.47] 0.31      1.41 [0.38,5.21] 0.60  0.78 [0.08,8.05] 0.84 
SES in childhood                        
Mid         -0.22 [-0.78,0.35] 0.45          1.04 [0.28,3.83] 0.95 
Most advantaged         -0.06 [-0.60,0.47] 0.82          1.15 [0.33,3.99] 0.83 
N   527       498       270       527       498       270              
Adjusted/ 
pseudo R-sq 
0.018     
  
0.017     
  
0.008     
  
0.02     
  
0.018     
  
0.024              
Coefficients (coef) or odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Reference categories were; normal term for gestational age 
categories; the least advantaged group for SES; and age 25-34 for maternal age. 
SES, socioeconomic status; RWG, rapid weight gai
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Table XVI  Multivariable linear regression parsimonious models for BMIz at ages 7 and 17 
   BMIz7      BMIz17   
  Coef CI p  Coef CI p 
        
Female -0.07 [-0.20,0.05] 0.26  -0.09 [-0.29,0.10] 0.35 
Gestation (weeks) 0 [-0.04,0.05] 0.90  -0.01 [-0.07,0.06] 0.80 
First-born 0.09 [-0.05,0.23] 0.20  0.03 [-0.18,0.24] 0.81 
Maternal age        
Less than 25 -0.01 [-0.21,0.20] 0.95  0.19 [-0.12,0.51] 0.23 
35+ -0.18 [-0.37,0.01] 0.066  -0.11 [-0.40,0.17] 0.44 
Birthweight z-score 0.35 [0.27,0.42] <0.001  0.12 [0.00,0.24] 0.043 
RWG 0.78 [0.63,0.94] <0.001  0.35 [0.12,0.59] 0.004 
Adversity - prenatal     0.34 [0.14,0.55] 0.001 
                
n 825    527               
Adjusted R2 0.142       0.028                
Coefficients (coef) presented with 95% confidence intervals (CI) and the corresponding level of significance (p). The reference 
category was age 25-34 for maternal age.  
n, sample size; SES, socioeconomic status; RWG, rapid weight gain. 
 
Table XVII Multivariable logistic regression parsimonious models for OWOB at ages 7 and 17 
   OWOB7                 OWOB17   
  OR  CI p  OR CI p 
        
Female 0.63 [0.40,0.97] 0.037  0.81 [0.64,1.03] 0.081 
Gestation (weeks) 1.00 [0.87,1.15] 0.99  1.03 [0.95,1.11] 0.45 
First-born 1.24 [0.79,1.95] 0.36  1.04 [0.81,1.33] 0.75 
Maternal age         
Less than 25 0.90 [0.46,1.77] 0.76  1.42 [0.97,2.09] 0.073 
35+ 0.56 [0.27,1.17] 0.13  0.98 [0.70,1.38] 0.93 
Birthweight z-score 1.86 [1.43,2.42] <0.001  1.26 [1.10,1.43] 0.001 
RWG 3.35 [2.04,5.50] <0.001                 
Adversity - prenatal     1.43 [1.12,1.82] 0.004 
SES at birth        
Mid     0.50 [0.25,0.97] 0.041 
Most advantaged     0.39 [0.20,0.76] 0.006 
SES in childhood        
Mid     0.74 [0.50,1.09] 0.12 
Most advantaged     0.67 [0.45,0.98] 0.039 
n 825    1952   
pseudo R-sq 0.066     0.026     
Odds ratios (OR) are presented with 95% confidence intervals (CI) and the corresponding level of significance (p). Reference 
categories were; the least advantaged group for SES; and age 25-34 for maternal age. n, sample size; SES, socioeconomic 
status; RWG, rapid weight gain. 
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RWG regression diagnostic plots 
 
Figure XIII  Regression diagnostic plots for the parsimonious model for RWG and BMIz7 in ALSPAC. 
From left-right and top-bottom: Leverage vs. squared residual plot; residuals vs. predicted values (Yhat) plot, Quintile-
normal plot and Standardize normal probability plot. 
 
Figure XIV Regression diagnostic plot for the parsimonious model for RWG and BMIz17 in ALSPAC.  
From left-right and top-bottom: Leverage vs. squared residual plot; residuals vs. predicted values (Yhat) plot, Quintile-




A. BMIz7 – basic model 
 
B. BMIz7 – basic model + SES (birth) 
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C. BMIz7 – basic model + SES (birth) + SES (childhood) 
 
D. BMIz17 – basic model 
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E. BMIz17 – basic model + SES (birth) 
 
F. BMIz17 – basic model + SES (birth) + SES (childhood) 
 
Figure XV Regression diagnostic plots for linear regression models (basic, adjusted for SES (birth) and for SES (childhood)) for 
BMIz at age 7 and 17. 
From left-right and top-bottom: Leverage vs. squared residual plot; residuals vs. predicted values (Yhat) plot, Quintile-
normal plot and Standardize normal probability plot. 
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Figure XVI Regression diagnostic plots for the RT multivariable linear regression models for BMI at age 7 and age 17.  
From left-right and top-bottom: Leverage vs. squared residual plot; residuals vs. predicted values (Yhat) plot, Quintile-




EWAS regression diagnostic plots 
1. Not adjusted for covariates 
 
2. Adjusted for covariates 
 
3. ISVA adjusted model 
 
4. SVA adjusted model 
 
Figure XVII EWAS regression diagnostic plots.  
An example of meffil q-q- plots for each adjustment model (none (1), all (2), ISVA (3) and SVA (4)). The Q-Q plots present 
the distribution of the p value for the association between CpG site methylation and RWG. The straight line is the expected 
distribution under the null hypothesis.  For example, in the ISVA model the locus highlighted in red deviated from the 




1. Not adjusted for covariates 
 
2. Adjusted for covariates 
 
3. ISVA adjusted model 
 
4. SVA adjusted model 
 
Figure XVIII EWAS regression diagnostic plots for RWG cell count sensitivity analysis.  
Q-Q plots of cell counts sensitivity analysis EWAS (age 7) for RWG for each adjustment model (none, all, ISVA and SVA). The 
Q-Q plots present the distribution of the p value for the association between CpG site methylation and RWG. The straight 
line is the expected distribution under the null hypothesis.   
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CpG island and gene associations  
Table XVIII Linear associations between RWG and CpG loci in nearby genes and/or CpG islands in ALSPAC participants (age 
7) 
  RWG   
 CpG loci Coef p R2 
CpGs in island cg24802244 0.00 0.255 0.014 
chr17:17206527-17207306 cg07527330 0.00 0.075 0.004 
 cg21614420 0.00 0.021 0.062 
 cg01379158 0.01 0.001 0.247 
 cg04495270 0.01 0.329 0.035 
 cg08693337 -0.00 0.932 0.131 
 cg09810313 -0.00 0.578 -0.014 
 cg18850434 -0.00 0.777 0.263 
 cg19118161 -0.00 0.771 0.021 
 cg27410828 0.01 0.479 -0.004 
CpGs in island cg02012576 0.00 0.618 -0.012 
chr12:133484658-133485739 cg20307302 0.00 0.431 0.080 
 cg25928819 -0.01 0.235 0.142 
 cg24427504 -0.00 0.612 0.022 
 cg03279164 0.01 0.459 -0.001 
 cg07388347 0.00 0.102 0.170 
 cg08572734 0.00 0.418 0.082 
 cg09831026 0.00 0.192 0.042 
 cg11531579 0.01 <0.0001 0.110 
 cg15607538 0.00 0.182 0.130 
 cg16562275 -0.00 0.288 0.063 
 cg24459893 0.01 0.510 0.217 
CpGs in NT5M cg24802244 0.00 0.255 0.014 
NT5M cg07527330 0.00 0.075 0.004 
 cg21614420 0.00 0.021 0.062 
 cg01379158 0.01 0.001 0.247 
 cg01979266 -0.01 0.203 0.014 
 cg04495270 0.01 0.329 0.035 
 cg08693337 -0.00 0.932 0.131 
 cg09810313 -0.00 0.578 -0.014 
 cg15761954 0.01 0.193 0.128 
 cg18850434 -0.00 0.777 0.263 
 cg19118161 -0.00 0.771 0.021 
 cg27410828 0.01 0.479 -0.004 
Linear regression models with methylation age 7 as the outcome, and RWG as the main exposure. All models are adjusted 
for WBCs, age and sex. Underlined are the significant CpG loci from the EWAS. n=116. R2 is adjusted r-squared. 
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Table XIX EWAS linear associations between significant CpG loci (age 7) and RT in ALSPAC participants  




Estimate SE P value 
With cell counts               
RT cg01379158 116 7 SVA 12 0.0078 0.0025 0.0022 
Without cell counts   
     
RT cg01379158 125 7 SVA 10 0.0065 0.0025 0.0107 
RT cg11531579 125 7 SVA 10 0.0056 0.0028 0.0493 
Models are adjusted for age, sex, SVAs and with or without adjustment for cell counts.  
Estimates represent beta coefficients. n, sample size; SE, standard error; SVA, surrogate variable analysis.   
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Consortium CpG loci featured in sub-analyses 
 
Table XX Consortium CpG loci and associated genes from (Wahl et al., 2016) featured in the candidate gene analysis 
1 cg00094412 GABBR1  95 cg11614585 ANGPT4 





3 cg00138407 KLHL18  97 cg11832534 WRAP73 
4 cg00144180 HDAC4  98 cg11927233 NPM1 
5 cg00238353 PTPRE  99 cg11969813 P4HB 
6 cg00244001 FAM53B  100 cg12484113 AHDC1 
7 cg00431050 ELOVL3  101 cg12593793 LMNA 
8 cg00574958 CPT1A  102 cg12992827 ZPLD1 
9 cg00634542 SLC11A1  103 cg13097800 RPL10L 
10 cg00673344 LINC00880  104 cg13123009 LY6G6F 
11 cg00711896 ZNF48  105 cg13274938 RARA 
12 cg00863378 BBS2  106 cg13591783 ANXA1 
13 cg00973118 AXIN1  107 cg13781414 NACC2 
14 cg01101459 LINC00184  108 cg13922488 PKN1 
15 cg01243823 NOD2  109 cg14020176 SLC9A3R1 
16 cg01511901 UBE2L5P  110 cg14264316 PRRC2B 
17 cg01798813 ZZEF1  111 cg14476101 PHGDH 
18 cg02119938 ACSBG1  112 cg15323828 TMEM63A 
19 cg02286155 SLC34A1  113 cg15357118 UGGT1 
20 cg02560388 LPIN1  114 cg15681239 DLEC1 
21 cg02650017 PHOSPHO1  115 cg15721584 SOX2-OT 
22 cg02711608 SLC1A5  116 cg16163382 CDC42EP3 
23 cg02716826 AQP3  117 cg16578636 PCGF5 
24 cg03050965 S1PR1  118 cg16594806 PHBP3 
25 cg03159676 GSE1  119 cg16611584 AKAP10 
26 cg03318904 TAB1  120 cg16815882 KIAA0319L 
27 cg03327570 ZEB2  121 cg16846518 EEFSEC 
28 cg03433986 BSCL2  122 cg17178175 NFE2L2 
29 cg03523676 CPNE6  123 cg17260706 BCL9L 
30 cg03725309 SARS  124 cg17501210 RPS6KA2 
31 cg03885055 SPATA21  125 cg17901584 DHCR24 
32 cg03940776 SYNJ2  126 cg17971578 STK40 
33 cg03957124 COX6A1P2  127 cg18098839 GOLIM4 
34 cg04011474 RNA5SP89  128 cg18120259 C6orf223 
35 cg04126866 C10orf99  129 cg18181703 SOCS3 
36 cg04232128 TMEM173  130 cg18217136 PPIAP3 
37 cg04524040 CREB3L3  131 cg18219562 MEOX1 
38 cg04577162 RFC2  132 cg18513344 MUC4 
39 cg05063895 SLC9A3R2  133 cg18608055 SBNO2 
40 cg05095590 MAD1L1  134 cg19217955 ACADVL 
350 
41 cg05648472 PRDM11  135 cg19373099 CRYGFP 
42 cg05720226 ST7  136 cg19566658 TRIP6 
43 cg05845030 DCN  137 cg19589396 RPL5P24 
44 cg06012428 ARID1B  138 cg19695507 BEND7 
45 cg06164260 BCL6  139 cg19750657 UFM1 
46 cg06192883 MYO5C  140 cg19881557 RNASE10 
47 cg06500161 ABCG1  141 cg19998073 ZC3H14 
48 cg06559575 IGFBP6  142 cg21108085 CD82 
49 cg06603309 KCNQ1  143 cg21429551 GARS 
50 cg06690548 SLC7A11  144 cg21486834 RHBDF2 
51 cg06898549 CNTN1  145 cg22012981 ACOX2 
52 cg06946797 RMI2  146 cg22103219 SH2B2 
53 cg07021906 SLC7A5  147 cg22488164 PLBD1 
54 cg07037944 DAPK2  148 cg22534374 RPS10P7 
55 cg07136133 PRR5L  149 cg22590032 FLT4 
56 cg07202479 DARC  150 cg22695339 CHD3 
57 cg07471614 LINC00964  151 cg22700686 S100A2 
58 cg07504977 LINC00263  152 cg23032421 IL5RA 
59 cg07682160 UPF1  153 cg23232188 EAF2 
60 cg07728579 FSD2  154 cg24174557 VMP1 
61 cg07769588 ATG4D  155 cg24403644 TOX2 
62 cg08305942 MAF  156 cg24469729 HOXA-AS2 
63 cg08309687 LINC00649  157 cg24531955 LOXL2 
64 cg08443038 CBFA2T3  158 cg24679890 MYO9B 
65 cg08548559 PIK3IP1  159 cg25001190 NFIA 
66 cg08648047 C1orf127  160 cg25096107 IGHA2 
67 cg08726900 ANKRD11  161 cg25197194 EFCC1 
68 cg08813944 CPSF4L  162 cg25217710 BCAN 
69 cg08857797 VPS25  163 cg25435714 RN7SL142P 
70 cg09152259 MAP3K2  164 cg25570328 SULT1C2 
71 cg09222732 EXOC2  165 cg25649826 USP22 
72 cg09315878 SDF4  166 cg26033520 ANAPC16 
73 cg09349128 CRELD2  167 cg26253134 TGFA 
74 cg09554443 CD247  168 cg26357885 HSPA2 
75 cg09613192 FTH1P20  169 cg26361535 ZC3H3 
76 cg09664445 CLUH  170 cg26403843 RNF145 
77 cg09777883 BCO2  171 cg26542660 CEP135 
78 cg10179300 TRIO  172 cg26663590 NFATC2IP 
79 cg10438589 LINC00504  173 cg26687842 LINC00598 
80 cg10505902 PDE4DIP  174 cg26804423 ICA1 
81 cg10513161 ABCC5  175 cg26836479 DEDD2 
82 cg10549088 PRICKLE2  176 cg26878209 SMC3 
83 cg10717869 SLC41A1  177 cg26894079 CLMP 
84 cg10734665 ATP10A  178 cg26952928 SLC45A4 
85 cg10814005 GPR68  179 cg27050612 NFE2L1 
351 
86 cg10919522 ELMSAN1  180 cg27087650 BCL3 
87 cg10922280 DUS2L  181 cg27115863 CARD10 
88 cg10927968 CTSD  182 cg27117792 DRAM1 
89 cg10975897 JARID2  183 cg27184903 APBA2 
90 cg11024682 SREBF1  184 cg27269962 SND1 
91 cg11080651 ROPN1L  185 cg27547344 TIE1 
92 cg11183227 MAN2A2  186 cg27614723 SLCO3A1 
93 cg11202345 LGALS3BP  187 ch.2.30415474F LBH 





Relationship between methylation and adiposity outcomes 
For cg01379158 methylation at age 7 and adiposity outcomes at age 7, there was evidence 
from the results of the ANOVA that at least one pair of means were not equal. There was a 
statistically significant difference between groups as determined by one-way ANOVA 
(F(3,121) = 3.35, p = .017). After all possible pairwise comparisons were performed, a 
Bonferroni post-hoc test revealed that DNAm was statistically significantly higher in those 
who had RWG and were OWOB (age 7) (2.2% increase, p = .049) compared to those who did 
not have RWG and were a healthy weight (age 7) (Figure XIX, left). There was no statistically 
significant difference between the other groups or for outcomes at age 17 (Figure XIX, right).   
As samples sizes for some categories were small, there is reduced likelihood of observing 
significant differences, and therefore whilst these results give an indication of methylation 
patterns, they are not conclusive. 
Table XXI Descriptive characteristics of CpG (cg01379158) methylation (age 7) by phenotype (at ages 7 and 17) in ALSPAC 
participants  
Groups  n Mean SD Median Min Max 
Age 7  
      
Healthy weight No RWG 74 0.069 0.017 0.068 0.033 0.125 
RWG 35 0.078 0.025 0.076 0.033 0.149 
OWOB No RWG 10 0.075 0.021 0.071 0.042 0.106 
RWG 6 0.091 0.019 0.090 0.064 0.114 
 Total 125 0.073 0.021 0.073 0.033 0.149 
Age 17  
      
Healthy weight No RWG 39 0.071 0.017 0.071 0.039 0.103 
RWG 26 0.078 0.026 0.077 0.033 0.149 
OWOB No RWG 13 0.067 0.016 0.062 0.042 0.106 
RWG 6 0.088 0.024 0.083 0.056 0.118 
 Total 84 0.074 0.021 0.073 0.033 0.149 




Figure XIX Box plots of methylation level (age 7), RWG and OWOB (age 7 (left), age 17 (right)).  
* indicates PBonf<0.05. Differences between groups were non-significant at age 17.   
 
For cg11531579 methylation at age 7 and adiposity outcomes at age 7, there was evidence 
of a statistically significant difference between methylation and the phenotype groups (χ2  
(3)=14.556, p 0.002). Correcting for multiple comparisons revealed that the differences were 
between no RWG and healthy weight and a comparative small increase in methylation in 
those who had RWG and were healthy weight (p=0.04)(Figure XX, left). Also, compared to 
those with no RWG and healthy weight, those with RWG and OWOB had a notably higher 
methylation (+2%, p=0.003), however there were few in this group (n=6). 
 
Table XXII Descriptive characters of CpG (cg11531579) methylation (age 7) by phenotype (at ages 7 and 17) in the ALSPAC 
cohort 
Groups  n Mean SD Median Min Max 
Age 7              
Healthy 
weight 
No RWG 65 0.036 0.011 0.034 0.016 0.084 
RWG 35 0.045 0.020 0.039 0.020 0.118 
OWOB 
No RWG 10 0.039 0.011 0.041 0.024 0.054 
RWG 6 0.057 0.013 0.059 0.042 0.075 
  116 0.040 0.016 0.036 0.016 0.118 
Age 17        
Healthy 
weight 
No RWG 47 0.037 0.012 0.035 0.023 0.084 
RWG 28 0.041 0.014 0.037 0.020 0.086 
OWOB 
No RWG 18 0.036 0.010 0.035 0.016 0.054 
RWG 9 0.059 0.027 0.057 0.025 0.118 
 Total 102 0.040 0.015 0.036 0.016 0.118 
n, total in each group; SD, standard deviation; min, minimum; max, maximum. Testing the assumptions of the ANOVA 
indicated that there was a slight positive skew in the residuals. Furthermore, Levene’s test statistic (to test for homogeneity 
of variances) was significant; therefore, variances were not equal. This was true when analysing adiposity outcomes in both 
childhood and adolescence. Instead, the non-parametric KW test was used to assess group differences, plus Dunn’s test with 




For methylation at age 7 and adiposity outcomes at age 17, there was evidence from the 
results from the KW test that there was a statistically significant difference between 
methylation and the phenotype groups (χ 2  (3)=8.735, p 0.033). Correcting for multiple 
testing revealed that there was a statistically significant difference between RWG and OWOB 





Levene’s test statistic; F(3, 112) =  3.55, p= 0.017 Levene’s test statistic; F(3, 98)=3.04, p= 0.033 
Figure XX Boxplots of childhood methylation and adiposity outcomes in childhood and adolescence.  
The tests for significance (p values) from the KW test with Bonferroni correction for multiple testing.  
 
Overall, methylation was consistently higher in those who were OWOB and experienced 
RWG, compared to those who did not experience RWG and were a healthy weight, at both 
time points. In those that had RWG, there is the potential that methylation at this CpG site 
may be able to act as a predictive biomarker of subsequent OWOB (Figure XXI); those who 
had RWG and were OWOB at age 7 or age 17, had higher methylation. Furthermore, those 
who were healthy weight at age 7, but then became OWOB at age 17 had higher 
methylation at age 7. Although this included few study members (n=6), methylation at age 7 
could have indicated future risk of OWOB in this group.  
Whereas, those who had RWG but were a healthy weight at age 7 and 17, had consistently 






RWG regardless of weight status. Sample sizes are for those with complete data at that time 
point. Group sizes were small for some phenotypes. 
 
Figure XXI Pathways of mean methylation levels (%, age 7) and body composition (at ages 7 and 17).  













































Additional laboratory methods  
 
Table XXIII Primers designed for examination of the 2 Significant CpG loci in the NTFS samples 
CpG site Direction Size 
(bp) 
Tm Sequence 
cg11531579 Forward 25 49.5 AGTTTTTGTGGAAATTTAGAAGTAA  
Forward (IUPAC) 25 49.5 RGTTTTTGTGGAAATTTARAAGTAA   
Reverse (bio) 20 52.3 AACCAACCCCATCCTAAATC  
Sequencing 15 38.2 TTTTTTGGGAATGAA 
cg01379158 Forward  17 42.7 GGAGGAGAAGTTTTTAA  
Forward (IUPAC) 17 41.5 GRAGGAGAAGTTTTTAA  
Forward (IUPAC 3' edit) 17 41.9 GRAGGAGAAGTTTTTAR  
Reverse (bio) 27 46.7 CCATAATAATCRATACAATAAAAAAAA  
Sequencing 15 38.0 YGTTTTTAGAAGGTT 
All primers are in the 5’3’ direction. If the original primers failed, they were redesigned with IUPAC ‘wobble’ base pairing 






Figure XXII Gel electrophoresis image for the cg11531579 assay. 
Gel image for the temperature gradient PCR for cg11531579 performed using HEK cell-line bsDNA.  
NTC, no template control. 
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Examining the relationship between RWG, DNAm and body composition in NTFS 
Within either the OWOB or healthy weight categories, there were differences in CpG3 
methylation levels between those who had/did not have RWG (p<0.1) (Figure XXIII). There 
were no significant differences observed for CpG 1 or 2. 
 
No RWG RWG No RWG RWG No RWG RWG No RWG RWG 
Healthy weight OWOB Healthy weight OWOB 
Figure XXIII Box plots of DNA methylation by phenotype groups.  
Kruskal-Wallis p value shows differences across groups. There were no significant differences at p<0.05 between groups 
(Bonferroni adjusted using Dunn's Pairwise Comparison), however differences were observed at p<0.1.   
 
Similar to results for body composition at age 50, those who had RWG and were subsequent 
OWOB (age 60) had the lowest levels of methylation (Figure XXIV). However, overall there 
were no significant differences between groups (Kruskal-Wallis, χ2(3) = 5.507, p = 0.14). 
There were no significant differences for CpG 1 or 2.  
 
 Mean methylation  Cpg3 methylation 
 Healthy weight  OWOB 
  Healthy weight  OWOB  












N 39 19  38 36 132  39 19  38 36 132 
p50 3.05 3.4  3.46 2.19 3.08  3.24 2.98  3.16 1.22 2.53 
min 0 0  0 0 0  0 0  0 0 0 
max 95.46 69.53  
65.1
2 
50.09 95.46  91.27 66.01  64.28 45.28 91.27 
p25 1.22 0  1.18 0 0.97  0.85 0  0.91 0 0 
p75 5.81 4.28  7.96 5.1 5.18  4.5 4.02  7.25 3.78 4.42 




Age 60 Cpg3 
 Healthy weight 
 OWOB  
 No RWG RWG  No RWG RWG Total 
N 16 10  38 27 91 
p50 2.81 1.80  3.16 1.41 2.42 
min 0 0  0 0 0 
max 5.32 4.02  91.27 45.28 91.27 
p25 1.47 0  0.98 0 0 
p75 4.36 3.53  7.64 4.01 4.45 
p value 0.14 
Figure XXIV Box plot for CpG3 methylation (age 50) by RWG and subsequent adiposity outcomes (age 60).  
The tests for significance (p values) from the Kruskal-Wallis test with Bonferonni correction for multiple testing. 
The Kruskal-Wallis test for differences between groups was non-significant overall, χ2(3) = 5.507, p = 0.14. 
 
  
No RWG RWG No RWG RWG 
Healthy weight OWOB 
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Examining the relationship between DNAm and body composition in those who had RWG  
Methylation was investigated further with respect to body composition only in those who 
experienced RWG in infancy, as this was the ‘exposed’ group in which differences in 
methylation were previously observed (in the ALSPAC cohort). There were no significant 
associations between DNAm and body composition in those who had RWG (Table XXIV). 
 
Table XXIV Logistic/linear regression models for weight outcomes (age 50) and DNAm (age 50), investigated only in those 
who had infancy RWG 
 
OB OWOB BMI 
  
 
coef CI p coef CI p coef CI p           
Mean methylation 0.97 [0.88,1.07] 0.57 0.99 [0.95,1.04] 0.72 0 [-0.10,0.10] 0.94 
Cpg1 0.93 [0.77,1.13] 0.48 0.99 [0.94,1.04] 0.63 -0.02 [-0.12,0.08] 0.72 
Cpg2 0.98 [0.92,1.06] 0.68 1 [0.95,1.04] 0.86 0 [-0.09,0.10] 0.96 
Cpg3 0.98 [0.90,1.07] 0.61 0.99 [0.94,1.04] 0.69 0.01 [-0.10,0.11] 0.92 
Weight outcome was the dependent variable and DNAm the independent variable. Healthy weight was the reference 
category for the OWOB and OB logistic regression models. Only in those who had infancy RWG. Adjusted for sex. n=55. 




NTFS samples (age 50) sequence traces 
 A B C 
pos90   
 TFS55, G TFS59   A/G TFS270   A>G 
Low 
   
 TFS314, A TFS296,  A/G TFS152, likely G 
High 
   
pos339   
 TFS55, C TFS59, C TFS270, C    
Low 
   
 TFS314 (C>T) TFS296 TFS152, C/T 
High 




pos424    
 TFS55 TFS59 TFS270 
Low 
   
 TFS314 TFS296 TFS152 
High 
   
Figure XXV SNP patterns in sequenced matched samples. 
There were differences observed at positions (pos) 90, 339 and 424 for matched pairs of high and low methylation. In these 
samples, there were SNP differences between high and low methylation in matched pairs A and C. These pairs 
demonstrated similarities in that they had RWG and a higher BMI, contrary to pair B which did not exhibit differences 






Linkage disequilibrium  











               rs4758916 
               C       T 
             ----------------- 
           A | 123   | 2     | 125   (0.687) 
rs2873193    ----------------- 
           G | 54    | 3     | 57    (0.313) 
             ----------------- 
               177     5       182 
              (0.973) (0.027) 
 
          A_C: 123 (0.676) 
          G_C: 54 (0.297) 
          G_T: 3 (0.016) 
          A_T: 2 (0.011) 
 
          D': 0.4176 
          R2: 0.0108 
      Chi-sq: 1.9662 
     p-value: 0.1609 
 
rs2873193 and rs4758916 are in linkage equilibrium 
 
Figure XXVI LDlink output for the SNPs in the region of interest for cg11531579 for European populations.  
The image output shows the chromosomal location and proximity of the SNPs, and the text output indicates there is no 
correlation between them (R2=0.01). The Χ2 and p-value (=0.16) indicate that the haplotypes do not deviate from the 
expected values and therefore there was no evidence of linkage disequilibrium.  
 
RS_number rs2873193 rs4758916 
rs2873193 1.0 0.095 
rs4758916 0.095 1.0 
